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ABSTRACT 
Introduction: The participation profile of patients with chronic obstructive pulmonary disease 
(COPD) in pulmonary rehabilitation (PR) and the effectiveness of a video-based home exercise 
programme (VBHEP) were investigated using various research methods. 
Methods: The content analysis of the Move-On-Up exercise video against NICE guidelines and 
published research was performed. The video was evaluated for its suitability for use in VBHEP 
through focus groups involving UK population of patients with COPD and respiratory clinicians. 
Using the data from the content analysis and the focus groups, questionnaire items were 
synthesised for a national survey of both patients and clinicians. 
A study examined the relationship between participation in outpatient PR and patient measures 
of depression (Brief Assessment Depression Card), social support (Duke Social Support Index), 
multidimensional health locus of control (MHLC) and COPD severity (Medical Research Council 
dyspnea score). 
A randomised control trial (RCT) evaluated the effect of combining VBHEP and conventional 
outpatient PR on walking ability and PR benefit maintenance. The intervention arm received 
VBHEP concurrently with outpatient PR, while the control arm received only outpatient PR. 
Outcome measures included: the endurance shuttle walk test (ESWT), quality of life (QoL) (St 
George’s Respiratory Questionnaire- SGRQ), MHLC and a modified Follick's activity diary. 
Measures were taken before PR, at the fourth and eighth weeks of PR and at six months post-PR.  
Focus groups were conducted between six and 20 months post-PR to evaluate patients’ 
experience of and adherence to the use of VBHEP. 
Results: Critical review of 46 RCTs aided evaluation of the video demonstrating that the video 
content was consistent with both NICE recommendations and published research. The six focus 
groups that were part of the initial evaluation of the video involved 14 patients and 14 
clinicians. The national survey generated responses from 60 patients and 62 clinicians; between 
79 and 100% of respondents in each domain of the questionnaire indicated that the video is 
suitable for use. 
Fifty-one patients completed the study investigating the profile of patients participating in PR. 
The results indicated that depression has a moderate and negative statistically significant 
association with the uptake of PR (p<0.05). 
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Fifty-seven patients participated in the RCT [mean age 66.51 years (SD 9.96), mean FEV1% 
predicted 54.51% (SD 10.47)]. The results indicated that the use of VBHEP with outpatient PR 
has no significant additive effect in improving or maintaining the benefits of walking ability 
following PR (p<0.05). 
Seven patients participated in the follow-up focus groups where findings suggested that 
patients were still participating in VBHEP up to 20 months after it was first prescribed, though 
the frequency of its use appeared to diminish after PR ended. 
Conclusion: The Move-On-Up exercise video is suitable for VBHEP in patients with COPD. 
Patients with COPD and depression are less likely to take up a referral to PR compared to those 
without depression. The use of VBHEP concurrently with PR has no additive effect in improving 
or maintaining benefits of walking ability following PR. Adverse social circumstances and 
disease severity reduce the duration of participation in VBHEP.  
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CHAPTER ONE - INTRODUCTION 
1.1 CONTEXT 
Chronic obstructive pulmonary disease (COPD) is characterised by progressive airway 
limitation with an inflammatory response of the lungs (Hunter, & King, 2001; Lapperre et al., 
2004). COPD is not completely reversible and does not change markedly over several months 
(National Institute for Health and Clinical Excellence [NICE], 2010). Shortness of breath at rest 
and during activities of daily living (ADL) can lead to an increasingly sedentary lifestyle, a 
progressive deterioration in functional capacity, and possible isolation at home (Ries et al., 
2007).  
A randomised controlled trial (RCT) (Sewell, Singh, William, Collier & Morgan, 2006) (n=100, 56 
males, mean age 70 years, mean FeV1=1.13litre/minute) indicated that a four week pulmonary 
rehabilitation (PR) programme is effective in improving walking ability in patients with COPD. 
The authors compared the effectiveness of a four-week PR programme of twice-weekly 
attendance at supervised exercise sessions to that of seven weeks of twice-weekly supervised 
PR sessions. Participants in both arms were assessed at the fourth and seventh weeks of study, 
and the sixth month post-PR. Though participants in both arms of the trial demonstrated a 
clinically significant increase in the endurance shuttle walk test (ESWT) score at the seventh 
week of study, those who participated in the four-week supervised PR programme 
demonstrated a greater and more significant (p=0.02) improvement in ESWT compared to 
those who participated in seven-week supervised PR programme. Assessment at the sixth 
month post-PR indicated no significant difference in ESWT between the two arms. The IMPRESS 
guidelines for PR, jointly published by the BTS and the Primary Care Respiratory Society-UK 
(PCRS-UK), assert that the UK average attendance of PR by patients is less than 50%. The 
guideline defined completers of PR as patients who attend at least four out of six weeks of 
twice-weekly exercise programme and evidence suggests that benefits from PR would have 
been achieved at four weeks (Sewell et al., 2006). 
Outpatient PR service can be provided as a ‘cohort’ PR programme or ‘rolling’ PR programme. 
The experience of the author as a PR physiotherapist for about ten years suggests that a high 
proportion of patients who are referred to PR programmes either fail to uptake or complete the 
programme. This observation is consistent with literature (Garrod et al., 2006; Singh et al., 
1998; Young et al., 1999).  
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Steurer-Stey, Dallalana, Jungi and Rosemann (2012) reviewed data from six international COPD 
guidelines (Australian, Canadian, German, Swiss, New Zealand, United Kingdom and the global 
initiative on obstructive lung disease [GOLD]) to identify elements of COPD care with Level II 
evidence and above in at least three of the guidelines. Steurer-Stey et al. (2012) define such 
elements of care as international benchmarks. Evidence Level II describes evidence based on 
only a few RCTs or RCTs that are small in size or were undertaken in a population that diﬀers 
from the target population of the recommendation or with results that are somewhat 
inconsistent (Lawrence, Mickalide, Kamerow & Woolf, 1990). Steurer-Stey et al. (2012) 
compared data on COPD management in Swiss primary care to the recognised international 
benchmarks, which included inclusion criteria for COPD. They identified that only about 19% of 
patients with severe COPD were referred for PR.  
Johnston, Grimmer-Somers, Young, Antics and Frith (2012) interviewed an Australian 
population of 15 patients (mean age =76 years, FEV1 predicted =58%) and nine doctors. The 
authors suggested that comorbities, problems of access and low awareness of health gains 
among some health professionals were barriers to uptake of PR by patients with COPD.  
A study by Jacobson, Rusch, Frølich, Andersen and Godftredsen (2013) compared 118 patients 
(who completed their PR between 2005 and 2007) to 3,474 individuals on the Danish National 
COPD Patient Register who were not enrolled in PR. The study concluded that patients who 
completed their rehabilitation were more likely to be women, of higher socioeconomic status 
and more dependent on COPD-specific medication. However, the study by Jacobson et al. (2013) 
was a retrospective analysis of the Danish National COPD Patient Register and a direct 
assessment of participants’ mood and depression status was not conducted.  
Singh, Smith, Hyland and Morgan (1998) described patient participation in their rolling 
outpatient PR programme. The programme required twice-weekly attendance for seven weeks, 
with each session lasting two hours. Each exercise group size was limited to maximum of eight 
patients and each education session was ‘sandwiched’ between two exercise groups. Singh et al. 
(1998) observed that of the 267 patients who were referred, 208 attended initial assessment, 
170 commenced PR and only 138 (52% of those referred) completed PR. The authors stated 
that participants gave various reasons for non-completion, including travel difficulties and 
infective exacerbations. 
Young, Dewse, Fergusson and Kolbe (1999) reported that of the 91 patients with COPD who 
were referred for PR, 30 refused to participate after an initial assessment which included the 
six-minute walk test. Six patients started PR but did not complete, while 55 patients (60.4% of 
those initially assessed) completed PR. The rehabilitation programme by Young et al. (1999) 
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involved attendance of a total of seven two-hourly sessions over a period of one month. The 
authors did not state whether their programme was of ‘rolling’ or ‘cohort’ protocol. Young et al. 
(1999) (n=91) identified social support as a significant predictor of drop-out from PR 
(p=0.001). 
Garrod, Marshall, Barley and Jones (2006) described that out of 111 patients with COPD who 
were referred to their rolling PR programme, 74 attended an initial assessment while 51 (46% 
of the total number invited for PR) completed PR. Garrod et al. (2006) identified that quadriceps 
strength, smoking pack-years, SGRQ score and depression each significantly correlates with 
drop-out from PR (p<0.05).  
The IMPRESS guideline for PR (2011) recommends an attendance of a minimum of four weeks 
of twice-weekly PR sessions. The programme protocols by Garrod et al. (2006) and Singh et al. 
(1998) appear to be consistent with this attendance recommendation. The attendance of seven 
PR sessions in the programme by Young et al. (1999) suggested that the participants in the 
study who were described as completers may have attended a number of PR sessions that was 
less than that recommended by the guideline.  
Kirscht (1972) surveyed 335 healthy individuals to identify any relationship among beliefs 
about personal control over events or health control, perceptions of disease and health-related 
practices. Analysis of the responses demonstrated an association between expectancy for 
control and beliefs in the effectiveness of actions, and between health control and taking action. 
Kirscht (1972) suggested that expectancy for control of health relates to experiences from past 
efforts and the wish to repeat the efforts in the future, while locus of control relates to a 
conviction that well-being can be achieved by one’s own contribution or by a contribution 
outside oneself. There is a need to examine whether the health locus of control of patients with 
COPD influences their uptake of and participation in outpatient PR. 
Bevan-Smith (2008) administered the Malvern pulmonary rehabilitation motivation 
questionnaire (MPRMQ) to a UK population of patients with COPD (n=77). Fifty-one of the 
participants were embarking on an eight-week PR programme that involved twice-weekly 
attendance, while 26 had previously attended a PR programme. Forty-one of the 51 patients 
who embarked on PR completed the programme while ten did not. The author identified that 
motivation correlated negatively with dropping out of PR. Bevan-Smith (2008) described 
domains of motivation as essential motivation (attitude, incentive and stamina/tenacity) and 
external motivation (family support, perceived effectiveness of intervention, goal setting, 
recreational activity, attending PR group sessions, concern about deterioration of condition, 
coping skill, symptom variability).  
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Altogether, the literature has established that the uptake and completion of PR in patients with 
COPD is a significant problem and suggest that patients’ baseline disease, psychosocial and 
health control beliefs may influence drop-out from PR. The literature has established that the 
uptake and completion of PR in patients with COPD is a significant problem and suggest that 
patients’ baseline disease, psychosocial and health control beliefs may influence drop-out from 
PR. In spite of the available evidence, the relationship between uptake of PR and each of 
baseline disease, psychosocial and health control beliefs is unknown. The current practice is to 
assess the psychosocial status of patients with COPD at the initial PR assessment, which is the 
first visit to the clinic (Garrod et al., 2006; Young et al., 1999). It may be important to assess the 
status of a patient earlier and identify whether it influences attendance at the clinic 
appointment or if any support is required to increase the chances of attending the first clinic 
appointment. Determining factors that influence participation in PR, including uptake and 
completion, may inform an adaptation of PR programmes to better meet patients’ needs. This 
area is explored in the research programme detailed in this report.  
The benefits of PR are estimated to have dissipated between six and twelve months post-PR. An 
RCT by Ries et al. (1995) (n=119) indicated that, in comparison to patients who participated in 
an eight-week education programme only, patients who participated in an eight-week PR 
programme (followed by monthly exercise sessions up to one year post-PR) demonstrated 
modest but non-significant differences in survival (67% versus 56% [P = 0.32]) and length of 
hospital stay (-2.4 days per patient per year versus +1.3 days per patient per year [P = 0.20]).  
Finnerty, Keeping, Bullough and Jones (2001) randomised 100 patients to receive either six 
weeks of twice-weekly outpatient PR sessions or only routine medical outpatient review. In 
addition to six-week PR, participants in the PR group were also offered “drop-in” exercise 
sessions at the eight, ninth and tenth weeks of study. The PR arm demonstrated a significantly 
higher improvement in QoL (St Georges Respiratory Questionnaire [SGRQ]) change of 10.4 
points (confidence interval [CI] = 3.6 to 17.3) at 12 weeks and 8.1 points (CI = 1.4 to 14.9) at 24 
weeks (p <0.05) of study. The minimum clinically important difference (MCID) in SGRQ score 
following PR is a change of 4 units.  
An RCT by Bestall et al. (2003) investigated whether the improvement in exercise tolerance and 
health-related QoL following PR was maintained one-year post-PR. Sixty-six patients with 
moderate COPD were randomised to either education alone or eight-week outpatient PR and 
once-monthly follow-up exercise sessions for a year. Compared to the education-alone group, 
participants in the PR group demonstrated significantly higher improvements in exercise 
tolerance and QoL (p<0.05) at the end of the eight weeks of PR and the significant between-
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group difference was maintained at  the sixth month post-PR in exercise tolerance and QoL. At 
the 12th month post-PR, the between-group difference in QoL was no longer significant. Bestall 
et al. (2003) indicate that at the 12th month post-PR, both groups demonstrated a decline in 
exercise tolerance but the PR group maintained a significantly greater exercise tolerance. 
 
It is important to investigate protocols of PR that can increase the benefits of the programme 
and improve the maintenance of these benefits. A large RCT (n=214) indicated that 
participation in video-based exercise at home is more effective than medical management alone 
in improving QoL in patients with COPD (Petty et al., 2006). However, the drop-out rate from 
the study was 18.7% and there was no intention-to-treat analysis. Pfizer, the Association of 
Physiotherapists in Respiratory Care (ACPRC) and the St George’s School of Physiotherapy 
developed an exercise video called Move-On-Up and suggested its use in the treatment of 
patients with COPD (ACPRC, 2006). However, the developers did not indicate at what stage in 
the COPD care-pathway (pre-outpatient PR, during outpatient PR or post-outpatient PR) the 
video-based exercise programme should be introduced. 
Part of the research project detailed in this dissertation investigated whether the use of an 
exercise video at home concurrently with outpatient PR is more effective than outpatient PR 
alone in improving walking ability and quality of life at the end of outpatient PR and in 
maintaining any significant benefit at six months post-outpatient PR. The study also 
investigated whether, in comparison to outpatient PR alone, participation in video based home 
exercise programme (VBHEP) concurrently with outpatient PR would result in a significant 
difference in change in health locus of control (HLC) at the end of outpatient PR and at six 
months post-outpatient PR. The findings from the study could inform PR guidelines and make a 
significant contribution to knowledge.  
In order for PR and VBHEP regimens to be effective, patients’ compliance is required. Earnest 
(2002) (n=27, male=13, mean age=69 years) administered SGRQ, Brief Symptom Inventory and 
semi-structured interviews to explore the factors that influence compliance with the use of 
oxygen in patients with COPD. Data from the study indicated that a sense of social stigma, poor 
symptom control and lack of perceived benefit influence compliance with oxygen therapy. 
Observational studies of patients with obstructive sleep apnoea by De Zeeuw et al. (2007) 
(n=85) and Wild, Engleman, Douglas and Espie (2004) (n=119) indicated that self-efficacy and 
locus of control influence the use of continuous airway positive pressure (CPAP). It is not known 
if locus of control affects compliance with VBHEP. Evidence of factors that affect compliance 
with VBHEP in patients with COPD is lacking. An understanding of the relationship between 
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compliance with VBHEP and physical, disease and psychosocial (depression, social support, 
health locus of control) factors each would benefit practice and this was investigated in the 
research programme detailed in this thesis. 
 
1.2 OVERVIEW 
The PhD research programme explored the relationship between participation in PR and 
specific psychosocial and disease factors in patients with COPD. It also examined the use of 
VBHEP concurrently with outpatient PR in patients with COPD and the effects on benefits of PR 
and on drop-out from outpatient PR. The research programme also investigated factors that 
affect participation in VBHEP in patients with COPD.  
COPD comprises a major healthcare burden. Chapter 1 continues by exploring these issues, 
including the current evidence base in the management of patients with COPD, the use of video-
based intervention and the areas where there are gaps in the knowledge base. The chapter 
introduces the scope of this research. 
Chapter 2 is a critical review of the various outcome measures and screening tools which have 
been used in the previous studies that have investigated the effectiveness of different 
interventions in the management of patients with COPD. The chapter also discusses the uptake 
and completion of PR by patients with COPD. 
Chapter 3 reports the content analysis of an exercise video (Move-On-Up) using the most recent 
COPD NICE guideline that was available as at the time of evaluation of the video (NICE guideline 
CG12 of 2004), and RCTs published between May 2003 and August 2008. The analysis of the 
literature and clinical guidelines informed the structure and the content of the focus groups 
(Chapter 4) and questionnaire survey (Chapter 5) that evaluated the video.  
The focus group reported in chapter 4 evaluated whether the video met the expectations of 
patients with COPD and respiratory clinicians (with regards to the desired content of a PR 
programme) based on their experience and estimations. The focus groups were conducted in 
two regions of England (London and the East of England) and ensured early user involvement in 
the research process, during which additional questionnaire items were synthesised towards 
the nationwide review of the video by the use of questionnaires. 
The data from the content analysis of the video (Chapter 3) and the focus groups (Chapter 4), 
was used to synthesise questionnaire items and set the stage for a national survey reported in 
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Chapter 5. Chapter 5 considers the nationwide evaluation of the video, which was the final stage 
of its content analysis. Questionnaires were completed by respiratory clinicians and patients 
with COPD to evaluate the suitability of the Move-On-Up video for VBHEP as adjunct to 
outpatient PR for patients with COPD in the UK.  
Chapter 6 of this thesis details the findings of the investigation into the relationship between 
participation in outpatient PR (including uptake and completion) and various disease and 
psychosocial factors including depression, social support and health locus of control.  
The results from this programme of research up to Chapter 6 suggested the following: 
 A high non-uptake and drop-out rate in outpatient PR.  
 That the Move-On-Up exercise video is suitable for VBHEP as an adjunct to outpatient PR 
for patients with COPD. 
 There is a need to explore an alternative protocol of PR which may reduce drop-out 
from outpatient PR. 
  There is also a need to explore an alternative protocol of PR which may enhance the 
benefits of PR and the maintenance of such benefits. 
All of the above set the stage for the stratified randomised control trial (SRCT) that followed. 
Primarily, the SRCT investigated the effectiveness of VBHEP, when used concurrently with 
outpatient PR, in improving walking ability and maintenance of benefits of walking ability when 
compared with outpatient PR alone in patients with COPD. Chapter 7 reports the findings of the 
SRCT. 
Chapter 8 recounts the findings of the focus group study that followed the SRCT in order to 
explore the experience of patients with COPD who used VBHEP concurrently with outpatient 
PR. It explored patients’ estimation of whether the VBHEP met their expectations, and whether 
the VBHEP enhanced attendance at outpatient PR and participation in prescribed self-directed 
exercise at home (during the eight weeks of outpatient PR and post-outpatient PR). 
The analysis and the integration of the findings from the various studies in the research project 
and areas of additional research needs are considered in Chapter 9. The chapter relates the 
findings from this PhD project to the existing evidence base in practice and emphasises the 
original contributions to knowledge in the following areas: 
 Depression as a risk factor in the non-uptake of PR. 
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 The effectiveness of VBHEP when used concurrently with outpatient PR, in improving 
walking ability and the maintenance of the benefits of walking ability at six months post-
PR in patients with COPD, compared to outpatient PR alone. 
 Patients’ experience and participation in VBHEP when used concurrently with 
outpatient PR.  
 
1.3 INCIDENCE OF COPD, BURDEN ON HEALTHCARE SYSTEM AND 
OUTLINE OF MANAGEMENT 
A survey conducted between 1993 and 2001 estimated prevalence of COPD to be 4.1% of the UK 
population (Frank, Hazell, Linehan, Morris, & Frank, 2007). Nacul, Soljak, and Meade (2007) 
developed a mathematical model from cross-sectional data on spirometry and risk factors of 
COPD from a sample (n=10,750, men= 5,269, aged between 30 and 80 years) representative of 
the population in England and estimated prevalence of COPD in England to be 3.1%. A 
consensus statement of the European Respiratory Society (ERS) estimates that about 75% of 
cases of COPD remained undiagnosed (Siafakas et al., 1995). 
About 24 million working days in the UK are lost annually to COPD with the cost to productivity 
being estimated at around £2.7 billion (NICE, 2010). COPD is the cause of one in every eight 
emergency admissions in the UK, making it the second largest cause of emergency admissions in 
the UK (British Lung Foundation, 2007; Healthcare Commission UK, 2006). In 2010 in England, 
the NHS spent around £850m to £900m on COPD (Lomas, 2010). 
 
1.3.1 PATHOPHYSIOLOGY OF COPD 
COPD comprises three related conditions: chronic asthma, chronic bronchitis and emphysema 
(British Medical Association, 2002; NICE, 2010). Chronic asthma features a state of lung 
remodelling in which the airway obstruction remains fixed (which makes chronic asthma differ 
from acute asthma in which the airway obstruction is usually reversible between attacks). 
Chronic bronchitis manifests itself with a prolonged inflammation of the mucous membrane of 
the bronchial tree. Emphysema usually starts with small airway disease and progresses to 
alveolar destruction, airway narrowing and mucous gland hyperplasia. Chronic bronchitis and 
emphysema may manifest together (Hunter & King, 2001; Lapperre et al., 2004). COPD mainly 
affects the distal airways with hyper-secretion that compromises the clinical and the 
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pathophysiological function of the airways and alveoli, including ventilation-perfusion efficiency 
(Barnes, 2000).  
Vascular remodelling of the pulmonary arteries in patients with COPD results in the right 
ventricle pumping against an abnormally high pressure within the pulmonary artery, which 
branches into the right and left lungs and its subsequent enlargement and strain (cor 
pulmonale) (Peinado et al, 1999). This results in peripheral oedema. 
Skeletal muscle dysfunction in COPD is due to muscle disuse atrophy, deconditioning, 
malnutrition, hormonal deregulation, prolonged hypoxemia and electrolyte imbalance and the 
muscles of ambulation are more severely affected. This compromises independence and results 
in a reduced quality of life (QoL) (Casaburi, 2000; Donaldson, Maddocks, Martolini, Polkey, & 
Man, 2012; van den Borst et al., 2012). 
The shortness of breath at rest and during ADL can lead to a progressive decline in functional 
capacity, an increasingly sedentary lifestyle, and potential isolation at home (ACSM, 2002)  
 
1.3.2 OVERVIEW OF MANAGEMENT OF COPD AND PULMONARY 
REHABILITATION 
The management of COPD involves smoking cessation advice if applicable, an optimal 
medication regimen, PR, oxygen supplementation and surgical intervention (NICE, 2010).  
Smoking cessation  
Lou et al. (2014) (n=179, mean age=35.6 years) indicated a positive association between 
exposure to second-hand smoking and diagnosis of COPD, and between pulmonary symptoms 
and smoking (p<0.05). Being a current smoker and depression were indicated to increase the 
risk of death by 3.8 times (odds ratio 3.78, 95% CI=2.51-5.05). Population attributable factor 
estimation suggests that smoking cessation would reduce the absolute risk of the incidence of 
COPD in China by 56% in men and 63% in women by 2033 (Lin, Murray, Cohen, Colijn, & Ezzati, 
2008). NICE (2010) recommends discussing benefits and available support of smoking 
cessation with patients with COPD who are currently smoking. The spontaneous quit rate in 
patients is 2% and support from clinicians increases the quit rate to 4-6%, while the inclusion of 
nicotine replacement therapy (NRT) or the anti-depressant, bupropion (or a combination of 
NRT and bupropion) increases this rate to 20% (Rennard, 2004; Sutherland & Cherniack, 2004). 
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Medical respiratory drugs  
The main functions of the respiratory system include the gas exchange between the lungs and 
the blood, acid-base balance, the evaporation of water in the airways (which helps in regulating 
body temperature), metabolism, speech and defence of the body (Cremona et al., 2011; 
Morrison & Nakamura, 2011). A mild degree of voluntary control on reflex breathing can be 
achieved by the connections between the cortex and the motor neurones that supply the 
respiratory muscles (Adams & Severns, 1982; Guyton & Walls, 2000). Medical respiratory 
drugs can be used in the treatment of cough and secretion clearance, exacerbation and infection 
management, relief of inflammation, relief of breathlessness and ventilation management. 
Cough mixture contains a combination of antitussives, expectorants, mucolytics and sedatives. 
Antitussive drugs act on the central nervous system (CNS) in one of three ways: through the 
medullary path of cough reflex, through the cerebral cortex or through a sub-cortical path 
(Carlisle, 2012; Kliachkina  & Dmitriev, 2012). A systematic review of RCTs (published until 
2012) that compared oral mucolytic therapy with placebo for a minimum of two months in 
adults patients with COPD (30 RCTs, n=7,436 participants) identified that the use of mucolytics 
resulted in a small reduction in the number of exacerbations per year (0.48) and number of days 
of disability per month (0.48). No clinically significant change in lung function was observed 
(Poole, Black, & Cates, 2012). Side effects of mucolytics could include bleeding from the 
gastrointestinal tract (BNF, 2014; Carlisle, 2012). 
Diuretics are recommended in cor pulmonale for managing water and salt retention (NICE, 
2010). This reduces the cardiac workload due to the pulmonary oedema, but it does not stop the 
progression of the disease (Laurence, Bennett, & Brown, 1997). Side-effects of diuretics include 
mild headache, gastro-intestinal disturbances, postural hypotension and cardiac arrhythmias 
(BNF, 2014). 
Antibiotics are used in the treatment of infective exacerbations (acute worsening of symptoms) 
in patients with COPD (NICE, 2010, p. 351). A systematic review of RCTs published between 
1966 and 2005 (11 trials, n= 917 patients), which compared antibiotics and placebo in patients 
with COPD indicated that antibiotic therapy, regardless of choice of antibiotic, significantly 
reduced mortality, sputum purulence and treatment failure (p<0.05) (Ram, et al. 2006). A side 
effect of antibiotics includes an increase in the risk of diarrhoea (BNF, 2014; Ram et al., 2002). 
A programme of vaccination against influenza and pneumococcus is also indicated for patients 
with COPD (NICE, 2010). Nichol (1999)  observed that over three influenza seasons (1993-
1994, 1994-1995, and 1995-1996),  receiving both pneumococcal and influenza vaccinations 
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was associated with a 63% decrease in the risk of hospitalization for pneumonia and an 81% 
decrease in the risk of mortality in patients with chronic lung disease. An RCT (n=167) 
identified a significant additive effect (p<0.05) of pneumococcal vaccination with influenza 
vaccination in preventing infectious exacerbation in patients with COPD (n=55) but not in those 
with pulmonary tuberculosis (n=50) or with other chronic lung disease (n=62) (Furumoto et al., 
2008). A cochrane review of six trials involving patients with COPD identified that vaccination 
is associated with a significant (p<0.05) reduction in number of exacerbations. A mild increase 
in fatigue, myalgia and low grade fever is associated with vaccination but these are transient 
and do not result in increase in early exacerbations (Poole, Chacko, Wood-Baker & Cates, 2006). 
Anti-inflammatory drugs include corticosteroids, sodium cromoglycates and others like 
ketotifen.  
Glucocorticosteroids, including prednisolone, betametasone and budesonide, are used to reduce 
the frequency and improve the symptoms of exacerbation in COPD, though any long- or short-
term effect on lung function (FEV1) is minimal. Glucocorticosteroids are recommended for 
COPD patients with FEV1 < 50% predicted, recurrent exacerbations or evidence of reversibility, 
i.e. with coexistent asthma (NICE, 2010). Prolonged use of corticosteroids has been linked with 
fluid retention, osteoporosis, depression and hoarse voice while sudden withdrawal may cause 
joint pain, fatigue, low blood pressure and vomitting  (Greenberg, Simpson, Jones, Holloway, & 
Seibert, 2006; Kearney & Lockey, 2006).   
Bronchodilators relieve breathlessness in COPD by increasing the diameter of air passageways 
via physiological opposition to bronchial muscle contraction (Calverley, 2004; Puente-Maestu & 
Stringer, 2006). The three classes of bronchodilators are: beta-2-agonists (also called beta-
adrenoreceptors agonists), anticholinergics and methylxanthines. The beta-2-agonists and 
anticholinergics include short-acting or long-acting preparations. Most of the adrenoreceptors 
in the bronchi are beta-2-type and do cause bronchial muscle relaxation when stimulated. 
Anticholinergics (also called antimuscarinics) blocks acetylcholine reception at M3-muscarinic 
receptors, thereby inhibiting parasympathetic nerve impulse (Montuschi, Macagno, Valente, & 
Fuso, 2012; Rennard, 2004).  
Short acting bronchodilators (SABAs) includes salbutamol (Ventolin) and terbutaline (Bricanyl); 
both beta-2-adrenergic receptor agonist. They are generally administered as the first-line 
treatment for breathlessness resulting from physical activity (Rennard, 2004). The onset of 
action is usually within five minutes, with peak action usually around thirty minutes and the 
duration of action between two and four hours. Short-acting anticholinergics include 
ipatropium (Atrovent); the onset of action is usually within ten to fifteen minutes, with peak 
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action usually within thirty minutes to one hour and duration of action lasting usually two to six 
hours. A Cochrane review (11 studies, n= 3912 participants) identified that the combination of 
short acting beta-2-agonists and anticholinergics have additive effects in improving post-
bronchodilator lung function and reducing the use of oral steroids (Appleton et al., 2006). 
Long acting beta-2-agonists (LABAs) include salmeterol (Serevent) and eformoterol (Foradil). 
They are available for oral administration and as inhalers. The duration of action is about 12 
hours, therefore administration is twice daily. To investigate the effectiveness of LABAs in 
patients with COPD, Appleton et al. (2006) conducted a systematic review of all RCTs (n=23) 
published in the Cochrane Airways Group Specialised Register for all years untill 2005, which 
compared inhaled LABAs with placebo with a treatment duration of at least four weeks. 
Analysis indicated that the use of LABA in patients with COPD resulted in significant 
improvement in FeV1 (51 mls, 95% confidence intervals = 32 to 70), reduction in the use of 
SABA by almost one puff per day and improvement in SGRQ QoL scores (p<0.05). A long-acting 
anticholinergic bronchodilator is available as tiotropium (Spiriva) with a half-life greater than 
36 hours. The optimum effect is achieved after a week of daily administration (Rennard, 2004). 
Results from a double-blind RCT (n=5,993, age>40 years, 487 centres in 37 countries) indicated 
that the use of tiotropium significantly improved post bronchodilator FeV1, frequency of 
exacerbations and QoL in patients with COPD (p<0.05) (Decramer et al., 2009). 
The side effects of anticholinergics include constipation, urine retention and glaucoma (BNF, 
2014; Decramer et al., 2009). The side effects of beta-2-agonists (LABAs and SABAs) include 
palpitation, headache, fine tremor and hypotension (BNF, 2014). 
Methylxanthines include theophylline, aminophylline and cholinetheophylline. Theophylline is 
usually administered as a slow release oral medication and a review of 20 RCTs established that 
it relieves breathlessness and improves QoL (Ram et al., 2002). Due to the side effects of 
theophylline, which include nausea, vomiting, seizures and arrhythmias, it is usually used only 
as a third line treatment if a patient’s symptoms remain irrespective of other bronchodilator 
therapy (Barnes & Stockley, 2005; Ram et al., 2002).  
Respiratory stimulants improve ventilation via chemoreceptors or the respiratory centre. 
Respiratory analeptics improve breathing by acting on the central nervous system to stimulate 
breathing muscles. Their prescription should be with caution, especially if the muscles are 
already working maximally (NICE, 2010). They are indicated in acute exacerbation of COPD 
with hypercapnia, drowsiness and inability to tolerate low (24%) concentrations of inspired 
oxygen. Doxapram is a respiratory stimulant that is indicated only when NIV is either 
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unavailable or inappropriate (NICE, 2010). Aminophylline has a bronchodilatory effect through 
relaxation of the smooth muscle surrounding the bronchial tubes and is administered by slow 
infusion (Pryor & Prasad, 2004).  
Inhalers or inhalation drugs are of immense use in the treatment of COPD. Drugs for inhalation 
are delivered either as dry powder inhaler or aerosol. Such drugs include bronchodilators and 
corticosteroids (NICE, 2010). The advantages of inhalation include the fact that, by inhalation, a 
reduced dosage of drugs is needed to achieve a therapeutic effect and there are fewer side 
effects (Borgstrom, 2001). Severe COPD patients can achieve an adequate inhalation flow 
required to generate an efficient drug spray from a DPI (Borgstrom, 2001, NICE 2010).  
Nebulisers are used for the inhalation of drugs when a simpler method of administration cannot 
produce maximum effect, or there is no alternative method of administration (Carlisle, 2012; 
Nebuliser Project Group, 1997). Nebulisers convert a solution or suspension of drugs into an 
aerosol and allow administration of larger doses than a pressurised aerosol (Carlisle, 2012; 
McCormack, Southern, & McNamara, 2012; Nebuliser Project Group, 1997). 
Oxygen therapy and Non-invasive Ventilation 
Oxygen prescription is indicated when there is inadequate tissue oxygenation (NICE, 2010). A 
retrospective study (Nakamura et al., 2000) (n=41, all with chronic emphysema) demonstrated 
a positive and significant correlation between haemoglobin level and both mean pulmonary 
arterial pressure and pulmonary vascular resistance (p<0.05).  The authors suggested that 
some chronically hypoxic patients maintain adequate tissue oxygenation with low arterial 
oxygen pressure (PaO2) by compensating with an increased mass of red blood cells (RBC).  
The various applications of oxygen therapy include HCOT (high concentration oxygen therapy), 
LCOT (low concentration oxygen therapy), and LTOT (long-term oxygen therapy), ambulatory 
oxygen and short-burst oxygen. 
HCOT is used when PaO2 is low and PaCO2 (arterial pressure of carbon dioxide) is low or at least 
normal. A high concentration of oxygen, up to 60%, may be used for a short period as there is 
minimal risk of inducing hypoventilation or CO2 retention (NICE, 2010).  
LCOT is indicated in patients with low PaO2 associated with high PaCO2, which occurs mostly in 
patients with hypercapnic COPD during an infective exacerbation. The aim should be to increase 
the patient’s oxygen sufficiently to alleviate hypoxia without resulting in hypoventilation (NICE, 
2010).  
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Long-term domiciliary oxygen therapy (LTOT) is recommended for patients with severe COPD 
who manifest persistent hypoxaemia or cor pulmonale, and a PaO2 below 7.3kPa without 
exacerbation in the previous three weeks (NICE, 2010). RCTs of patients with COPD and severe 
hypoxaemia (PaO2 <55 mmHg) by Nocturnal Oxygen Therapy Trial Group (NOTTG) (1980) 
(n=203, participants observed for an average of 19.3 months) and Medical Research Council 
Working Party (MRCWP) (1981) (n= 87, participants observed for an average of five years) 
demonstrated a statistically significant difference (p<0.05) in survival in favour of the oxygen 
therapy group. The participants in these RCTs received oxygen therapy at home for at least 12 
to 15 hours each day and NICE (2010) recommends LTOT administration for at least 15 hours a 
day.  
Tarrega et al. (2011) (n=80, mean age=67.8 years, mean FeV1=23.4%) prospectively 
investigated the occurrence of nocturnal hypoventilation (NHV) (≥10 mm Hg increase in 
PaCO2 levels when asleep compared to PaCO2 levels when awake) in patients with COPD and 
hypercapnia while awake. The authors identified the occurrence to be about 21% (n=17). 
Logistic regression demonstrated that NHV has a significant association with body mass 
index (p = 0.006) and lower PaO2 after oxygen administration (p = 0.010). Elliot, Simonds, 
Carroll, Wedzicha and Branthwaite (1992) (n=12) conducted a non-randomised study to 
investigate the benefits of the use of nasal intermittent positive pressure ventilation (IPPV) 
during sleep in patients with COPD and hypercapnic respiratory failure. The authors reported 
that IPPV significantly (p<0.05) improves mean PaO2 (mean=11%), transcutaneous carbon 
dioxide tensions (mean=-2.7kPa) and sleep time (mean= +72.5 minutes) overnight compared 
with spontaneous breathing. A recent Cochrane review (7 trials, 245 patients with stable COPD) 
found significant differences in change in PaCO2 following 3 months of ventilation with IPAP 
levels of 18 cm H2O or more, for 5 hours per night or more and in patients with baseline PaCO2 
of 55 mm Hg or more. However, no long term benefit (at 3 to 12 months post NIPPV) was found 
in 6 minute walking test, health-related QoL, lung functions or quality of sleep (Struik, Lacasse, 
Goldstein, Kerstjens & Wijkstra, 2014). 
Ambulatory oxygen is indicated in patients with COPD who desaturate (while exercising on air) 
by at least 4% below 90% SaO2 (arterial oxygen saturation as measured by pulse-oximeter). 
Ambulatory oxygen is administered to increase walking ability and QoL, however, it is only 
prescribed if a patient demonstrates significant improvement in exertional desaturation and 
breathlessness during a laboratory-based walk test (NICE, 2010). The evidence for the use of 
ambulatory oxygen therapy is conflicting. A 12-week RCT (McDonald, Blyth, Lazarus, 
Marschner, & Barter, 1995) (n=26, male=24, mean FEV1= 0.9) indicated that 4l/m ambulatory 
oxygen administered intranasally during activities only resulted in modest improvement in 
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exercise tolerance but no significant improvement in QoL. On the contrary, a larger 12-week 
RCT (Moore et al., 2010) (n=143, male=99, mean FeV1) indicated that 6l/m ambulatory oxygen 
administered intranasally during activities that provoke breathlessness did not result in a 
significant improvement in breathlessnesss, QoL, mood disturbance or exercise tolerance 
compared to placebo treatment.  
Short-burst oxygen is the intermittent use of oxygen to achieve relief of breathlessness. Uronis 
et al. (2014) conducted a systematic review of RCTs involving adults with COPD and mean PaO2 
≥7.3 kPa without prior treatment with home oxygen therapy. The authors included RCTs that 
investigated oxygen versus medical air as an intervention, delivered intervention via a non-
invasive method and included breathlessness as a study outcome. Their search of the Cochrane 
Airways Group Specialised Register (up until November 2009), EMBASE (1980 until November 
2009) and MEDLINE (1966 until November 2009) highlighted 18 RCTs with 431 participants. 
Analysis indicated that oxygen therapy administered during exertion significantly improved 
dyspnoea, compared to medical air (−0.37, 95% confidence interval= −0.50 to −0.24). This is, 
however, not the case when oxygen is administered as short-burst oxygen therapy. The NICE 
guidelines (2010) concluded that the results from studies that investigated benefits from short-
burst oxygen therapy appear inconsistent and any benefit could be due to the placebo effect.  
The British Thoracic Society guidelines indicate oxygen therapy should be administered to 
achieve 94–98% saturation for the most acutely ill patients or 88–92% saturation for patients 
who are at risk of hypercapnic respiratory failure (O’Driscoll, Howard, & Davison, 2008). 
Surgical intervention 
Surgical intervention in the management of COPD is infrequent but some patients with COPD 
can benefit from bullectomy, lung-volume-reduction surgery (LVRS) or lung transplant (Clark et 
al., 2014; NHS Choices, 2010).  
Bullectomy is a treatment of choice when the bullae occupy over 30% of the hemi-thorax. The 
benefits include improvement in pulmonary function (FeV1) and breathlessness, and are 
maintained for up to five years post-intervention (Benditt, 2006). Data collected between 
January 2000 and September 2012 indicated that there was no deaths within 90 days of 
unilateral lung volume reduction (n = 81), bullectomy (n = 20) or intracavity drainage (n = 14) 
procedures (Clark et al., 2014). 
Fishman et al. (2003) (RCT, n= 1218, female=472, mean age=66.6 year) suggested that lung 
function improvement following LVRS could be due to resection of the unhealthiest 
hyperinflated regions which improves the elastic recoil of the remaining lung, expiratory gas 
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flow, exercise tolerance, clearance of airway secretions and survival particularly in patients with 
predominantly upper-lobe emphysema and low baseline exercise capacity. 
 
Lung transplant is indicated in a patient with FEV1 <25% predicted, PaCO2 >7.3kPa, or the 
concomitant pulmonary hypertension with progressive clinical deterioration despite other 
interventions (American Society for Transplant Physicians/American Thoracic 
Society/European Respiratory Society/International Society for Heart and Lung Transplant, 
1998; Trulock, 1998; Trulock et al., 2007). The three types of lung transplant are:  
 Single lung transplant (replacing one of the two lungs), which is suitable for pulmonary 
fibrosis but unsuitable for a case of cystic fibrosis when infection could spread from the 
remaining lung. 
 Double lung transplant (replacing both lungs), which is suitable for cystic fibrosis and 
COPD.  
 Heart-lung transplant (replacing both lungs and the heart), which is the type of 
transplant usually indicated in a case of pulmonary hypertension (NHS Choices, 2010; 
Trulock et al., 2007).  
Pulmonary rehabilitation 
PR is a multidisciplinary programme of care for patients with chronic respiratory impairment 
that is individually adapted and organised to optimise physical and social performance and 
independence (ATS, 1999; NICE, 2010). PR consisting of exercises, breathing retraining, 
psychosocial support and disease management education (e.g. teaching of inhaler use, energy 
conservation techniques, relaxation techniques and dietary advice) is effective in the 
management of COPD by improving exercise tolerance and quality of life (Bestall et al., 2003; 
Finnerty et al., 2001; Sewell et al., 2006). 
PR is indicated when patients with COPD have impairment attributable to pulmonary disability, 
have an optimised medical regimen to achieve adequate symptomatic relief, have consented, are 
motivated and are capable of compliance with the rehabilitation advice (NICE, 2010). 
Contraindications include severe cognitive dysfunction, unstable comorbidity (e.g. unstable 
angina, uncompensated congestive heart failure), severe exercise-induced hypoxemia not 
correctable with O2 supplementation, and severe neurological or musculoskeletal problems 
(NICE, 2010). 
The Medical Research Council (MRC) scale classifies patients with COPD on a 5 point scale of 
dyspnea severity (refer to section 2.5.7). Patients of all the MRC COPD severity levels were 
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reported to demonstrate improvement in exercise tolerance (6MWT) following PR, though 
patients with severe COPD (grade five on the MRC scale) demonstrated a smaller magnitude of 
improvements (Garrod et al., 2006). Von Leupoldt et al. (2008) (n=210, mean FEV1= 54%) 
suggest that milder and more severe COPD patients improved similarly in the majority of the 
outcome measures. However, the study was a non-randomised trial and participants received 
three weeks of PR, which is less than the four-week PR length recommended by guidelines 
(IMPRESS, 2011). Ries , Kaplan, Limberg and Prewitt (1995) (n=119) enrolled current smokers 
only if they demonstrated a commitment to quitting smoking before and smoking cessation 
counselling was included in the PR programme for patients randomised to the PR group. 
Interestingly, Hill, Williams and Shaw (2008) (n=46, male=28, mean age=65 years) reported 
that both the groups of current smokers and ex-smokers demonstrated significant improvement 
in exercise tolerance following seven-week PR. The authors also indicated that only the group of 
current smokers demonstrated significant improvement in QoL and only the group of ex-
smokers demonstrated significant improvement in FeV1 (post-PR (p<0.05). Smoking-pack years 
have been reported to be an independent predictor of drop out from PR (Garrod et al., 2006) 
(p=0.04). Martinez et al. (2007) (n=1053, women= 409) suggested that women with COPD 
generally have less extensive emphysema than men but evidence from studies that investigated 
gender differences in the benefits of PR are unclear (Foy, Rejeski, Berry, Zaccaro, & Woodard, 
2001; Verrill, Barton, Beasley, & Lippard, 2005). 
PR education which includes advice on the management of breathlessness, airway clearance, 
quitting smoking, use of medication and dietary intake reduced patient dependence on reliever 
medication and visits to GP (p<0.05) (Gallefoss, 2004). PR education can be given to patients at 
face-to-face sessions (Toshima, Kaplan, & Ries, 1990), through COPD educational booklets 
(Moore, Fiddler, Seymour et al., 2009) or as a video-based educational package (Hoberty et al., 
1998; Kingston, Gray, & William, 2010). Video-based education at home has been demonstrated 
to increase self-belief and compliance with a home exercise programme in patients with 
brachial plexus palsy (Murphy et al., 2012), and shoulder and back pain (Miller, Litva, & Gabbay, 
2009).  
 
Sinclair and Ingram (1980) (non-RCT, n=33, mean FeV1=1.05L) revealed that patients who 
participated in clinician supervised exercise sessions had greater improvement in 12-minute 
Walk test than patients on self-monitored exercise programmes (p<0.05). However Wijkstra et 
al. (1995) (RCT, n=36, mean FeV1= 1.3L) indicated that post-outpatient PR, patients on a once-
monthly maintenance programme demonstrated better maintenance of improvement in CRQ 
score compared with patients on a once-weekly programme. The ATS/ERS guidelines (Nici et 
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al., 2006) recommend a staff-to-patient ratio of 1:8. However, a survey of PR centres in the 
UK indicated an average staff-to-patient of ratio of 1:4, with 12% of respondents indicating a 
ratio of greater than 1:7 (Hoberty et al., 1998).  
Pulmonary Rehabilitation (PR) can be delivered as inpatient, outpatient, home and community 
centre based programmes. In addition to the details in this section, section 3.5.2 of this thesis 
contains analysis of research publications on outpatient, home and community centre based PR 
between May 2003 and August 2008. 
Inpatient PR has been investigated as part of treatment during admission for exacerbation of 
COPD and the evidence of its effectiveness is unclear. A prospective study by Stewart et al. 
(2001) (n=157, all with moderate to severe COPD) indicated that an average of 21 day inpatient 
PR programme significantly improved exercise tolerance and QoL (p<0.0001) in patients with 
COPD. However, the patients in this study were not randomised. Tang et al. (2012) (n=32) 
randomised patients during an admission for acute exacerbation of COPD into low intensity 
exercise for 15 minutes twice daily, moderate-to-high intensity exercise for 15 minutes twice 
daily, or a control group which received once-daily physiotherapy consisting of airway secretion 
clearance, mobility and functional training necessary for safe discharge. The authors reported 
that there was no significant between-group difference in a three-minute walk test, upper and 
lower limb strength, activity status, FEV1% predicted and length of stay. However, there was a 
small but non-significant effect size in the length of admission in favour of the moderate-to-
high-intensity exercise group over the other two groups (d=-0.3, 95% CI:-0.6 to 1.2). Greening et 
al. (2014) conducted the largest prospective RCT to date. Within two weeks of acute admission 
for exacerbations of chronic respiratory disease, participants in the study (n=389, 320 
diagnosed with COPD, aged between 45 and 93) commenced a six-week PR programme, 
comprising progressive aerobic, resistance and neuromuscular electrical stimulation training, 
as well as self-management education, or usual care, which included techniques for airway 
clearance, assessment and the supervision of mobility and smoking cessation advice without 
any progressive exercise programme. Similar to the findings by Tang et al. (2012), Greening et 
al. (2014) found no significant difference in improvement in exercise performance immediately 
post-PR between the exercise and control groups (p<0.05). Tang et al. (2012) observed 
participants from admission to the end of rehabilitation. In contrast, Greening et al. (2014) 
observed participants for a longer period (12 months) and the authors found no significant 
difference between groups in readmission over one year but there was an increase in mortality 
in the intervention group at one year (odds ratio 1.74, 95% confidence interval 1.05 to 2.88, 
p=0.03). The authors suggest that progressive exercise training should not commence during 
the early stage of admission due to acute exacerbation of COPD. 
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Outpatient PR involves supervised rehabilitation classes with sessions consisting of education 
and exercise programmes. Karapolat et al. (2007) ( n=54, 46 males, mean FeV1=54.9%) 
reported that patients with COPD who participated in eight-week outpatient PR demonstrated 
significantly higher improvement in 6MWT (at the eighth week) and SGRQ (at the eighth week 
of PR and at one month post PR) (p<0.05) compared to the control group who received no 
rehabilitation. Evidence has established effectiveness of programme duration of at least four 
weeks, with twice-weekly attendance at outpatient sessions (Sewell et al., 2006). 
Elci et al. (2008) (n=78, 67 males, mean age=58.9+/-10.1 years) reported that patients with 
COPD who received three months of twice-weekly community PR demonstrated significantly 
higher improvements in 6MWT and SGRQ scores compared to the control (no exercise) group 
(p<0.05). Elliot et al. (2004) (n=43, 23 males) reported that there was no significant difference 
in 6MWT and CRQ score between patients with COPD who participated in three months of 
twice-weekly community-based PR and those who participated in three months of twice-weekly 
hospital outpatient-based PR-(p< 0.05).  
Home-based PR involves self-directed exercise programmes for patients at home. Home-based 
PR needs minimal equipment and an RCT by Fernandez et al. (2009) (n=42) indicated its 
effectiveness in significantly improving exercise tolerance (p<0.05). Another RCT (Maltais et al., 
2008) (n=252) indicated that there was no significant difference in the improvement in QoL 
between the participants who received hospital-based PR and those who received home-based 
PR (p<0.05). Strijbos, Postma, Altena, Gimeno and Koeter (1996) (n=45) indicated that patients 
who received outpatient PR and those who received home-based PR demonstrated similar 
improvement in an incremental symptom-limited cycle ergometer test at the end of 12-week 
PR. However, patients who received home-based PR maintained the benefits of exercise 
tolerance for up to 18 months after the end of 12 weeks of a home-based PR programme, while 
patients who received outpatient PR only maintained the benefits of exercise tolerance for up to 
six months post-outpatient PR. 
NICE (2004; 2010) recommends that all PR programmes should incorporate a walking 
programme of exercise. Prospective non-randomised studies indicate that participation in 
walking exercise led to significant reduction in the risk of re-admission for COPD by 54% 
(Garcia-Aymerich, Farrero, Felez, & Izquierdo, 2003) (n=340, men=313, mean FeV1=36%) and 
significant improvement in ventilatory capacity in this patient group (Paolo et al., 2000) (n=9, 
all male, mean FeV1=1.2L; p<0.05). The majority of UK rehabilitation programmes are provided 
on a hospital outpatient basis and there is a need to continually develop a clinically and cost 
20 
 
effective home-based PR in order to enhance participation by patients (CSP, 2003; Yohannes 
and Connolly, 2004). 
 
1.3.3 AUDIO-VISUAL BASED INTERVENTION IN THE MANAGEMENT OF 
ASTHMA AND COPD 
The use of audiovisual resources in the care of patients is an expanding field of research in the 
respiratory field of patient care, with ongoing advancement in information technology.  
Sorknaes, Madsen, Hallas, Jest and Hansen-Nord (2011) (n=100, male=43, mean FeV1=0.67L), 
demonstrated that participation in teleconsultation, in addition to conventional treatment, 
significantly protects against early readmission (16% versus 30%, hazard ratio 0.25, 95% CI= 
0.09–0.69). Additionally, patients who participated in teleconsultation reported high levels of 
satisfaction. The weakneses of the study include a lack of blinding or randomisation and the 
short study duration (28 days). 
  
An RCT by Liu et al. (2013) (n=60, mean FeV1=0.95L) indicated that participation in an online 
breathing programme of animated diagram- and video-based advice resulted in a significant 
improvement (p<0.05) in exercise tolerance, health-related QoL and pulmonary function in 
patients with COPD. However, the intervention group received only a breathing exercise 
programme, which is not representative of a full PR programme of exercise and education. 
Further, the authors did not conduct between-group comparisons of outcomes.  
A 3-arm RCT (Petty et al., 2006) (n=174, male=122) compared the effects of a library of 
individually-customised PR videotapes against a standard videotape (two tapes on PR exercises 
and education) and against usual care (which may have included written or verbal information) 
on QoL in persons with COPD. Participants in the individually-customised video group were 
given videotapes according to COPD disease level/psychological state of motivation to 
participate in exercise activity. The authors achieved this classification by using participants’ 
responses to questions about their past and planned future exercise behaviour in the Stages of 
Change questionnaire. The Stages of Change questionnaire classifies a subject into 
precontemplative, contemplative, preparation, action, and maintenance stages. The study 
indicated that participants in the customised videotape arm demonstrated a significant 
improvement in the emotional function and coping skills domains of the Seattle Obstructive 
Lung Disease questionnaire score (SOLQ), compared to participants in the other two groups 
(p<0.05). In addition, participants in the individually-customised videotape group 
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demonstrated significantly larger improvement in the physical function domains of the SOLQ, 
compared to participants who received usual care (p<0.05) but not when compared to 
participants who received the standard video (p=0.069). There was no between-group 
significant difference in the Fatigue Impact Scale (FIS) or SF-36 score. None of the arms in this 
study received outpatient PR, without or in addition to the video. However, drop-out from the 
study was 20% with no intention-to-treat analysis conducted, and the authors stated that this 
may have limited the significance of the results. 
A smaller RCT by Moore, Fiddler, Seymour et al. (2009) (n=20, male=5) compared patients with 
COPD who received a standard exercise video and education to a control group who received 
the educational COPD booklet only. Participants in the video group demonstrated a significant 
improvement in the incremental shuttle walk test (p<0.05) and in the dyspnea, emotion and 
fatigue domains of the chronic respiratory questionnaire (CRQ) (p<0.05) but not in the mastery 
domain of the CRQ (P=0.25). However, the study was a pilot and none of the arms in this study 
received outpatient PR, without or in addition to the video. 
While the intervention groups in the studies by Moore, Fiddler, Seymour,  et al. (2009) and Petty 
et al. (2006) received video-based exercise programmes, none of the control groups received 
conventional PR. Conventional PR has been shown to be more effective than disease education 
and advice only (Roger et al., 2002; Toshima, Kaplan, & Ries., 1990). Whereas the participants in 
the study by Toshima et al. (1990) received centre-based educational intervention biweekly 
over eight weeks, the participants in the study by Roger et al. (2002) received the educational 
intervention at a single outpatient appointment and the study did not analyse participants’ 
compliance with advice at home. Therefore, no study has compared VBHEP against the 
currently best available treatment protocol (which involves PR) or has investigated the 
effectiveness of the combination of VBHEP and PR.  
Hogg et al. (2012) conducted a focus group study of patients with COPD, who had completed 
eight weeks of outpatient PR (n=16, male=9, time since completion of PR < 2 years). Nine of 
these patients had maintenance input through attendance at maintenance gym session run by 
PR staff or by being given an induction into existing community exercise class by PR staff. The 
other seven did not receive maintenance input by PR staff. Themes that emerged from the study 
suggested that the wish to exercise in patients with COPD is related to encouragement and 
companionship offered by PR staff (Hogg et al., 2012). Moore, Hogg and White (2012) 
conducted one-to-one semi-structured interviews of patients with COPD. Of the twenty four 
patients (fourteen males), twelve had never been referred for PR, seven had completed PR, (out 
of which three had initially declined PR), four had commenced PR but did not complete and one 
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had been referred for PR but never attended. Moore et al. (2012) concluded that the 
participants’ locus of control (as demonstrated by their beliefs in the recommendations of 
health professionals) influenced attendance of PR programme.  
 
Qian et al. (2014) demonstrated that in patients with COPD (n = 74,863, 36.8% male, 36.6% 
diagnosed with depression) depression is associated with lower compliance with medication 
(adjusted prevalence ratio = 1.09; 95% CI = 1.04, 1.14).  The knowledge of factors that are 
associated with the use of VBHEP in patients with COPD is lacking and this is an important area 
that requires research. There is a need to examine whether in comparison to outpatient PR 
alone, the use of a VBHEP concurrently with outpatient PR result in a significant difference in 
change in health locus of control at the end of outpatient PR. 
Considering the aforementioned studies, further investigation into applications of videos of 
exercise in PR of patients with COPD is a justified and viable area of research. 
 
1.4 DEFINING PROBLEMS AND GAPS IN EVIDENCE 
Audio-visual based intervention has been applied in the management of patients within and 
beyond the respiratory field of patient care. Reo and Mercer (2011) taught healthy subjects 
(n=40, age=26 to 51 years) five shoulder exercises in a variety of ways through live modelling, 
corrected-error videotape, error-free videotape or handouts alone. Results indicated that 
demonstration during live sessions or the use of videotape was more effective than the use of 
handouts in achieving the correct performance of prescribed exercises. Further, there was no 
significant difference in the effectiveness of live demonstration sessions compared to the use of 
videotape in achieving the correct performance of prescribed exercise in the general population. 
Rasmussen, Justice, Chang, Nelson and Yang (2013) conducted a prospective evaluation of 
demonstration of the accuracy of home exercise performance by adult caregivers of children 
with neonatal brachial plexus palsy (n=76) at times three, six and 12 months post-prescription 
of a home exercise DVD. The study suggested that the use of a home exercise DVD significantly 
enhanced correct performance of the exercises (p<0.05). 
Previous RCTs in patients with COPD (Moore, Fiddler, Seymour et al., 2009; Petty et al., 2006) 
indicated that the use of an exercise video at home in patients with COPD resulted in improved 
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exercise tolerance, exercise habits and QoL. Investigation into the application of VBHEP in the 
PR of patients with COPD is an emerging area of research.  
An in-depth review of research works and guidelines indicated that outpatient PR is effective in 
improving exercise tolerance (Bestall et al., 2003; Sewell et al., 2006) and QoL (Finnerty et al., 
2001) in patients with COPD. However, the uptake and the completion of PR continue to be a 
significant problem (Garrod et al., 2006).  
While previous studies suggest that a video-based exercise programme offers benefits to 
patients who are not participating in PR (Moore, Fiddler, Seymour et al., 2009; Petty et al., 
2006), none of the studies compared a video-based exercise programme with PR, which is 
established as a necessary intervention in the management of patients with COPD (NICE, 2004; 
2010). There is a lack of evidence that it offers additional benefit when it is provided to patients 
who are already participating in PR.  
The following issues were identified: 
 There is a high incidence of COPD in the UK. 
 There is a high occurrence of non-uptake of PR and drop-out from PR (Garrod et al., 
2006; Singh et al., 1998).  
 Socio-demographic, clinical and psychological variables have been indicated as possible 
causes of drop-out (Garrod et al., 2006; Young et al., 1999). 
 There is a lack of knowledge of the effect of the combination of VBHEP and outpatient 
PR on walking ability and maintenance of the benefits of PR (including QoL). 
 There is a lack of knowledge of the effect of the combination of VBHEP and outpatient 
PR on drop-out from outpatient PR. 
 There is insufficient knowledge of factors that affect participation in VBHEP in patients 
with COPD. 
Investigation into the following areas would make a significant contribution to knowledge in 
research and clinical practice:  
 Factors that affect the uptake of PR and participation in PR in patients with COPD. 
 The effect of the combination of VBHEP and outpatient PR on walking ability and 
maintenance of the benefits of PR (including QoL). 
 The effect of the combination of VBHEP and outpatient PR on drop-out from outpatient 
PR. 
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1.5 RESEARCH QUESTIONS 
The following research questions were thus proposed:  
i) Are depression, social support, health locus of control or COPD disease severity confounding 
factors in the non-uptake of, or drop-out from PR? 
ii) Is the use of a VBHEP concurrently with outpatient PR more effective than outpatient PR 
alone in improving walking ability (measured with endurance shuttle walk test) at the end of 
outpatient PR and in maintaining any significant benefit at six months post-outpatient PR? 
iii) Is the use of a VBHEP concurrently with outpatient PR more effective than outpatient PR 
alone in improving quality of life (measured with St George’s Respiratory Questionnaire) at the 
end of outpatient PR and in maintaining any significant benefit at six months post-outpatient 
PR? 
iv) In comparison to outpatient PR alone, would using a VBHEP concurrently with outpatient PR 
result in a significant difference in change in health locus of control at the end of outpatient PR 
and at six months post-outpatient PR?  
v) Would using a VBHEP concurrently with outpatient PR result in a significant change in the 
drop-out rate from outpatient PR? 
vi) What are the experiences of patients with COPD who have used the Move-On-Up exercise 
video at home concurrently with outpatient PR? 
In addition, the programme of research includes an in-depth review of the Move-on-Up exercise 
video to investigate its suitability as a tool for VBHEP as an adjunct to outpatient PR in the UK 
population of patients with COPD. 
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1.6 PROJECT DURATION AND TIME LINES 
The figure below represents the time line of the various studies. 
Study designing
Programme 
registration
Video review 
using guidelines 
& publications
Uptake study
Focus groups 
evaluating video
Questionnaire  
survey evaluat-
ing video
SRCT
Focus groups 
post-SRCT
Data analysis of 
SRCT and FU  
study
Writing up
Time(month) 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60
 
Figure 1.1- Studies and time lines 
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CHAPTER TWO - LITERATURE REVIEW 
2.1 INTRODUCTION  
This literature review informed the direction of the PhD research, and design of the various 
mixed methods for full investigation of the research questions. Specifically it addressed exercise 
modalities in PR, the length of PR programme in the management of patients with COPD, uptake 
and drop-out in PR and outcome measures/screening tools in rehabilitation of patients with 
COPD. 
A review of outcome measures was carried out in order to identify appropriate outcome 
measures to detect statistically and clinically significant changes in walking ability and quality 
of life in response to PR, as well as identification of the appropriate outcome measures for 
depression, social support, HLC and disease severity in patients with COPD. 
An appropriate level of cognition is crucial to the effectiveness of a programme of self-
management in patients with COPD (Ozge, Ozge and Unal, 2006) (n=78). Severe cognitive 
impairment was an exclusion criterion in the SRCT (Chapter 7). Identification of an appropriate 
outcome measure(s) for cognitive impairment was thus vital. 
 
2.2 LITERATURE SEARCH STRATEGIES 
Databases searched were PubMed, CINAHL (Nursing and Allied Health Literature), Web of 
Science, Cochrane Library and PEDro. The specific search terms that were used were ‘COPD 
AND video of exercis*’, ‘COPD AND pulmonary rehabilitation’, ‘COPD AND respiratory exercis* 
AND outcome measures’, pulmonary rehabilitation AND quality of life’. The search included only 
papers published in English. 
Titles were reviewed followed by abstract review to decide whether to review the publication 
as a whole. Further references identified from the initial sources were followed up and 
reviewed. Papers published before 1980 were rejected because guidelines on disease 
classification in COPD have since changed (ATS, 1979). Publication years searched ranged from 
1980 to 2009. The search was limited to human studies. COPD participants of all ages and both 
genders were included. 
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Publications in journals, conference papers and clinical guidelines that cover the area of PR of 
COPD patients, including current evidence in the management of this patient group and 
evidence relating to the use of an ‘exercise video’ in the patient group are included in this 
review.  
 
2.3 EXERCISE MODALITIES IN PR 
PR is a treatment protocol that addresses the multiple needs of a patient with COPD, beyond the 
standard care of medication alone, and it addresses the disabling loss of exercise ability and 
quality of life (NICE, 2010). 
Various RCTs demonstrated that the exercise protocol in PR can be varied to be strength 
training (O’Shea et al., 2007) (n=54), endurance training (Arnadottir et al., 2006) (n= 42), 
interval or continuous training (Puhan et al., 2006) (n=98), and upper limb (Holland et al., 
2004) (n=38) or lower limb training (Casaburi et al., 2004) (n=53). Previous studies by Faager, 
Stahle and Larsen (2008) (RCT, n=32) and (Garrod et al., 2005) (non-RCT, n=69, mean 
FeV1=44.3+/-18.4%) suggest that pursed lip breathing (PLB) resulted in a significantly (p<0.05) 
higher improvement in perceived exertion during exercise and end-exercise respiratory rate as 
well as reduced physiological stress regarding oxygen desaturation when participating in ESWT 
compared to the control group (Roberts, 2010) (RCT, n=41, mean FeV1=47+/-15.8%). 
A pilot SRCT (Moore, Fiddler, Seymour et al., 2009) (n=20, mean FeV1=0.95L) indicated that 
participants who used an exercise video at home demonstrated significantly larger 
improvement (p<0.05) in exercise tolerance and QoL compared to the control group who 
received only the COPD educational booklet. A larger RCT (Petty et al., 2006) (n=174) 
demonstrated that patients who used an individually-customised exercise video demonstrated 
significantly larger improvement in the QoL compared to participants who received usual care 
(p<0.05). Notably, no study to date has investigated a possible additive effect or otherwise of a 
combination of video-based exercise programme and standard PR programme, the maintenance 
of any such effect or the effect of such a combination on drop-out from an outpatient PR 
programme.  
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2.4 OPTIMAL LENGTH OF PROGRAMME, DEFINITION OF UPTAKE AND 
DROP-OUT 
Outpatient PR service can be provided as a ‘cohort’ PR programme or ‘rolling’ PR programme. In 
rolling programmes, there is continual assessment and enrollment of new patients over the 
course of the programme. This differs from a ‘cohort’ PR protocol in which all patients are 
assessed and start the programme at the same time. In the cohort protocol, no new patient is 
enrolled into PR until a particular cohort has ended.  
The term ‘uptake’ has a clearer definition i.e. patients who enrol into PR after their referral, than 
the term ‘drop-out’ which relates directly to the proportion of sessions a patient attends. The 
minimum number and frequency of supervised PR sessions that a patient requires to achieve 
minimum clinically important difference (MCD) through PR and technically not be a “drop-out” 
therefore may vary as research progresses into the optimal duration of PR. Guidelines (NICE, 
2004; NICE, 2010) recommended that COPD patients should be offered a minimum of six weeks 
PR, with a minimum of two supervised PR sessions per week. The IMPRESS guideline jointly 
published by the British Thoracic Society and the Primary Care Respiratory Society UK 
indicated that the UK average attendance of PR by patients is less than 50%. IMPRESS (2011) 
defined ‘completers’ of PR as patients who attend at least four out of six weeks of exercise 
programme because evidence (Sewell et al., 2006) suggests that benefits from PR would have 
been achieved at four weeks. Based on the IMPRESS guideline (2011) and the findings of the 
RCT (Sewell et al., 2006), the studied reported in Chapters 6 and 7 of this dissertation defined a 
‘completer’ as a patient who attended a minimum of eight outpatient PR sessions (which is also 
50% of the 16 sessions offered). 
The word ‘compliance’ is used to describe participation in an intervention to a defined degree. 
For example, compliance with a prescribed self-directed home exercise session in Chapter 7 
means participation in at least one such session at home. Benefit from PR describes an 
improvement following PR, in which the improvement is of a magnitude that is equal or greater 
than the MCID in the particular outcome (e.g. 173m or more in endurance shuttle walk test 
distance-ESWD). The term maintenance of benefits of PR in a participant, describes the 
existence of benefit based on comparisons of outcome taken at baseline and that taken at a 
timeline post outpatient PR. For example, in the SRCT reported in Chapter 7, maintenance of 
benefits describes the existence of a gain of 173m or more in ESWD between baseline ESWD 
and ESWD at week thirty two of the study (i.e 6 months post outpatient PR) (Waterhouse et al., 
2006). 
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Bulley et al., (2009) studied patients with COPD (n=9, male=4) who accepted participation in 
PR. The patients participated in semi-structured interviews prior to participation in PR. The 
results indicated that the level of ethusiasm by the therapist and the provision of consultations 
that are informative enhanced the probability that patients would participate in PR. Moore, 
Hogg, and White (2012) interviewed 24 patients with COPD (male=13, seven had completed PR, 
four had dropped out of PR, one had declined and never attended PR and 12 had never been 
referred to PR). The authors indicated that the way the PR programme was presented to a 
patient by the referring clinician influenced the possibility that the patient would participate in 
PR. 
Williams et al. (2014) observed that inconsistencies in reporting of attendance at PR sessions by 
studies into PR of patients with COPD may hinder accurate calculation of the dose-response 
relationship between attendance of PR and improvement in exercise tolerance. Only 37% of the 
234 studies reviewed reported attendance and only 12% indicated a prior criterion for 
attendance. The authors suggest that analysis of the studies demonstrated little to no 
relationship between improvements in exercise tolerance and training volume (prescribed r = 
−0.03, P = 0.88; attended r = −0.24, P = 0.18) (Williams et al., 2014). 
Beauchamp, Janaudis-Ferreira, Goldstein and Brooks (2011) conducted a systematic review of 
RCTs (cumulative n=451, mean age=69) that investigated the optimal duration of PR. The 
search was limited to publications in six databases (MEDLINE, PubMed, CINAHL, EMBASE, 
PEDro and Cochrane Library of Clinical Trials) from inception until June 2010 and secondary 
searches included the reference lists of all of the identified studies, key author searches and the 
use of the PubMed related-article function.  
Table 2.1 summarises the findings by Beauchamp et al. (2011) which suggests that longer PR 
programmes can achieve higher improvement in exercise tolerance and QoL and that significant 
improvement in exercise tolerance is evident after four weeks of twice-weekly PR session.  
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Table 2.1 Summary of review by Beauchamp et al. (2011). 
* = study used exercise tolerance as outcome, 
 ^ = study used QoL score as outcome 
RCT Berry et al., 
2003 
Foy, Rejeski, 
Berry, 
Zaccaro, & 
Woodard, 
2001 
Green, Singh, 
Williams, & 
Morgan, 2001 
Sewell et al., 
2006 
Swerts, 
Kretzers, 
Terpstra-
Lindeman, 
Verstappen, & 
Wouters, 1990 
Number of 
participants 
140 140 21 100 27 
% of male 56 56 61 56 89 
Outcomes 
investigated 
 *    ^         ^ *   ^  *     ^ * 
 
Four of the five RCTs evaluated exercise tolerance. Berry et al. (2003) and Swerts et al. (1990) 
indicated that a longer duration PR programme resulted in a significantly higher improvement 
in exercise tolerance. Berry et al. (2003) compared three months versus 18 months of thrice-
weekly PR sessions while Swerts et al. (1990) compared eight weeks of thrice-weekly PR to a 
protocol that combined twice-weekly for two weeks, once weekly for the next two weeks and 
alternate weeks for the subsequent eight weeks. The two studies in which a longer duration PR 
programme did not result in a significantly higher improvement in exercise tolerance (Green et 
al., 2001; Sewell et al., 2006) were evaluations of PR programme durations of less than eight 
weeks (i.e. four weeks versus seven weeks). Four of the five RCTs evaluated QoL and three of 
them (Berry et al., 2003; Foy et al., 2001; Green et al., 2001) indicated that longer duration PR 
programme resulted in significantly higher improvement in QoL (CRQ). In the study by Foy et al. 
(2001), comparing three months versus 18 months of thrice-weekly PR sessions, the additional 
benefits of the longer-duration PR was significant in male participants but modest in the female 
participants. Foy et al. (2001) suggest that the course and presentation of COPD may be 
different between men and women.  
Sewell et al. (2006) (n=100, 56 male) asserted that a 4-week PR, requring twice weekly 
attendance is effective in improving walking ability in patients with COPD (p<0.05). von 
Leupoldt et al. (2008) (n=210, mean age=64, male=124 and mean FeV1=53%) indicated that 
participants who received five supervised PR session each week over three weeks 
demonstrated improvements in 6MWT of 39 metres (p < 0.001). However, the study suffered 
from significant risk of bias because participants were not randomised. While the programme 
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duration in the study by von Leupoldt et al. (2008) was shorter than that in the study by Sewell 
et al. (2006) (i.e. three weeks versus a minimum of four weeks), it involved 15 outpatient PR 
sessions, which is more than the eight PR sessions in the study by Sewell et al. (2006). O’Neil et 
al. (2007) (n=66, 46 males, mean FeV1 =41.33%) suggested that there was no significant 
difference in the improvement in walking ability and health related QoL between patients who 
received once-weekly and those who received twice-weekly supervised PR sessions each week 
over six weeks. However, the rate of drop-out (27.5%) resulted in the study being too 
underpowered to determine the effects of twice-versus once-weekly supervised PR on exercise 
capacity and QoL in patients with COPD. The intensity of exercise in the various studies was 
comparable and appropriate (exercise intensity of 3 to 4, i.e. moderate to somewhat severe on 
Borg scale CR10). Garrod et al., (2006) (n=74 commenced, mean age=68, mild COPD=21, 
moderate COPD =29) defined ‘drop-outs’ as patients who attended fewer than ten out of the 
possible 14 supervised PR sessions in a seven-week PR, research however suggested fewer than 
ten supervised PR sessions to be effective in improving walking ability in patients with COPD 
(Sewell et al., 2006).  
This thesis evaluated the effect of adding VBHEP to a standard PR programme and it was 
concluded at the planning phase of this research that an eight-week PR programme (consisting 
of twice-weekly sessions) qualified as a standard PR programme and is appropriate in this 
study. It is also a programme that is sufficient for the detection of an MCID in a trial with 
primary outcome measures such as ESWT. Also, the definition of completers in this PhD study 
as participants who attend eight PR sessions (which is 50% of the 16 sessions offered and 
would require at least four weeks of the twice weekly attendance) is in line with evidence 
(Sewell et al., 2006) and existing guidelines (IMPRESS, 2011).  
 
2.5 REVIEW AND SELECTION OF QUANTITATIVE SCREENING TOOLS 
AND OUTCOME MEASURES  
Screening tools are devised to identify individuals of particular characteristics while an outcome 
measure is used in the clinical or research setting to measure a change in the disease 
presentation or its impact on the patient following an intervention (Patient-Reported Outcome 
Measurement Group, Oxford, 2009). The various studies in this PhD programme involved the 
use of a large number of screening tools and outcome measures. A detailed and critical appraisal 
of the available screening tools and outcome measures was carried out in order to choose the 
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most appropriate ones for the research programme. This involved an in-depth literature review, 
networking with researchers and attendance of research meetings. 
Consideration was given to the validity, reliability, responsiveness and acceptability of the 
various screening tools and outcome measures that were reviewed in the population of study. 
Andresen (2000) recommend that for an outcome measure to be appropriate to a study, it 
needs to measure the area of interest in the study population and have the correct 
discriminative, evaluative and predictive properties.  
 
2.5.1 RELIABILITY  
The reliability of a measurement tool is the degree to which it produces a consistent and 
repeatable result when the property being measured remains unchanged (Kramer et al., 2009). 
Inter-rater reliability is the consistency when the measurement is taken by different persons. 
Test-retest reliability is the consistency when the measurement is taken at different times. 
Internal reliability is the consistency of results across items within a test (Andresen, 2000; ATS, 
2008).  
 
2.5.2 VALIDITY 
The validity of an instrument is the extent to which it measures what it is designed to measure 
(Kramer, Bernstein, & Phares, 2009). The validity of a tool is established by comparing it with 
other tools already proven to be valid. Construct validity refers to the degree to which a tool 
compares with other tools that evaluate the same or similar items. Content validity is the extent 
to which the elements of the test conform to a content domain associated with the construct 
(ATS, 2008; Curtis & Patrick, 2003). Face validity of a tool refers to whether the tool appears to 
measure a certain criterion, and this is important to both the population being studied and the 
researchers applying the tool (ATS, 2008). 
 
2.5.3 RESPONSIVENESS  
Responsiveness is the extent to which an assessment tool is capable of measuring change and 
the more categories of response on the scale of an instrument, the more responsive the 
instrument is likely to be (ATS, 2008; Jones & Kaplan, 2003). To enhance interpretation, it is 
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essential to know the smallest change on the scale of an instrument that represents a clinically 
meaningful improvement (Redelmeier, Bayoumi, Goldstein, & Guyatt, 1997, Waterhouse, 
Walters, Clarke, & Lawson, 2006). Questionnaire instruments should have a clearly stated time 
frame to which a response applies (Meek, 2004) e.g. the last week, the last two weeks.  
 
2.5.4 ACCEPTABILITY 
Acceptability describes the degree of the burden (of using the instrument as a measuring tool) 
to the staff and participants in a research or patients in the clinical setting. A test that is too 
complex or takes an excessive length of time to carry out may discourage potential participants 
from participating in a study or increase the drop out from the study. A battery of tests that 
involves the use of too many tools may result in a similar unwanted effect (Andresen, 2000; 
ATS, 2000). 
 
2.5.5 COPD DIAGNOSTIC/SEVERITY CLASSIFICATION TOOLS AND OUTCOME 
MEASURES IN PR OF PATIENTS WITH COPD  
Breathlessness is experienced by patients with COPD as well as patients with other conditions 
like asthma and lung cancer.  Lung function tests are confirmatory tests which can distinguish 
COPD in a patient from other conditions that cause breathlessness. To determine the incidence 
of COPD and whether spirometry offers independent prognostic value relating to pulmonary 
outcomes, Wilt et al. (2005) conducted a systematic review of publications in English from 1966 
to May 2005 in MEDLINE and the Cochrane Database. Analysis indicated that using the fixed 
ratio of spirometry may result in over diagnosis of COPD in the elderly population and under 
diagnosis of COPD in adults aged below 45 years. The classifications of COPD based on European 
Respiratory Society (ERS), American Thoracic Society (ATS) and Global Initiative for Chronic 
Lung Disease (GOLD) guidelines used lung function tests (FVC and FEV1) as tests of reference 
for COPD diagnosis because they show the least variability (Quanjer et al., 1993; Siafakas et al., 
1995; Wan et al., 2005).  
Tsoumakidou et al. (2004) (n=67, mean age=69.4 years, current smokers=22) compared the 
three scales and demonstrated that the ERS and GOLD severity scales of COPD do significantly 
correlate with the frequency of exacerbation while the ATS scale of COPD severity does not. 
However, 97% (n=65) of the participants in the study by Tsoumakidou et al. (2004) were males. 
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Barbarito, Vaghi and De Mattia (2011) (n=184) conducted post-bronchodilator lung function 
tests to identify airway obstructions in patients with respiratory symptoms or diagnosis. The 
authors demonstrated that the ERS scale is the most sensitive of the three scales while the ATS 
scale and especially the GOLD scale of severity of COPD can lead to a significant under-diagnosis 
of COPD. A limitation in the study by Barbarito et al. (2011) is that participants were all smokers 
and this limits the application of its findings to non-smokers with COPD. 
The NICE guidelines (2004) recommended the use of the ERS guideline (Quanjer et al., 1993) in 
the diagnosis of COPD in the UK, which is the population of study in this research. 
Lung function tests are of diagnostic relevance; however, the GOLD Committee stated that 
specific spirometry severity cut points are ‘‘for the purposes of simplicity and have not being 
clinically validated’’ (GOLD, 2010, p. 3). Findings of a study of 22 patients with COPD (Singh, 
Morgan, Hardman, Rowe, & Bardsley, 1994) demonstrated a weaker relationship between 
maximal oxygen consumption and FeV1 (r=0.36) compared to the relationship between the 
shuttle walk test and maximal oxygen consumption (r=0.88) (p<0.05). Also, Joo, Au, Fitzgibbon, 
McKell and Lee (2011) (n=1052, male=283, age ≥35 years) demonstrated that diagnosis based 
on spirometry was accurate only in 50.9% of cases. 
Paladini, Hodder, Cecchini, Bellia and Incalzi (2010) used a telephone survey of patients with 
physician diagnosed COPD to examine the reliability of the MRC dyspnea score as a surrogate 
indicator of perceived health status in patients with COPD. Two hundred patients (aged>64 
years, 146 male, MRC disease severity domains [76 with MRC 1, 53 with MRC 2/3, 74 with MRC 
4/5]) completed questionnaires on indicators of health status which included emotional status, 
limitations in social life and limitations in functional status. The authors also investigated the 
percentage of patients in each MRC domain that were on LTOT. Paladini et al. (2010) identified 
a significant association between patients’ MRC domain and each of the indicator of health 
status (p<0.02) and between MRC domain and percentage of patients on LTOT (p<0.01). The 
authors concluded that the MRC score is a reliable marker of COPD severity. The study was 
limited in generalisability due to underrepresentation of females (27%). Also, the authors had 
no access to data on participants’ lung function tests and were unable to compare their findings 
with spirometry based COPD severity measurement. 
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2.5.6 CHOICE OF EXERCISE TESTING; MAXIMAL VERSUS SUBMAXIMAL 
EXERCISE TESTING  
Maximal exercise tests are used to measure or predict the maximum oxygen consumption 
(VO2max) (Ellestad, 2003). In theory, a maximal test is defined by the plateau of the oxygen 
consumption (VO2) with additional rise in workload (Jenkins, 2008; McArdle et al., 2007).  
Nooman and Dean (2000) suggest that using submaximal exercise testing in patients makes it 
possible to overcome many of the limitations of maximal exercise testing with various 
impairments. Submaximal exercise capacity is often evaluated in patients with COPD as the time 
or distance to exhaustion during a constant workload or when the endurance test is carried out 
at intensity between 60% and 85% of maximum work capacity (Oga et al., 2000; Revill, Morgan, 
Singh, Williams, & Hardman1999). In a cross-over randomised, placebo-controlled trial of 
patients with COPD (mean FeV1 = 40.8%), Oga et al. (2000) compared the six-minute walk test, 
maximal oxygen consumption during progressive cycle ergometry and cycle endurance test at 
80% of the maximal workload to see which of the tests is most sensitive to changes in exercise 
performance following administration of oxitropium bromide. Each patient in a random order 
participated in each of six-minute walk test, progressive cycle ergometry and cycle endurance 
test. Comparison of pre- and post-intervention exercise performance demonstrated that 
oxitropium bromide resulted in a significant increase of endurance time (19%, p<0.001) in cycle 
endurance test, and resulted in a small but significant increase in the six-minute walk test (1%, 
p<0.05), but no significant increase in maximal oxygen consumption during progressive cycle 
ergometry.The result indicated that the responses to intervention in the three tests were 
different, with the endurance test being the most sensitive to changes in exercise performance 
following the use of oxitropium bromide in patients with COPD. A limitation of this study was 
that the participants were all male, which limited the generalisation of the findings to females. 
Further, while the study was conducted on patients with COPD, the intervention was not PR, 
which is being investigated in the studies detailed in this report.  
 
In the study by Revill et al. (1999) (n=21), the sensitivity of endurance shuttle walk test (ESWT) 
and incremental shuttle walk tests (ISWT) were compared following PR. Patients participated in 
the ESWT and ISWT at the beginning and end of a seven-week, twice-weekly outpatient PR. 
Comparison of pre- and post-intervention walk tests demonstrated an increase of 160% in 
ESWT duration compared to an increase of 11% in ISWT distance (Revill et al., 1999). Pepin et 
al. (2011) identified a minimal clinically important difference (MCID) for ESWT following the 
use of a bronchodilator but the authors were unable to identify the MCID for ESWT following 
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PR. Waterhouse, Walters, Clarke & Lawson (2006) defined the MCID for ESWT following PR in 
patients with COPD as a change of 173m, standard deviation (SD) =180m (refer to section 7.4). 
 
2.5.6.1 SUBMAXIMAL EXERCISE TESTING IN COPD; 6MWD VERSUS ESWT 
Jenkins (2008) suggested that the particular exercise test in patients with COPD could be 
decided based on outcome of interest, intervention, patient characteristics and availability of 
resources. These are detailed below. 
(i) Outcome(s) of interest: The outcome of interest in the management of patients with COPD 
may include changes in maximal, submaximal or functional exercise capacity. Field walking 
tests are good alternatives to laboratory-based tests because walking is representative of 
activity in daily living and a measure of exercise tolerance; additionally, the test procedure 
needs minimal equipment (Noonan & Dean, 2000). The outcome of interest could be the 
distance walked e.g. as in the ISWT and six-minute walk test (6MWT) or the time to exhaustion, 
as in the ESWT.  
(ii) Intervention: The aim of the intervention, e.g. improvement of exercise tolerance, could 
influence the choice of an exercise test. The use of the same exercise mode (e.g. walking) for 
testing and training ensures a more direct conversion of the exercise prescription to the training 
programme (Palange et al., 2000). Noonan & Dean, (2000) suggested that the advantages of 
externally paced walk tests, such as the ESWT, over self-paced tests like the 6MWD, include the 
ability to compare exercise responses and symptoms at a standardised work rate (isowork rate) 
or time (isotime). 
(iii) Patient characteristics: Stein et al. (1998) investigated the relationship between heart rate 
variability and COPD. The authors compared 18 patients with alpha1-antitrypsin deficiency (13 
male, 13 with COPD and five with normal FeV1) with 18 age- and gender-matched, non-smoker 
control subjects. Results demonstrated significant correlations (r=0.48 to 0.88, p<0.05) between 
abnormal FeV1 and abnormal heart rate recovery. This may impact on altered autonomic tone 
during exercise, thereby limiting the usefulness of heart rate as a measure of exertion in this 
patient group. All participants in the study were below 47 years of age and this may limit the 
generalisability of the result.  
iv) Availability of resources: Eaton, Young, Nicol and Kolbe (2006) study of 20 patients with 
COPD (male=11, mean age=71 years) compared pre- and post-walk tests following eight-week 
PR. The study identified that the ESWT (92% change) is more responsive than the 6MWD (17% 
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change) to PR intervention. Solway, Brooks, Lacasse and Thomas (2001), however, conducted a 
systematic overview of clinical trials and observational studies published in MEDLINE (1966 to 
January 2000) and CINAHL (1982 to December 1999) in order to identify the most frequently 
used walk tests. The authors identified 52 studies which examined measurement properties of 
the different walk tests; five on the two-minute walk test, four on the shuttle walk test, six on 
the self-paced walk test, 13 on the 12-minute walk test and 29 on the 6MWT. Brooks (2006) 
argues that the use of the ESWT is not as common as 6MWT because of time limitation and 
patient tolerance.  
 Al-Ameri (2006) studied 129 patients (41% male, mean age=43 years, 65 with respiratory 
illness) and indicated that the 6MWT correlated significantly with patients’ height, spirometry 
parameters and diffusion capacity (p<0.05). For two years, Pinto-Plata, Cote, Cabral, Taylor and 
Celli (2004) observed 198 patients with severe COPD (85% male, mean FeV1= 1.04L) and 41 
age-matched control subjects (76% male, mean FeV1=2.54) to examine the correlation between 
6MWT and survival. The authors identified that 6MWD was an independent predictor of 
survival (risk ratio of death =0.82) per 50m increase in 6MWD (p<0.003). An interpretation of a 
change in 6MWD following an intervention may be invalid unless the participants undergo two 
practice tests (American Thoracic Society, 2002). Though the test requires a patient to “walk as 
far as possible for six minutes” with an instruction that the patient is expected to “become 
exhausted” (American Thoracic Society, 2002, p.113), the test is not externally paced (hence an 
individual can choose the walking speed). Brooks and Solway (2006) argue that it is therefore 
not a true measure of endurance. 
The 6MWT distance is influenced by an individual’s age (Tsang, 2005) (n=548, age between 21 
and 70 years), gender, height, and weight (Enright et al., 2003) (n=3,333, age>/=68 years) race 
and ethnicity (Poh et al., 2006) (n=35, age between 45 and 85 years). For the result of the 
6MWD in a PR programme to be valid, the PR programme would have to design its own 
regression equation taking into consideration the race and ethnicity of the participants. Notably, 
while Redelmeier, Bayoumi, Goldstein and Guyatt (1997) (n = 112, mean FEV1 = 0.98L) indicate 
the MCID for 6MWD to be 54 metres, an RCT by Guyatt et al. (1984) (n=43, mean FeV1<70%) 
found that giving simple encouragenment to a COPD patient could actually lead to increase of up 
to 60 metres in 6MWD; this is an increase which could be misinterpreted as the impact of an 
intervention.  
ESWT is an externally paced field endurance walking test in which a patient with COPD is 
required to walk at 85% of his or her maximum walking ability, which is decided by the 
maximum ISWT performed around two cones, nine metres apart on a flat floor (Revill et al., 
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1999; Singh et al., 1992). The developers indicate that the ESWT walking speed is calculated by 
using the larger of two ISWTs based on the formula: 85% [4.19 + (0.025 x ISWT distance)]. The 
outcome is referenced against a graph which gives predicted VO2 max versus walk speed (Revill 
et al., 1999) to decide the ESWT speed. The ESWT itself is preceded by a slower warm up period 
of 90 seconds, following which the test proper commences. The test result is the duration of the 
walk at the constant speed minus the warm -up time.  
The ESWT was developed in a population of patients with COPD (n=32) (Revill et al., 1999). 
The test was validated against an endurance treadmill test and there was no significant 
difference in the distance walked, post-exercise heart rate or Borg breathlessness score (Revill 
et al., 1999). ESWT has been demonstrated to have good reliability and two ISWTs are required 
for determining the ESWT speed. Gray, Smith, Britton, Murray and Bott (2006) (n=392) 
observed that performing a practice ISWT showed an average change in ESWT of one level, with 
a range of -4 to +6 seconds. The negative and positive range of the change demonstrates that if 
both ISWTs are performed on the same day, the second ISWT is not consistently longer than the 
first ISWT. A recent study of 48 patients with COPD (Spencer, Alison, & McKeough, 2014) 
(male=22, mean FeV1=59%) demonstrated that the difference in walk distance between the first 
and second ISWT was significant (p<0.05) on day zero (mean 17m, SD 33m) before 
commencement of a maintenance exercise programme and at three months (mean 18m, SD 
39m) after commencement of a maintenance exercise programme. However, the difference 
between the first and second ISWT was not significant at the sixth month (mean 6m, SD 36m) or 
12th month (mean -2m, SD 39m) after commencement of a maintenance exercise programme. 
However, the data in the study by Spencer et al. (2014) was taken from patients with COPD 
undergoing a maintenance exercise programme following PR and the authors were unable to 
determine what the baseline ISWT of participants would have been before PR. Singh et al. 
(1992) had previously established the existence of learning effect prior to participation in PR in 
patients with COPD.  
The procedure of the one-walk protocol ESWT (Revill et al., 2009) involves the following: 
A participant performs two ISWTs. 
The larger ISWT value is used to compute the ESWT level using the formula: 85% predicted VO2 
max (ml/min/kg) = 4.19 + (0.025 x ISWT distance).  
The value of the 85% predicted VO2 max is used to identify the appropriate walking speed from 
the graph supplied by the ESWT developer. 
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The ESWT level nearest to the calculated walking speed would be the level at which the 
participant would perform the ESWT.  
The ESWT itself is preceded by a slower warm up period of 90 seconds, following which the test 
proper commences.  
The test result is the duration of the walk in seconds at the constant speed minus the warm up 
time (Revill et al., 2009) 
Calculating the ESWT based on the longer of the two ISWTs ensures that a participant is 
assessed at the highest possible level of ESWT appropriate for him, thereby minimising the 
occurrence of ceiling effects. 
Following PR, an ESWT improvement of 92% (p< 0.05) (Eaton et al., 2006) and 160% (p < 0.05) 
(Revill et al., 1999) over the baseline value were reported. Eaton et al. (2006) (n=20, mean FeV1 
=0.95L) assert that the ESWT is more responsive than the 6MWD (92% versus 17%) and Revill 
et al. (1999) (n=32, mean FeV1 =0.80L) found that ESWT is more sensitive than ISWT (160% 
versus 11%). Waterhouse et al. (2006) identified the MCID for ESWT following PR as a change 
of 173m (SD 180) (refer to section 7.4).  
The need for two ISWTs and two ESWTs was a limitation to the acceptability of the ESWT 
clinically and in research (Brooks & Solway, 2006). However, previous studies suggest that a 
practice ESWT walk is not required when ISWT has been performed on the same day. Revill, 
Williams, Sewell, Collier and Singh (2009) (n=44, male=33, mean FeV1=37%) reported within-
day repeatability of ESWT between the two ESWTs carried out on the same day as mean 
individual differences of 12 seconds (and limits of agreement of ± 100 seconds with p<0.05). 
Another study (Roberts, Stern, Schreuder, & Watson, 2010) (n=41, male=26, mean FeV1=47%) 
demonstrated a mean difference of -26 seconds (p<0.05) between the one-walk ESWT protocol 
and the two-walk ESWT protocol. The authors suggested that a practice ESWT walk is not 
required, especially in measuring change related to exercise treatment, although when 
evaluating non-exercise treatments, two protocol ESWT is probably more sensitive to marginal 
changes and shows fewer ceiling effects. 
Roberts (2010) demonstrated a higher completion rate at baseline and discharge when the one-
walk ESWT protocol was used compared to when a two-walk ESWT protocol was used (71% 
versus 54%). While there was a greater ceiling effect with the one-walk ESWT protocol 
compared to the two-walk ESWT (12.2% versus 7.3%), the ceiling rate was within an acceptable 
limit and both protocols showed the same floor rate of 4.9% (Roberts, 2010).  
40 
 
2.5 7 MEASURES OF BREATHLESSNESS AND DISABILITY  
The reduced exercise tolerance in patients with COPD is due to ventilatory impairment and 
dyspnea (Mejia, Ward, Lentine & Mahler, 1999). Measures of breathlessness include exertional 
and standard measures of breathlessness (Meek, 2004). 
Exertional outcomes measure breathlessness before, during, and after exercise. The exertional 
outcome that were evaluated were the original Borg scale (which ranges between 6 and 20), the 
modified Borg scale CR10 (which ranges between 0 and 10), the modified Borg scale CR100 
(which ranges between 0 and 100) and the visual analogue scale. The Borg scale CR10 and the 
Borg scale CR100 assign numerical values to degree of exertion and they are modification 
versions of the original Borg scale (which ranges between 6 and 20) (Borg, 1970). Borg and 
Kaijser (2006) studied 64 healthy subjects (male=36) and indicated that the Borg scales CR10 
and CR100 showed a more linear relationship with increasing heart rate and blood lactate than 
the original Borg scale. The authors also observed that in a significant number of participants, 
the description of breathlessness experienced on the original Borg scale did truncate and some 
individuals indicated the rating “20” more than once. Developers of the modified Borg scales 
CR10 and CR100 managed this limitation of the original Borg scale by the use of decimals above 
the written value (e.g. 0.5) on the modified Borg scales (Borg & Kaijser, 2006). They identified 
that despite the fact that the CR100 has number range than the CR10, there was no significant 
difference (p<0.05) in exponents or between the number ranges that participants used to 
describe the perceived exertion between the first and the last work levels.  
Wilson and Jones (1989) compared the use and repeatability of Borg scale CR10 and the visual 
analogue dyspnea scale in healthy subjects (n=10). The two scales demonstrated similar 
strength of same-day repeatability but the modified Borg scale CR10 demonstrated better 
repeatability with a mean decrease of 16% compared to the mean decrease of 27% that was 
observed on the VAS score for breathlessness. 
The Borg scale CR10 rates the total effort or distress that an individual feels during exercise on a 
12-point scale between 0 to 10; number 0 represents no perceived breathlessness while 10 
represents the greatest degree of breathlessness (Borg, 1970).  
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Table 2.2 Modified Borg scale of perceived exertion (CR10) (Borg, 1970) 
0 No breathlessness 
0.5 Very very slight 
1 Very slight 
2 Slight 
3 Moderate 
4 Somewhat severe 
5 Severe 
6  
7 Very Severe 
8  
9 Very very severe 
10 Maximal breathlessness 
 
The Borg scale CR10 was developed in a population of healthy individuals (Borg, 1970). Mejia 
et al. (1999) conducted an RCT (n=44, 21 male, 40 to 75 years) and using either targeted 
dyspnea rate (TDR) or targeted heart rate (THR), patients with COPD were instructed on 
exercise intensity appropriate for 75% of maximal oxygen uptake (VO2max). At follow up visit 
and compared to the recommended VO2max, the TDR arm demonstrated individual percent 
differences in VO2max of -2.3 +/- 17.0% compared against 2.6 +/- 30.6% by the THR arm. This 
indicated that Borg CR10 is as valid as heart rate as an outcome measure of targeted exercise 
intensity. The modified Borg scale (CR10) significantly (p < 0.05) but weakly correlates with 
change in inspiratory capacity following exercise (r = -0.34) (O'Donnell et al., 1998). In healthy 
subjects, same-day repeatability demonstrated no significant difference in outcome, though a 
significant difference of 16% was demonstrated over two to six weeks (Wilson & Jones, 1989). 
The test score indicated a normal distribution in patients with COPD (Hajiro et al., 1998), 
including a significant intraclass coefficient of reliability (p<0.0001) over eight weeks 
(O'Donnell, Lam and Webb., 1998).  
Borg scale CR10 is responsive to exertion and a dyspnoea score of 2.5 (“slight” to “moderate”) 
on the scale corresponds to 75% VO2 peak on the bicycle ergometer (Mejia, Ward, Lentine & 
Mahler, 1999). A retrospective review of clinical trials that evaluated the scale in patients with 
COPD who participated in PR suggested the MCID to be one unit change (Ries, 2005a).  
The study by Mejia et al. (1999) (n=44) suggested good acceptability of Borg scale CR10 in 
patients with COPD.  
A standard measure of breathlessness is used to describe activity-related breathlessness. While 
lung function (FeV1) is used for classification of COPD severity, Singh et al. (1994) (n=22) 
demonstrated that FeV1 has a weaker relationship with maximal oxygen consumption (VO2max) 
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(r=0.36) compared to the relationship between the VO2max and shuttle walk test (r=0.88) 
(p<0.05). Fletcher et al. (1959) developed the MRC scale in 384 (male=192) subjects and 
identified a significant association between the existence of bronchitis and MRC dyspnea score 
(p<0.05). Bestall et al. (1999) validated the scale in a population of patients with COPD 
(n=100, men= 55, mean age=70 years) and observed a significant relationship (p<0.05) 
between MRC scale and shuttle walk, mood and quality of life assessment tools respectively. 
Participants with different MRC scores (three versus four) demonstrated significant differences 
in SGRQ total (odds ratio=1.09, CI [confidence interval] =1.06 to 1.39), incremental shuttle walk 
test (odds ratio=0.33, CI=0.001 to 0.613), and HAD depression score (odds ratio=1.42, CI= 1.37 
to 1.95) (p<0.03). Participants with MRC 4 demonstrated significant difference in incremental 
shuttle walk test compared to participants of MRC 5 (odds ratio=0.11, CI= 0.02 to 0.6) (p<0.01). 
Paladini et al. (2010) study of 200 patients with physician diagnosed COPD (146 male, aged>64 
years, 76 with MRC 1, 53 with MRC 2/3, 74 with MRC 4/5) demonstrated a significant 
association between patients MRC score and each of emotional status, limitations in social life, 
imitations in functional status (p<0.02) and percentage patients on LTOT (p<0.01). The authors 
indicated that the MRC score is a reliable indicator of COPD severity. 
As indicated below, the MRC scale classifies patients with COPD on a 5 point scale based on their 
dyspnea disability level.  
Level 1-I only get breathless with strenuous exercise. 
Level 2-I get short of breath when hurrying on the level or up a slight hill. 
Level 3-I walk slower than people of the same age on the level because of breathlessness, or 
have to stop for breath when walking at my own pace on the level.  
Level 4 -I stop for breath after walking 100 yards or after a few minutes on the level. 
Level 5 - I am too breathless to leave the house (Fletcher, 1959, page 265). 
MRC dyspnea levels 1 and 2=mild COPD,  levels 3 and 4 =moderate COPD, and level 5 = severe 
COPD. 
In patients with COPD Lorenzi et al. (2004) (n=71, mean age = 73 years) demonstrated 
responsiveness of MRC dyspnea scale to six week PR (from mean 4.2 to 3.2, p < 0.01) and 
Nishimura, Izumi, Tsukino, & Oga (2002) (n=227, mean age = 68 years, male=90%) 
demonstrated that the scale is predictive of 5-year survival (p < 0.001). 
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A survey of 550 men and women (age>/= 15 years, with mixed respiratory symptoms) 
demonstrated statistically significant test-retest reliability of the MRC scale over four times in 
duration of two years (Lende, Meulen, & Wever-Hess, 1972). Mahler et al. (2009) evaluated the 
MRC score of 101 patients with stable COPD (mean FeV1=53%, mean age=66 year, female=52) 
and repeated the same in 89 of these patients at three months follow-up visit. The authors 
identified intraclass correlate on coefficients at baseline and at follow up for the MRC scale was 
0.90 and 0.84. 
No study has directly evaluated the acceptability of the MRC scale in patients or clinicians. 
However, it has widespread clinical use and it is the recommended tool on which referral of 
patients (with COPD) to PR is based (NICE, 2010). It was reported to take one to two minutes to 
administer for patients with COPD (Roberts, 2010).  
 
2.5.8 QUALITY OF LIFE OUTCOME MEASURES 
Goodinson and Singleton (1989) suggest that individuals’ priorities may change over time and 
result in them changing the idea of what aspect of life is important or not important. The 
internal reliability and the test-retest reliability of a quality of life (QoL) instrument are 
important.  
QoL measuring tools are broadly divided into generic (non-disease specific) and disease-
specific. 
Previous studies have established the validity and reliability of generic QoL questionnaires and 
disease-specific questionnaires in patients with COPD following PR. Boueri, Bucher-Bartelson, 
Glenn and Make (2001) (n=37, mean age>66 years, mean FeV1 =29.6%) demonstrated the 
existence of a significant correlation between the 6MWT and three of the SF-36 scales: physical 
function (r =0.70), bodily pain (r =0.38) and general health (r =0.42) (p<0.05). Singh, Sodergren, 
Hyland, Williams and Morgan (2001) (n=97, mean age=67 years, mean FeV1 =59%) found a 
significant correlation (p<0.05) between the the shuttle-walking test and the CRQ (r=0.33) and 
SGRQ (r=-0.39) respectively. The authors also noted a significant correlation (p<0.05) between 
the breathing problems questionnaire (BPQ) and the CRQ (r=0.54) and SGRQ (r=0.69) 
respectively. 
 
Harpers et al. (1997) (n=156, mean age=64 years, mean FeV1 =47%) compared the SF-36 and 
disease-specific questionnaires (SGRQ and CRQ) and indicate that, while the SF-36 reflected 
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other health problems more than the SGRQ and CRQ, it is not as sensitive to change (in the 
specific symptoms of a COPD disease) in comparison to the two disease-specific health related 
QoL instruments. Glaab, Vogelmeier and Buhl (2010) suggest that the lack of established MCID 
for SF-36 is a major disadvantage compared to the disease-specific questionnaires. 
 
In the management of patients with COPD, the CRQ and the SGRQ are the most commonly used 
and referenced disease-specific QoL instruments (ATS, 2008). Singh et al. (2001) indicate that 
both the SGRQ and CRQ were sensitive to change following PR, though the Breathing Problem 
Questionnaire (BPQ) has no known MCID. In the study by Singh et al. (2001), the SGRQ had the 
lowest questionnaire completion rate (66%) compared to the CRQ (78%) and BPQ (79%), 
though Aggarwal et al. (2007) report a 100% questionnaire return rate in their study of 50 
patients with COPD who completed the Hindi version of the SGRQ and there was no missing 
item in any of the returned questionnaires. Compared to the CRQ, the SGRQ demonstrated a 
slightly higher correlation with the shuttle walk test (r=0.39 versus 0.33) and the BPQ (r=0.69 
versus 0.54) (p<0.05) (Singh et al., 2001).  
 
Further, while the study by Singh et al. (2001) was a short-term evaluation of patients with 
COPD, another study by Griffiths et al. (2000) (n=200, male=120, mean age=68 years, mean 
FeV1 =39%) studied the effectiveness of PR in patients with COPD over a duration of one year. 
The authors reveal that immediately post-six-week PR, both SGRQ and CRQ demonstrated a 
significant (p<0.05) difference in favour of the PR group over the control group. However, at one 
year post-PR, only the SGRQ demonstrated a sensitivity that maintained a significant (p<0.05) 
difference between the study arms (in favour of the PR arm). This suggests that changes 
observed in the SGRQ may be more stable than that observed using the CRQ. Hence, the SGRQ 
may be a more appropriate QoL tool in the study presented in this report which investigated 
effectiveness of an intervention (PR concurrently with VBHEP) at the eighth week of PR and at 
six months post-PR. The CRQ can take up to 30 minutes to administer and, unlike the SGRQ, 
does not examine activity restriction. The SGRQ has a discrete section for cough, phlegm and 
frequency of attack.  
 
The SGRQ (Jones, Quirk, & Baveystock, 1991; Jones, Quirk, Baveystock, & Littlejohns, 1992) is a 
disease-specific tool developed to measure impact on overall health and daily perceived well-
being. It requires face to face administration and completion time is about ten minutes. It 
contains 76 items in three domains, namely symptoms (frequency and severity), activity 
(caused or limited by breathlessness) and impacts (on social functioning and psychological 
disturbances resulting from airway impairment). Section I is scored on a scale of one to five, 
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while sections II and III are dichotomous, requiring yes or no answers. Scoring is computed for 
each section and overall for all sections, with each item weighted based on empirical data with 
scores ranging from 0 to 100, and higher scores indicating poor health. Empirical data and 
interviews with patients by the authors of the questionnaire indicated that a mean change in a 
score of four units represents a slightly effective treatment, eight units for a moderately 
effective treatment and 12 units for very effective treatment (Jones et al., 1992). Domingo-
Salvany et al. (2002) (n=321 patients with COPD) determined that every four-point increase in 
SGRQ total score is associated with an increased risk of global mortality of 5.1% (95% CI: 0.97–
9.4%). However, all participants in the study were male, which limits the generalisability of the 
findings to female patients with COPD.    
Jones et al. (1992) developed and validated the SGRQ in a population of patients with COPD 
and asthma (n=141, mean age=63 years, mean FeV1=47%). The authors found that the activity 
domain of SGRQ correlated with 6MWT (r=-0.35) and MRC score (r=0.5) while the impact 
domain correlated with 6MWT (r=-0.35) and MRC score (r=0.44) (p<0.001). Jones et al. (1992) 
further evaluated reliability of the SGRQ by administering it to a subset of the participant (40 
with asthma, 20 with COPD) twice, two to three weeks apart. In the COPD population, the 
coefficient of variation was 19% and the coefficient of repeatability for the domains was 0.91 
(symptom), 0.87 (activity) and 0.88 (impact). In patients with COPD who participated in PR, the 
SGRQ correlates significantly (p<0.05) with change in exercise capacity and other QoL 
instruments (Singh et al., 2001). The SGRQ was responsive to seven weeks (Singh et al., 2001) 
and six weeks (Griffiths et al. 2000) of PR intervention in patients with COPD and improved 
beyond the minimal clinically significant difference. Change in the SGRQ was demonstrated to 
be durable over a one-year period (Griffiths et al. 2000). 
Subsequent to the original English version, the SGRQ has been demonstrated to be acceptable 
and has been validated in many languages (ATS, 2007). Singh et al. (2001) indicate a 66% 
completion rate. A more recent study by Malek-Yazdi, Lewczuk, Haddon, Choudry and Ryan 
(2007) (n=244 [91 healthy and 153 with COPD]) reported a 91% completion rate by patients in 
the clinical settings, and suggested that clinicians considered cost and time of administration as 
limitations. Aggarwal et al. (2007) reported a 100% completion rate of the Hindi version of the 
SGRQ. 
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2.5.9 DEPRESSION IN PATIENTS WITH COPD AND RELIABILITY IN 
DEPRESSION SCREENING AND ASSESSMENT 
A study of 137 outpatients with COPD (69 men, mean age=73 years, mean FeV1=0.89L) who 
completed the Brief Assessment Depression Card (BASDEC) showed that depression affects 
approximately 40% of this patient population (Yohannes, Baldwin, & Connolly, 2000). A 
retrospective study (Jennings, Digiovine, Obeid & Frank, 2009) (n=194, men=95, mean age=61 
years, mean FeV1=44.5%) demonstrated a significant positive association between depression 
and acute exacerbations in patients with COPD (relative risk =1.44, confidence interval= 1.09–
1.92, p< 0.01). A prospective study (Crockett, Cranston, Moss & Alpers, 2002) (n=150, female 
=83, age<80 years) identified a significant positive correlation between poor CRQ emotional 
score at the time of commencing LTOT treatment and increased mortality in the female patients 
with COPD. 
Previous observational studies of patients with depression by Banki, Karmacsi, Bissette and 
Nemeroff (1992) (n=24) and Bob et al. (2008) (n=30) suggest an inverse relationship between 
cortisol (a stress hormone) concentration and depression symptom. Another study of coping 
techniques in civil servants population (n=542, male=350, mean age=61 years) indicated that 
salivary cortisol output was indirectly associated with seeking social support (p=0.034) and 
problem engagement (p=0.003) (O'Donnell, Badrick, Kumari, & Steptoe, 2008). 
Bhagwagar, Hafizi and Cowen (2005) study of 20 unmedicated depressed subjects versus 40 
healthy control) disclosed that acutely depressed individuals secreted 25% more cortisol within 
60 minutes of waking than controls, after which the cortisol levels in the two groups were about 
the same. The authors maintain that this early morning increase is dependent upon the time of 
waking. Den Hartgo et al. (2008) study of 27 unmedicated patients with depression and 36 
healthy controls, reported significant direct association (0.236, p=0.025) between cortisol level 
and cognitive speed. The authors suggest that this relationship is not causal but both altered 
cortisol curve and cognitive speed were functions of the severity of depression. 
Carrying out depression screenings in the same half of the day may enhance validity of the 
results of the screening by avoiding any error that may be due to the diurnal hormonal 
variation. 
A literature review highlighted various depression tools: the Hospital Anxiety and Depression 
Scale (HADS); the Brief Assessment Depression Card (BASDEC); Beck Depression Inventory-
Fast Screen (BDI-FS); Symptom Check List (SCL-5); Geriatric Mental State Schedule (GMS) 
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and Geriatric Depression Scale (GDS). While no single publication was found to have compared 
all the outcome measures together in one study, different studies were found to have compared 
two or more of the depression tools in different patient populations, including patients with 
COPD. In a population of non-demented geriatric patients (n=102, mini-mental-state 
examination score 24 to 30), BASDEC demonstrated better sensitivity than SCL-5 (91% 
compared to 77%) (Loke et al., 1996). In a study of 49 stroke survivors (male=21, mean age=79 
years), BASDEC demonstrated significantly higher validity than the HADS (0.57 versus 0.40) and 
the BDI-FS (0.57 versus 0.44) (p<0.05) (Healey et al., 2007). 
The BASDEC is a set of 19 statements relating to depression symptoms, each written on a 
separate card). The respondent is instructed to place the statement card next to a ‘‘true’’, ‘‘false’’, 
or ‘‘don’t know’’ card according to the respondent’s current view. ‘True’’ statements are scored 
one point; ‘don’t know’ responses are scored 0.5 points, with the exception of two statements - 
in card numbers six and seven, which are scored as two points if “true” or one if “don’t know”. 
‘False’ statements are scored 0. The maximum possible score is 21, with higher scores indicating 
greater symptom of depression. A score of seven and above is classified as depressed and a 
score of less than seven is classified as non-depressed (Adshead et al., 1992; Yohannes et al., 
2000).  
Yohannes et al. (2000) validated BASDEC in a population of patients with COPD (n=137, 
male=69, mean age=73 years, mean FeV1=0.89L). BASDEC with a cut-off of seven demonstrated 
100% sensitivity in the diagnosis of depression against the GMS. Yohannes, Roomi, Waters and 
Connolly (1998) studied reliability in clinically stable patients with COPD (n=96, male=56, 
mean FeV1=45.5, mean age=78) and age-matched healthy subjects (n=55, male=23, mean 
FeV1=71.4). The authors reported that the BASDEC demonstrated a significant (p<0.0001) 
positive predictive value of CRQ quality of life score in patients with COPD. There are 
indications that carrying out depression screening in the same half of the day accounts for 
diurnal hormonal variation and enhances reliability (Bhagwagar et al., 2005; den Hartgo et al., 
2008). 
A prospective observational study (Adshead et al., 1992) (n=79) reported that BASDEC is more 
acceptable and user-friendly than the GDS. Seventy-two of the 79 participants completed both 
BASDEC and GDS), in which one respondent (1.26%) refused to complete the BASDEC, 
compared to seven (8.86%) who refused to complete the GDS. Analysis of completed 
questionnaires from the 72 non-demented elderly subjects (male=21, mean age=78 years) who 
completed both questionnaires concludes that both tools demonstrated identical sensitivity 
(71%), identical specificity (88%) and identical positive predictive value (74%).  
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2.5.10 SOCIAL SUPPORT SCALES 
Various studies established the importance of social support in patients with COPD. A large 
study (Prescott, Godtfredsen, Vestbo, & Osler, 2003) (n=26,392, male=12,400) monitored 
patients with COPD for an average duration of 12 yrs. The authors obtained information on 
housing from the record of building and dwelling statistics and demonstrated that in this 
patient group, people who cohabitate lived longer; female ( risk ratio=1.07, CI= 0.79–1.45), male 
(risk ratio= 0.67, CI=0.52–0.87). A smaller study of patients with COPD on LTOT (Crockett et al., 
2002) (n=157, male=74, age<80 years) confirmed a significant association (p<0.05) between 
cohabitation and an additional 12 months’ survival. Another study (n=156, mean age=71) 
administered the Duke Social Support Index scale (DSSI) to patients with COPD and 
demonstrated significant positive association (p < 0.05) between social support and overall 
functioning as measured by World Health Organization Disability Assessment Schedule II 
(Marino, Sirey, Raue, & Alexopoulos, 2008).  
In the evaluation of social support in patients, some authors presented a dichotomy of 
cohabiting versus living alone (Crockett et al., 2002; Prescott et al., 2003). Another study of 
patients participating in PR (Haave & Hyland, 2008) (n = 132, 92 with asthma, 40 with COPD), 
simply considered participants’ responses to the question “Are you living alone?” as a measure 
of social support. However, these approaches do not represent the multidimensional nature of 
social support. 
Various multidimensional scales of social support include the Yale Social Support Index 
(Seeman & Berkman, 1988), Interview Schedule for Social Interaction (ISSI) (Henderson, 
Duncan-Jones, Byrne, & Scott, 1980) and DSSI (Koenig et al., 1993). 
 The Yale Social Support Index has 29 items, but some of the words are in American English that 
may not be appropriate for the UK population. The ISSI is a 45 minute interview which 
evaluates details of an individual’s network of social support (supportive social relationship) in 
the last 12 months. The questions cover close relationships like family, and diffuse associations 
like work associates. The shortcomings of the ISSI are that it takes a long time to complete, 
which may cause a low return rate, and that the 12-month recollection period required for 
completion of ISSI may be challenging to respondents’ memory, and may reduce the accuracy of 
the responses. The 11-item DSSI (Koenig et al., 1993), with a one-week recollection period, was 
considered to be more appropriate for the UK population of patients with COPD.  
The 11-item and 23-item versions of the DSSI depict the most significant dimensions of social 
support measured by the original 35-item DSSI (Koenig et al., 1993). The 12 items that are the 
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difference between the 23-item and 11-item scales constitute the instrumental support 
subscale. The authors indicate that the instrumental support subscale has no vital role in 
chronically ill elderly individuals (Koenig et al., 1993). 
The 11-item DSSI includes two subscales of social support (seven items) and social interaction 
(four items); each can be treated as a separate scale and the scores from both scales can be 
added together (Koenig et al., 1993). An individual can score a maximum of three on each item 
and the maximum possible total score when the scores from both scales are combined is 33. 
Higher scores indicate greater social support. 
No study was found to have used the 11-item DSSI specifically in a population of patients with 
COPD. However, a study of randomly selected older adults (Goodger, Byles, Higganbotham, & 
Mishra, 1999) (n=565, male=55%, response rate=76%) revealed concurrent validity of the 11-
item DSSI by a significant moderate to strong correlation with the ISSI (r=0.30-0.57) (p<0.05). 
The authors also demonstrated the construct validity of the scale by significant moderate 
correlation with a five-point scale self-rated quality of life (r=-0.4) and loneliness (r=0.3) 
(p<0.05) survey. Powers, Goodger and Byles (2004) (n=12, 939, aged 70-75 years) reported 
internal reliability to be reasonable for ten of the eleven items and its factors, social interaction 
(four items) and social support (six items), using Cronbach's alpha of 0.8, 0.6, 0.8.  
 Additionally, the 23-item DSSI has shown responsiveness and significant positive association 
(p < 0.05) with overall functioning as measured by World Health Organization Disability 
Assessment Schedule II (Marino, Sirey, Raue, & Alexopoulos, 2008). 
Evaluation of responsiveness of the DSSI over three-year period in a large sample of elderly 
women (n=6,373, aged 70 to 75 years) established that the DSSI is sensitive to social association 
and perceived emotive factors (Pachana, Smith, Watson, McLaughlin, & Dobson, 2008). 
Goodger et al. (1999) reported acceptability of the 11-item DSSI in terms of the response rate 
as 76%. A mailed survey (Powers et al., 2004) reported a response rate of 94% in 12,939 
participants, though all the participants in the study were female, which limits the 
generalisability of its findings to males. 
 
2.5.11 HEALTH LOCUS OF CONTROL 
The health locus of control (HLC) is used to assess self-management behaviour in chronic 
illnesses (Wallston & Wallston, 1981). HLC distinguishes between a person’s internal HLC, 
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attributing events in one’s life to its own contribution, and the external HLC, attributing events 
to the contributions of others and to chance (Wallston & Wallston, 1981). Rotters (1966) 
advanced that when reinforcement is regarded by an individual as not being entirely dependent 
on his/her action, it is naturally regarded as the result of chance, the control of other powerful 
persons, or as unpredictable due to the complex influences surrounding him/her. Kirscht 
(1972) administered a questionnaire to non-academic university staff (n=335) to identify 
relationships between the perception of personal control and health control, beliefs about 
disease, and health-related practices respectively. Analysis of the responses indicated that while 
motivation or expectancy for control of health positively relates to having made efforts in the 
past (including controlled diet and exercises) and the desire to do these things in the future, 
locus of control relates to a belief that health can be determined by one’s own contribution or by 
a contribution outside of oneself.  
Attitudes are better predictors of behaviour when both attitudes and behaviour are specifically 
defined and measured. This led to the development of condition-specific locus of control scales 
(Wallston & Wallston, 1981). There are three discrete approaches to domain specificity as 
explained below: 
i) The first approach is by dividing the space of perceived control into various ‘behavioural 
spheres’ (Paulus & Christie, 1981). 
 
Table 2.3 Behavioural spheres of perceived control (Paulus & Christie, 1981) 
Perceived Control Sphere 
Personal efficacy Non-social environment in circumstances of personal 
attainment. For example, climbing mountains.  
Interpersonal control Control during interractions with others in team and group 
situations. For example, protecting one’s interests in 
meetings, upholding harmony in a family. 
Socio-political control Examples of this include circumstances where an individual’s 
control often clashes with those of the socio-political system. 
For example, boycotting a certain product to bring down its 
price or writing to a congressman. 
 
 
This yields a classification matrix (2 internal by 3 external) wherein a person can be internal in 
one sphere (e.g. personal) and external in another (e.g. socio-political) (Paulus & Christie, 1981). 
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ii) The second approach was advanced by Rothbaum, Weisz and Snyder (1982) who redefined 
control as primary and secondary, each with four domains: predictive, illusory, vicarious and 
interpretive. Primary control aligns the environment with an individual’s wishes, while 
secondary control aligns an individual with environmental forces. When perceived control is 
acknowledged in both the primary and secondary forms, a series of inward behaviours can be 
observed as efforts to maintain control instead of surrendering it (Rothbaum, Weisz, & Snyder, 
1982). 
iii) The third approach is by developing a questionnaire instrument with the aim of 
investigating behaviour in a specific area, e.g. a work-related or health-related area. This is 
achieved by defining the relevant issues particular to this area of investigation. This has resulted 
in the development of numerous, original, locus-of-control scales. Wallston and Wallston (1973) 
suggested that individualising patient care based on locus of control beliefs was a potentially 
important utilisation of the construct. 
Rotter (1966) developed the 29-item Rotter Internal-External Control Scale to differentiate 
between a belief in internal control versus external control. The scale uses a forced-choice 
format. Gregory (1978) surveyed 107 undergraduates and participants were asked to rate as 
internals, moderates, or externals on Rotter's Internal–External Locus of Control Scale. 
Participants were given an instructional set emphasising the achievement of a positive outcome 
or the avoidance of a negative outcome dependent on successful task performance. Internals 
performed more than externals only in the negative outcome condition, while there were no 
significant differences in performance for positive outcomes. Gregory (1978) postulated that 
the usefulness of Rotter's Internal–External Locus of Control Scale has been limited because it 
measures behaviour only on occasions when an event has a negative influence (Gregory, 1978), 
and it insufficiently describes locus of control as a unidimensional construct in which an 
individual is internal or external.  
The original Health Locus of Control Scale (HLC) (Wallston & Wallston, 1973) consisted of 11 
items in a six-point Likert format and high scores suggested agreement with externally worded 
beliefs. Individuals with scores above the median were labelled "health-externals" and were 
presumed to have generalised expectancies that the factors that decide their health are ones 
over which they have little control (i.e. chance, or powerful others). Individuals who score 
below the median were labelled "health-internals" who believe that one stays or becomes 
healthy or sick as a result of his or her own behaviour. However, this scale, like Rotter’s 
Internal-External Scale, insufficiently described locus of control as a unidirectional construct.  
52 
 
Levenson (1973; 1974; 1975) developed three eight-item Likert scales (the IPC Scales - internal, 
powerful others, and chance). The IPC scale was developed to measure generalised locus of 
control beliefs. However Levenson's scales did not include items specific to expectations about 
health. 
The multidimensional health locus of control (MHLC) (Wallston & Wallston, 1981) contains 18 
items and describes locus of control as a multidimensional construct with three distinct 
dimensions. The dimensions are internality (IHLC); chance externality (CHLC); and powerful 
others externality (PHLC). It particularly evaluates the health expectations of an individual. 
These considerations make the MHLC scale (Wallston & Wallston, 1981) a more appropriate 
tool for measurement of health locus of control in patients with COPD than the original HLC 
(Wallston & Wallston, 1973) scale, the Rotter Internal-External Control Scale (Rotter, 1966)or 
Levenson’s IPC scales (Levenson, 1973; Levenson, 1974; Levenson, 1975). 
The MHLC scales for the assessment of the health locus of control belief (Wallston & Wallston, 
1981) have three versions: form A for a relatively healthy individual; form B for an individual 
with chronic illness and form C for an individual concerning an existing and specified medical 
condition. Each version of the MHLC has three distinct sub-scales: the IHLC; the CHLC; and the 
PHLC. Each of the sub-scales consists of six-item scales (Wallston, 1998; Wallston, Stein & 
Smith, 1994; Wallston & Wallston, 1981).  
In a large population of patients with chronic illness (chronic pain, diabetes, rheumatoid 
arthritis and cancer) (n=588), Wallston et al. (1994) demonstrated concurrent validity of the 
MHLC scale by identifying a high correlation between scale C and the counterpart domains of 
scale B (r=0.3 to 0.65, p<0.001). Further, every MHLC subscale identified criterion validity by 
positive and significant correlation with the corresponding tool on the Levenson’s generalised I, 
P and C scales (r=0.3 to 0.5, p<0.001) (Wallston et al., 1994). The instrument has been used in 
various studies of respiratory patients: asthma (Apter et al., 1998) (n=50), (ten Brinke et al., 
2001) (n=127); obstructive sleep apnoea (De Zeeuw et al., 2007) (n=85); (Wild, Engleman, 
Douglas, & Espie, 2004) (n=119); and COPD (Boom, 1997) (n=20). 
The alpha reliabilities of the MHLC scales A or B (six-item forms) varied from 0.67 to 0.77 and 
0.83 to 0.86 when both forms were joined into 12-item scales. The three MHLC dimensions (A, B 
and C) are nearly statistically independent, especially in the internal domain (IHLC scale) and 
the powerful others domain (PHLC scale). The IHLC and chance domain (CHLC scale) are 
negatively correlated (but share less than 10% common variance), while the CHLC and PHLC 
scales are moderately correlated (the 12-item versions correlate + 0.20) (Wallston & Wallston, 
1981). 
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As an indication of acceptability, the developer of the MHLC cited numerous research works 
that have been conducted using MHLC (Wallston, 2005). Some published studies that used the 
MHLC included studies involving patients with asthma (Apter et al., 1998; ten Brinke et al., 
2001), obstructive sleep apnoea (De Zeeuw et al., 2007; Wild et al., 2004) and COPD (Boom, 
1997). 
 
2.5.12  MEASURE OF COMPLIANCE WITH FREE-LIVING PHYSICAL ACTIVITY  
The measure of compliance with self-management advice given to patients by clinicians is 
crucial to the implementation and success of a home programme. Compliance assessment tools 
include electronic and paper diaries.  
A study of healthy individuals (n=20, female=13, age=18-65 years) indicated that weak 
movements may not elicit enough force (>/=3.5g) that is required to achieve closure of the 
circuit that records steps in pedometers and the accuracy of an electronic diary could be 
reduced by low walking speed (Bassett et al., 1996). A study of 26 nursing home residents and 
28 recreation centre older adults (Cyarto, Myers, & Tudor-Locke, 2004) revealed a significant 
association between gait scores and walking speed; the pedometer significantly underestimated 
observed steps taken by up to 74% in the nursing home residents and up to 25% in the 
recreation centre older adults (p < 0.0001).  
Pitta et al. (2006) conducted a review of studies published in English on MEDLINE that 
investigated physical activity in patients with COPD for 15 years up to November 2005 as well 
as references to relevant studies over the same period. No exclusion was made on the basis of 
study design or sample size. The authors identified the limitations of a paper diary to include 
recall bias and misreporting of activity levels. Pitta et al. (2005) (n=10) prospectively studied 
the modified Follick’s diary in patients with COPD and identified the simplicity of completion 
and the short recall time as some of the advantages of diary, though the authors note that 
patients may overestimate the elements of walking times and underestimate standing times.  
The original Follick’s diary (Follick, Ahern, & Laser-Wolston, 1984) was developed as a tool for 
measuring physical activities’ time in patients with chronic pain. The modified Follick’s diary is 
a simplified version of the original Follick’s diary and was adapted and validated for measuring 
physical activities’ time in patients with COPD. Moore, Berlowitz, Denehy et al. (2009) (n=80) 
suggest that the modified Follick’s diary was reliable in measuring standing and walking times 
in patients with COPD. Patients can use the diary to report the duration of time spent each day 
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in doing a defined activity e.g. using oxygen. The outcome is the time (e.g. in half hours) spent in 
doing the activity.  
Moore, Berlowitz, Denehy et al. (2009) (mean age= 71 years, mean FeV1 =46.3%, mean body 
mass index=28.2kg/m2) validated the modified Follick’s diary in patients with COPD (n=80) 
and revealed that the diary is reliable in the measurement of standing and walking times 
(r=0.37, p=0.001) in this population. Further, 95% of the participants successfully completed 
the modified Follick’s diary compared to 82% that used the pedometer for 7 days as prescribed. 
The authors concluded that the paper diary was a more reliable tool for the measurement of 
free-living physical activities in a COPD population. 
 
2.5.13 MEASURE OF COGNITIVE FUNCTION IN COPD  
Folstein, Folstein and McHugh (1975) developed the mini-mental state examination (MMSE) as 
a brief objective measurement of cognitive performance and changes in cognitive state. This is a 
30-item questionnaire that was developed for the assessment of cognitive abnormalities in 
individuals (Folstein et al., 1975). It examines an individual’s functioning, including in 
arithmetic, memory or recall ability, comprehension, orientation and basic motor skills. The 
regular application of identical questions enhances the reliability of the assessment and the 
comparisons made using the instrument (Folstein et al., 1975).  
Mitrushina and Satz (1991) evaluated the reliability and validity of the MMSE in 122 healthy 
elderly volunteers (aged 57–85 years) and identified that the test–retest reliability was between 
0.45 and 0.50 over a one-year interval and 0.38 over a two-year period. Another prospective 
study of randomly selected, non-demented individuals (n=215, aged >75 years) with a follow-
up period of three to six years demonstrated that a score of less than 24 on the MMSE 
significantly correlates with a diagnosis of dementia within three years of the MMSE test; 
p<0.001 (Braekhus, Laake, & Engedal, 1995). In 24 patients with a clinical diagnosis of 
Alzheimer's disease, MMSE significantly correlated with the Blessed Information-Memory-
Concentration Test (r=-0.83, test-retest correlation =0.89 for MMSE) (p<0.05) (Fillenbaum, 
Heyman, Wilkinson, & Haynes, 1987). In a random sample of 93 demented patients, Juva et al. 
(1994) demonstrated an overall agreement of 64% (Kappa 0.44) between MMSE and the 
Diagnostic and Statistical Manual of Mental Disorders -III-R (DSM-III-R) criteria and 55% 
(Kappa 0.33) between MMSE and the clinical dementia rating scale.   
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Valle et al. (2009) conducted a cross-sectional study of 1,588 older adults with low schooling 
(aged > 60 years). These authors identified a significant correlation between poor cognitive 
status (MMSE score=22) and age > 80 years (p<0.05) (odds ratio=2.20, 95% CI=1.52-3.48). Teng 
and Chui (1987) identified that a limitation of the MMSE includes its failure to discriminate 
between persons with mild dementia and those who were not demented, and a degree of false-
positive errors because of its bias against subjects with low education. To correct for the 
limitations of MMSE, Teng and Chui (1987) developed the modified mini mental state 
examination (3MSE) which has four additional subsets to the original MMSE. In a study of 249 
patients (Alzheimer type=170, amnestic syndrome=24, Parkinson's disease=21, multi-infarct 
dementia=11, Pick's disease=6, progressive supranuclear palsy=4, normal-pressure 
hydrocephalus=3, and other=10), interscorer agreement between the MMSE and the 3MSE was 
high (mean 5.49 versus 5.44) (correlation=0.98, df=247, p< .0001) (Teng & Chui, 1987). The 
score in 80% of cases was identical; 16% of cases showed a difference of one point, and 4% of 
cases showed a difference of two points. Teng and Chui (1987) thus concluded that 3MSE 
demonstrated no additional sensitivity and has no significant advantage when compared to 
MMSE.  
Previous studies in populations of patients with COPD reported conflicting findings on the 
relationship between cognitive abnormalities and functional abnormalities. Salik, Ozalevli and 
Cimrin (2007) examined 22 patients with COPD (mean age 66.7 years, mean FeV1-= 53%, 
male=18) and 26 healthy individuals (mean age 65.7+/-7.3 years, male=14) to evaluate the 
relationships between cognitive function and QoL. These authors reported no significant 
difference in impaired cognitive function between the two groups (mean MMSE scores 24.8 
versus 25.4) (p>0.05). Thakur et al., (2010) administered MMSE to a cohort study of patients 
with COPD (n = 1,202) and a control group of 302 subjects without COPD who were matched in 
age, sex and race. Analysis of the results indicated a significant association between COPD and 
the risk of cognitive impairment compared to subjects without COPD (odds ratio 2.42= 95%, 
CI=1.043-6.64). Further, Ozge, Ozge and Unal (2006) evaluated the relationship between the 
duration of COPD and cognitive functioning in 54 patients with COPD and 24 age- and sex-
matched controls. While there was no significant difference in the incidence of depression 
between the two groups, the study deduced that subjects with COPD demonstrated significantly 
more subjective and objective cognitive limitation (p<0.05).  
The MMSE demonstrated a statistically significant test-retest reliability (r =5.13, p<0.002), 
with the mean difference in scores between two assessments being less than 0.5 (Tombaugh, 
2005). Rait, Fletcher and Smeeth (2005) (n= 15,051, female=61.5%, aged>75 years) 
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demonstrated that a poor cognitive score (less than 24) on the MMSE significantly correlates 
with hearing problems (odds ratio 1.7), vision problems (odds ratio 1.7), urinary incontinence 
problems (odds ratio 1.3), or the incidence of two or more falls in the last six months (odds ratio 
1.4).  
The administration of the MMSE takes about five to ten minutes (Folstein et al., 1975). Previous 
studies suggested high acceptability of the tool with only 2.9% of participants in the study by 
Rait et al., 2005 (n=15,051) indicated as having failed to complete the questionnaire. 
 
2.6 QUALITATIVE RESEARCH AND OUTCOMES  
Quantitative data can provide a snapshot of outcomes, while qualitative data obtained from 
narratives of individuals about the outcomes can provide improved understanding of the trend, 
for example barriers to outcomes, how outcomes are achieved, the desires and contribution of 
individuals to attaining any outcomes and how any changes affect them (Bryman, 2012). Some 
qualitative data can be coded into quantitative form. 
Various data collection methods were evaluated in order to ensure collection of essential data to 
answer research questions in this thesis. Chapters 4 and 8 report focus group studies while 
Chapter 5 reports a questionnaire study.  In each of these chapters, the study paradigm which 
informed the choice of qualitative outcome data and guided the conduct of the investigations 
and the interpretation of the results was discussed in more details (refer to chapters 4, 5 and 8).  
An interview could be conducted between two or more people (e.g. in focus group) to gather 
reliable and valid data that is relevant to research question. An interview could be unstructured, 
semi structured or structured, including standardised self-completed questionnaires; termed 
'questerviews' (Adamson, Gooberman-Hill, Woolhead & Donovan, 2004). Questionnaires are 
broadly divided into self-administered questionnaire (which are typically completed by the 
participants and returned through post, e-mail, the internet or by hand to the researcher) and 
interviewer administered questionnaire which could be administered face-to-face or over the 
telephone (Saunders, Lewis & Thornhill, 2008). Questionnaires returned through post can be 
used to collect data from a larger sample of participants than can be achieved through personal 
interview (Wood, 2006). The information gathered by the use of a structured questionnaire can 
be limited in its depth but the risks of this can be limited by initially using more qualitative 
methods to define appropriate facts and beliefs and a questionnaire is subsequently used to 
identify how widespread these facts and beliefs are (Wood, 2006). 
57 
 
The different qualitative data analysis techniques are the interpretive, recursive abstraction, 
and mechanical techniques (Oun & Bach, 2014).  
Hayes (1985) defines interpretive analysis as “any analysis where we try to understand and 
explain human action by reference to the intentions it expresses”.  A code can be a word or 
phrase which distinguishes a section from other codes, and inform the researcher of the 
objective of the section. Analysis is achieved by identifying, summarising, comparing codes and 
determining the relationship between the individual codes (Saldana, 2012). 
Mechanical technique relies on computers to count words and phrases (referred to as content 
analysis) to analyse qualitative data sets. Mechanical techniques are useful particularly in 
analysing large data set which might be too much for human to analyse properly. Muller (1970) 
suggested that computers lack the knowledge, experience and understanding that a human 
analyst would apply.  
Recursive abstraction is based on summarising the data in stages. The initial summary is further 
summarised and so on until the analyst ends up with an accurate condensed summary.  
Hershkowitz, Schwarz and Dreyfus (2001) suggested that due to multiple stages of summaries, 
recursive abstraction can lead to a poor conclusion due to poor initial summarisation.  
 
2.7 TRUSTWORTHINESS IN RESEARCH 
Guba (1981) recommended that in order to enhance trustworthiness, qualitative researchers 
should consider the four criteria of credibility, transferability, dependability and conﬁrmability 
in a study. 
Shenton (2004) described credibility as the qualitative investigator’s equivalent concept of 
internal validity and evaluates how congruent are the ﬁndings of a study with the reality. 
Shenton (2004) advised that the following could improve the accuracy of the account of the 
phenomena under scrutiny:  
 the use of a well established research methods. 
 triangulation, including the use of different methods such that one method could 
compensate for the limitations of another and the strength of the different methods 
could be combined.  
 random sampling and/or self-volunteering of participants. Random sampling enhance 
even distribution of ‘unknown influences’ while self-volunteering ensure that eventual 
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participants would be those who sincerely are willing to participate and would 
contribute candid opinions (Shenton, 2004). 
 regular debriefing between the researcher and steering group as well as peer review of 
the research project. 
 the use of appropriately experienced investigator. Silverman (2000) identified the 
researcher as the major instrument of data collection and analysis. Shenton (2004) 
advised that any arrangement on investigator funding and ethical approvals for a study 
should be reported. 
 appropriate transcriptionist arrangement. Creswell (2009) suggested that it is 
important that the transcript should match the informants words and that the use of a 
tape recorder could ensure that participants’ articulations are correctly captured 
 comparison with ﬁndings from previous studies. Comparison of the ﬁndings of a study 
to the existing literature would enhance the understanding of the degree to which the 
results from a particular study fits with those of previous studies (Silverman, 2000). 
 
Transferability is the qualitative investigator’s equivalent concept of external validity and 
evaluates how the ﬁndings of a study could be applied to other situations (Shenton, 2004).  A 
quantitative study attempts to identify if the findings of the work in question can be generalised 
to the wider population. However, the results of a qualitative research are particularised to a 
small number of situations and individuals and less generalisable. Gomm, Hammersley and 
Foster (2000) suggested that while the results of every study may be unique, it still constitutes 
an example within a larger population, with a possibility of transferability. It is crucial that an 
investigator identifies the limits of a study and the factors that can inform on transferability 
including the number of participants and organisations, any exclusion criteria, the data 
collection methods, duration of data collection sessions and duration of entire study (Shenton, 
2004).   
Dependability is the qualitative investigator’s equivalent concept of reliability which evaluates 
whether if a study is repeated in the same environment and population, and using the same 
methods, similar results would obtain (Shenton, 2004). Marshall and Rossman (1999) advised 
that the varying character of the phenomena examined by a qualitative researcher makes the 
concept of dependability difficult to establish. Morse (2009) suggested that credibility and 
dependability are interrelated and they can be demonstrated by “overlapping methods” e.g. 
focus group and individual interview. Assessment of dependability in a study includes 
evaluation of study design, minutes of field work and reflective appraisal of the research 
(Johnson, Onwuegbuzie & Turner, 2007). 
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Conﬁrmability is the qualitative investigator’s equivalent concept of objectivity and evaluates 
whether the ﬁndings of a study are the result of the experiences and ideas of the study 
participants, and not the imposition of the preferences of the investigator (Shenton, 2004).  
Triangulation promotes conﬁrmability by reducing the effect of investigator bias (Johnson et al, 
2007). To enhance confirmability, a researcher should identify the principle that guided 
decisions made and methods used in the study, the reasons for rejecting alternatives as well as 
advantages and disadvantages of the techniques eventually used. Conﬁrmability can be 
enhanced by the use of “audit trail”; a detailed methodological and chronological description of 
the steps taken from the beginning to the end of a research project, including the development 
and reporting of findings (Morse, 2009). 
 
2.8 TRIANGULATION IN RESEARCH   
Triangulation enhances the credibility, dependability and conﬁrmability of research (Creswell, 
2009; Johnson et al, 2007). 
In this thesis, the findings from the content analysis of a video of exercise against guidelines and 
published RCTs (Chapter 3) and the findings from the focus group study of respiratory clinicians 
and patients with COPD (Chapter 4) contributed to the development of questionnaires that was 
used for national survey (Chapter 5). This approach is similar to that described by Potter, Cairns 
and Stokes (2012).  The authors developed an initial questionnaire (with 27 questions) which 
was based on research publications and guidelines, to examine the use of ultrasound imaging by 
physiotherapist in the UK. To establish that all relevant areas in the use of ultrasound imaging 
were covered, experts registered in the UK (n=12, 9 physiotherapists, 3 sonographers with one 
professional being dual qualified) were asked to comment on the initial questionnaire. This 
resulted in a revised questionnaire (with 38 questions) which was subsequently completed by 
forty-six respondents (Potter, Cairns and Stokes, 2012). 
In the research project detailed in this thesis, triangulation was employed. Denzin (1994) 
defines triangulation as the use of more than one approach in studying the same phenomenon 
with the aim of improving confidence in the findings that emerge. Hussein (2009) suggests that 
triangulation may be used only for enhancing broader comprehension of a phenomenon and, 
even when the two sets of findings from a triangulation may be conflicting, such a situation may 
highlight the risk associated with relying on one method or prompt further investigation. Other 
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authors (Denzin, 1994; Golafshani, 2003; Smith, Sparkes, Phoenix, & Kirkby, 2012) argue that 
triangulation is a validity measure which can increase the accuracy of study findings.  
Denzin (1994) describes four types of triangulation: data triangulation; investigator 
triangulation; theory triangulation; and methodological triangulation. Data triangulation means 
gathering data through many sampling techniques and it comprises three types: that obtained 
through slices of data at different times; social situations; and on a variety of people (Begley, 
1996). Theory triangulation involves the use of multiple perspectives to interpret one single set 
of data for the purpose of supporting or rejecting findings, for example, holding interview 
sessions with clinicians, patients and relatives of patients involved in an outpatient programme 
in order to understand their viewpoints of the programme outcomes (Guion, Diehl, & McDonald, 
2011). A disadvantage that is common to data triangulation and theoretical triangulation is that 
they involve lengthy, time-consuming processes which may not be practicable at all times. 
Methodological triangulation requires the use of more than one method for investigating the 
same phenomenon and the triangulation may take place at the stage of research design or data 
collection (Hussein et al., 2009). However, this method usually requires more time and 
resources to conduct and more skill to analyse the information gathered than when only one 
method is used. Investigator triangulation involves the use of more than one researcher in any 
one stage (observation, interviewing or data analysis) of one study. Nevertheless, there is a 
potential risk of conflicting findings which may be due to investigator biases or disharmony 
(Guion, Diehl, & McDonald, 2011).  
 
2.9 CONCLUSION 
Following an extensive networking and literature review of outcome measures/screening tools, 
the outcome measures and screening tools with the best evidence of validity, reliability, 
responsiveness and acceptability were chosen and used in the studies detailed in this report 
(Table 2.4).  
The ERS guideline on diagnosis of COPD (Quanjer et al., 1993) was chosen as diagnostic tool of 
COPD for the studies in this report and the MRC scale was used to classify participants in terms 
of COPD severity (Paladini et al., 2010).  
The ISWT and the ESWT that were conducted in the SRCT reported in Chapter 7 of this thesis 
were conducted according to pre-recorded instructions played to each participant at the start of 
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the test. Participants completed the one-walk ESWT protocol. The ESWT has a maximum 
duration of 20 minutes, though participants were not informed of this.  
Similar to the practice in the study by de Torres et al. (2002) (n=37, mean FeV1 < 40%), cardio-
respiratory outcomes were measured in the study reported in this thesis with a finger probe 
oximeter, at rest and before the commencement of every walk test in order to confirm 
participants’ return to the pre-exertion state before each walk. Holmes and Peffers (2009) 
assert that pulse oximeters are accurate between oxygen saturation of 70% to 100% with a 
measurement error of +/-2%.  
The Borg scale (CR10) was identified as the most appropriate tool for assessing the participants’ 
state of exertion between walking tests (Table 2.4). When conducting a walk test during the 
studies, each participant was allowed to return to the pre-exertion state before each walk.  
The use of different research approaches (desk research as reported in Chapter 3, focus groups 
as reported in Chapters 4 and 8, and a questionnaire study as reported in Chapter 5) constituted 
methodological triangulation (Bryman, 2006; Denzin, 1994; Hussein et al., 2009) for the review 
of the suitability of the Move-On-Up (video of exercise) for VBHEP, as an adjunct to outpatient 
PR in patients with COPD.  
The evaluation of the video as reported in Chapter 4 involved focus group study to evaluate the 
perceptions of patients who have only watched the video but not used it concurrently with 
outpatient PR. On the other hand, the evaluation of the video (as reported in Chapter 8) 
involved patients who have used the video for VBHEP concurrently with outpatient PR. This 
constituted data triangulation of perception of suitability of the video by a variety of patients 
with COPD at different points of their care pathway (Denzin, 1994).  
Further, theory triangulation of different populations (respiratory clinicians and patients with 
COPD) in different social situations was employed during the study reported in Chapter 4 by 
comparing the findings of focus group sessions of clinicians with the findings of the focus group 
sessions of patients with COPD. Similarly, theory triangulation was used during the study 
reported in Chapter 5 by comparing the findings from the analysis of the questionnaire 
responses of respiratory clinicians with the findings from the analysis of the questionnaire 
responses of patients with COPD.  
It is important to note that the definition of triangulation in this report did not involve using the 
same group of individuals at different points in time. Rather, different groups of patients with 
COPD were involved in the different stages of their experiences with the video. This is similar to 
the case in previous study by Hughes et al. (1997). The authors conducted door-to-door 
62 
 
recruitment of 56 young people who participated in group discussions about alcohol and 
designer drinks. Findings from the focus group sessions were triangulated with findings from 
questionnaire responses from another group of young people (n=824) who were recruited 
through a multi-stage cluster probability sampling of 12-17 year olds registered with a general 
practitioner within the health board area.
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Table 2.4 - Tests and outcome measures used in the various studies. 
Screening tests 
and outcome 
measures for 
the study that 
investigated 
participation 
profile of 
patients with 
COPD in PR 
(Chapter 6 of 
this thesis) 
Screening 
tests and 
outcome 
measures 
for SRCT 
(Chapter 7 
of this 
report) 
Screening 
tests and 
outcome 
measures for 
study that 
evaluated 
patients’ 
experience of 
using exercise 
video 
(Chapter 8 of 
this report) 
Key properties of the chosen screening 
tool/outcome measure over other tools. 
Limitations/weaknesses of screening 
tool/outcome measure. 
Brief 
Assessment 
Schedule 
Depression 
Card (BASDEC)  
BASDEC BASDEC BASDEC was validated in a large study of 
patients with COPD (Yohannes et al., 2000) 
(n=137, male=69, mean age=73 years, mean 
FeV1=0.89L) with 100% sensitivity in the 
diagnosis of depression against the GMS. 
BASDEC was demonstrated to have an 
average completion time of 3 to 4 minutes 
and a lower refusal rate compared to GDS 
(1.26% versus 8.86%).  
BASDEC (Adshead, Cody, & Pitt, 1992) 
is a more recent tool compared to 
older ones like HADs (Zigmond & 
Snaith, 1983) for measuring 
depression and fewer studies were 
found to have used it in patients with 
COPD. 
11-item Duke 
Social Support 
Index (DSSI) 
11-item 
DSSI 
11-item DSSI The 11-item DSSI (Koenig et al., 1993) 
represents the multidimensional nature of 
social support compared to the 
dichotomous dimension of cohabiting 
versus living alone (Crockett et al., 2002). 
Also, DSSI requires only a one-week 
recollection period compared to the 
Interview Schedule for Social Interaction, 
which requires a 12 month recollection 
period. The DSSI is a sensitive and valid 
outcome measure with a good return rate in 
No study was found to have used the 
11-item DSSI specifically in patients 
with COPD. However, a large study 
(n=565, response rate=76%) 
demonstrated strong correlations 
between the 11-item DSSI and the 
Interview Schedule for Social 
Interaction scale in older adults 
(aged>70 years) (Goodger, Byles, 
Higganbotham, & Mishra, 1999). The 
23-item DSSI also demonstrated a 
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evaluating the level of social support.  significant positive association (p < 
0.05) with overall functioning as 
measured by World Health 
Organization Disability Assessment 
Schedule II. The difference between 
the 23-item and 11-item scales (12-
item instrumental support subscale) 
was indicated by Koenig et al. (1993) 
to have no vital role in chronically ill 
elderly individuals. 
Medical 
Research 
Council  (MRC) 
COPD Severity 
Scale  
Medical 
Research 
Council   
COPD 
Severity 
Scale 
 
 
Medical 
Research 
Council COPD 
Severity Scale  
 
 
 
The MRC scoring is the basis of referral of 
patients with COPD to PR (NICE, 2010). It 
correlated significantly with exercise 
performance, quality of life and depression 
score (Bestall et al., 1999). MRC is more 
sensitive to breathlessness than the 
dyspnoea domain of the CRQ (Hajiro et al., 
1998). Paladini et al. (2010) indicated that 
the MRC score is a reliable indicator of 
COPD severity. 
 
Though the MRC scale has widespread 
clinical use and it is the recommended 
tool on which referral of patients to 
PR should be based (NICE, 2010), no 
study was found to have directly 
evaluated the acceptability of the MRC 
scale in patients or clinicians. Roberts 
(2010) reported that completion of 
the questionnaire takes one to two 
minutes. 
Multi-
dimensional 
Health Locus of 
Control Scales 
(MHLC) B and 
C 
MHLC Scales 
B and C 
MHLC Scales 
B and C 
The Rotter Internal-External Control Scale 
scale uses a forced-choice format which 
insufficiently describes locus of control as a 
unidimensional construct of internal or 
external. Levenson's scales did not include 
items specific to expectations about health. 
The MHLC has advantages in that it 
embodies the multidimensional 
characteristic of locus of control and the 
items are specific to expectations about 
health. It has been demonstrated to have 
No study was identified that 
conducted validity study of MHLC in 
patients with COPD. However, in a 
large study of 588 patients with 
chronic conditions, MHLC scale C 
demonstrated concurrent validity 
with counterpart domains of scale B 
(r=0.3 to 0.65, p<0.001) and criterion 
validity with the corresponding 
instrument on the Levenson’s 
generalised I, P and C scales (r=0.3 to 
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good validity in patients with chronic 
conditions. 
 
0.5, p<0.001) (Wallston et al., 1994). 
Also several studies have used the 
MHLC in respiratory patients with 
ailments including asthma, 
obstructive sleep apnoea and COPD 
(Apter et al., 1998; Boom, 1997; De 
Zeeuw et al., 2007; ten Brinke et al., 
2001; Wild, Engleman, Douglas, & 
Espie, 2004).  
Though the validity study of MHLC 
was conducted in a population of 
patients with chronic illness (n=588), 
the condition was not COPD.  
The instrument has been used in 
various studies of respiratory 
patients: asthma (Apter et al., 1998) 
(n=50), (ten Brinke et al., 2001) 
(n=127); obstructive sleep apnoea 
(De Zeeuw et al., 2007) (n=85), (Wild 
et al., 2004) (n=119); and COPD 
(Boom, 1997) (n=20). 
 St George’s 
Respiratory 
Questionnai
re (SGRQ) 
for 
assessing 
health-
related 
quality of 
life  
SGRQ Changes observed in the SGRQ may be more 
stable than those observed using the CRQ     
(Griffiths et al., 2000). The SGRQ is a valid, 
reproducible and sensitive HRQL tool. It has 
a well defined MCID. In preference to the 
CRQ, it has a domain that measures activity 
restriction as well as discrete sections for 
cough, phlegm and frequency of attack.  
In a comparison study of SGRQ, BPQ 
and CRQ (Singh et al., 2001), the SGRQ 
had the lowest completion rate which 
the authors suggested was an aspect 
of patient acceptability. Another study 
of 50 patients with COPD, however, 
indicated that all questionnaires were 
returned with no missing responses in 
the returned questionnaires 
(Aggarwal et al., 2007). 
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 Endurance 
Shuttle 
Walk Test  
(ESWT) - for 
assessment 
of walking 
ability  
ESWT  Following PR in patients with COPD, the 
ESWT is more sensitive than the 6MWD 
(92% versus 17%) (Eaton et al., 2006) and 
the ESWT is more sensitive than ISWT 
(160% versus 11%) (Revill et al., 1999). The 
ESWT has a known minimum clinically 
significant difference (MCID) (Waterhouse 
et al., 2006).  
In a review of the identified 52 studies 
which examined measurement 
properties of the different walk tests 
(Solway et al., 2001), the shuttle walk 
test was the least used (used in four 
studies compared to 29 for the 
6MWT). Brooks and Solway (2006) 
argue that the need for two ISWTs 
and two ESWTs was a limitation to 
the use of the ESWT clinically and in 
research, due to time limitations and 
patient tolerance.  
Roberts (2010) demonstrated a 
higher completion rate when patients 
participated in the one-walk ESWT 
protocol compared to the two-walk 
ESWT protocol (71% versus 54%). 
Though the one-walk ESWT protocol 
led to a greater ceiling effect 
compared to the two-walk ESWT 
(12.2% versus 7.3%), the ceiling rate 
was within an acceptable limit and 
both protocols resulted in the same 
floor rate of 4.9% (Roberts, 2010).  
The study detailed in this report used 
the one-walk-ESWT protocol. 
 Modified 
Follick’s 
diary 
Modified 
Follick’s diary 
Modified Follick’s diary was more reliably 
used than an electronic diary as an outcome 
measure for free-living physical activity in 
patients with COPD (95% versus 82%). It is 
less complex to complete and requires a 
relatively short recall time.  
In using the modified Follick’s diary, 
Pitta et al. (2006) suggest that 
patients may overestimate walking 
times and underestimate standing 
time. However, a larger study in the 
same patient population (Moore, 
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Berlowitz, Denehy et al., 2009) (n=76) 
reported that the diary was reliably 
completed by participants in the 
measurement of standing and walking 
times (r=0.37, p=0.001). 
 Mini Mental 
State 
Examination 
(MMSE) - 
for 
measuring 
cognitive 
status 
MMSE In a study by Thakur et al. (2010) of patients 
with COPD, a significant association 
between COPD and the risk of cognitive 
impairment based on MMSE (odds ratio 
2.42= 95%, CI=1.043-6.64) was identified. 
The MMSE is valid, brief and easy to 
administer. MMSE score can be indicative of 
other makers of vulnerability, like 
depression.  
The weakness of the MMSE included 
its failure to discriminate between 
individuals with mild dementia and 
those who were not demented and 
substantial degree of false-positive 
errors because of its bias against 
subjects with low education (Teng & 
Chui, 1987).  
 Borg scale of 
breathlessn
ess 
 Patients with COPD produce a targeted 
exercise intensity using a Borg dyspnoea 
rating more reliably than using heart rate 
(Mejia et al., 1999). 
 
Roberts (2010) suggested that due to 
an inclination by patients with COPD 
to record breathlessness on recent 
activity (rather than current 
breathlessness), it is important to 
advise patients that when completing 
the questionnaire, they should record 
their present breathlessness level. 
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CHAPTER THREE - CONTENT ANALYSIS OF THE MOVE-
ON-UP EXERCISE VIDEO  
3.1 JUSTIFICATION  
Pfizer in association with the Association of Chartered Physiotherapists in Respiratory Care 
(ACPRC) and the St George’s School of Physiotherapy, developed an exercise video called Move-
On-Up, and suggested its use as part of a treatment protocol for patients with COPD (ACPRC, 
2006). Personal communication indicated that a content analysis of the video had not been 
conducted and the approval was given to evaluate the video (Boehringer-Ingelheim, December 
6 2006) (refer to Appendix 3A). 
Previous studies have demonstrated the benefits of video-based exercise at home in improving 
exercise habits, exercise tolerance and QoL (Moore, Fiddler, Seymour et al., 2009; Petty et al., 
2006; Yamanaka et al., 2009), though none of the studies involved outpatient PR as an 
intervention or compared the use of video-based home exercise programmes (VBHEP) with 
outpatient PR programmes. The study by Petty et al. (2006) was conducted in the United States, 
each participant in the video arm received either an exercise video that was customised to each 
individual user’s level of COPD disease severity and psychological state, a standard exercise 
video and education, or usual care from their physician, which may have included written or 
verbal information. However, none of the participants received PR. Moore, Fiddler, Seymour et 
al. (2009) conducted a pilot study of patients with COPD (n=10) in each of the intervention and 
control arm, none of who received PR. Patients in the intervention arm participated in video-
based exercise at home while those in the control arm received COPD educational booklet. 
Yamanaka et al. (2009) (n=42) conducted a study in males with COPD. The findings from these 
studies are thus limited in generalisability, either with regard to the suitability of an exercise 
video like Move-On-Up for VBHEP (in terms of content), the effect of VBHEP on participation in 
outpatient PR, or the effectiveness of VBHEP when received concurrently with outpatient PR in 
a UK population of patients with COPD. Hence, the need for the research.   
 Audiovisual intervention is mostly self-administered by patients, and the acceptance of a self-
management plan by the patient is an important factor to consider when evaluating such 
interventions (Bradley, Webster, Schlesinger, Baker & Inouye, 2006). The evaluation should 
cover areas such as the convenience of use, the comparison with face-to-face consultation, the 
motivation that patients can derive from its use and the cost. An intervention that a patient finds 
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easy to administer is likely to give more satisfaction to the patient and encourage compliance 
with it (Bradley et al., 2006; Caroll et al., 2007). 
For an intervention to be beneficial to an existing healthcare protocol, it requires a smooth 
integration into the mainstream clinical and administrative protocols. Its content should enable 
clinicians and healthcare managers to administer the intervention with minimal deviation from 
a routine care pathway. Whilst a programme may be effective in a controlled research setting, it 
is important to evaluate its acceptance in an uncontrolled setting or the practical world (Bradley 
et al., 2006). 
Programme implementation fidelity is the extent to which a programme is carried out as 
planned by its developers (Dusenbury, Brannigan, Falco & Hansen, 2003). Programme 
adaptation is the deliberate or accidental modification of a programme which is required to 
ensure its effectiveness in a local setting. Evaluating the programme fidelity and adaptation is 
crucial to its successful and sustained implementation in a particular setting (Backer, 2000).  
Evaluation of the content of the Move-On-Up exercise video against NICE guidelines in the 
various domains of suitability enhances the robustness of the research since these domains of 
suitability are the areas of PR contained in the BTS guideline on PR (BTS, 2001) and reviewed in 
the NICE guideline on PR (NICE, 2004). 
The evaluation of the Move-On-Up video for its suitability for VBHEP as an adjunct to outpatient 
PR was carried out through the combination of three studies. This chapter reports on the 
evaluation of the video’s content against the NICE guidelines and research evidence. Chapter 
Four reports on the focus group study that provided patients’ and clinicians’ evaluations of the 
video. The outcomes from the studies reported in this chapter and Chapter Four were used to 
develop the content of a questionnaire, which was used in the nationwide survey reported in 
Chapter Five. The combination of the three studies provided methodological triangulation for 
evaluation of the video for its suitability for VBHEP as an adjunct to outpatient PR. 
The evaluation of the suitability of the Move-On-Up video as reported in this chapter is 
necessary in order to assess if the video meets the criteria of a PR exercise programme as 
recommended by the NICE guidelines and research publications. In addition to the areas 
addressed in the NICE guideline (2004), it was considered that other areas like intervention 
complexity, dosage and progression as well as the extent to which patients are able to engage 
with the intervention (considering other daily activities) are crucial to ensuring their 
participation in VBHEP (Caroll et al., 2007; Dane & Schneider, 1998; Dusenbury et al., 2003; 
Mihalic, 2004); therefore areas of conceptual framework of fidelity evaluation were also 
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addressed in the suitability evaluation. A conceptual framework of fidelity evaluation is 
described as having five elements, namely: (i) the adherence to intervention; (ii) exposure or 
dosage; (iii) quality of delivery; (vi) participant responsiveness; and (v) programme 
differentiation (Dane & Schneider, 1998; Dusenbury et al., 2003; Mihalic, 2004). Caroll et al. 
(2007) define two additional measures of implementation fidelity as intervention complexity 
and facilitation strategies.  
 
3.2 RESEARCH QUESTION AND AIMS OF RESEARCH 
3.2.1 RESEARCH QUESTION 
Is the Move-On-Up exercise video suitable for use in VBHEP as an adjunct to outpatient PR by the 
UK population of patients with COPD based on recommendations in the NICE guideline CG12 
and research publications between May 2003 and August 2008? 
 
3.2.2 AIMS OF RESEARCH 
The aims of this review are two-fold: first, to evaluate whether the content of the Move-On-Up 
video meets the criteria of a PR exercise programme as recommended by the NICE guidelines 
and research publications. Secondly, it seeks to synthesise questionnaire items in order to 
review the video using focus groups and generate appropriate questions for a national survey. 
 
3.3 METHODS 
The most recent NICE guidelines on PR of patients with COPD, as at 2008 (the time of the 
review), were the NICE Guidelines CG12, dated February 2004 (NICE, 2004). The publication 
dates of the papers reviewed in the NICE guidelines CG12 ranged between 1977 and 2003. The 
last date of searches conducted by NICE GDG was May 2003 (National Collaborating Centre for 
Chronic Conditions, 2003, page 16). Therefore, the starting point for the searches was May, 
2003. A literature search was carried out in order to enable a review of publications on PR of 
patients with COPD between May 2003 and August 2008. 
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3.4 SEARCH REPORTED BY GUIDELINE DEVELOPMENT GROUP FOR 
NICE GUIDELINE CG12. 
The formulation of the guideline published by the NICE CG12 Guideline Development Group 
(GDG) was examined. Inclusion criteria were studies in which patients received exercise 
training for a minimum of four weeks (with or without education and/or psychological support) 
and with evaluation of changes in quality of life (QoL) and exercise capacity. These inclusion 
criteria appear to be in line with current evidence, which suggests that the minimum length of 
an outpatient PR programme from which a patient could achieve benefits that reach MCID is 
four weeks (Sewell et al., 2006). The GDG reported that the literature search produced 609 
published papers. Of these, 42 met the inclusion criteria and were selected. A further 29 were 
excluded following a full paper review. An additional seven references were suggested by the 
members of the NICE GDG and were critically appraised (NICE, 2004). This resulted in a total of 
20 papers included in the review. 
 
3.4.1 CONTENT ANALYSIS OF THE MOVE-ON-UP VIDEO AGAINST THE 
RECOMMENDATIONS IN THE NICE GUIDELINE CG12 
NICE recommendations are rated using the the Grades of Recommendation Assessment, 
Development and Evaluation (GRADE) (Atkins et al., 2004). The details of GRADE are as below. 
Code A (high quality of evidence) - The recommendation is based on several high-quality 
studies with consistent results or, in special cases, one large, high-quality multi-centre trial. 
Further research is very unlikely to change the confidence in the estimate of effect. 
Code B (moderate quality of evidence) - The recommendation is based on one high-quality 
study or several studies with some limitations. Further research is likely to have an important 
impact on the confidence in the estimate of effect and may change the estimate. 
Code C (low quality of evidence) - The recommendation is based on one or more studies with 
severe limitations. Further research is very likely to have an important impact on the confidence 
in the estimate of effect and is likely to change the estimate. 
Code D (Very low quality of evidence) - The recommendation is based on the opinion of experts, 
or one or more studies with very severe limitations, or no direct research evidence. Any 
estimate of effect is very uncertain. 
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(Atkins et al., 2004). 
Table 3.1 shows the findings of the evaluation of the content of the video against 
recommendations in the NICE guideline CG12 (NICE, 2004) 
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Table 3.1- Summary of the findings from comparison of the content of the Move-On-Up video against the recommendations in the NICE guideline 
CG12 (2004). 
Area of PR of 
patients with 
COPD that 
was reviewed  
Recommendations in the NICE guideline CG12 on pulmonary rehabilitation of patients with COPD (NICE, 
2004). 
Recommendations 
in the Move-On-Up 
video. 
Settings in 
which PR is 
effective 
Pulmonary rehabilitation is effective in all settings including hospital inpatient or outpatient, the 
community and the home (strength of evidence = A). Cost comparison suggests that hospital outpatient PR 
is presently the most efficient form of delivery (strength of evidence = C).  
The video is 
recommended for 
home use by its 
makers. 
Evaluation of 
effectiveness 
of 
strengthening 
exercises as 
part of PR 
Strength training including that of the upper limb is recommended (strength of evidence = B).  Strength exercises 
are included in the 
video e.g. biceps 
bend. 
Evaluation of 
effectiveness 
of endurance 
exercises as 
part of PR 
Endurance training including brisk walking or cycling is mandatory (strength of evidence = A). Endurance 
exercises are 
included in the 
video, with 
particular 
emphasis on 
walking. 
Evaluation of 
effectiveness 
of breathing 
exercises in 
COPD patients 
The guideline did not recommend the routine use of ventilatory muscle training, though ventilatory 
muscle training could be considered in selected patients who have reduced respiratory muscle strength 
and breathlessness (strength of evidence = B). 
Inspiratory 
muscle training is 
not included in the 
Move-On-Up video 
but breathing 
exercise is 
included in the 
video especially. 
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Pursed lip 
breathing. 
Evaluation of 
upper 
extremity 
exercises as 
part of PR 
Strength and endurance exercises improve arm functioning in patients with COPD and should be part of 
the rehabilitation programme (strength of evidence = B). 
Upper extremity 
exercises are 
included. 
Evaluation of 
lower 
extremity 
exercises as 
part of PR 
Lower extremity training consistently improves measures of exercise capacity and should included in 
pulmonary rehabilitation (strength of evidence = A).  
Lower extremity 
exercises are 
included. 
Length of 
programme 
Outpatient programme should contain a minimum of 6 weeks of physical exercise (strenght of evidence 
=B) 
The video is 
available for 
continuous use at 
home 
Frequency of 
exercise 
session per 
week in PR 
Training frequency of three sessions weekly is recommended, each session of 20 to 30 minutes duration. 
At least two of the three sessions should be supervised (strength of evidence = C).  
It is recommended 
in the video that 
individuals should 
observe exercise 
sessions of 3 to 4 
times a week. 
Training 
intensity 
Training intensity of 60-70% of VO2 peak is recommended, though benefits can be obtained from lower 
intensity training (strength of evidence = C). 
The advice in the 
video is for a 
patient to exercise 
to a point of 3 to 4 
on Borg scale 1 to 
10, for 30 minutes 
or more, three 
times weekly. 
 
75 
 
3.5 LITERATURE SEARCH  
A search was conducted for all randomised control trials involving PR of patients with COPD 
published between May 2003 and August 2008 to evaluate each domain of the video against 
evidence from the literature. NICE (2004) indicates that it is only the guideline development 
group (GDC) that can endorse the final evidence level given to any intervention study, unless the 
GDC delegates the process to the reviewer. However, since this evidence was completed in 
2003, all further randomised control trials were critically reviewed using the data extraction 
and evidence table (DEET) published by NICE (2006) for evaluation against the video for 
completeness. A quantitative evidence table template should include concise details of reference 
or bibliography (author and date), study aim, design, population, intervention, outcome 
measures and key findings (NICE, 2006). 
The Oxford Centre for Evidence Based Medicine describes levels of methodological quality in 
consideration of evidence base from best quality to least quality consecutively as follows: 
systematic review/meta-analysis, individual RCTs, cohort studies, case control studies, opinion 
of experts (Phillips et al., 2001). A significant advantage of RCTs over non-randomised studies is 
that these ensure that any differences that are observed between the trial arms are due to 
differences in the intervention alone and not due to the effects of confounding factors or bias 
(whether known or unknown). Randomisation can establish that the groups are similar and 
comparable in every respect with the exception of the intervention under investigation (Phillips 
et al., 2001). Consequently, good quality evidence is associated with an RCT or group of RCTs 
(meta-analyses).  
The following databases were searched: PubMed, Scopus, CINAHL Plus and the Physiotherapy 
Evidence Database (PEDro) for publications on PR of patients with COPD between May 2003 
and August 2008. The following search terms were used: ‘COPD and pulmonary rehabilitation’, 
‘exercis* and education’, ‘COPD and respiratory exercis*’. Exercise and education are core 
components of the pulmonary rehabilitation programme for patients with COPD and the use of 
these search terms and their truncated versions (e.g. exercis* for exercise, exercises, exercising) 
was aimed at ensuring a search result that would highlight relevant publications on PR of 
patients with COPD. Details of the literature searches are presented in the appendix 3B.  
Firstly, the results from the databases were matched and each publication found repeatedly 
from different databases was managed to ensure that it was identified as the same. Secondly, 
the titles of all the publications that were highlighted by the search strategy were reviewed to 
identify the publications that fell outside the topic of interest. Thirdly, the abstracts of the 
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remaining publications were reviewed to identify those publications that evaluated the 
intervention of interest (PR) in the patient population of interest (COPD) and the publications 
that did not meet these criteria were excluded. Subsequently, all the remaining papers were 
reviewed in full. Additional relevant publications were identified from the references listed 
from some of the publications for further review. 
Inclusion/exclusion criteria 
Types of publications: Search was conducted for all published randomised control trials 
involving PR of COPD. Review publications were excluded; only primary data publications were 
included. 
Publication language: Limitations included publications in English or translated into English by 
the publishers. The specific search terms used in databases were in English.  
Participant age and gender: All ages and genders of patients with COPD were included. 
Publication year: Publication years searched ranged from May 2003 to August 2008. Papers 
published before May 2003 have already been reviewed in the NICE guideline CG12 (NICE, 
2004). 
 
3.5.1 CRITICAL DISCUSSION OF RESEARCH PUBLICATIONS ON PR (MAY 2003 
- AUGUST 2008) 
Sixty-two RCTs abstracts were identified from the literature search. An additional four were 
identified from the reference lists during the review of the full text of the initial 62 publications. 
All of the 66 RCTs were reviewed. Twenty RCTs were excluded based on the inclusion and 
exclusion criteria (Appendix 3C) and 46 RCTs were included in the final critical review 
(Appendix 3D). A flowchart of the search is illustrated in figure 3.1. 
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436  Publications were 
highlighted
374 non-RCTs were 
excluded
62 RCTs identified
4 RCTs added from 
references of initial 58 
RCTs making 62 RCTs
46 RCTs were reviewed in 
full
20 RCTs were 
excluded based on 
exclusion criteria
 
Figure 3.1 Results of literature search towards evaluation of the exercise video 
 
The 46 RCTs have been scored on the PEDro database using the PEDro scale, which evaluates 
the quality of reporting of trials. The scale assess two aspects of the quality of a trial, namely the 
internal validity (or believability) and interpretability (between-group statistical analysis, 
detailing both points estimates and measuring variability). The strength of the PEDro scale over 
other scales for measuring quality of trials is that it combines all the items on the three-item 
Jadad scale (random allocation, blinding and description of drop-outs) and the Delphi list 
(eligibility criteria, random allocation, blinding, concealment of allocation, group similarity at 
baseline, intention-to-treat analysis, reporting of point/variability measure). In addition, it 
scores the reporting of between-group statistical comparisons. While the reliability of the Jadad 
scale is in dispute (Bhandari et al., 2001; Jadad et al., 1996; Oremus et al., 2001), the reliability of 
PEDro scale is evaluated as varying between "fair" and "substantial," and the reliability of the 
total PEDro score varies between "fair" and "good’’ (Maher, Sherrington, Herbert, Moseley & 
Elkins, 2003). 
The PEDro scale is reliable for the assessment of the quality of a randomised control trial with 
an intra-class correlation co-efficient of 0.68 at a 95% confidence interval (Maher et al., 2003). It 
is also valid to sum the PEDro scale item scores into an overall score that can be regarded as an 
interval level of measurement of quality of studies (de Morton, 2009). The PEDro scale is valid 
with a mean score of 4.8 (SD 1.6) for papers published between 1966 and 2006 and a mean 
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score of 5.2 (SD 1.5) for papers published between 1972 and 2006 (de Morton, 2009).  The RCTs 
were categorised based on the domain of the evaluation of suitability of the Move-On-Up video 
to which they were relevant. The score for each of the 46 RCTs was retrieved from the PEDro 
database and for the various domains, the mean PEDro score was calculated. 
 
3.5.2 ANALYSIS OF RESEARCH PUBLICATIONS ON PR (2004 - 2008) 
The evaluation of the Move-On-Up video against research publications was carried out in various 
domains of suitability. 
Evaluation of RCTs that investigated effectiveness of outpatient-based PR  
Eight RCTs investigated the effectiveness of outpatient PR in patients with COPD (Barakat et al., 
2008; Guell et al., 2006; Lindsay et al., 2005; Karapolat et al., 2007; Man et al., 2004; Mineo et al., 
2004; Paz-Diaz et al., 2007; Petersen et al., 2007).The participant numbers (and demography) 
were 80 (mean FeV1=42.8%), 40 (mean FeV1= ), 50 (mean FeV1=0.85 litre/minute) 54 (mean 
FeV1=54.9), 42 (mean FeV1=39.2% ), 60 (all severe COPD), 24 (all severe COPD) and 19 (mean 
FeV1=31%) respectively. The qualities of the studies varied: three of the RCTs ensured that 
assessors were blinded to participant allocation (Barakat et al., 2008; Guell et al., 2006; Mineo et 
al., 2004). Some of the studies used outcomes with undefined MCID, e.g. BODE (Body-Mass 
Index, Airflow Obstruction, Dyspnea, and Exercise) index (Barakat et al., 2008). The mean 
PEDro score for the eight RCTs was 5.0. Each of the eight studies concluded that outpatient PR 
resulted in a significant gain in either exercise ability (measured by 6MWT or ISWT or ESWT) or 
QoL (measured by SGRQ or CRQ) p<0.05. This is in agreement to the advice in the NICE 
guidelines (NICE, 2004). 
 
Evaluation of RCTs that investigated effectiveness of community-based PR  
Elci et al. (2008) (n=78, 67 males, mean age=58.9+/-10.1 years) and Elliot et al. (2004) (n=43, 
23 males) investigated the effectiveness of community-based PR in patients with moderate to 
severe COPD. The mean PEDro score of the two studies was 4.0. However, neither study ensured 
the blinding of assessors. Elci et al. (2008) demonstrated that participants who received three 
months community PR had significantly higher improvements in 6MWT and SGRQ scores 
compared to the control (no exercise) group (p<0.05). Elliot et al. (2004) indicated that the 
gains from three months community-based PR measured by 6MWT and CRQ score were not 
significantly different from the gains from three months of twice-weekly hospital outpatient-
based PR-(p< 0.05).  
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Evaluation of RCTs that investigated effectiveness of home-based PR  
Six RCTs evaluated the effectiveness of home-based PR in patients with COPD (Boxall et al., 
2005; Guell et al., 2008; Maltais et al., 2008; Murphy et al., 2005; Oh, 2003; Resqueti et al., 2007). 
The numbers (and demography) of participants were 60 (26 males; every-participant had 
severe COPD), 57 (all male, mean FeV1=38.2%), 252 (140 men, mean FeV1=44.5%), 26 (17 
males, mean FeV1=40%), 23 (14 males, mean FeV1=43%) and 38 (35 males, mean FeV1 =28.6%), 
respectively. The mean PEDro score for the five RCTs was 5.5. Only two of the RCTs (Guell et al., 
2008; Maltais et al., 2008) ensured the blinding of assessors and only one of the RCTs (Maltais et 
al., 2008) conducted intention-to-treat analysis. Boxall et al. (2005), Murphy et al. (2005) and 
Oh (2003) compared patients that received home-based PR with a control (no exercise) group. 
The three studies concluded that the PR group demonstrated significantly higher improvements 
in QoL (SGRQ and CRQ scores) and exercise capacity (6MWT and ISWT) p<0.05. Resqueti et al. 
(2007)indicated that patients who received eight weeks of a supervised, home exercise 
programme demonstrated significantly higher improvements in the CRQ score and three-
minute walk test (3MWT), compared to patients who received eight weeks of an unsupervised, 
home exercise programme, however, the study suffered 23.7% drop-out rate. Additionally, 
these authors did not conduct intention-to-treat analysis, and the use of 3MWT as a measure of 
exercise capacity has no defined MCID (Resqueti et al., 2007). While the study by Guell et al. 
(2008) (n=57), concluded that hospital-based PR resulted in significantly higher improvements 
in the QoL (CRQ score) (p<0.05), a larger study by Maltais et al. (2008) (n=252), concluded that 
there was no significant difference in the improvement in QoL (CRQ score) between the 
participants who received hospital-based PR and those who received home-based PR (p<0.05). 
It was noted that participants in the study by Maltais et al., (2008) were provided with exercise 
bikes for home-based exercise, which is not a routine practice in the UK. This may have 
contributed to the difference in the findings of the two studies. 
Evaluations of the settings in which PR have been demonstrated to be effective, and comparison 
of the findings regarding the content of the Move-On-Up video suggest that the recommendation 
by the makers of the video that it should be used at home was appropriate. It was not the 
objective of this study to evaluate the use of the video during outpatient exercise sessions. 
Evaluation of RCTs that investigated effectiveness of strengthening exercises 
rehabilitation of patients with COPD                                                                                                                                                          
A review of the effectiveness of strengthening exercises in PR of patients with COPD highlighted 
five RCTs (Alexander, Phillips & Wagner, 2008; Kongsgaard et al., 2004; Mador et al., 2004; 
O’Shea, Taylor & Paratz,, 2007; Phillips, Benton & Wagner, 2006). The participant numbers (and 
demography) were 20 (14 men, mean FeV1=69%, mean age= 69 years), 18 (all male, mean 
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FeV1= 46%, ages 65-80 years), 24 (mean FeV1=48.1%, mean age 71 years), 54 (21 males, mean 
FeV1=51%) and 19 (5 males, mean FeV1 =37.6%), respectively. The mean PEDro score for the 
five RCTs was 5.0. 
Only the studies by Mador et al. (2004) and O’Shea et al. (2007) ensured the blinding of 
assessors. Mador et al. (2004) compared eight weeks of endurance plus strength training 
(combined group) to eight weeks of endurance-only training. The study concluded that, at the 
eighth week, there was no significant change in 6MWT or CRQ between the two arms, though 
the increase in muscle strength was significantly greater in the combined group than in the 
endurance-only group. O’Shea et al. (2007) studied a larger sample of participants (n=54) and 
compared 12 weeks of progressive resistance exercises (experimental group) versus no 
exercise (control) group. The study concluded the resistance training group demonstrated a 
significantly higher improvement in muscle strength measured by dynamometry muscle 
strength test. 
Kongsgaard et al. (2004) reported that, at three months, self-reported health and activities of 
daily living (ADL), stair climbing time and quadriceps’ cross-sectional area were significantly 
higher in the strength training group compared to the control group, which received only 
breathing exercises (p<0.05). Phillips, Benton and Wagner (2006) concluded that the strength 
plus endurance training group demonstrated significantly greater improvement in the 6MWT 
and muscle strength test (chest press and leg press), compared to the control group, which 
received only endurance training (p<0.05). Alexander, Phillips and Wagner (2008) concluded 
that there was no significant difference between patients who received strength training in 
addition to traditional PR (TPR) and patients who received the latter only in changes in 6MWT 
(p<0.05). However, the strength training group demonstrated significantly higher improvement 
in 1 RM seated leg press (p<0.05). No MCID has been defined for the dynamometry muscle 
strength test or 1 RM.  
The review of these studies suggests that the advice in the Move-On-Up video which encouraged 
strength training (including biceps-bend) in patients with COPD is appropriate. The findings 
from this review of publications are also in agreement with the advice in the NICE guidelines 
CG12 (NICE, 2004). 
 
Evaluation of RCTs that investigated effectiveness of endurance exercises in 
rehabilitation of patients with COPD                                                                                                                                                                  
Arnadottir et al. (2006) (n= 42 patients with COPD, 21 males, mean FeV1 =37.5%) compared 
participants who received eight weeks of endurance, resistance and calisthenics training to a 
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control group that received resistance and calisthenics training. At the end of eighth weeks of 
study, the former group, demonstrated significantly higher improvement (p<0.05) than the 
control group in peak exercise capacity measured by the incremental cycle ergometer test, 
perceived breathlessness (Borg CR-10) and rate of perceived exertion. There was no significant 
difference between the groups in a 12-minute walk test, SGRQ or HADs at all points. The PEDro 
score for the study was 4.0. Weaknesses of the study include a high drop-out rate of 33.3%, and 
a failure to conduct an intention-to-treat analysis. The findings suggest that the advice in the 
Move-On-Up video which encourages endurance training (including walking) in patients with 
COPD is appropriate. The findings from this review of publications are also consistent with the 
advice in the NICE guidelines CG12 (NICE, 2004). 
Evaluation of RCTs that investigated effectiveness of upper extremity exercises in 
rehabilitation of patients with COPD                                                                                                                                              
Holland et al. (2004) (n=38 patients with COPD, 24 males, mean FeV1 =36.6%) compared the 
effects of six weeks of upper limb and lower limb training (the experimental group) with that of 
lower limb (control) training alone. At the sixth week of study, there was no significant 
between-group difference in 6MWT and CRQ. The experimental group demonstrated 
significantly higher improvement (p<0.05) than the control group in an incremental 
unsupported upper limb exercise test, though there is no defined MCID for this test. The PEDro 
score for the study was 7.0. The findings suggest that the advice in the Move-On-Up video which 
encouraged upper limb training in patients with COPD is appropriate. The findings from this 
review of publications corroborate the advice in the NICE guidelines CG12 (NICE, 2004). 
Evaluation of RCTs that investigated effectiveness of lower extremity exercises in 
rehabilitation of patients with COPD                                                                                                                                                                                                                  
Two RCTs investigated the effectiveness of lower extremity exercises in the PR of patients with 
COPD (Casaburi et al., 2004; Hoff et al., 2007). The participant numbers (and demography) were 
53 (all men, mean FeV1 =40%, mean age 67.4 years) and12 (8 males, mean FeV1=36.2%, mean 
age 61.7 years), respectively. The mean PEDro score for the two RCTs was 5.5. Neither of the 
RCTs ensured that assessors were blind to participant allocation and neither of the outcomes 
used in both studies (body composition analysis, cycle ergometer endurance test, 1 RM leg 
press, FeV1) has a defined MCID. Both studies concluded that the lower extremity exercises 
groups demonstrated improvements that were significantly greater than that in the control 
groups (no exercise training) in 1 RM leg press (p<0.05) at the end of the rehabilitation 
programme. Analysis of findings of these studies indicated that the advice in the Move-On-Up 
video which encouraged lower limb training in patients with COPD is appropriate. The findings 
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from this review of publications are also in agreement with the advice in the NICE guidelines 
CG12 (NICE, 2004). 
Evaluation of RCTs that investigated effectiveness of breathing exercises in rehabilitation 
of patients with COPD                                                                                                                                                                                                
Seven RCTs investigated the effectiveness of different types of breathing exercises in the PR of 
patients with COPD (Beckerman et al., 2005; Faager, Stahle & Larsen, 2008; Garrod et al., 2005; 
Magadle et al., 2007; Norweg et al., 2005; Puente-Maestu et al., 2003; Sykes et al., 2005). The 
participant numbers (and demography) were 42 (32 males, mean FeV1 =42.5%), 32 (12 males, 
mean peak expiratory flow at rest= 247+/-85 litre/minute), 69 (mean FeV1=44.3+/-18.4%, 
mean age = 68), 34 (26 males, mean FeV1=45.5%, mean age =65.6 years), 43 (13 males, mean 
FeV1=55.9%, mean age=75.3 years), 23 (19 males, mean FeV1<50%, mean age=62 years), 40 (34 
males, age range 60 to 80 years) respectively. The mean PEDro score for the six RCTs is 5.3. 
Three of the RCTs (Beckerman et al., 2005; Magadle et al., 2007; Sykes et al., 2005), conducted 
blinding of assessors and investigated the effectiveness of inspiratory muscle training (IMT) in 
the rehabilitation of patients with COPD. The IMT group in each study demonstrated a 
significantly larger improvement compared to the control group in inspiratory muscle strength, 
exercise capacity (6MWT) and QoL (SGRQ, CRQ) p<0.05. One RCT (Puente-Maestu et al., 2003) 
examined the effects of expiratory muscle training (EMT) on expiratory muscle performance, 
exercise performance and the sensation of breathlessness in patients with COPD. These authors 
identified significant between group difference in expiratory muscle strength, expiratory muscle 
endurance and 6MWT in favour of the EMT group (p < 0.05). Three RCTs (Faager, Stahle & 
Larsen, 2008; Garrod et al., 2005; Norweg et al., 2005) investigated the effectiveness of dyspnea 
management including pursed lip breathing (PLB) in the rehabilitation of patients with COPD. 
None of the studies conducted blinding of assessors. The study by Norweg et al. (2005) 
additionally did not report between-group comparisons of FeV1 at baseline due to missing data 
in 49% of participants; this makes it difficult to evaluate COPD severity distribution in the study 
arms. In the three RCTs, the between-group difference in the change in exercise capacity 
following PLB did not reach MCID. However, the group that received PLB demonstrated a 
significantly higher improvement in perceived exertion during exercise (Faager, Stahle & 
Larsen, 2008) and end-exercise respiratory rate (Garrod et al., 2006) (p<0.05). 
The Move-On-Up video advised the use of PLB but did not advise on IMT or EMT. This is similar 
to the advice in the NICE guideline (NICE, 2004) which indicated that IMT should not be 
routinely included in PR. The review of the RCTs suggests that the advice in the video which 
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encouraged breathing retraining (especially pursed lip breathing) during exercise in patients 
with COPD is appropriate. 
Evaluation of RCTs that investigated training intensity in rehabilitation of patients with 
COPD                                                                                                                                                                    
Bjornshave and Korsgaard, (2005) studied 20 patients with COPD (10 males, mean FeV1=34.8%, 
mean ages = 62.6 years) and compared the effects of a four-week home-based low intensity (15 
step/minute x 15 minute and quiet pace walk for 15 minute, two days/week) to a four-week 
home-based middle intensity (30 step/minute x 15 minute and high intensity walk for 15 
minute, five days/week) frequency training programme. Results indicated a significantly higher 
improvement in a standardized treadmill walk test (178 seconds, p<0.01) in favour of the 
middle intensity exercise group (p<0.01). There was no significant between-group difference in 
SF-36 and FeV1. However, there was a high drop-out rate (35.5%) in the study and intention-to-
treat analysis was not conducted. The advice in the Move-On-Up video is for a patient to exercise 
three times or more every week similar to the participants in the home-based middle intensity 
group in the study by Bjornshave and Korsgaard, (2005). The advice in the Move-On-Up video is 
that at each exercise session, users should exercise to a point of Borg 3 to 4 on Borg scale 1 to 
10, for 30 minutes or more. The findings from this review of publications are consistent with the 
advice in the NICE guidelines CG12 (NICE, 2004) and thus with the advice in the video. 
Evaluation of RCTs that investigated interval and continuous training in rehabilitation of 
patients with COPD. 
Three RCTs compared interval to continuous training in the PR of patients with COPD 
(Arnardottir et al., 2006; Puhan et al., 2006; Vogiatzis et al., 2005). The participant numbers 
(and demography) were 60 (6 males, mean FeV1=34%), 98 (all with severe COPD) and 19 
(FeV1=41.6%) respectively. The studies indicated no significant difference in change (pre- to 
post-intervention) between the two study arms in walking ability (6MWT and 12-minute walk) 
and QoL (CRQ) (Arnardottir et al., 2006; Puhan et al., 2006), the incremental cycle ergometer 
test (Arnardottir et al., 2006; Vogiatzis et al., 2005) or a change in muscle cross-sectional area 
(Vogiatzis et al., 2005). However, the study by Arnardottir et al. (2006) had a 40% drop-out rate 
and these authors did not conduct an intention-to-treat analysis. The study by Vogiatzis et al. 
(2005) additionally had a low number of participants who were also predominantly male 
(84%). Puhan et al. (2006) ensured the blinding of assessors and conducted an intention-to-
treat analysis, which strengthens their findings. The mean PEDro score for the three studies was 
6.3. This mean PEDro score in this domain of content analysis is higher than the mean PEDro 
score in other domains and it indicates the strength of evidence.  
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The advice in the Move-On-Up video was not specific in terms of a continuous or intermittent 
protocol of exercise. The advice was for a patient to exercise to a point of Borg 3 to 4 on Borg 
scale 1 to 10 for 30 minutes or more, three times weekly. The Borg’s scale was explained in the 
video, with the Borg’s scale explained in the video. 
Evaluation of RCT that investigated progression of exercises in rehabilitation of patients 
with COPD. 
Alexander and Bento (2008) compared two single-set resistance training sessions of different 
intensity progressions in elderly PR patients (n=20, mean age=68 years) to detect if there is a 
threshold effect for training intensity. All of the participants received the same load of eight 
weeks of one set of 8-15 repetitions of five exercises. The rapid progression (RP) arm had a 5-
10% load increase immediately after a session where ten repetitions were completed. In 
contrast, the delayed progression (DP) arm had 3-5 pounds load increase following two 
consecutive sessions where 12 repetitions were completed. RP arm demonstrated improvement 
in the outcomes of chest press, arm curl and lift & reach test that were significantly higher than 
that demonstrated by the DP arm (p<0.05). The number of participants was low and there is no 
known MCD for the outcomes used in the study. The PEDro score was 3.0.  
It is recommended in the Move-On-Up that users of the video should aim to increase the amount 
of exercise that they do over time, but no particular threshold of repetition was defined at which 
exercise must be progressed.  
Evaluation of RCTs that investigated effects of varying the number of supervised exercise 
session in rehabilitation of patients with COPD. 
Three RCTs (mean PEDro score =5.7) investigated the effect of varying the number of 
supervised PR sessions in patients with COPD. Carrieri-Kohlman et al. (2005), studied 103 
patients (46 male, mean age 66, FeV1=44.8%) and compared three rehabilitation protocols; DM 
(a self-management programme including exercise) versus DM-exposure (i.e. DM added to a 
once-biweekly/-total of four supervised exercise sessions over two months) versus DM-training 
(DM added to a thrice-weekly/total of 24 supervised exercise sessions over two months). The 
DM-training group demonstrated significantly greater improvement (p<0.05) than the DM-
exposure and DM groups in CRQ score (at 2nd month i.e. end of supervised exercise programme) 
and SF-36 score (at 4th month i.e. 2 months post supervised exercise programme). Nguyen and 
Carrieri-Kohlman (2005) conducted further analysis of the earlier published study (Carrieri-
Kohlman et al., 2005) and indicated that the study found no significant difference according to 
study groups (DM versus DM exposure versus DM training)in improvement in 6MWT or CES-D 
depression score (Centre for Epidemiological Studies depression scale) p<0.05. O’Neil et al. 
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(2007) ( n=91, 61 male, mean FeV1 =41.33%) compared six weeks of twice-weekly supervised 
PR sessions against six weeks of once-weekly supervised PR sessions. These authors found no 
significant difference between the study arms in an improvement in outcomes of ISWT and CRQ 
(p<0.05). There was a significant difference in outcome of ESWT. However, this between-group 
difference in ESWT had been present at baseline and continued to be present at the sixth-week, 
second month and sixth month post-PR. The proportion of drop-out (27.5%) resulted in the 
study been underpowered and intention-to-treat analysis was not conducted. 
Evaluation of RCT that investigated effects of varying length of PR programme 
Sewell et al. (2006) evaluated the effect of PR programme length in 100 patients with COPD (56 
males, mean age 70 years, mean FeV1=1.13litre/minute). The study compared four weeks of 
twice-weekly supervised PR sessions (four-week-PR-group) to seven weeks of twice-weekly 
supervised PR sessions (seven-week-PR-group). At the seven week point, the former group only 
demonstrated greater improvement in ESWT that was statistically significant (p=0.02) 
compared to the seven-week-PR-group. At the sixth month post-PR, there was no significant 
difference in outcome between the groups. Sewell et al. (2006) proposed that the awareness by 
patients that the supervised PR programme was limited to four weeks may have influenced the 
degree of motivation and participation by participants in the four week PR group, hence the 
higher improvement in outcome demonstrated at seven week. The PEDro score of the study is 
6.0.  
Evaluation of RCT that investigated optimal frequency of repeating PR intervention 
Romagnoli et al. (2006) investigated the optimal frequency of delivering PR. Twenty-nine 
patients with COPD (19 males, mean FeV1=36.5%) participated in an in-patient PR programme. 
The PR programme involved 12 exercise sessions over two weeks (6 days/week) and each 
session lasted for 3 hours. Participants were then discharged and randomised into group 1 
(n=14) and group 2 (n=15). Patients in group 1 participated again in the PR programme  
(twelve session over two weeks) at the sixth and twelfth months post-discharge. Patients in 
group 2 participated again in the PR programme only at twelfth months post-discharge. The 2 
weeks duration of PR in the study was shorter than the minimum of 4 weeks recommended by 
guideline (IMPRESS, 2011; NICE, 2004). However, the study was conducted before the 
publications on optimal duration of PR (IMPRESS, 2011; Sewell et al, 2006).  
Both groups in the study by Romagnoli et al. (2006) had similar significant improvements in 
6MWT post-inpatient PR (p<0.05), but both groups had lost the gains six months after inpatient 
PR. A significantly larger number of patients in group 2 experienced ten or more days of 
hospitalisation (p<0.05). The PEDro score was 5.0.  
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The Move-On-Up video is available for continuous use at home with the recommendation that 
patients should observe about three exercise sessions a week. The findings from the review 
suggest that the advice in the Move-On-Up video is appropriate towards achieving improvement 
in QoL.  
 
Evaluation of RCT that investigated effect of audiovisual stimuli on training outcomes in 
patients with COPD 
Four RCTs investigated the effect of audiovisual stimuli on training outcomes in patients with 
COPD (Bauldoff et al., 2005; Liu et al., 2008; Nguyen et al., 2008; Petty et al., 2006). The 
participant numbers (and demography) were 30 (13 males, mean FeV1=41.27%, mean age 63 
years), 48 (all male, mean FeV1 =45.6%, mean age=72.1 years), 50 (33 male, mean FeV1=49.6%, 
mean age 69.5 years) and 174 (120 males, mean age=70 years) respectively. The mean PEDro 
score for the four RCTs was 4.5. None of the RCTs conducted blinding of the assessors to 
participant allocation. 
Nguyen et al. (2008) demonstrated that there was no significant difference (p<0.05) in 
improvement in QoL (CRQ) or exercise capacity (6MWT) between patients with COPD who 
received a dyspnea self-management programme (involving self-management skill training and 
independent exercise) delivered via the internet or personal digital assistant-based (eDSMP), or 
delivered face-to-face (fDSMP). Neither of the arms received outpatient PR.  
Liu et al. (2008) indicated that patients who received a daily endurance walk at 80% maximal 
capacity by following the speed of music recorded on a mobile phone had a significantly higher 
improvement in walking ability (ISWT) (p<0.01) compared to a control group which received a 
similar daily endurance walk programme without music. However, all of the participants in this 
study were males which limits generalisation of the findings to females. Bauldoff et al. (2005) 
indicated that patients who received upper extremity training in addition to slow or moderate 
distractive auditory stimuli (DAS) demonstrated significantly higher improvement in 6-Minute 
Peg and Ring Board Count (6MPRB) counts (p<0.05) compared to the control group that 
performed similar upper extremity training without DAS. There was no significant difference 
between the groups in the SGRQ. There was also no significant difference in the 6MPRB scores 
between the moderate and slow DAS groups and the 6MPRB has no defined MCD. The 
interventions in the study by Liu et al., (2008) and Bauldoff et al., (2005) were audio distractive 
stimulation. Neither of the studies involved the use of exercise videos and participants did not 
receive outpatient PR. 
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Petty et al. (2006) concluded that patients who used a individually-customised videotapes in a 
home rehabilitation programme demonstrated significantly larger improvement in the 
emotional function and coping skills domains of the Seattle Obstructive Lung Disease 
questionnaire score (SOLQ), compared to participants who received standard video or usual 
care from physicians (which may have included written or verbal information) (p<0.05). 
Participants in the individually-customised videotapes group also demonstrated significantly 
larger improvement in the physical function domains of the SOLQ, compared to participants 
who received usual care (p<0.05) but not when compared to participants who received 
standard video (p=0.069). There was no between-group significant difference in the Fatigue 
Impact Scale (FIS) or SF-36 score. None of the arms in this study received outpatient PR, 
without or in addition to the video. 
The findings from the review of publications support the content of the Move-On-Up video which 
contains audio and video stimulation in terms of sounds and images of individuals 
demonstrating the exercises. 
 
3.6 CONCLUSION 
The analysis of the video content against the NICE (2004) guidelines indicated that the 
Move-On-Up exercise video is suitable for VBHEP as an adjunct to outpatient PR and is 
consistent with both the NICE (2004) guideline and the evidence from published RCTs (May, 
2003 to August, 2008).  
The analysis of various research studies is considered important because, while the NICE 
guidelines are reviewed and published periodically, research in the area of PR of patients with 
COPD continues to be undertaken each year. The review of research publications carried out 
here therefore attempts to bridge any gap between the period this research was carried out and 
the last publication of the NICE guidelines prior to this research. The review provided useful 
insights into the areas not included in the NICE guidelines such as the effect of auditory and 
visual stimuli in PR of patients with COPD (Bauldoff et al., 2005; Liu et al., 2008; Nguyen et al., 
2008; Petty et al., 2006). 
The recommendations in the NICE guidelines and research publications on all the identified 
areas of PR were compared with the content of the Move-On-Up video. The content of the video 
was consistent with and complied with all recommendations by NICE (2004) guidelines and 
were supported by the reviewed research publications. Additionally, questionnaire items were 
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generated for the focus groups reported in Chapter Four and initial questionnaire items for the 
national questionnaire survey (reported in Chapter Five) were also formulated based on the 
domains of analysis reported from this review. 
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CHAPTER FOUR- FOCUS GROUP: LOCAL EVALUATION 
OF THE MOVE-ON-UP EXERCISE VIDEO 
4.1 JUSTIFICATION  
This chapter reports on the six focus group sessions which explored the perspectives of a local 
population of patients with COPD and respiratory clinicians in two regions of England (London 
and the East of England) on the suitability of the Move-On-Up exercise video for use in a video-
based home exercise programme (VBHEP) as an adjunct to outpatient PR for the UK population 
of patients with COPD. It was considered that, besides the evaluation of the video against NICE 
(2004) guidelines and research publications (May 2003 and August 2008), examining the 
perspectives of respiratory patients and clinicians with experience in PR could give insight on 
the suitability of the video. Cumulatively these areas of research added to the questionnaire 
used in the national survey detailed in Chapter 5. 
The themes from the discussions with respiratory clinicians and patients with COPD give insight 
into other areas of the suitability of the video as an adjunct to outpatient PR that were not 
covered in Chapter Three. Conducting a focus group presented patients and clinicians with the 
opportunity to explain, reflect and illuminate their views on the suitability of the video in a 
group setting (Kitzinger, 1995) and what they consider as desirable contents of such video. 
According to McLeod, Meagher, Steiner and Boudreau (2000), the development of questionnaire 
items based on the findings of a preliminary focus group study can enhance the validity of the 
questionnaire.   
 
4.2 RESEARCH QUESTION AND AIMS OF RESEARCH 
The primary research question is whether the Move-On-Up exercise video is suitable for use in 
VBHEP as an adjunct to outpatient PR for the UK population of patients with COPD from both 
clinicians’ and patients’ perspectives.  
The study also aim to synthesise questionnaire items for a broader review of the video through 
a national questionnaire survey, particularly the questionnaire items on clinical areas that relate 
to experience and opinions of clinicians and patients with COPD. 
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4.3 ETHICAL APPROVAL 
Ethical approval for the focus group was obtained from the University of Hertfordshire Ethics 
Committee (HEPEC 08/08/68). 
 
4.4 POPULATION  
Six different focus groups (each meeting once) were conducted to explore the perspectives of a 
local population of patients with COPD and respiratory clinicians on the suitability of the 
exercise video for use in a VBHEP as an adjunct to outpatient PR for the UK population of 
patients with COPD. 
 
4.4.1 SETTING 
Community centres in six communities in London and the East of England were chosen as the 
location for the clinician and patient focus groups in this study. 
 
4.4.2 PARTICIPANTS 
The inclusion criteria for participants in the study were as follows: 
 Patients with a clinical diagnosis of COPD. 
 Respiratory clinicians with at least two years’ experience of PR with patients with COPD.  
It was considered that the experience of participants would be crucial to being able to 
contribute to the topic of discussion (Van-Oosten, Hoste & Tanghe, 2011). 
The exclusion criteria for the study were as follows: 
Cognitive impairment that compromised the ability to give informed consent 
Non-English speaking (because the video is in English and the targeted population of patients in 
this study was UK patients with COPD).  
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4.5 RESEARCH PARADIGM  
A paradigm is described as a cluster of beliefs and principles which should guide scientists in a 
particular discipline on how to conduct a particular investigation and how to interpret the 
findings (Bryman, 2006; Kuhn, 2012). A qualitative research design is based on a constructivist 
or participatory philosophy which relies as much as possible on the participant’s view of the 
subject being examined while in contrast, a quantitative research is based on a positivist or 
post-positivist theory which indicates a ‘deterministic philosophy’ in which cause may 
determine outcomes (Creswell, 2009). An advantage of qualitative research design over 
quantitative research design is that it can give in-depth insight into the experiences and 
perceptions of research participants on complex subjects (Bowling, 1997). A qualitative 
research design was considered to be the appropriate research design to answer the research 
question. 
Various approaches are described in the literature about the constructivist philosophy of 
qualitative research, including grounded theory, discourse analysis, phenomenology, and an 
exploratory and descriptive approach. Grounded theory was considered inappropriate 
because the common recommendation in grounded theory (Glaser & Strauss, 1965, 1967) is to 
avoid consulting relevant literature before data collection commences in order to avoid 
preconception from previous studies, rather than being grounded purely in the current data 
(Braun & Clarke, 2006; Glaser & Strauss, 1965, 1967). Discourse analysis is not relevant to this 
study since it mainly involves evaluating social interactions (Fulcher, 2005). 
Phenomenological research is primarily concerned with the lived experience of the research 
participants and requires close and long period of observation of the participants by the 
principal researcher (Creswell, 2009) which is not relevant to this study. A descriptive 
research approach relates to where there is existing data from initial exploratory research 
(Stebbins, 2011).  
Since the area of research in this study is one in which little is known in terms of the specific 
video, an exploratory research approach was considered appropriate since it would provide 
understanding of the perceptions of clinicians and patients with COPD on the suitability of the 
Move-On-Up exercise video, as well as other matters they consider desirable in such video. The 
exploratory approach would also enhance the synthesis of questionnaire items for a broader 
nationwide review of the video. 
The research methods considered for answering the research question also included the use of 
‘think-aloud’ technique, one-to-one interviews and focus group sessions. The think-aloud 
technique involves participants vocalising what they are looking at, thinking about, doing or 
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feeling while executing a task (Abdollahzadeh & Zolfaghari, 2012; Kuusela & Paul, 2000). The 
think-aloud technique slows the thought process of participants and increases their 
mindfulness in a way which prevents mistakes and inaccuracies that might normally take place 
in the actual workplace (National Institute for Aviation, 2004). lt is strenuous to verbalise 
thought processes for an hour or more while doing a task, which could make participants find 
the method unnatural, distracting and different from the learning process to which they are 
accustomed (Kuusela & Paul, 2000; National Institute for Aviation, 2004). Ericsson & Simon 
(1993) suggested that collecting data in real-time can be difficult and think aloud utterances are 
often incoherent and less coherent than that from interviews. The method was therefore 
considered inappropriate in this study. One-to-one interviews may discuss only limited areas 
of interest, when compared to a focus group but in more depth in order to achieve a substantial 
description of an event that the participant experiences. This is achievable only with a low 
number of participants (Denscombe, 2005). One-to-one interviews were thus rejected since 
focus groups offer the unique advantage of enabling individuals to explain, illuminate and 
examine their views (including when opposing views are presented by others) in situations that 
are less achievable in a one-to-one interviews (Kitzinger, 1995). Based on all the considerations, 
the focus group method was used in this study. 
A disadvantage of focus groups is that these can lead to ‘groupthink’ , a psychological 
phenomenon in which groups end up making irrational or dysfunctional decision due to the 
influence of the desire for agreement and conformity (Douglas, 2005). However, group 
consensus is only a risk when individuals in the groups are compelled to work towards a group 
verdict rather than share their different views (Morgan & Krueger, 1993). Each focus group 
consisted of either clinicians or patients in order to discourage groupthink and to ensure that 
the participants in each focus group were confident in expressing their views and that the less 
confident participants were not discouraged from expressing their views (Sim, 1998; Stewart & 
Shamdasani, 1990).  The researcher assumed the position of an independent entity and 
encouraged discussions on the experience and perceptions of focus group participants without 
influencing each participant’s position.   
 
4.5.1 SAMPLING TECHNIQUE 
Participants knowledge regarding COPD and PR were required in the focus group sessions in 
order to have appropriate contributions to the discussion on the suitability of the Move-On-Up 
exercise video for use in VBHEP as an adjunct to outpatient PR. Different sampling techniques 
considered included convenience sampling and purposive sampling. 
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Purposive sampling serves the definite need (or purpose) of gathering data from a specific 
category of participants and requires the conscious selection of individuals who can provide the 
required data in order to solve the research problem (Polit & Beck 2006). It is not intended to 
be a representative subset of the larger population (Parahoo, 2006). The involvement of only 
the accessible population as participants means that the result from a study that uses purposive 
sampling may not be generalisable (Moule & Hek, 2011). Convenience sampling is not entirely 
random (where every member of the population has an equal chance of participating) but it 
involves a less guided selection process (Parahoo, 2006). It can enable recruitment of 
participants who are able to provide the data required to meet the research objective. Moule 
and Hek, (2011) suggested that a process could be in place to reduce the risk of bias associated 
with the non-probability nature of convenience sampling. Element of self-volunteering was 
involved in the study.  
The advertisement for recruitment of patients with COPD was made through the Breathe Easy 
(BE), an arm of the British Lung Foundation (BLF). The advertisement was available to BE 
members through the BLF and any individual member of the BE that met the inclusion criteria 
was in a position to volunteer for the study. In a similar manner, the advertisement for 
recruitment of respiratory clinicians as participants in the focus group study was made in 
professional journals and websites and members  of the professional bodies that met the 
inclusion criteria was in a position to volunteer for the study. 
 
4.5.2 RECRUITMENT AND FOCUS GROUP CONDUCT 
PR programmes in the UK use a multidisciplinary approach which involve physiotherapists, 
occupational therapists, dieticians, nurses, respiratory physicians, pharmacists, social workers, 
psychologists, exercise physiologists and geriatricians (NICE, 2004; Yohannes & Connolly, 
2004). Therefore, the recruitment advertisements were placed in relevant multidisciplinary 
journals (e.g. European Respiratory Journal, Frontline) and web pages (e.g. Association of 
Respiratory Nurse Specialists) to attract relevant professionals involved in the PR of patients 
with COPD. 
Recruitment advertisement was placed with the BLF and circulated to all 229 BE groups. A 
Breathe Easy group whose members were receiving PR in a hospital, where at the time, the 
principal researcher was a staff member, was excluded from participation in the study in order 
to prevent any bias. 
94 
 
The conduct of the focus group conformed to ethical research protocols. Each volunteer study 
participant was telephoned by the principal researcher to answer any questions, and was, 
thereafter sent an information leaflet about the study and a copy of the Move-On-Up video. 
These were sent at least a week before the date that the participant was due to attend the focus 
group session, to ensure that the participant had enough time to watch the video. Each 
volunteer participant signed a consent form on the day of the focus group. A refund of the cost 
of public transport was offered to all participants and transportation arrangements were made 
available for subjects with severe COPD who required such arrangement.   
The roles of the moderator and the independent researcher were defined in line with the 
recommendations advanced by Canning, (2004). The roles of the moderator (principal 
researcher) included overseeing data gathering, facilitating discussion, debriefing each session 
with the independent researcher, transcribing and analysing recordings of sessions. The roles of 
the independent researcher included taking notes of verbal and non-verbal communications 
during sessions and participating in the debriefing sessions with moderator. 
Overall, six focus group sessions were held at different locations, which resulted in a broad base 
of participant opinions. Three sessions were held for clinicians in Enfield, Newham and 
Stevenage and three sessions were held for patients in Bromley, Hornchurch and Kingston. An 
independent researcher was present at each focus group session to take notes, including notes 
of behavior, gestures and similar non-verbal communications. This enhanced the ability of the 
principal researcher to concentrate on interactions between the participants and the record of 
non-verbal communications was considered to be of analytical importance in enhancing the 
understanding of emphasis placed by participants when making particular contributions 
(Cannin, 2004; Stewart, Shamdasani & Rook, 2007).  
 
4.6 DEVELOPMENT OF GROUP DISCUSSION GUIDELINES 
The areas explored by the focus group in order to ascertain the suitability of the exercise video 
as a tool for VBHEP as an adjunct to outpatient PR included:  
 (i) Participants perceptions regarding the elements of an exercise programme for 
individuals with COPD within the content of the video.  
(ii) Participants perceptions on whether the video content conformed to the conceptual 
framework of implementation fidelity evaluation when considering areas like the adherence to 
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intervention, the dosage of exercise advised in the video, the quality of delivery of the 
instructions, the participant responsiveness, intervention complexity and the facilitation 
strategies (Caroll et al., 2007; Dane & Schneider, 1998; Dusenbury, Brannigan, Falco & Hansen, 
2003; Mihalic, 2004) (refer to Section 3.1). 
DuBay (2004) defined readability and understandability as the degree of ease in reading or 
understanding a text. Van-Oosten et al., (2011) suggest that the concept of readability and 
understandability is subjective and that the most important factor that determines the easiness 
of a reader to understand a text is the reader’s background knowledge. Readability and 
understandability can be determined by quantitative analysis of the number of syllables per 
word and words per sentence, however because readability and understandability evaluate 
interaction between the readers and the text, the qualitative approach to understandability 
testing, through piloting the text with readers that are similar to the population of interest is 
essential (Abdollahzadeh & Zolfaghari, 2012; Van-Oosten et al., 2011). A copy of the group 
discussion guideline (Appendix 4B), was therefore sent to a group of 3 PR experts. The 3 PR 
experts were volunteer clinicians who responded to the recruitment advertisements.  They 
were asked to evaluate the focus group discussion guideline and indicate if any modification 
was required to make it more readable or understandable as discussion guideline for a focus 
group session. The three experts all agreed that the group discussion guideline sent to them was 
an appropriate tool for the intended focus groups. They however did not take part in the focus 
groups so as to avoid any researcher bias due to prior understanding of the study or its design.  
 
4.7 OUTCOME DATA 
Outcome measures for this research were: 
Transcriptions by the principal researcher of tape recordings of all focus group sessions 
(Krueger, 1994, Stewart et al., 2007).  
Independent records of verbal and non-verbal communications during the focus groups which 
was derived from the notes and observations of the sessions as documented by the independent 
researcher (Stewart, Shamdasani & Rook, 2007).  
The principal researcher (who did transcription of the audio recording) and the independent 
researcher (who took minutes of the sessions) compared notes (of the transcript against the 
minutes of sessions). This was to ensure credibility of the transcript (Polit & Beck 2006). 
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4.8 MANAGEMENT OF BIAS 
Guba and Lincoln (1994) note that bias can undermine the validity of a research.  In order to 
enhance the validity of the research findings, the area of study was defined and the data 
collected in line with the procedures advanced by Canning (2004) and Krueger (1994). Data 
were carefully transcribed by the moderator and verified by the independent researcher against 
the notes of the focus group sessions by the independent researcher. Data were coded by an 
agreed and verified methodology and each transcript was compared to ensure the coding 
encompassed all possible data interpretations. This multi-layered process ensured that 
comments were not being taken out of context, that wrong assumptions were not being made 
and that the data were not just being reported but rather analysed appropriately (Pope & Mays, 
2000).  
 
Complete records of various stages of the research process should be kept including interview 
transcripts and data analysis process to ensure dependability but not any data that can lead to 
identification of individual participants (Bryman, 2012). Credibility requires that the researcher 
ensures that the information provided by the participants retains its original meaning (Polit & 
Beck 2006). A complete diary of each focus group discussion was kept as audio recording as 
well as documentation of each session by an independent researcher in order to ensure that the 
research conformed to best practice. 
In order to ensure the credibility of the data, both the use of an independent researcher as 
transcriptionist and the use of study participants as transcriptionists were considered. The 
latter option was rejected due to its many disadvantages. The study population largely consisted 
of elderly individuals (some with problems of breathlessness and other co-morbidities) who 
may find transcribing difficult, time-consuming and impractical. Grundy, Pollon and McGinn 
(2003) suggest that participants sometimes select other individuals to transcribe for them 
which may reduce the credibility of the transcript. Lynch (2001) contends that participants as 
transcriptionists may also choose to expand or change their responses (to the interview 
questions) based on further reflection after the interview or focus group session. Additionally, 
transcribing requires motivation, good typing skills and the ability to sit and stay focused for a 
relatively long time. These skills can be present in trained researchers, but may not be present 
in all of the study participants (Grundy, Pollon & McGinn, 2003) and making such set of skills a 
requirement for any participants would have led to a reduced number of participants. Also, the 
clinicians may be too busy to transcribe the sessions. Based on these considerations, the study 
was conducted with the researcher as the transcriptionist. The content of the verbatim 
transcript by the principal researcher was compared and found to be consistent with the notes 
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of the sessions as documented by the independent researcher. This contributed positively to the 
credibility of the transcript (Polit & Beck 2006). 
A UK study indicated that 100% of the PR programmes reported having a physiotherapist on 
their teams, 84% had an occupational therapist, 81% had dietician, 77% had a nurse, 76% had a 
respiratory physician, 51% had a pharmacist, 43% had a social worker, 21% had a psychologist; 
12% had an exercise physiologist and 3% had a geriatrician (Yohannes & Connolly, 2004). An 
online discussion on the Interactive Chartered Society of Physiotherapy forum in 2007 indicated 
that the clinician profile per PR programme varies from programme to programme across the 
UK (Appendix 4C). Attempts were made to reflect this in the constitution of the membership of 
the focus group sessions where each session was constituted with different professionals, 
although, recruitment was not aimed at matching percentage profile of professionals.  
Each focus group was comprised of only clinicians or patients. This was to ensure that the 
members of each focus group were confident in voicing their views and that the less confident 
participants were not discouraged from expressing their views, in accordance with the 
approach advanced by (Sim, 1998; Stewart & Shamdasani, 1990).   
 
4.9 METHODS 
The study method was inductive and the approach was exploratory (Bloor, 1978), using focus 
group sessions with clinicians and patients with COPD. While a deductive approach usually 
focus on testing a theory and starts with a hypothesis, the emphasis in an inductive approach 
generates new theories by evaluating new phenomenon or a previously researched 
phenomenon from a different viewpoint (Bryman, 2006).  In an attempt to remove elements of 
bias, the principal researcher (who is a respiratory physiotherapist) adopted a dualist and 
objectivist position during the focus groups (Smith, Sparkes, Phoenix & Kirkby, 2012). Adopting 
a dualist and objectivist approach requires that the principal researcher separate himself from 
the research and become an independent entity (Sim, 1998), with the ability to evaluate the 
experiences and perceptions of the focus group participants about the VBHEP, without 
influencing each participant’s position. The tape recording enhanced the ability of the principal 
researcher to concentrate on engaging with the group without the risk of losing the information 
been gathered (Krueger, 1994). The role of the principal researcher was to initiate discussions 
on the topic of interest without creating a bias in the mind of participants. For example, topics of 
discussion were introduced as follows: 
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Moderator (session 3), line 5 and 6: ‘‘What is or are your idea(s) of an ideal video for home-
based exercises by COPD patients. Basically, what would you be looking out for?’’ 
A process of concurrent data analysis, as recommended by Sim (1998), was employed. The data 
from each focus group session were transcribed and analysed before the day of the following 
focus group session. The information gathered from earlier focus groups were used to guide the 
discussion and seed questions in the later focus group sessions. A point of saturation was 
reached when no new theme appeared to be emerging (Basch, 1987; Krueger, 1994; Pope & 
Mays, 2000). 
Seven steps were followed to explore the views of participants on the suitability of the Move-On-
Up video for VBHEP for the UK population of patients with COPD. 
Step 1-  The initial categories of suitability factors were identified from NICE (2004) guidelines 
and research publications between 2003 and 2008 in line with a comprehensive description of 
the contents of a PR programme, and a conceptual framework of implementation fidelity 
evaluation (Dusenbury, et al., 2003; Dane & Schneider, 1998; Mihalic, 2004; Caroll et al., 2007). 
Step 2- Views of focus group participants were explored on general suitability of content for an 
exercise video for VBHEP for the UK population of patients with COPD or what was considered 
desirable content in such a video. The sessions commenced with introductory questions by the 
moderator, including the following: 
Moderator (session 1), lines 10 and 11: ‘‘From your idea of an ideal video-based exercise 
programme for COPD patients, what do you think of or how do you see the Move-On-Up 
video?’’  
Moderator (session 2), lines 4 to 6: ‘‘What are your ideas of an ideal video for a programme of 
home exercise? What are the things you would be looking out for?’’  
Moderator (session 3), lines 5 and 6: ‘‘What is or are your idea(s) of an ideal video for home-
based exercises for COPD patients. Basically, what would you be looking out for?’’ 
Moderator (session 4), lines 4 and 5:  ‘‘What are your ideas of an ideal video for home-based 
exercise for COPD patients? What will you be looking out for?’’ 
Moderator (session 5), lines 4 and 5: ‘‘If I may just start by saying what are your ideas of an 
ideal video for a home-based exercise programme for COPD patients?’’ 
Moderator (session 6), lines 5 to 7: ‘‘What are your ideas of an ideal video for home-based 
exercise programme for COPD patients? Generally, what are the things you will be looking 
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out for or what are the things you will consider as ideal that will make such a video 
suitable?’’ 
Step 3- Focus group participants explored the content of the video using some seeding 
questions that related to the suitability items earlier identified from the NICE guidelines and the 
research publications as in Step 1. 
Step 4- The participants’ responses (from steps 2 and 3) were examined and themes were 
identified. Some of the themes fell within the categories of the suitability factors that were 
identified in Step 1 and some did not.  
Step 5- The new themes identified in Step 4 were examined. This informed a decision to modify 
some categories of the original suitability factors (from Step 1) to include new categories  
Step 6- Participants in subsequent focus group sessions explored all the expanded categories of 
suitability factors from step 5 to assess the suitability of the Move-On-Up exercise video for 
VBHEP by the UK population of patients with COPD. The process of concurrent data analysis 
(Sim, 1998) made it possible to identify new categories which were of interest to participants of 
the earlier focus group session. The new categories were added to the interview guideline of the 
subsequent focus group. Therefore, participants in the later focus groups had more interview 
guidelines to discuss than the earlier groups (Bloor, 1978). 
Step 7- The relevant steps, as described above, were followed until no new theme could be 
found in the focus group transcript which would require inclusion of an additional category of 
suitability factors, and until all the existing items had been explored by the focus group 
participants. 
These steps were followed for both the clinician and patient focus groups. 
Content analysis is used to identify patterns across qualitative data and involves a frequency 
count of words and phrases which can lead to quantitative analyses of originally qualitative data 
(Ryan & Bennard, 2000). Content analysis can be treated like thematic analysis (Wilkinson, 
2000), though in thematic analysis, themes are not always quantified (Braun & Clarke, 2006) 
and the units of analysis tend to be more than a word or phrase (Boyatzis, 1998). A suggested 
practice in grounded theory (Glaser and Strauss, 1965, 1967) is to avoid consulting related 
literature prior to data collection, in order to avoid bias in the analysis of data which could 
result from preconception from previous studies, instead of being accurately grounded in the 
current data (Braun and Clarke, 2006; Glaser and Strauss, 1965, 1967). This is not applicable 
practicable in the current study because the formulation of the research protocol required 
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familiarization with the existing publications and guidelines in the area of research. Thematic 
analysis does not suffer from the restrictions that apply when grounded theory or content 
analysis is used. In essence, the advantage of thematic analysis includes the fact that it is 
theoretically adaptive to wide ranging types of data (including interviews, focus groups or 
diaries), it is not tied to any pre-existing framework and there is no definite constraint for 
sampling number in the use of thematic analysis(Braun & Clarke, 2006). Based on the 
aforementioned considerations, thematic analysis of transcripts of recordings from the focus 
group sessions was carried out. 
 
4.10 RESULTS AND DATA  
Fourteen patients with COPD (5 males), 10 with a combination of mild/moderate COPD (using 
the MRC scale), and 4 patients with severe COPD participated in the research. There was at least 
one patient with severe COPD in each of the patient focus group sessions and an average of 5 
patients with COPD per session. There were 14 clinicians that participated with an average of 5 
clinicians per session. Clinicians comprised 5 (35.71%) respiratory physiotherapists, 1 (7.14%) 
consultant chest physician, 6 (42.86%) respiratory nurses, and 2 (14.29%) occupational 
therapists. The participant distribution was multidisciplinary in nature as suggested by 
previous survey of PR programmes (Yohannes & Connolly, 2004). 
 The average length of the focus group session for patients with COPD was 35 minutes and the 
average length of focus group session for the clinicians was 36 minutes. Conceptual saturation 
was reached by the 4th focus group session, after which no new category was generated from 
the data in a session.  
A manual transcription and analysis of the recordings from the focus groups was undertaken to 
identify the key themes expressed by participants, in line with the method proposed by Pope 
and May (2000). The full transcript is included in the appendix 4E. After each focus group 
session, the principal researcher and the independent researcher met to discuss observations 
from the focus group session. The principal researcher also listened to the audio recording of 
each session and transcribed them. All these enhanced the accuracy and content representation 
of the data analysed.   
Thematic analysis was carried out by breaking down, examining, comparing and categorising 
data on the basis of themes. Themes are subjects that pervade in a discussion (Sim, 1998; Steel, 
2000). The raw data were studied in three phases of coding (Braun & Clarke, 2006; Tuckett, 
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2005).  First, themes were identified and the researcher was open to finding new themes, 
including those that did not belong to any previously known category. Next, links and 
relationships between themes were examined.  Lastly, major themes were organised into core 
ideas. Items that were different from those previously listed in the tentative categories of 
suitability factors were examined and this informed the decision to expand the categories of 
suitability factors and modify some of the tentative categories. Refer to sections 4.10.1 to 
section 4.10.4.  
 
4.10.1 GENERAL THEMES FROM THE FOCUS GROUPS 
Participants discussed areas of information covered in the Move-On-Up exercise video and the 
choice of participants in the video. The themes suggested that the appearance of some patients 
with COPD alongside clinicians (in the Move-On-Up video) who were discussing the experience 
of managing breathlessness would encourage other patients to overcome the fear of 
breathlessness and participate in exercise.  
Nurse (session 3), lines 40 and 41: ‘‘I think it is good the patients took part actually. The 
patients to some degree see doctors all the time; they like to see other people’’.  
Physiotherapist (session 3), lines 42 and 43: ‘‘I think it is good the way X kept reiterating: be 
breathless. Usually, they [patients] felt scared getting breathless’’. 
Patient VI (session 2), lines 22 and 23: ‘‘What they need to tell people, so they don’t get 
frightened when you get out [i.e. go outdoors], you are not harming yourself. It doesn’t hurt 
you to get out of breath’’.  
Patient VI (session 5), lines 25 to 27: ‘‘They showed you the neck exercises by the 
physiotherapist to get all the muscles to relax. All the muscles are tight and actually 
stopping you from breathing. I think the introduction by the doctor, the professor, [was] 
very good, very exciting’’. 
Patient III (session 5), lines 18 and 19: ‘‘Some of the things I do, I don’t know why I do it, I don’t 
know what I do but that [video] explained it and I thought it was good’’. 
 
Participants discussed how to moderate the exercises and avoid harm or injuries, including 
holding on to some form of support when doing exercises while standing. It was evident from 
the emerging themes that patients were able to moderate their exercises in a way to avoid 
harm, avoid over-exertion and manage the symptoms of exertion. 
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Nurse (session 3), line 138:  ‘‘I think they are very satisfactory. When standing, they were told 
to hold on to something’’. 
Patient II (session 2), lines 52 and 53: ‘‘I do my exercises. Because of the breathing, I exercise 
with a 9 inch fan. I couldn’t do it without a fan’’. 
Patient II (session 4), lines 61 and 62: ‘‘It is after each exercise. At the end of doing that, then 
you think, what is my breathing like and you decide that (referring to the Borg scale)’’. 
Patient IV (session 4), lines 144 and 145:‘‘Take it easy with yourself. You don’t have to do [it] 
all. You could hurt yourself. Say do it in fives, then sixes, sevens’’. 
 
Patient III ( session 4), lines 77 and 78:  “It is just all about, you don’t have to do it and hurt 
yourself because if you hurt yourself, you are not going to do it!’’ 
 
Patient III (session 4), line 79: ‘‘Hold on to something [when doing exercises].’’ 
Participants discussed the appropriateness of the video in terms of the amount of exercises. 
Some clinician participants pointed out a need for more emphasis on progression of the 
exercises while other clinician participants suggested that the intensity of the exercises may be 
too much for some patients with COPD. In general, the patients demonstrated an appropriate 
understanding of how much exercise is sufficient in order to achieve improvement in their 
health condition and how to pace the exercises. 
Physiotherapist II (session 1), lines 26 and 27: ‘‘Difficult to say [the effectiveness of exercises 
chosen]; good balance of upper and lower limb exercises, but they did no progression’’.  
 
Physiotherapist II (session 3), lines 15 to 18: ‘‘I think the video as it is now is a bit on the high 
level for the patients. You probably need something more sub-acute unfortunately, when 
they are not as good as those people in the video. A little bit more of chair-based exercises. 
Something to start with and then they can put the rest into it afterwards’’. 
 
Patient II ( session 5), lines 34 and 35: ‘‘I start off with 1 minute, then I go 1 minute, 30 
seconds, then I go to 2 minutes by progressing my fitness’’. 
 
Patient VI, session 5, lines 64 and 65: “In a way, do what you can do and then remember what 
they always taught us: as soon as you start puffing around, stop!” 
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Patient II (session 2), lines 67 and 68: ‘‘Like I said, the British Lung Foundation and the British 
Heart Foundation say between 20 minutes and half hour’’. 
 
Patient III (session 2), line 70: ‘‘The video takes an hour for me’‘. 
 
Patient IV (session 2), lines 74 to 75: ‘‘. And like I said if you don’t listen to all this; what is 
exactly good for you, you just do the exercises, you do plenty of it. You have to keep going 
forward with the video [i.e. progress the exercises]’’. 
 
Patients discussed the Move-On-Up video regarding how motivational its content could be. The 
themes suggested that the video could motivate patients to overcome the fear and anxiety 
associated with breathlessness and encourage an exercise habit. 
Physiotherapist I (session 1), line 69: “Very positive and reassuring but I think all the patients 
look too well’’. 
Patient IV (session 4), lines 130 to 131: “Yes, I did [walked out of the house]! I actually took my 
stick, as I open the door, got to the main road, trying to cross; the bus [was]coming, then I 
lost my confidence.” 
 
Patient III (session 4), lines 14 to 18:  “What impressed me is that they said “don’t be afraid of 
getting breathless”. Yeah, because I have heart problem[s] and lung problem[s], so between 
the two of them, I don’t know which one I am being breathless with. So being breathless 
mean[s] I have to stop. My heart starts racing off. But this morning, I was breathless, I was 
alright, I wasn’t so worried about it’’ (smiling broadly). 
 
The participants discussed the appropriateness and suitability of the way communication was 
handled in the video. The themes indicated that the advice on exercise was practical and the 
language of communication was appropriate to the audience. Participants’ understanding was 
enhanced by the audio-visual effect. One of the clinicians, however, pointed out that the 
concurrent dialogue and activity level meant that there is a risk that comprehension of the 
message may be hindered. 
Nurse (session 1) line 66: ‘‘I think there were clear messages about exercise intensity’’. 
 
Nurse (session 1), line 71: “The language; no jargons. Communication is clear”. 
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Patient IV (session 4), line 123: ‘‘X [the presenter] as she speaks, she used minimum language 
and it works very well”. 
Patient I (session 4), lines 108 to 111: “One of the benefits of the video is…when I had heart 
surgery, I went into the hospital and they gave me sitting exercises. When I went out of the 
hospital, I couldn’t remember how to do them. Much better when you actually see someone 
doing it [in the video]’’. 
Physiotherapist I (session 1), lines 72 and 73: “Practical [advice was] given, [although] 
sometimes pictures [were] going over voice, [and there was] too much talking at times’’. 
 
4.10.2 NEW THEMES FROM THE FOCUS GROUPS, NOT IN EARLIER 
SUITABILITY CATEGORIES 
Participants in the focus group discussed that it was important that the user of the video was 
able to progress the exercises recommended as appropriate. It was suggested that appropriate 
advice on the need for exercise progression was included.  
Physiotherapist II (session 1), lines 58 and 59: “Each patient can identify where they fit, weight 
by weight, you can progress”. 
In addition, the groups discussed the importance of users being able to structure the exercises 
recommended into their daily activities in order to enhance compliance.  
Physiotherapist II (session 1), line 32: ‘‘The exercises are okay – they did walking outdoor, etc. 
It is more to do with the progression’’. 
 
Furthermore, the groups identified the importance of users being able to access the equipment 
required in order to do the exercises. The focus groups suggested that the exercises 
recommended in the video were basic and that users should not have a problem acquiring the 
equipment required. 
Patient II ( session 5), line 114:  ‘‘ There are the sitting room exercises, the kitchen exercises, 
the tins are been used and I think let’s do two of each, let’s do these three and then four. If 
you just do four of those, in a long time, you are doing eight)’’. 
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Following analysis of the themes that arose from the focus group participants, new categories of 
suitability were included:  
Appropriateness of the advice in the Move-On-Up video on progression of the exercises.   
Appropriateness of the advice in the Move-On-Up video on structuring of the exercises into 
activities of daily living. 
Suitability of the Move-On-Up video for home based exercise programme considering equipment 
needed to be able to do the exercises at home. 
 
4.10.3 RELATIONSHIPS THEMES OF THE FOCUS GROUPS 
The themes from the focus group suggested that the Move-On-Up video contains an ideal set of 
exercises. However, while some participants suggested that for some categories of COPD 
severity patients to realise the full benefits, the exercises need to be progressed, some 
participants suggested that the exercises might be too difficult for some patients with severe 
COPD to carry out. 
Physiotherapist I ( session 3), line 72: ‘‘I think the exercises they’ve chosen are actually quite 
good. I think it is okay to start with but that needs to be progressed’’. 
Physician (session 3), line 100: ‘‘Exactly, exactly, depending on their MRC. For example, for 
mild COPD, they’ll be able to do 100%, severe COPD would do maximal 10% to 15%’’. 
 
Physiotherapist III ( session 1), line 83: Maybe another video different one for different COPD 
severity level. 
Chorus by other participants , in response to the above comment by Physiotherapist III (session 1), 
line 84:  Yes. 
 
OT (session 3), line 22 to 24: ‘‘…and I said, it’s obviously difficult having one video for 
moderate and one video for severe, but we only need say within same film, for this one 
(section) is for people that have moderate [COPD], this one (section) for severe. You also 
want your severe people to actually get up and do something’’. 
 
Patient II (session 4), line 89: ‘‘You might be doing 5 or 6 now, then three weeks time, you 
might be doing 10’’. 
106 
 
Patient VI (session 5), lines 59 to 62: ‘‘There are different levels of exercises. You’ve got one for 
people that are not able or would never be able to go out. These are the people that are 
doing the neck, the shoulder, things they can actually do by sitting down in the chair. Then 
you’ve got the next step which is the one standing up by the mantle piece raising their legs, 
some people would never be able to do that’’. 
 
In relation to the above points, there are themes from other clinicians and patients in the focus 
group suggesting that the patients have understanding that they are required to progress the 
exercises.  
Patient III (session 4), lines 71 and 72: ‘‘I think they leave it to your own (decision). Where you 
used to say, breathless 5 today, you may be able to be 2 later (referring to Borg scale of 
breathlessness). It’s just the initial one. It is just all about you’’. 
Patient I ( session 4), line 77: ‘‘Four? That’s another bad score for a beginner’’. 
 
Also, some patients expressed that they have even derived some improvement in their 
condition following use of the video. 
Patient II (session 4), lines 84 to 87: ‘‘I very much sit in the chair. I get out through the door 
step and become breathless and have to sit back again. I just thought what do I have to do 
and then started watching the video. And I did the exercises with them as they were saying 
it, and I managed about three days going with the exercises and I’ve stopped just slouching 
along in house slippers. I put proper shoes on, in the home, I walked properly as I am using 
my muscles; I am not slouching in the house slippers. I’m just slouching in the house but the 
video made me buckle shoes and walk with them.I find the breathing exercises wonderful 
because I find it hard to relax because panting. I think I am better now. I am able to control 
the aspect of my breathing and I’m so much more relaxed’’. 
Patient V ( session 4), lines 84 to 87: “ Because you are breathless, you’ve been sitting and 
doing nothing, no exercise, this was before I got the video, and so I find all my joints, my 
neck, my shoulder…stiff. Now, I’ve been doing this (video), a few times, I’m using my legs, 
that is alright. If you are sitting there thinking of these whole tiredness, you won’t be doing 
nothing!’’.  
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4.10.4 CORE IDEAS FROM THE FOCUS GROUP 
According to the themes from the focus groups reported in this chapter, the video appears to be 
suitable in its content and the knowledge of COPD reflected, including its explanation of the 
benefit of exercise to COPD. The video covered the major areas of information concerning the 
effects of exercise on COPD that were relevant to the patients. This included advice on why they 
should be doing the exercises, how to do them, breathing patterns and breathing retraining, 
motivation and reassurance on the breathlessness that may be experienced. 
According to the participants of the focus group, the video is considered to be suitable in its 
explanations and demonstration of exercises for patients with COPD. The participants all 
indicated that the mode of communication in the video is satisfactory and the possible benefits 
of using the video may include an enhanced understanding of the exercises demonstrated in it. 
The Move-On-Up video contained an ideal set of exercises and patients in the focus group 
indicated that they understood that they are required to progress the exercises.  
In terms of whether the exercises in the video were proportionate for different levels of 
breathlessness or different levels of exercise ability, as might be experienced by a patient with 
COPD, opinions by the focus group participants suggested that some of the exercises may be 
suitable for a patient with moderate or severe COPD, while all the exercises may be suitable for 
a patient with mild COPD. 
The participants of the focus group assert that it is safe for a patient to do the chosen exercises 
in the video in the absence of a clinician. Also, the patients have an appropriate understanding 
that each individual needs to do the exercises according to his or her exercise ability and know 
how to moderate their exercises and avoid harm. 
The participants of each of the six focus groups suggested that the Move-On-Up video is 
adequate with regards to the motivation needed to comply with a home-based exercise 
programme. 
The video was considered suitable in terms of the duration of exercises per session, in terms of 
the recommended level of exertion during exercise and the recommended frequency of exercise. 
The video is suitable in terms of its overall length and its recommendation on exercise 
progression.  
The video is suitable in terms of the advice on structuring the exercises into activities of daily 
living. Participants of the focus groups felt that the video was appropriate for a home-based 
exercise programme, considering the equipment needed to be able to do the exercises at home. 
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4.11 DISCUSSION 
The focus groups were conducted in line with documented recommendations; without the 
researcher encouraging consensus or dissent (Canning, 2004; Sim, 1998). In his previous role as 
a researcher, the principal researcher conducted focus group sessions involving clinicians and 
served as the moderator, enhancing his skills and experience in managing such group sessions. 
Also, he attended various training at the University of Hertfordshire and consulted appropriate 
literature to enhance his ability to conduct a focus group study. It is proposed that this approach 
enhanced the quality of the data collection and analysis.  
During the planning stage, it was considered whether prior experience of PR should be made a 
requirement for all patient participants in the focus group study. However, Yohannes and 
Connolly (2004) established wide variations in the content and protocols of PR across the 
various clinical services in the UK. The variations include different durations of PR session 
(range 1 to 3 hours), length of programme (range 5 to 24 weeks), and contents of programme 
(97% include upper extremity training, 84% include relaxation training, 28% include 
inspiratory muscle training) (Yohannes & Connolly, 2004).  Since the focus groups were to be 
held in different locations in the UK, it was considered that variations in the PR experience of 
potential participants may introduce confounding factors. Hence, this approach was rejected.   
Also, it was considered whether to conduct focus groups before and after every participant 
would have watched the exercise video. This approach would require each participant to attend 
two focus group sessions which would require more participant involvement in terms of time 
and commitment. Applebaum et al. (2012) (n=153 patients with cancer) investigated the factors 
associated with study attrition. Study attrition was evaluated as the percent of patients who 
failed to participate in the assessments at the three different time points in a study.  The study 
attrition increased with duration of study and required number of attendance by participants. 
Of the 153 participants that met the inclusion criteria, 110 attended pre-treatment assessment, 
83 attended the mid-treatment assessment, 66 attended post-treatment assessment. However, 
the study by Applebaum et al. (2012) was an RCT while the study reported in this chapter is a 
qualitative study. It was considered in the current study that the number of volunteers and 
eventual participants could be less with longer duration of study and a requirement to attend 
more than one focus group session. Based on the aforementioned, it was considered 
appropriate to conduct focus groups in which every participant would have already watched the 
exercise video and would be required to attend only one focus group session. It was possible 
that watching the Move-On-Up video of exercise before attending the focus group session may 
have influenced what the participants considered as desirable content of a video of exercise. 
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There were conflicting views among some clinician participants over whether a greater 
emphasis on progression of the exercises would ensure that patients who use the video do not 
stay on the same level of exercise intensity or whether exercises of lower intensity are actually 
required. The themes that emerged from the patients however indicated that they were 
satisfied with the advice in the video. The patients appeared to demonstrate appropriate 
understanding of how to pace and progress the exercises, remain safe while doing it and 
manage their symptoms. The patients indicated that they were able to distinguish between 
exercises in the video that are appropriate and those that need to be progressed. This 
observation of disparity between expectation of patients and clinicians as relate to the content 
of the video is in agreement with the findings of previous studies (Gardner et al., 2001; Meis et 
al., 2014).  
Meis et al. (2014) conducted focus groups and semi-structured interviews to evaluate the 
experience of patients with COPD who attended inpatient pulmonary rehabilitation.  Fourteen 
clinicians (3 males, aged 24 to 52 years) including physiotherapist, respiratory nurse, 
occupational therapist, dietician, physical trainer, psychologist and pulmonary physician, 
participated in the study. Thirteen patients with COPD (aged between 54 and 78 years), most of 
whom had severe to very severe COPD, also participated in the study. Out of the 13 patients, 
seven had just commenced on the PR programme and six had almost completed PR. Seven of the 
14 clinicians were interviewed at the beginning of PR while the remaining seven were 
interviewed at the end of PR. Meis et al. (2014) identified that at the beginning of PR, there were 
disparities in the opinions of patients and clinicians to what were considered as achievable 
goals and clinicians considered patients’ goals as abstract and immeasurable. Further, patients’ 
descriptions of their abilities were considered by clinicians as underestimating or 
overestimating their ability.  
Gardener et al. (2001) compared nurses’ and cancer patients’ perceptions of what they 
considered as important caring behaviours using the 50-item Care-Q questionnaire.  A 
convenience sample of 35 nurses and 30 patients participated in the study. Analysis of 
responses indicated statistically significant differences between patients’ and nurses’ 
perceptions of caring behaviour in 14 of the 50 statements (P <0.05). Gardener et al. (2001), 
based on the results concluded that clinicians’ interpretations of care may not always 
correspond to those of the patient.  
110 
 
The findings from this research corroborate that of Meis et al., (2014) and Gardener et al. 
(2001) which suggest that the degree of acceptance of an intervention by patients can be 
different from that of clinicians.  
Participants, both patients with COPD and respiratory clinicians mostly consider the Move-On-
Up video as suitable for VBHEP.  A small minority of clinicians in the focus group argued the 
need for even lower intensity of the exercises, including the need for more chair-based exercises 
in the video. Others commented that a patient with mild COPD would need to be able to 
progress some of the exercises recommended in terms of intensity, duration and frequency in 
order to achieve an appropriate exercise dose. Most of the participants in the focus group with 
severe COPD indicated that they were doing the exercises as prescribed without any problem, 
while small minority remarked that not all of the exercises in the video would be suitable for 
their level of breathlessness, and as such, they could do some of the exercises but not others. 
The findings of this study suggest that the video may be suitable for a patient with COPD who 
can pace the exercise content, according to his or her exercise tolerance, from time to time.  
The majority of the clinicians and small minority of patients with COPD expressed that a 
different video could be made for each of the COPD severity levels (so that each patient could do 
just the exercise within his or her level of breathlessness). The majority of patients with COPD 
and minority of clinicians argued that the same video could contain exercises relevant to the 
various COPD severity levels (so that the same patient with COPD who experiences varying 
degree of breathlessness from day to day can either progress to harder exercises or do less 
difficult exercises). Based on these themes of consensus and dissent within the participants, a 
question was included in the patient version of the questionnaire (partly developed based on 
the results of the focus group) asking: 
What proportion of the exercises in the video would you be able to perform within the limits of 
your breathlessness? 
In the clinician version of the questionnaire (partly developed based on the results of the focus 
group), the question was modified to address the different COPD severity levels separately, as 
follows: 
(i) What proportion of the exercises in the video would you describe as relevant to mild COPD 
patients? 
(ii) What proportion of the exercises in the video would you describe as relevant to moderate 
COPD patients? 
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(iii) What proportion of the exercises in the video would you describe as relevant to severe 
COPD patients? 
Following themes from focus group participants, new categories of suitability were also added 
as indicated in section 4.9.2 (New themes from the focus groups, not in earlier suitability 
categories) 
The use of focus groups in the final stage of developing the national survey questionnaire 
provided greater understanding of the concepts to be reviewed. This follows the advice of 
Schechter, Trunzo and Parsons, (1993) (n=9, females= 6) where the use of focus group made it 
possible for investigators of post-polio-syndromes to determine whether the proposed survey 
objective and instrument were appropriate. The modification of the questionnaire items for 
national evaluation of the Move-On-Up video based on the findings of the focus group enabled 
the questionnaire to be valid in accordance with the qualitative methodological approach 
advanced by McLeod, Meagher, Steinert and Boudreau (2000). 
 
4.12 CONCLUSION 
Focus groups are designed to elicit the perceptions, feelings and opinion of participants and not 
for seeking a consensus opinion (Krueger, 1994). While group conformity is not the aim of the 
researcher, group consensus is only a risk when individuals in the groups are forced to work 
towards group verdict rather than share their different views (Morgan and Krueger, 1993). At 
the conclusion of the focus group study, the vast majority of themes suggested that the Move-On-
Up exercise video is suitable for VBHEP as an adjunct to outpatient PR for the UK population of 
patients with COPD from both clinicians’ and patients’ perspectives. The benefits of its use 
include appropriate advice on the benefits of exercise for patients, enhancement of patient’s 
confidence to exercise, appropriate advice on suitable exercises and demonstration of the 
exercises. The possible drawbacks were mainly perceived by PR clinicians in the over or under 
estimation of patient effort/ abilities which were in line with other studies on the subject (Meis 
et al., 2014). 
 
Based on the outcomes and the analysis of the focus groups, modifications were made to the 
items of the domains of the video suitability evaluation as indicated in Table 4.1.  
 
A copy of the final questionnaire which was developed following further validity (as reported in 
Chapter Five) is in appendix 5E.  
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Table 4.1- Synthesis of key questionnaire items for national survey 
Key areas of initial 
questionnaire items 
following review of 
content of the video 
against NICE guidelines 
& publications 
Modifications to the questionnaire items following analysis of 
focus groups 
(i) Knowledge of COPD  
 
(ii) Explanation on 
benefits of exercises in 
COPD  
 
(iii) Explanations and 
demonstration of 
exercises 
 
(iv) Motivation 
 
(v) Duration of exercise 
per session. 
 
(vi) Level of exertion 
during exercise. 
 
(vii) Frequency of 
exercise 
(viii) Overall length of 
the video 
 
(i) Inclusion of an item on appropriateness of the advice in the 
Move-On-Up video on exercise progression  
 
(ii) Inclusion of an item on appropriateness of the advice in the 
Move-On-Up video on structuring of the exercises into activities of 
daily living. 
 
(iii)Inclusion of an item on suitability of the Move-On-Up video for a 
home-based exercise programme, considering equipment needed 
to be able to do the exercises at home. 
 
(iv) To investigate whether a different video should be made for 
each of the COPD severity levels or whether the same video should 
contain exercises relevant to the various COPD severity levels, a 
question was included in the questionnaire asking ‘What 
proportion of the exercises in the video would you (i.e. the 
questionnaire respondent) be able to perform within the limits of 
your breathlessness?  
 
(v) In recognition of the various levels of COPD severity, the item 
on the proportion of the exercises in the video that is relevant to 
COPD was restructured in the clinician questionnaire to address 
each COPD severity level separately. 
 
(vi) Inclusion of item on safe performance of recommended 
exercises in the absence of clinician. 
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CHAPTER FIVE-NATIONAL SURVEY ON EVALUATION OF 
THE MOVE-ON-UP  EXERCISE VIDEO 
5.1 JUSTIFICATION  
This chapter reports the results of the prospective national survey which investigated the 
evaluations of both patients with COPD and respiratory clinicians on the suitability of the Move-
On-Up video for use in VBHEP as adjunct to outpatient PR by UK population of patients with 
COPD.  
The initial evaluation of the video used the NICE guidelines and research publications as 
reported in Chapter 3. This was followed by the use of focus groups which enabled patients with 
COPD and respiratory clinicians to confer on appropriate domains of suitability of an exercise 
video for VBHEP as reported in Chapter 4. Focus groups can precede a broader survey as a way 
of identifying and validating the items of the survey (McLeod, Meagher, Steinert and Boudreau, 
2000).  
Wood (2006) suggested that questionnaires can be used to collect information on facts and 
belief from a larger sample of participants than can be achieved through personal interview; a 
nationwide survey was thus necessary to investigate perspectives of the wider population of 
patients and clinicians on the suitability of the Move-On-Up exercise video. 
Cross checking the findings from the desk research (Chapter 3), with the findings from the focus 
group study (Chapter 4) and further with the findings from the nationwide survey (this chapter) 
constituted methodological triangulation for investigating the suitability of the Move-On-Up 
exercise video for VBHEP as adjunct to outpatient PR by the UK population of patients with 
COPD. 
 
5.2 RESEARCH QUESTION AND AIMS OF RESEARCH 
The research asked: Is the Move-On-Up exercise video suitable for use in VBHEP as adjunct to 
outpatient PR by the UK population of patients with COPD from both clinician and patient 
perspectives? 
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The aim was to investigate the clinicians’ and patients’ perspectives of the suitability of the 
Move-On-Up exercise video for VBHEP as adjunct to outpatient PR by UK population of patients 
with COPD. 
 
5.3 ETHICAL APPROVAL 
The national survey was approved by the University of Hertfordshire Ethics Committee. The 
initial ethics approval (HEPEC 03/09/73) was granted in March 2009 for 6 months. An 
extension of the approval (HEPEC 03/09/73) was granted in July 2009 for the study to end in 
November 2009 (Appendices 5a and 5b).  
 
5.4 METHODS 
A nationwide questionnaire survey was used to evaluate the perceptions of a larger number of 
respiratory clinicians and patients with COPD, since this is the most appropriate method to 
reach a larger sample of participants (Wood, 2006) and questionnaire data are easier to analyse 
for this size of sample population (Anne and Cox, 2008). 
 
5.4.1 STUDY PARADIGM 
The target population for studies evaluating the suitability of the Move-On-Up video for VBHEP 
included respiratory clinicians and patients with COPD who met the inclusion criteria. At the 
time of the study, 229 Breathe Easy (BE) groups and 211 PR services were identified in the UK 
(Section 5.4.3). In considering the appropriate research approach and method, the size of the 
target population and the geographic spread of the BE groups and PR services, were put in 
perspective.   
Various research approaches were considered for this study. Grounded theory was considered 
inappropriate since content of the domains of evaluation were already based on previous 
findings from NICE guideline (NICE 2004), research publications (between 2003 and 2008) and 
themes from focus groups (Chapter Four). Discourse analysis is mainly about evaluating social 
interactions and it was considered inappropriate to the research objective (Fulcher, 2005). 
Phenomenological research would have required close and far-reaching observation of the 
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research participants by the principal researcher (Creswell, 2009) and was not relevant to this 
study. The interpretive approach to qualitative research aims to investigate ‘why does an 
observation or a phenomenon come about?’ (Elliot & Timulak, 2005) and it was also considered 
as not applicable for the research question in this study. As suggested by Wood (2006) it was 
considered that a survey can be used to investigate the generalisability of facts and belief 
previously defined by the findings of the desk research and the focus group  about the suitability 
of the Move-On-Up video for VBHEP as adjunct to outpatient PR in patient with COPD. 
The disadvantage with the use of questionnaires is that the information might be limited in its 
depth but the risks associated with this limitation can be minimised where appropriate and 
clearly defined facts and beliefs have been established by more qualitative methods and a 
questionnaire is subsequently used to explore how generally these facts and beliefs apply 
(Wood, 2006). There was initial content analysis of the Move-On-Up video (as detailed in 
Chapter 3) which resulted in identification of questionnaire items. This was followed by focus 
group study detailed in Chapter 3 which evaluated the perceptions of clinicians and patients 
with COPD on the suitability of the Move-On-Up exercise video for VBHEP by the UK population 
of patients with COPD and was also used to synthesise questionnaire items (particularly on 
areas that relate to the experience of respiratory clinicians and patients with COPD and what 
they consider as desirable content of such video) for a broader nationwide review of the video. 
The studies detailed in Chapters 3 and Chapter 4 have minimised the risks associated with a 
limitation in the depth of information that might be collected by questionnaire survey alone. An 
open-ended or unstructured questionnaire is appropriate if the purpose of a study includes the 
identification of qualitative materials (Creswell, 2009). In contrast, a closed-ended 
questionnaire is more appropriate if the purpose of the study is to seek responses to fixed 
categories (Creswell, 2009).  The above considerations led to the decision to use a questionnaire 
approach in the nationwide evaluation of the video.  
 
5.4.2 QUESTIONNAIRE DESIGN AND PILOT  
A Likert-scale questionnaire demonstrates respondents’ opinions on each item, as well as the 
strength of opinion (Churchill & Peter, 1984). The questionnaire used in this survey was 
synthesised from the studies reported in Chapter Three and Chapter Four. Each item of the 
questionnaire, had four possible responses, such as ‘very appropriate’, ‘appropriate’, 
inappropriate’ and ‘very inappropriate’ (Appendix 5E). A neutral option was not included 
because previous study comparing the use of four- and five-point Likert scales demonstrated 
that the overall difference is negligible when the neutral option is removed (Armstrong, 1987). 
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Four-point scales were demonstrated to have a greater internal consistency than six-point 
scales (Chang, 1994) and the test retest-reliability was demonstrated to decrease for scales with 
more than ten scale points (Preston & Colman, 2000). Furthermore, the use of four-point Likert 
scales on the questionnaires allowed sub-analysis of the responses as well as the strength of the 
responses. Based on these evidences, this study used a four-point Likert scale for each of the 
questionnaire items; ‘very unsuitable’ (coded as 1 in the analysis), ‘unsuitable’ (coded as 2 in the 
analysis), ‘suitable’ (coded as 3 in the analysis) and ‘very suitable’ (coded as 4 in the analysis). 
As indicated in Sections 4.10 and 4.11, two types of questionnaire were developed; one for 
patients and one for clinicians. Both versions of the questionnaire were assessed for content 
validity, readability and understandability. This was considered in conjunction with the findings 
reported in Chapters Three and Four.  
The content validity of the questionnaires was achieved by the studies reported in Chapter 
3 (which involved review of NICE guidelines and research publications on PR of patients 
with COPD) and Chapter 4 (involving focus groups of respiratory clinicians and patients 
with COPD). 
The questionnaires were evaluated for readability and understandability. Readability and 
understandability refer to the ease with which members of a target population can read and 
understand a text (DuBay, 2004). Readability and understandability can be investigated by 
quantitative analysis of the number of syllables per word and words per sentence 
(Abdollahzadeh & Zolfaghari, 2012).  
Readability indices considered were Flesch Reading Ease (Flesch, 1948) and SMOG reading 
grade (McLaughlin, 1969).  The SMOG grade is the number of years in education that is 
considered required to be able to understand best a written text. Calculating the SMOG grade 
involves counting 10 consecutive sentences near the beginning, 10 in the middle and 10 near 
the end of a text. In the selected 30 sentences, the number of words made up of 3 or more 
syllables is calculated. The square root of the number of polysyllabic words is calculated to the 
nearest perfect square e.g. for 95 polysyllabic words, the nearest perfect square is 100. If the 
number lies between two perfect squares, the authors stated that the lower perfect square 
should be used (McLaughlin, 1969). Therefore, if the number of polysyllabic words lies between 
100 and 121, the authors indicated that 100 should be used in the calculation. Adding 3 to the 
approximate square root obtained would give the SMOG grade.  
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The Flesch reading ease is the more definite and most widely used (Kincaid, Fishburne, Rogers 
& Chissom, 1975 ) and is automatically computed (for example on the Microsoft word). Flesch 
reading ease is computed as follow: 
 206.835-1.015 (total words/total sentences)-84.6 (total syllables/total words).  
The definition of the Flesch score is as follow: 
90.0-100.0: Easily understood by an average 11 year old student. 
60.0-70.0: Easily understood by 13 to 15 year old student. 
0.0-30.0: Best understood by university graduate. (Flesch, 1948) 
Kirkwood and Wolfe (1980) found that readability tests indicate only the surface arrangement 
which is made up of the layout of words and sentence length. It does not include the deep 
language rule and semantic structure. The authors indicated three flaws in readability scores as: 
failure to consider the factors of cohesion, difficulty of idea and representation; failure to 
consider readers’ specific factors including reasons for reading; non-existence of statistical 
support for most readability index. The lack of consideration of interaction between reader and 
text in computation of readability index suggest that they are not in line with the 
psycholinguistic theory of reading (Kirkwood & Wolfe, 1980).  
Van-Oosten et al. (2011) indicated that readability and understandability depends on the 
interaction between the readers and the text; accordingly and that piloting the text with readers 
who are similar to the population of interest is important. Van-Oosten et al. (2011) proposed 
that the concept of readability and understandability is subjective and the main factor that 
determines the ease of understanding a text is related to the reader’s background knowledge.     
A pilot for understandability and readability of the nationwide survey involved a convenience 
sample of ten. The clinician questionnaire initially developed, containing all items of the 
domains of the video suitability evaluation as indicated in Chapter 4, was sent to 3 respiratory 
clinicians that volunteered from a PR service that was approached. The patient questionnaire 
initially developed, containing all items of the domains of the video suitability evaluation as 
indicated in Chapter 4, was sent to 7 patients with COPD that volunteered from the Breathe Easy 
(BE) group that was approached. The PR service and BE group that took part in the pilot were 
excluded from the final questionnaire survey (Appendices 5C and 5D). The ten participants in 
the pilot were asked to indicate if any modifications were required to make the questionnaires 
more readable or understandable. Following the pilot for understandability and readability, the 
participants indicated that all the items of the domains of suitability evaluation were 
118 
 
appropriate without any need for adjustment.  However, one of the patient participants 
recommended an adjustment in the questionnaire, which was that the age class “80 and above” 
should be included on the questionnaire; this adjustment was made. In the eventual data, it was 
observed that three of the sixty patients (5%) that participated in the nationwide survey were 
in this age category (refer to section 5.5 and 5.6 of this report). 
The Flesch readability score was computed for the final questionnaire. Flesch readability score 
for the clinician version of the questionnaire was 45.0 and the Flesch readability score for the 
patient version of the questionnaire was 56.5. The Flesch scores suggested reading score of each 
of the documents to be between that of a document easily understood by 13 to 15 year old 
student and best understood by university graduate. The eventual data indicated that of the 
patients that participated, 3.3% have degree, 8.3% have diploma, 5.0% have A-level 
qualification, 20% have O-level qualification and 63.3% indicated their qualification as ‘others’ 
on the questionnaire. All sections of the questionnaires returned by participants were 
completed (refer to section 5.5 and 5.6 of this report). 
 
5.4.3 MANAGEMENT OF BIAS, DISTRIBUTION OF QUESTIONNAIRES AND 
SAMPLING TECHNIQUE. 
In order to achieve an unbiased recruitment of participants in the national survey, the PR 
services and the BE groups in the UK were put through a computer randomisation process. 
While there was an existing list of all the 229 BE groups in the UK, as compiled by the British 
Lung Foundation (BLF), a new list that was representative of all PR services in the UK had to be 
compiled using an inclusive approach (Table 5.1). Two hundred and eleven PR services were 
identified in the UK (153 in England, 21 in Scotland, 16 in Wales, and 21 in Northern Ireland) at 
the time of the study. 
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Table 5.1- Steps followed in compiling a list representative of all PR services in the UK 
(i) Consultation of Binley's NHS Service Year book containing all clinical services in the 
various UK hospitals. All hospitals offering respiratory services were contacted to 
establish whether they offered PR. 
(ii) Consultation of a previous PR service list (BTS/BLS, 2002) to include services not 
found in Binley’s NHS Service Yearbook. The BLF and BTS were contacted and they 
confirmed that as at the time, the 2002 list had not been updated. 
(iii) Consultation of all 39 physiotherapy educational institutions in the UCAS directory 
(as at April 2009). PR services in the initial list compiled through Binley’s NHS 
Service Yearbook and BLF/BTS list were classified according to NHS 
trust/healthcare boards and co-ordinators of physiotherapy programmes were 
asked to include any respiratory service (where their students do clinical posting) 
that was not listed already. 
Outcome 88 PR services were identified from approach (i) 
Additional 91 PR services were identified from approach (ii) 
Additional 32 PR services were identified from approach (iii)- through responses 
from 5 Physiotherapy schools 
Altogether, 211 PR services were identified  
 
 
A Breathe Easy group (Tower Hamlets) whose members receive PR in a hospital where the 
principal researcher was employed during the period of the research and the Breathe Easy 
group (Bromley) that was involved in the face validity of the questionnaire were excluded from 
the final national survey. Also, the PR service (Haringey PCT) that was involved in the face 
validity of the questionnaire, and a PR service (King’s College, London) that was involved in the 
development of the video were excluded from the final national survey. This was in order to 
prevent bias from respondents which might arise from participants’ familiarity with the 
principal researcher or participants involvement in the development of the questionnaires used 
in the survey or participant involvement in the development of the video. 
Sampling participants exclusively according to their BE group distribution, professional 
affiliation, or their NHS trust distribution, may not be an accurate representation of the 
distribution of the stakeholders of PR in the UK (Kings College NHS, 2009; Manchester PCT, 
2008; O’Neill et al, 2008; Yohannes & Connolly, 2004); therefore, the study focused on ensuring 
geographical representation in accordance with household distribution per the 2001 census 
which was the most recent census at the time of the study. The census indicated that the 
approximate ratio in persons for Northern Ireland: Wales: Scotland: England was 1:2:3:29 
(Office for National Statistics, 2008). Therefore, the aim at the beginning of the study was that 
the sampling would be carried out as illustrated in table 5.2. 
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Table 5.2- Illustration of the sampling ratio in place at the beginning of the national survey 
Regions of United Kingdom England 
 
Scotland 
 
Wales 
 
Northern  
Ireland  
Number of participating Breathe Easy groups    
29 
 
3 
 
2 
 
1 
 
Number of participating PR programme 
 
29 
 
3 
 
2 
 
1 
 
5.4.4 PARTICIPANTS AND RECRUITMENT 
Members of each participating PR services chosen by the randomisation process were accessed 
through the service manager. A letter requesting for volunteers from the PR service to complete 
questionnaires evaluating the suitability of the Move-On-Up exercise video for VBHEP for 
patients with COPD in UK was sent to the respective PR service manager. A copy of the 
questionnaire, a reply slip and contact details of members of the research team were attached to 
the letter of invitation. After approaching the first set of thirty five PR services chosen by the 
randomisation process, any PR service that did not return the reply slip by the deadline of two 
weeks indicated on the slip was sent a reminder. If after another two weeks, the particular PR 
service still did not return the reply slip, it was taken that such PR service was not interested in 
participating in the study.  Each non-participating PR service was replaced with the next PR 
service on the randomisation table which is in the same Strategic Health Authority (or Health 
Board) and that had not previously participated in the survey. Each PR service that returned the 
reply slip indicating an interest to participate was sent the appropriate number of 
questionnaires and SAEs (stamped and addressed envelopes) and copies of the Move-On-Up 
video. Completed questionnaires were returned directly to the research team. When no 
response had been received after 2 weeks, a reminder letter was sent to the particular PR 
service for return of questionnaires. When no questionnaire was received from the particular 
PR service by two weeks after a reminder letter had been sent out to the service, the particular 
PR service was replaced with the next PR service on the randomisation table in the same 
Strategic Health Authority (or Health Board) and that had not previously participated in the 
survey.  
COPD subjects were recruited by approaching the ‘Breathe Easy’ arm of the BLF for permission 
to recruit from their members. The choice of BE was in order to involve participation of a 
respiratory patient group with organised membership across the UK with the particular disease. 
Members of each of the participating BE group were accessed through the group chairperson 
via a letter requesting volunteers from the BE group to complete questionnaires evaluating the 
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suitability of the Move-On-Up exercise video for VBHEP for patients with COPD in UK. A copy of 
the questionnaire, a reply slips and contact details of members of the research team were 
attached to the letter of invitation. After the participation of 3 Breathe Easy groups in the focus 
group study, many of the remaining groups of BE that the principal researcher had included in 
the randomisation ahead of the national questionnaire survey (which followed within months 
after the focus group study) declined participation. Every possible step was taken to recruit 
participants in line with the protocol of the study, but only 3 additional BE groups (2 in 
Scotland, 1 in England) participated in the national survey. Each BE group that returned the 
reply slip indicating an interest to participate was sent the appropriate number of 
questionnaires and SAEs (stamped and addressed envelopes) and copies of the Move-On-Up 
video. Completed questionnaires were returned directly to the research team. 
 
5.5 RESULTS 
Two hundred and thirty-three questionnaires were sent out (120 to clinicians, 113 to patients 
with COPD). 122 responses were received (62 from clinicians, 60 from patients with COPD), 
which resulted in 51.6% and 53.1% response rate for clinicians and COPD subjects respectively.  
Of the clinician respondents, 33.3% (n=21) were males, 61.3% (n=38) were Physiotherapists, 
27.4% (n=17) were nurses, 9.7% (n=6) were physicians and 1.6% (n=1) described herself as 
‘others’. Of the patient respondents, 58.3% (n=35) were males, 28.3% (n=17) have mild COPD, 
and 61.6% (n=37) have moderate COPD, 10.1% (n=6) have severe COPD. Three BE groups; 2 in 
Scotland, 1 in England (Appendix 5C) and 32 PR services; 26 in England, 3 in Scotland, 2 in 
Wales, 1 in Northern Ireland (Appendix 5D) participated.   
A response of ‘appropriate’ or ‘very appropriate’ is indicative of acceptance, thus, the four types 
of responses for each item on the questionnaire were ultimately put into two categories. 
Responses of ‘appropriate’ and ‘very appropriate’ were categorised as ‘suitable’ while responses 
of ‘inappropriate’ and ‘very inappropriate’ were categorised as unsuitable. The respondents 
indicating each questionnaire item as suitable were represented as a percentage of overall 
respondents to that particular questionnaire item.  
Further, part of the research interest was sub-analysis to identify possible pattern in the 
strength of the responses. It was considered that a response of ‘suitable’ rather than ‘very 
suitable’ in a domain could be indicative that such domain could benefit from further 
development.  
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Descriptive analysis (relative frequency) of the returned questionnaire responses was carried 
out (Appendix 5F), including sub-analysis to identify the possible existence of a pattern in the 
strength of the responses (comparing the responses of ‘suitable’ against ‘very suitable’). Items in 
table 2 in Appendix 5F relate to clinicians only, while items in table 3 in Appendix 5F relate to 
COPD subjects only.  
Between 79.0% (n=96) and 100% (n=122) of respondents in each questionnaire domain 
indicated that the video was suitable. While clinicians unanimously agreed on the suitability of 
the video in one domain of the questionnaire (that is the advice on how often a patient should 
exercise), COPD patients unanimously agreed on the suitability of the video in 5 domains of the 
questionnaire (that is advice on appropriate rest during the exercise session, exercise duration, 
exercise intensity, frequency of exercise and safety of performing the exercises by patients 
without physical presence of the clinician to supervise the session) (tables 1 to 3 in Appendix 
5F).   
Sub-analysis of the strength of responses highlighted some of the suitability domains where 
more than 50% of respondents suggested the video as ‘suitable’ rather than ‘very suitable’ 
(table 4 and 5 in Appendix 5F).  While there were 16 such domains observed in the analysis of 
the clinician responses, there were only 4 such domains observed in the analysis of the patient 
responses. 
 
5.6 DISCUSSION 
The study did set out with the sampling ratio indicated in table 5.2 however despite numerous 
strategies, only three BE groups participated in the questionnaire survey compared to 32 PR 
services. The three BE groups were from two out of the four regions of the UK. The total number 
of patients with COPD who participated in the questionnaire survey was however similar to the 
number of the clinician participants (n = 60 and 62 respectively). This could be due to the 
patient participants being reminded at their BE monthly meeting of the need to complete and 
return their questionnaires within the study period, which may have led to an increased 
response rate. 
There was proportionate representation of the different categories of COPD patients as defined 
in the MRC scale (Fletcher, 1960) and the profile of the clinician participants in the national 
survey is as widespread as seen in previous study of PR clinicians (Yohannes & Connolly, 2004). 
It could not be established whether responders in the survey mainly represent patients with 
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COPD and clinicians who were more strongly motivated. Previous studies suggest that 
responders in a patient survey are more likely to be married or employed (Shahar, Folsom and 
Jackson, 1996), have higher education (Etter and Perneger, 1997), and more healthcare usage 
(Bootsman –van der Wiel et al, 2002; Rupp et al, 2002) than non-responders. The questionnaire 
survey reported in this Chapter did not collect data on participants’ use of healthcare, 
employment or marital status. Analysis indicated that 16.6% of the patient participants in this 
study have above O-level qualification.  
All completed questionnaires from the participants were returned without any missing 
responses. This may suggest that the questionnaire was of appropriate reading level for the 
respondents. This is similar to the case in the study by Aggarwal et al. (2007), in which a self-
completed Hindi translation of SGRQ was administered to each of fifty patients with COPD on 
two occasions, at four weeks apart and all questionnaires were returned with no missing 
responses in the returned questionnaires.  
The analysis of the responses from clinicians suggested that approval or disapproval of the 
video is not distributed along a specific geographical area of the UK. Positive responses were 
observed across most domains of the questionnaire in majority of respondents.   
The observed difference in the degree to which clinicians regarded the Move-On-Up video as 
suitable for VBHEP as an adjunct to outpatient PR, and the degree to which patients with COPD 
regarded the video to be suitable for the same purpose, reflected the disparity of expectations 
of patients and clinicians as to the content of the video. Evidence from previous publications on 
agreements between patients’ and clinicians’ perception of elements of care are conflicting 
(Gardner et al., 2001; Keane, Chastain & Rudisill, 1987; Meis et al., 2014; Widmark-Petersson, 
vonEssen & Sjöden, 2000).  
Meis et al. (2014) studied patients with COPD (n=13, most of whom had severe to very severe 
COPD) and respiratory clinicians (n=14, including a physiotherapist, respiratory nurse, 
occupational therapist, dietician, physical trainer, psychologist and pulmonary physician). The 
authors reported that what patients described as their abilities were considered by clinicians 
as underestimates or overestimates.  
Keane et al. (1987) studied a convenience sample of nurses (n=26) and patients (n=26) from 
three units of a rehabilitation hospital who completed the 50-item Caring Assessment Report 
Evaluation Q-Sort (CARE-Q) (Larson, 1981) to describe their perceptions of important nursing 
care behaviours. The 50 items were ranked by participants in a seven-point Likert scale from 
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most important to least important. The six subscales of CARE-Q described: (i) accessibility to 
the nurse, (ii) how the nurse explains and facilitates patient care plan, (iii) how the nurse 
comforts patients, (iv) how the nurse anticipates, (v) how the nurse develops a trusting 
relationship, and (vi) how the nurse monitors and follows through with the patient.  Patients 
and nurses in this study concurred, identifying the most important item of the scale as ‘knows 
when to call the doctor’. Both groups indicated the two subscales of ‘accessibility to the nurse’ 
and ‘how the nurse monitors and follow[s] through with the patient’ as the most important 
subscales of nursing care. Gardner et al. (2001) (35 nurses, 30 patients) compared nurses’ and 
cancer patients’ perceptions of what is considered as important caring behaviors. Analysis of 
responses demonstrated a statistically significant difference between patients’ and nurses’ 
perceptions of caring behavior in 14 of the 50 statements on the Care-Q questionnaire (P 
<0.05). Gardner et al. (2001) concluded that clinicians’ preference of care may not always 
correspond to patient’s inclinations and beliefs. Widmark-Peterson et al. (2000) (23 nurses, 21 
patients) examined patient and staff perceptions of the importance of caring behaviors in 
cancer patients. Analysis of the responses demonstrated that while staff understanding of 
patient perceptions about the value of caring behaviors strongly correlated with staffs’ own 
perceptions, it was not related to patient anxiety, depression, health or quality of life. There 
were no correlations between patient and staff perceptions of the relevance of caring 
behaviors, patient health, quality of life, or the utmost health-related concern. Authors 
suggested that if staffs do not inquire from patients about their needs or preferences, they may 
be endorsing patient care and interventions from their own perception rather than from 
patient’s perception. However, the participants in the studies by Gardner et al. (2001), Keane 
et al. (1987) and Widmark-Peterson et al. (2000) were patients with non-respiratory 
diagnoses. 
In the national survey reported in this Chapter, the questionnaire domains where there are 
disparities may suggest areas that require improvement in clinicians understanding of the 
needs and preference of patients with COPD in an exercise video.  
The result from the survey in this report suggested that both the clinicians and the patients 
perceived the Move-On-Up exercise video as suitable for VBHEP for the UK population of 
patients with COPD. A high percentage of patients with COPD and respiratory clinicians who 
were respondents in this survey indicated approval of the suitability of the video in all domains 
of the questionnaire. This ranged between 79% (n=96) and 100% (n=122) of respondents in 
each questionnaire domain. 
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The areas highlighted by the analysis in which responses predominantly suggested the video to 
be ‘suitable’ rather than ‘very suitable’ (Tables 4 and 5, Appendix 5F) may benefit from further 
development. There were 16 such domains in the analysis of the clinician responses (88.89% of 
all the domains). There were only 4 such domains in the analysis of the patients’ responses 
(19.05% of total number of all the domains). Furthermore, it was observed that out of the 18 
domains of suitability of the video for VBHEP as suggested by the clinician version of the 
questionnaire (Table 6 in Appendix 5F), physiotherapists indicated a median suitability score of 
three in 14 domains and a median suitability score of four in four domains, physicians indicated 
a median suitability score of three in 16 domains and a median suitability score of four in two 
domains; and nurses indicated a median suitability score of three in 17 domains and a median 
suitability score of four in one domains. The clinician group that responded under the category 
of ‘others’ (n=1) indicated a suitability score of two in two domains, a suitability score of three 
in 12 domains and a suitability score of four in four domains. Physiotherapists were observed to 
have rated the video more highly than all other clinicians in terms of its suitability for VBHEP.   
When a comparison was made among patients with different MRC ratings of COPD disease 
severity in the 21 domains of suitability of the video for VBHEP in the patient version of the 
questionnaire (Table 7, Appendix 5F) , patients with mild COPD indicated a median suitability 
score of four in 19 domains and a median suitability score of three in two domains, patients 
with moderate COPD indicated a median suitability score of four in 12 domains and a median 
suitability score of three in nine domains, patients with severe COPD indicated a median 
suitability score of four in only one domain and a median suitability score of three in the 
remaining 20 domains. Patients with mild COPD were observed to have rated the video more 
highly than patients with moderate or severe COPD while patients with severe COPD were 
observed to give lowest rating of the video in terms of its suitability for VBHEP.  
When the responses from all clinician groups were combined and the responses from all 
patients were combined, it was observed that patients indicated median suitability score of 4 in 
13 of the 21 domains and median suitability score of 3 in the remaining 8 domains while 
clinicians indicated median suitability score of 4 in 2 of the 18 domains and median suitability 
score of 3 in the remaining 16 domains. The above analysis suggests that though clinician and 
patient groups perceived the video to be suitable for VBHEP as an adjunct to outpatient PR, 
there is a gap in the strength of the perceptions of these two groups. The lower degree of 
approval of the suitability of the video by clinicians could be because respiratory clinicians have 
higher expectations in the amount of information that they perceive as required by patients 
with COPD in particular areas of VBHEP for patients with COPD. These areas included advice on 
appropriate rest during the exercise session, exercise duration, exercise intensity, frequency of 
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exercise and safety of performing the exercises by patients without physical presence of the 
clinician to supervise the session. 
 
5.7 CONCLUSION 
The Move-On-Up video is considered suitable for VBHEP as adjunct to outpatient PR for the UK 
population of patients with COPD by a greater percentage of respiratory clinicians and patients 
with COPD. The approval is evident across the various regions of the UK. The degree of approval 
by patients was greater than the degree of approval by clinicians.  This observation 
corroborates the findings of previous studies of patients’ and clinicians’ preference or 
interpretation of care (Meis et al., 2014; Papastavrou, Efstathiou, & Charalambous, 2011; 
Widmark-Peterson et al., 2000). This confirms that patients’ care may not always correspond to 
clinicians’ inclinations and beliefs.  
The findings reported in Chapter 3, and Chapter 4 and the questionnaire responses in this 
Chapter are in agreement and suggest that the Move-On-Up video is considered suitable for 
VBHEP as adjunct to outpatient PR for the UK population of patients with COPD. 
The video evaluated in the reports of Chapter 3, 4 and 5 was subsequently used in the stratified 
randomised control trial (SRCT) reported in Chapter 7. The SRCT investigated the effectiveness 
of VBHEP, when used concurrently with outpatient PR, in increasing walking ability and 
maintenance of benefits of PR when compared with outpatient PR alone in patients with COPD.   
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CHAPTER SIX - PARTICIPATION PROFILE OF PATIENTS 
WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
IN PULMONARY REHABILITATION. 
6.1 JUSTIFICATION  
Evidence suggests that there are major factors that influence non-completion (or drop-out) of 
PR by patients with COPD (Garrod et al., 2006; Singh et al., 1998; Young, Dewse, Fergusson, & 
Kolbe, 1999) (please refer to section 1.1). There is however insufficient evidence to enable 
identification of the possible causes of non-uptake. This chapter reports the research that 
investigated factors which correlate with participation (uptake and drop-out) in PR, by patients 
with COPD. 
‘Non-uptakers’ are patients who have been referred to pulmonary rehabilitation (PR) but who 
do not enrol in the programme, while ‘drop-outs’ are patients who, after initial assessment, did 
not start PR or failed to do the final assessment (Garrod et al., 2006). Outpatient PR service can 
be provided as a ‘cohort’ PR programme or ‘rolling’ PR programme (refer to section 2.4 of this 
thesis). A study by Garrod et al. (2006) (n=74, mean age=68 years) indicates that, 33% (37 out 
of 111) of patients with COPD referred for PR, do not start the programme, also that only 46% 
(51 out of 111) of patients referred do complete PR. These authors also identified four factors 
(quadriceps strength, smoking pack years, SGRQ score and depression) that independently 
discriminate between completers and non-completers. An earlier study by Singh et al. (1998) 
(n=267, mean age=63 years) reported that only 52% of patients referred to PR completed the 
programme. Young et al. (1999) (n=91mean age=68.9) reported that only 60% patients that 
attended the clinic for initial PR assessment (including walk tests) completed the programme.  
The PR programme in this study was a total of seven sessions over a period of one month but it 
was not stated whether it was of ‘rolling’ or ‘cohort’ protocol. These authors indicated that 
current smokers and individuals that are socially isolated are more likely to be non-completers 
of PR programme.  
A qualitative study by O’Shea, Taylor and Paratz (2007) (n=22, mean age =66.7 years) reported 
that bad weather is a major barrier to participation in PR by patients with COPD. Marks et al. 
(2001) suggests the airways in patients with respiratory disease can be more reactive in poor 
weather with higher concentration of allergenic particles. The PR programme in the studies by 
Garrod et al. (2006) and Singh et al. (1998) were ‘rolling’ programmes of seven weeks duration. 
The period of recruitment in the study by Garrod et al. (2006) and Young et al. (1999) could not 
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be established. Singh et al. (1998) indicated that the patients that they studied were referrals to 
their rolling PR programme between 1993 and 1996 but these authors did not state whether 
this recruitment was during the different seasons in the year. 
Various factors have been identified which influence drop-out from PR (Garrod et al., 2006; 
Young et al., 1999). However, insufficient evidence of factors that influence the uptake of PR 
remains a gap in knowledge and care of patients with COPD. Consequently, the study reported 
in this chapter investigated whether the COPD disease severity and psychosocial profiles of 
patients with COPD influence their uptake and completion of PR.   
Based on published evidence (refer to section 2.4), this study defined completers as those 
participants who attended at least eight sessions of PR. Completers in the study reported in 
Chapters Six and Seven are therefore defined as participants who attended eight or more PR 
sessions, which is 50% of the 16 sessions offered. This is in line with evidence (Sewell et al, 
2006) and existing guidelines (IMPRESS, 2011).  
 
6.2 RESEARCH AIM AND QUESTION  
The aim of research is to determine the relationship between participation in outpatient PR and, 
respectively, depression, social support, health locus of control (HLC) and disease severity in 
patients with COPD.  
The research questions is stated as ‘Are depression, social support, health locus of control or 
COPD disease severity confounding factors in the non-uptake of, or drop-out from PR?’ 
 
6.3 METHODS: SCREENING TOOLS 
Each of the measures of depression, social support, health locus of control and MRC COPD 
disease severity score are indicated to be of importance in patients with COPD. Garrod et al. 
(2006) (n=74, mean age=68 year), investigated whether patient’s baseline disease severity 
score is a predictor of significant change in walking ability following PR i.e. as a change of 54m 
in 6MWD following PR. Participants in the non-randomised retrospective study attended twice 
weekly outpatients PR sessions over a period of seven weeks and results indicated that baseline 
MRC score is not a predictor of significant change in walking ability. However, participants with 
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MRC score 5 demonstrated smaller degree of improvement compared to individuals with other 
MRC scores.  
 
Cote et al. (2008) prospectively observed 1,379 (male=1,221) patients with COPD over a period 
averaging 55 months (SD= +/-30months). Each participant completed 6MWD within six weeks 
of entry into the study and was subsequently monitored every six months or until death. These 
authors identified that a 6MWD< 350m is significantly associated with mortality (r=0.93). Al-
shair et al. (2009) (n=122, mean age=66 years) and Spruit et al. (2010) (n=1795, age 40-75 
years) evaluated patients 6MWD results against their depression scores. Al-shair et al. (2009) 
and Spruit et al. (2010) defined ‘‘less than 350m’’ walk as poor 6MWD performance. Both 
studies (Al-shair et al., 2009; Spruit et al., 2010) reported depression as significant and 
independent predictor of poor 6MWD performance in patients with COPD.  
 
Fischer et al. (2009) (n=217, male=122, mean age=63.4 years) indicated that ‘living alone’ is not 
an independent predictor of drop-out from PR. Patients who stopped attending PR sessions 
before the programme ended or who missed the follow-up assessment were defined as non-
completers. These authors also investigated patients’ health belief using the Illness Perception 
Questionnaire. They identified that patient’s belief in the effectiveness of PR is an independent 
positive predictor of attendance.  
 
While COPD disease severity, depression score, social support and health locus of control of 
patients with COPD have been identified as important clinical screening tools, no known 
prospective study has investigated relationship between these and non-uptake of PR (i.e. 
patient been referred to PR but with failure to enrol in the programme).   
 
Chapter 2 details the review of various aspects of the screening tools used in this research and 
alternative screening tools. The review considered properties, including population of patients 
for which the  tool (s) are suitable, validity of those tool(s), reliability of said tool(s), 
responsiveness and acceptability of each tool. Therefore, the screening tools indicated below 
were used for the research. 
 
- The Brief Assessment Schedule Depression Card (BASDEC) to measure depression 
- The sub-scales of the 11-item Duke Social Support Index (DSSI) were used to measure social 
support. These are the social support and social interaction subscales. 
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- The Multidimensional health locus of control (MHLC) scale B and scale C to measure health 
locus of control 
- The Medical Research Council (MRC) scale to measure COPD severity. 
Further, the data on attendance of patients at the outpatient PR assessment and PR session 
were obtained to assess non-uptake and drop-out. 
 
6.4 STUDY SETTING AND ETHICAL APPLICATION  
The study setting was the PR unit of the Whittington Health NHS Trust (formerly Haringey 
Teaching PCT). In line with guidelines (IMPRESS, 2011; NICE, 2004), two supervised outpatient 
PR sessions were offered each week for 8 weeks and participants were advised to do one self-
directed exercise session at home each week. There were two PR staff (a physiotherapist and a 
nurse) present at each PR session, staff: patient ratio was consistently below 1:8 and a 
physiotherapist was present to supervise every exercise session. Each outpatient PR session 
lasted 2 hours. The routine PR session involved 1 hour of exercises which included walking 
exercise, leg, arm and trunk exercises including strengthening and endurance exercises. In 
addition to the exercise component, each routine PR session involved 1 hour of self-
management education class.  The PR education talks were combinations of talks on managing 
breathlessness, breathing retraining, managing exacerbation, energy conservation techniques, 
importance of exercise in COPD, chest clearance techniques, medications, inhaler techniques 
and information on the Breathe Easy arm of the British Lung Foundation (Haringey PCT, 2007; 
NICE, 2004). 
Participants were advised that during the once weekly self-directed exercise session at home, 
they should do exercises similar to the ones that they do in the hospital for 15 to 30 minutes. 
The NHS ethics approval for the study was obtained in July 2008 from the Barnet, Enfield & 
Haringey Research Ethics Committee (reference 08/H0723/55) (Appendix 6C).  
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6.5 METHOD: POPULATION, RECRUITMENT AND MANAGEMENT OF 
BIAS  
Individuals who met the following inclusion criteria and were referred to the Haringey Primary 
Care Trust PR programme were invited to participate in this study. The inclusion criteria were 
in line with the NICE guidelines (NICE, 2004; NICE, 2010) and were as follows. 
- Clinical diagnosis of COPD based on the patient’s spirometry (FEV1> or =70% predicted value) 
as defined by European Respiratory Society (ERS, 1993; NICE, 2004). 
- Dyspnoea level of Medical Research Council scale (MRC) 3 and above on referral to PR. The 
MRC 3 is defined as ‘‘walks slower than contemporaries on level ground or has to stop for 
breathing when walking at own pace’’ (NICE, 2004)..  
Individuals with the following criteria were excluded: 
- Cognitive impairment which may compromise informed consent being obtained. 
- Exclusion criteria that would be applied to any PR participant, such as a severe cardiac 
complication or severe musculoskeletal condition that affects walking. 
- Lack of a good understanding of English (since the questionnaires were written in English). 
Patients with COPD on the waiting list of the PR unit of the PCT were informed of the study by 
the hospital staff when first contacted for their PR programme. Details of patients who indicated 
that they were interested in the study were given to the principal researcher. An information 
sheet and a consent form for the study were posted to each of the patients who showed interest. 
The principal researcher contacted each of the patients to discuss the study and answer any 
questions. An appointment for a home-visit for each of the patients was booked after agreement 
in the telephone call to carry out assessments and screenings prior to the date of the initial 
assessment for outpatient PR at the PR unit. Following signed consent, each assessment lasted 
about 35 minutes. Each participant completed screenings for depression, level of social support, 
Health Locus of Control and Medical Research Council (MRC) COPD severity score. Data on 
subsequent attendance or non-attendance at the initial PR assessment and classes at Haringey 
PCT (by consented pre-screened patients) was taken from the hospital’s PR attendance record.  
Various steps were taken to prevent and manage bias. No additional contact was made with the 
patients between the home assessment and the first PR session. This was to ensure that there 
was no motivation, towards uptake or otherwise, derived by a patient from additional contact 
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with the principal researcher. No participant was informed that attendance at the PR initial 
assessment or completion of PR programme were measures of interest to the researcher. 
The depression screenings were carried out in the same half of the day (between 12 noon and 
4pm), to enhance the reliability of data collected, since there are indications that this accounts 
for diurnal hormonal variation which may affect manifestations of depressive symptoms 
(Bhagwagar, Hafizi & Cowen, 2005; Den Hartgo et al., 2008 ). 
Participants were recruited over  a year (September 2008 to September 2009). covering four 
cycles of referrals and four PR cycles (each lasting eight weeks) in order to rule out a direct 
effect of any circumstances particular to a group or a season. 
 
6.6 METHODS: DATA ANALYSIS 
The study investigated whether there was significant correlation or association between 
participation in PR (including uptake and completion of PR) and each of patients’ baseline MRC, 
BASDEC, DSSI and MHLC scores. Uptake and completion as well as depression status were 
nominal data, while variables of MRC score, DSSI score and MHLC scale (B and C scores) were 
ordinal data.  Different statistical tools for measuring correlation were considered. Pearson's 
correlation can only be conducted for parametric data since it requires both variables to be 
measured on an interval or ratio scale, whereas Spearman Rho correlation analysis could be 
utilised for nonparametric data including where one of the variables was categorical and one 
ordinal (Myers & Well, 2003). Spearman Rho correlation was conducted in the data analysis to 
investigate the relationships between the non-dichotomous independent variables (scores of 
HLC, DSSI and MRC) and the participants’ uptake status or PR completion status. Chi-square was 
conducted to investigate the relationships between the dichotomous independent variable 
(depression) and the participants’ uptake status or PR completion status. Crewson (2014) 
defined the coefficients for measuring strength of association between variables. 1 represents 
perfect association, less than 1 but greater than 0.5 represents strong association, between 0.5 
and 0.3 represents moderate association, less than 0.3 but greater than 0.1 represents low 
association, 0.1 and below represents little if any association. 
The alpha level (p) represents the risk of a type I error i.e. the risk of a test indicating a 
difference, effect or relationship when such actually does not exist. Usually, p is set at 0.05 (i.e. 
in one of twenty statistical tests, there will be a type one error). When more than one statistical 
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test is conducted, the chance of type 1 error increases in the multiples of the number of tests 
(McLaughlin & Sainani, 2014). Multiple testing correction relates to whether, when performing 
multiple tests in a study, the alpha level should be adjusted to reduce the chance of incorrectly 
proclaiming a difference, effect or relationship to exist which in fact is due to chance producing 
the observed outcome (Altman, 1991). It was important to evaluate the possible impacts of 
multiple testing since this research involved the use of multiple variables. 
Multiple testing correction methods considered were Bonferroni, Holm’s step-down, and 
Hochberg’s step-up multiple correction methods. Bonferroni’s correction method involves 
dividing the p value (0.05) by k, where k is the number of tests being conducted (Dunn, 1961). 
The application of this would ensure that the overall-experiment wise- risk for the number of 
tests remains 0.05. Holm’s step-down correction (Holm, 1979) is conducted by arranging the p 
values from the smallest to the largest and comparing them to successively less conservative p 
value cut-off. Hochberg’s step-up correction (Hochberg, 1988) is the reverse of Holms’s step-
down correction and it involves arranging the p values from the largest to the smallest and 
comparing them to successively greater conservative p value cut-off. The benefit of Holm’s step-
down and Hochberg’s step-up correction is that they always lead to lesser hypotheses being 
rejected compared to the case with Bonferroni correction (McLaughlin & Sainani, 2014). 
However, each of these two methods is most effective when the sample sizes in a study are 
equal (Stewart-Oaten, 1995). Bonferroni correction is widely effective and its application is not 
as limited as is the case with Holm’s step-down correction and Hochberg’s step-up correction. 
The sample sizes in the two arms of the SRCT reported in Chapter 7 are not equal (n=32 versus 
n=25) and the sample sizes reported in Chapter 6 [for example: patients with COPD and 
depression (n=21) versus patients with COPD but no depression (n=30)] are not equal. 
Bonferroni correction was thus used. In addition to literature consulted, the statistical research 
support team at the University was consulted to validate this decision and this decision was 
indicated to be appropriate. 
 
A disadvantage of application of Bonferroni correction (as well as other multiple testing 
correction methods) however, is that when the risk of type I error is reduced, the risk of type II 
error (not finding a difference, effect or relation when such actually does exist) is increased 
(Nakagawa, 2004; Altman, 1991).  
Spearman correlation was conducted for ordinal variables that were non-dichotomous (disease 
severity, 2 domains of social support, 3 domains of MHLC scale B, 4 domains of MHLC scale); 
where correlation was conducted, the Bonferroni correction was applied as recommended by 
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Mundfrom, Perrett, Schaffer, Piccone and Roozeboom (2006). Ten variables were used in the 
Spearman Rho correlation (Table 6.2 and 6.4); therefore p was set at 0.005.  Chi-square 2x2 
analysis was conducted for the only independent dichotomous variable (i.e depression versus 
no-depression); therefore p for 2x2 Chi-square analysis was set at 0.05.  
 
6.7 RESULTS 
 One hundred and fifty three patients with COPD were referred to the NHS Trust during the 
recruitment period of the research; all were approached. Fifty-two volunteered into the study, 
one withdrew consent to participate at the point of data collection.  
Twenty-two of the 51 participants (43.1%) who were referred to PR did not uptake. 
Fifteen of the 29 (51.7%) patients who commenced PR dropped out; only 14 of the 51 (27.4%) 
patients referred for PR completed PR.  
 
OBSERVATIONAL 
STUDY REPORTED 
IN CHAPTER SIX
Total referrals 
to hospital 
(153)
51/153 (33%) 
participated in 
study
Did not participate 
in study (102/153) 
67%
29/51(57%) 
started PR
Completers: 48% 
(14/29) of starters, 
28%  (14/51) of  
referrals 
                                
Figure 6.1- Flow chart on participation and drop-out in PR by patients with COPD 
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153 referred , all were 
approached 
1 withdrew, 51 completed study
(5 mild, 29 mod, 17 severe)
Depressed
BASDEC ≥ 7
N= 21
Non depressed
BASDEC < 7
N= 30
38% uptake
N= 8
70% uptake
N= 21
52 volunteered, 21 male
(5 mild, 29 mod, 18 severe)
101 declined 
participation
 
 
 
 
Figure 6.2- Flow chart and participation profile of patients in the study 
indicating the association between depression and uptake of PR. 
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Analysis of data demonstrated that there was a moderate association (Phi value 0.32) which is 
statistically significant (p<0.05) and with the relationship in a negative direction between 
depression status and uptake of PR; Pearson Chi-Square = 5.126 (degree of freedom=1, n=51, 
p=0.02, 2- tailed).  Analysis of the cell frequencies indicated that 70% (21 out of 30) of the 
patients who were not depressed did uptake PR, while only 38% (8 out of 21) of the patients 
who were depressed did uptake PR (odds ratio=3.11, 95% confidence interval = 0.97 to 9.97) 
(Table 6.1a and 6.1b).  
Table 6.1a: 2x2 contingency table of depression status versus uptake of PR. 
 
Uptake label 
Total uptaker non-uptaker 
Non-Depressed 
Depressed 
 21 9 30 
  8 13 21 
Total             29 22 51 
 
Table 6.1b Chi-square test of depression status versus uptake of PR 
 Value Df Sig. (2-sided) 
Pearson Chi-Square 5.13 1 0.02* 
* Pearson Chi-Square significant at the 0.05 level (2-tailed). N=51 
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There was no significant correlation between uptake status and any of the HLC, DSSI 
interaction, DSSI social support or MRC domains (based on statistical significance alpha <0.005, 
2-tailed) (Table 6.2). 
 
Table 6.2: Spearman Rho Correlations of PR uptake versus psychosocial and disease variables 
 
Baseline variable Correlation Coefficient  Sig. (2-tailed) 
COPD severity 0.273 0.052 
Social interaction -0.206 0.146 
Social support -0.123 0.392 
MHLC internal B -0.062 0.665 
MHLC Chance B 0.182 0.202 
MHLC Powerful Others B 0.139 0.331 
MHLC Internal C 0.042 0.771 
MHLC Chance C 0.043 0.764 
MHLC Doctors C -0.041 0.777 
MHLC Other C -0.026 0.858 
 
                        
* Correlation is significant at the 0.005 level (2-tailed). N=51 
 
There was no significant association between depression status and drop-out (Pearson Chi-
Square 0.368, p=0.54, 2- tailed) (Table 6.3a and 6.3ba). 
Table 6.3a: 2x2 contingency table of depression status versus completion of 
PR. 
 
Completion label 
Total Completer non-completer 
Non-Depressed 
Depressed 
 11 10 21 
  3 5 8 
Total 14                   15 29 
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Table 6.3b Chi-square test of depression status versus completion of PR 
 Value df Sig. (2-sided) 
Pearson Chi-Square 0.37 1 0.54 
* Pearson Chi-Square significant at the 0.05 level (2-tailed). N=29 
 
Further, there were no significant correlation between drop-out and any of the HLC, DSSI 
interaction, DSSI social support or MRC domains (based on statistical significance alpha <0.005, 
2- tailed) (Table 6.4). 
 
Table 6.4: Spearman Rho Correlations of PR completion versus psychosocial and disease 
variables 
Baseline variable Correlation Coefficient  Sig. (2-tailed) 
COPD severity 0.096 0.614 
Social interaction -0.028 0.884 
Social support -0.299 0.108 
MHLC internal B -0.124 0.513 
MHLC Chance B 0.085 0.655 
MHLC Powerful Others B -0.116 0.541 
MHLC Internal C -0.220 0.242 
MHLC Chance C 0.031 0.871 
MHLC Doctors C -0.160 0.400 
MHLC Other C 0.093 0.625 
 
    * Correlation is significant at the 0.005 level (2-tailed). N=29 
 
It was the intention at the planning stage of the study that a regression analysis would be 
conducted to examine how the value of the dependent variable (e.g. uptake of PR) changes when 
the value of any one of the independent variables (MRC score, BASDEC score, DSSI score and 
MHLC score) changes, while the other independent variables remain constant. However, since 
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none of the variables in the correlation analysis demonstrated significant correlation with 
uptake or drop-out, it was not feasible to conduct a regression analysis. Depression was the only 
dichotomous independent variable (BASDEC Score > or=7 is an indication of depressive 
symptom). It was not included in Spearman Rho analysis; it was however included in a 2x2 Chi 
Square analysis. This step was taken in order to reduce the effect of Bonferroni correction.   
 
6.8 DISCUSSION 
Evidence from this study indicated a moderate and negative statistically significant association 
between depression status and uptake of PR (Phi value 0.32, p<0.05). The square of the Phi 
value is 0.10 which suggests that the data explains the relationship in about 10% of the study 
population.  Patients with COPD who were not depressed were twice as likely to uptake PR 
compared to patients who were depressed. In addition, the data did not find a significant 
correlation between uptake of PR and any of MRC disease severity, HLC domains or DSSI social 
support domains based on p (significance) value of 0.005. 
This study did not find a significant association between drop out from PR and depression. A 
non-randomised study by Tselebis et al. (2013) (n=101 patients, all completers of PR, mean 
age=64.1 years, male=80) indicated that participation in PR resulted in benefits of improvement 
in anxiety and depression (p<0.05).  It may be that drop-out in the study reported in this 
chapter is not related to the baseline depression status since participants may have been 
benefiting from the PR with relief of depression symptoms. Further, the data did not find a 
significant correlation between drop out from PR and any of MRC disease severity, HLC domains 
or DSSI social support domains based on p (significance) value of 0.005.  
 
Bjoernshave, Korsgaard and Nielsen (2010) reviewed 26 RCTs of PR of which only three (12%) 
identified the sampling as the total number of patients contacted. Of these, 28% completed PR. 
These authors observed that 75% of those patients suitable for the PR programme were lost 
due to sampling exclusion and drop-out from study. The study concluded that comparison of the 
patients that participate in a trial to patients that do not may provide information that can 
enhance evaluation of the generalisability of the results. The participants in the study in Chapter 
6 of this report (and the SRCT reported in Chapter 7) were patients of the Haringey Teaching 
PCT (later changed to Whittington Healthcare NHS Trust). Therefore, an evaluation of the 
external validity of the patients with COPD in the studies and the PR programme of the Haringey 
PCT within the UK context was considered important.  
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The proportion of patients with COPD in this research who manifest symptoms of depression 
(BASDEC score ≥7) was about 41%. This proportion is very similar to the result of a previous 
study which indicated that about 42% of patients with COPD have depression (Yohannes, 
Connolly & Baldwi, 2000). Furthermore, the Haringey Teaching PCT pulmonary rehabilitation 
programme (refer to section 6.4) conforms with the standards of PR programme (NICE, 2004; 
NICE, 2010). The fact that the PR programme protocol and the prevalence of depression in the 
participants of the study reported in this chapter is similar to that reported in other 
publications (NICE, 2004; Yohannes, Connolly & Baldwi, 2000) suggests that the findings of this 
study may be generalisable. 
The single visit by the principal researcher to the participants at home and the assessment 
conducted may still have influenced their behaviour and responses. However, effort was made 
to minimise the effect of such visit by making sure the number of visit/contacts was the same 
for all participants.  The patients who volunteered for the study may not be representative of all 
the patients with COPD who were referred to the Whittington Health NHS Trust during the 
period of the study. They may be the more strongly motivated members of the population. 
However, since only 51 of the 153 patients referred to the PCT during the time of the study 
participated in the study, it is not possible to know the PR participation profile of the remaining 
102 patients since the ethical approval granted for the study only allowed the principal 
researcher to collect data from patients that did consent to participate. Also, email and personal 
communication with the NHS Trust indicated that the required data on participation profile of 
these patients has not been kept and the trust has changed its patient database since that time 
(Whittington, 2014). Respondents in a patient survey have been indicated to be more likely to 
be patients who are married or employed (Shahar, Folsom and Jackson, 1996), have higher 
education (Etter and Perneger, 1997; Shahar, Folsom and Jackson, 1996), and a greater usage of 
healthcare services (der Wiel et al, 2002; Etter and Perneger, 1997; Rupp et al, 2002; Shahar, 
Folsom and Jackson, 1996) than non-respondents. This means the result in the study reported 
in this chapter may be biased towards patients who were married, employed, with higher 
education and greater usage of healthcare. Also, due to the small sample (n=51), the result may 
be tentative. 
A study by Jacobson, Rusch, Frolich, Andersen and Godftredsen (2013) (rehabilitation group 
n=118 and comparison group n=3474, mean age= 70 years) indicated that gender, 
socioeconomic status and frequency of the use of COPD-specific medication were associated 
with enrolment into PR. The report of significant association between frequency of the use of 
COPD-specific medication and enrollment in PR by Jacobson et al. (2013) is interesting 
considering that the study reported in this chapter did not find a significant correlation between 
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COPD disease severity and uptake of PR. The study by Jacobson et al. (2013) is larger than the 
study reported in this chapter. However the study detailed in this report was a prospective 
study of patients referred to PR while the study by Jacobson et al. (2013) was a retrospective 
analysis of data from National COPD Patient Register. Also, Jacobson et al. (2013) investigated 
the differences in socio-demographic and medical characteristics of the two groups (i.e. patients 
with COPD who enrolled and completed PR versus those who did not) but no direct assessment 
of participants’ mood and depression status was conducted. 
 
Hayton et al. (2013) (n=711 invited, 557 commenced PR, drop out=161), indicated that social 
support is an independent predictor of drop out from PR; but not of commencement of PR. 
Hayton et al. (2013) reported inverse relationship between participants’ COPD severity and 
completion of PR (p<0.05). Further, Hayton et al. (2013) identified depression as an 
independent predictor (p<0.05) of drop out from PR.  The differences between the study by 
Hayton et al. (2013) and that reported in this chapter could be because the study reported in 
this chapter was a prospective study of patients with COPD referred to PR while the study by 
Hayton et al. (2013) was a retrospective analysis of two PR services in the UK between January 
2005 and June 2010. Also Hayton et al. (2013) evaluated social support in their study as a 
dichotomous of living alone versus not living alone, whereas the study reported in this chapter 
evaluated social support as a multidimensional scale which included social support and social 
interaction. The study by Hayton et al. (2013) is larger and used participants spirometry (FeV1) 
as a measure of disease severity while the study reported in this chapter used MRC score as a 
measure of COPD disease severity. Hayton et al. (2013) used the HADS score as measure of 
depression while this research used the BASDEC to measure depressive symptoms.  
 
The findings of non-significant correlation between completion of PR and social support in the 
current study is in agreement with the findings by Fischer et al. (2009) (n=217, drop out = 
23%). These authors indicated that living alone has no significantly association with completion 
of PR. However, there are interesting differences between the study by Fischer et al. (2009) and 
the current study which was conducted between 2008 and 2009. While the current study was 
conducted with a PR protocol of 8 weeks of twice weekly sessions, the study by Fischer et al. 
(2009) combined PR programmes that vary largely in protocol. The PR programme in some 
centres involved in the study by Fischer et al. (2009) was based on a protocol of thrice weekly 
outpatient exercise sessions while the PR programmes in another centre involved five times a 
week outpatient exercise sessions. While the protocol of the current study involved a home visit 
to each participant who consented to take part in the study, the study by Fischer et al. (2009) 
involved sending questionnaires to the participants at home prior to commencement of PR and 
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only the questionnaires that were returned were analysed. While the study reported in this 
chapter did not find significant correlation between participation in PR participants’ health 
locus of control, Fischer et al. (2009) reported that patient’s belief in the effectiveness of PR was 
an independent positive predictor of attendance.  
 
The study reported in this chapter is the first prospective quantitative investigation of drop out 
in PR within the protocol of eight sessions of twice weekly attendance as advanced by 
guidelines (IMPRESS, 2011; NICE, 2004). Also, it is the only prospective study to investigate 
factors that affect uptake of PR in patients with COPD. 
 
A systematic review by Keating et al, (2011) evaluated publications (up to April 2010) of studies 
that investigated drop-out from PR. The systematic review included studies which evaluated 
attendance at PR and drop-out from PR in individuals with a diagnosis of COPD. The review was 
limited to studies published in English and excluded articles in which participants had diagnosis 
of conditions other than COPD or participants were evaluated for attendance at programmes 
other than PR.  The systematic review identified 11 studies, five were qualitative studies 
(Arnold, Bruton & Ellis-Hill, 2006; Fischer et al, 2007; Fischer et al, 2009; Harris, Hayter & 
Allender, 2008; Taylor et al, 2007) and six other studies were based on a quantitative design 
(Fan et al, 2008; Garrod et al, 2006; O’Shea et al, 2007; Sabit et al, 2008; Steele et al, 2008 ; 
Young et al, 1999). Each of the studies adopted different definitions of ‘drop-out’ (which varied 
between attendance of seven and sixteen PR sessions), probably since these studies were 
conducted before the guidelines by IMPRESS was produced. IMPRESS (2011) recommended 
attendance of two PR sessions weekly for at least four weeks. This is in line with the evidence 
that twice weekly participation in outpatient PR for a duration of four weeks resulted in 
significant improvement in walking ability (Sewell et al, 2006). 
In the studies by Fan et al., (2008) (n=1,218, FeV1 ≤ 45% predicted) and Garrod et al., (2006) 
(n=74, 21 with mild COPD, 29 with moderate COPD), the definition of completers as patients 
that attended 10 PR sessions is not consistent with the PR guideline (IMPRESS, 2011).  The 
evaluation of drop out in the study by Fan et al., (2008) was conducted as part of a randomised 
control trial investigating lung volume reduction and participants were all individuals with 
severe COPD who have had surgery. This limits the application of the findings to individuals 
with mild or moderate COPD or to those patients with COPD who have not had surgery. The 
definition of completers as patients that attended seven PR sessions in the study by Young et al., 
(1999) (n=91) suggested that participants in the study were not required to attend the 
minimum number of PR sessions recommended by the guidelines (IMPRESS, 2011). Moreover 
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all participants in the study were 50 years and above and have history of at least twenty 
smoking pack years. The definition of completers as patients that attended sixteen PR sessions 
in the study by Steele et al., (2010) suggested that participants were required to attend in excess 
of the number of PR sessions recommended by the IMPRESS guidelines. While the study had a 
good number of participants (n=146), the fact that 140 of the 146 participants were male limits 
the application of its finding to females patients with COPD. The protocol of PR in the study by 
O’Shea et al, (2007) was not in line with twice weekly supervised session recommended by 
guideline (BTS, 2013, NICE, 2004). While O’Shea et al. (2007) indicated that the PR protocol in 
their study consisted of thrice weekly exercise sessions over 12 weeks, only one of the three 
sessions each week was an outpatient supervised session while the other two were 
unsupervised. This is not in line with guidelines (IMPRESS, 2011; NICE, 2004) which 
recommend that patients with COPD should participate in two supervised PR sessions each 
week. The study by Sabit et al., (2007) was a retrospective analysis of attendance at PR and the 
study did not investigate variables of depression.  
 
Previous studies by Garrod et al. (2006), Al-shair et al. (2009) (n=122, male=75, mean age=66 
years) and Spruit et al. (2010) (n=1795, age 40-75 years) established that depression was a 
significant and independent risk factor for dropout and poor exercise performance in patients 
with COPD. Therefore, it may be prudent to consider the depression status of a patient with 
COPD when referring such patient for PR and decide if depression management is required in 
order to enhance uptake and completion of PR. Such an approach could improve the chances of 
a patient with COPD benefiting from PR. 
 
6.9 CONCLUSION 
The study reported in this chapter demonstrated that there is a moderate and negative 
statistically significant association between the uptake of outpatient PR and patient baseline 
measures of depression status. It further found that the correlation between the uptake of 
outpatient PR and social support, HLC and COPD severity was not statistical significant 
(p<0.005).  
The existence of association between two phenomena is not an indication of cause and effect. 
The finding of significant association between depression and non-uptake of PR in the current 
study is not an indication that depression is the cause of non-uptake of PR but does support the 
co-existence of the disease and depression as seen in the literature. A prospective study which 
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observed 376 patients with COPD for 369 days indicated a significant positive correlation 
(p<0.05) between depression score and disease symptoms as well as between depression score 
and frequency of admission (Ng et al, 2007). Another prospective study of 715 (age 22 to 44 
years) patients with asthma indicated a significant positive correlation between depression 
score and the number of breathlessness attacks at rest (p < 0.01),  as well as between 
depression score and reported wheezing (p < 0.05) (Janson, Björnsson, Hetta and Boman 
(1994). Furthermore, large studies (Al-shair et al., 2009; Spruit et al., 2010) reported depression 
as a predictor of poor 6MWD performance in patients with COPD (p<0.05). While the studies by 
Ng et al. (2007) and Janson, et al. (1994) used HADS to measure depression, the study by Spruit 
et al. (2010) used Epidemiologic Studies Depression Scale (CES-D) to measure depression and 
the study by Al-shair et al. (2009) used both CES-D and BASDEC to measure depression. The 
findings from these various studies suggest that depression has significant association with 
other important screening tools in patients with COPD.  Since depression is a risk factor for 
some other baseline factors or phenomenon like hospital admission and breathlessness attack, 
non-uptake or drop out in PR by patients with COPD may have been the direct result of some of 
these other factors.  It was not the aim of this study to investigate the cause and effect 
relationship between the screening tests and uptake of PR or between the screening tools and 
completion of PR. Investigating cause and effect relationships between depression and 
participation in PR may require randomising a number of patients with COPD into two arms, 
seeking to introduce depressive symptoms into one arm while participants in the other arm 
would not have such depressive symptoms introduced. It was considered that such study was 
not ethically viable. 
 
The current study did not find a significant association between drop-out from PR and 
depression (p<0.05). Moreover, the correlation between drop-out from outpatient PR and each 
of social support, HLC and COPD severity was not statistically significant either.  
The findings from the current study add to the existing body of knowledge on how a patient’s 
baseline psychosocial or disease factors may influence participation in PR programme. As 
suggested by the findings of Garrod et al. (2006) which reported significant positive association 
between depression and drop-out from PR, it is important to identify the depression status of a 
patient with COPD.  It should be assessed whether depression management is required to 
increase the chances of participation in PR. The finding of the current study suggest further 
assessing patients with COPD for depression at the point of referral to PR programme may be 
more appropriate than assessing them for depression only at the start of the programme. This is 
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an important point to have discovered because the probability that a patient with COPD would 
attend the initial PR assessment is significantly reduced by the presence of depression.  
The results from the research reported in this chapter suggested: 
 A high non-uptake and drop-out in outpatient PR.  
 The need to investigate an alternative protocol of PR which may reduce drop-out from 
outpatient PR and improve maintenance of the benefits of PR. 
The findings from the study reported in this chapter has relevance to the SRCT reported in 
Chapter 7.  Part of the investigation in the SRCT was into whether there was a significant 
difference in drop out from outpatient PR between patients with COPD who receive outpatient 
PR alone and those who receive outpatient PR concurrently with VBHEP.  
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CHAPTER SEVEN-RANDOMISED CONTROL TRIAL 
INVESTIGATING THE EFFECTIVENESS OF A VIDEO 
BASED HOME EXERCISE PROGRAMME IN THE 
PULMONARY REHABILITATION OF PATIENTS WITH 
CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
7.1 JUSTIFICATION  
The developers of the Move-on-Up exercise video (Pfizer, the ACPRC and the St George’s School 
of Physiotherapy) suggested its use in the rehabilitation of patients with COPD (ACPRC, 2006). 
However, the developers did not specify at what stage in the COPD care-pathway (pre-
outpatient PR, during outpatient PR or post-outpatient PR) that the video based exercise 
programme should be initiated. A randomized control trial (Petty et al., 2006) (n=214, mean 
age=70 years) indicated that the use of an exercise video at home is more effective than care 
that merely consists of medication and verbal or written information alone in improving 
exercise habits and QoL. No previous study has evaluated whether the combination of VBHEP 
and conventional outpatient PR has additional benefits compared to outpatient PR only. The 
study reported in this chapter addressed this gap in knowledge by investigating whether the 
combination of VBHEP and outpatient PR results in additional and clinically significant 
improvements in walking ability and QoL. It also evaluated the maintenance of these benefits, 
compared to outpatient PR alone. Further, the study investigated whether there is a significant 
difference in the change in HLC and in drop-out rate from outpatient PR in participants that 
received a combination of VBHEP and outpatient PR compared to participants that received 
outpatient PR only. 
 
7.2 THE STUDY 
The aim of the stratified randomized control trial (SRCT) was to investigate the effectiveness of 
using VBHEP at home concurrently with outpatient PR, in increasing walking ability and the 
maintenance of benefits of PR when compared with outpatient PR alone, in patients with COPD. 
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Primary research question 
Is the use of a VBHEP concurrently with outpatient PR more effective than outpatient PR alone 
in improving walking ability (measured with endurance shuttle walk test) at the end of 
outpatient PR and in maintaining any significant benefit at six months post-outpatient PR? 
Secondary research questions 
Is the use of a VBHEP concurrently with outpatient PR more effective than outpatient PR alone 
in improving quality of life (measured with St George’s Respiratory Questionnaire) at the end of 
outpatient PR and in maintaining any significant benefit at six months post-outpatient PR? 
In comparison to outpatient PR alone, would using a VBHEP concurrently with outpatient PR 
result in a significant difference in change in health locus of control at the end of outpatient PR 
and at six months post-outpatient PR?  
Would using a VBHEP concurrently with outpatient PR result in a significant change in the drop-
out rate from outpatient PR? 
The following null hypotheses were advanced: 
i) There was no significant difference in the change in walking ability between patients with 
COPD who receive outpatient PR alone and those who receive outpatient PR concurrently with 
VBHEP, at the end of an outpatient PR. 
ii) There was no significant difference in the maintenance of benefits of walking ability between 
patients with COPD who receive outpatient PR alone and those who receive outpatient PR 
concurrently with VBHEP, at 6 months post outpatient PR. 
iii) There was no significant difference in the change in QoL between patients with COPD who 
receive outpatient PR alone and those who receive outpatient PR concurrently with VBHEP, at 
the end of an outpatient PR. 
iv) There was no significant difference in the QoL between patients with COPD who receive 
outpatient PR alone and those who receive outpatient PR concurrently with VBHEP, at 6 months 
post outpatient PR. 
v) In comparison to outpatient PR alone, using a VBHEP at home, concurrently with outpatient 
PR, results in no significant difference in change in HLC at the end of an outpatient PR.  
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vi) In comparison to outpatient PR alone, using a VBHEP at home, concurrently with outpatient 
PR, results in no significant difference in change in HLC at 6 months post outpatient PR.  
vii) There was no significant difference in drop out from outpatient PR between patients with 
COPD who receive outpatient PR alone and those who receive outpatient PR concurrently with 
VBHEP. Significant difference in drop out in this study was defined as a difference in drop out 
=/>25% between the two arms. 
 
7.2.1 CONSORT GUIDELINE AND RCT DESIGN. 
The study was designed, executed and reported in a way that conforms to the specifications of 
the Consolidated Standard of Reporting Trials (CONSORT) statement and the CONSORT 
checklist (Moher, Schulz & Altman, 2001; Moher et al, 2010). The CONSORT statement sets out 
the guidelines for the complete and transparent reporting of randomised trials in a way that 
reduces the effect of bias on the results and enables critical appraisal and interpretation of the 
study. The key components of the CONSORT document covers the explanation of rationales for 
the study including objectives and hypotheses, eligibility criteria of participants, settings where 
data are collected, details of the intended intervention for each group of participants and what 
was actually administered. The CONSORT statement also promotes clear definitions of primary 
and secondary outcome measures and how the quality of data was enhanced – in this instance 
through multiple observations and the use of trained assessors. The CONSORT statement 
requires that the process of sample size calculation and the method of random allocation 
including details of any restriction (e.g. stratification) should be stated. There should also be a 
clear explanation on the blinding of participants (Moher et al., 2001; Moher et al, 2010). The 
CONSORT statement requires that the results of a trial should state clearly the flow of 
participants, the intervention received, and the number of drop-outs or any deviation from the 
initial study protocol. A baseline comparison of participants in each group should be stated and 
the number of participants in each group that is included in the result analysis should be stated. 
Interpretations of results should consider study hypotheses, sources of potential bias and issues 
of ambiguity. In addition, generalisability and the external validity of the data should be 
examined as well as issues that relate to overall interpretation with due consideration being 
given to current evidences (Moher et al., 2001; Moher et al, 2010).  
A series of research strategies and their limitations were considered to ensure a comprehensive 
approach in answering the research questions (Creswell, 2009; University of Wisconsin 
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Institute for Clinical and Translational Research-UW ICTR, 2015). These considerations are 
summarised in tables 7.1 and 7.2.  
It was concluded that a SRCT was the most appropriate study design that could answer the 
research question. The limitations of the SRCT were addressed through various approaches as 
indicated in Table 7.2. 
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Table 7.1- Comparison of various study designs and strategies. 
Study design Advantages and limitations 
Cohort design The advantages include 
-Low cost  
-Shorter study duration if a control group is taken from the data of 
previous studies 
 
The limitations include: 
-Lack of control over assignment of risks 
-The observational nature of a cohort study makes evidence derived 
from it weaker compared to the evidence derived from RCT. 
Cross-over 
randomised 
controlled trial 
The advantages include: 
-Smaller study population required 
-Control over intervention assignment 
-Randomisation limits errors due to confounding factors 
-Blinding and concealment of allocation limits bias 
-Cross-over RCT may provide a stronger evidence base than a cohort 
study design 
 
The limitations include: 
-Easy contamination of interventions because every participant 
knows the intervention in each of the groups 
-When the effect of an intervention still exists during the evaluation 
of another intervention, such is referred to as ‘carry-over’ effect and 
it can leads to erroneous outcomes, especially if the administration of 
the interventions is not separated by an adequate length of time to 
allow the effect of one intervention to have ended before the 
administration of the other intervention begins (a ‘wash-out’ period).  
-Additional ‘wash out’ periods could lead to a prolonged study period 
- The prolonged study period for each participant could increase 
drop out from the study 
-It is equally expensive to finance and manage 
Stratified 
randomised 
controlled trial 
The advantages include: 
-Control over intervention assignment 
-Randomisation limits errors due to confounding factors 
-Blinding and concealment of allocation removes bias 
-Risk of contamination is reduced by ensuring that a group starts and 
completes outpatient PR before any other group starts 
- Overflow effect is avoided; therefore, risks of erroneous results are 
minimised. 
- Since there is no need for a wash-out period, the study period for 
SRCT is expected to be shorter than that of a cross-over RCT design 
and more participants are expected to complete the research study 
-RCT provides one of the strongest evidence bases for healthcare 
practice 
 
The limitations include: 
-Larger number of participants is required 
-It is more expensive to finance and manage, especially as more staff 
are required in the research team in order to be able to achieve 
blinding of the principal researcher 
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Table 7.2- Management of limitations of the SRCT 
Limitation Approach to managing limitation 
Larger number of 
participants is required. 
Haringey Teaching PCT usually has a relatively high referral 
rate of patients with COPD for PR (about thirty-two referrals 
per cycle of eight weeks of PR). It was therefore, feasible that 
the required number of participants could be achieved. 
The SRCT was designed as a pragmatic study with inclusion 
criteria simply being the clinical diagnosis of COPD and an 
MRC score of three and above on referral to PR. The exclusion 
criteria were largely the same exclusion criteria that would 
be applied to any PR participant. 
A SRCT is more 
expensive to finance 
and manage. 
The stages of evaluation of the Move-On-Up video were partly 
supported by the University of Hertfordshire by the provision 
of stamped addressed envelopes. 
A good support network was established with the Haringey 
Teaching PCT (later known as Whittington Healthcare NHS 
Trust), which hosted the study, and the Trust provided some 
of the staffing required.  
 
The characteristics of this SRCT qualify it as a pragmatic trial (Yi, Qiuju, Jie & Ce, 2013; 
Zwarenstein et al, 2008). The research question is highly pragmatic rather than highly 
explanatory. This is because a highly pragmatic research investigates whether the intervention 
works when used in normal practice, with a selection of participants that is largely within the 
clinical indication of interest. In contrast, highly explanatory research simply investigates 
whether the intervention works in an ‘ideal’ or well-resourced selected setting with a restricted 
selection of participants (Yi, Qiuju, Jie & Ce, 2013; Zwarenstein et al, 2008). In highly 
explanatory research, participants with conditions which might dilute the effect of intervention 
are usually excluded as Campbell (2008) further comments. As a pragmatic study, the 
intervention was applied flexibly. The exercise video was given to participants in the 
appropriate group who were advised to use it at home, this being the usual approach to the 
prescription of a home exercise programme in a normal healthcare practice (Zwarenstein et al, 
2008). 
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7.2.2 INTENTION TO TREAT ANALYSIS IN RCT  
In a randomized clinical trial, the strict application of intention-to-treat is limited by two main 
situations: missing outcome measures for some study participants and non-adherence to the 
trial protocol (allocation contamination) (Moher et al., 2010). 
In consideration of participants in the SRCT, for whom follow up data was missing, various 
approaches to the management of missing data in intention-to-treat analysis were examined. 
Approaches to managing missing data include multiple imputations and single imputation 
approaches (European Medicine Agency, 2010). Multiple imputations generate multiple copies 
of the original data set to replace missing values by randomly generated values. This approach 
could introduce bias by overestimating the effect size of the treatment likely to be seen in real 
practice (European Medicine Agency, 2010). A realistic approach to filling in missing data in 
intention-to-treat analysis is best achieved by assuming the best possible outcome for all, or the 
worst possible outcome for all, without bias to any group allocation (Cochrane collaboration, 
2002; European Medicine Agency, 2010; Werts, 1995). This is the single imputation method. 
The single imputation methods of managing missing data in intention-to-treat include the ‘last 
observation carried forward’ (LOCF) and the ‘baseline observation carried forward’ (BOCF). 
Various authors of simulation reports (Altman, 2009; Barnes, Mallinckrodt, Lindborg & Carter, 
2008; Lane, 2008) and the guidelines by the European Medicine Agency (2010) indicate that the 
LOCF approach is not appropriate in a trial where the individual patient’s condition is expected 
to deteriorate. In the case of patients with COPD, LOCF analysis is inappropriate because loss of 
the benefits of PR over time is the usual pattern reported after outpatient PR has ended (Bestall 
et al., 2003). Using the LOCF analysis would give untrue results that suggest that participants 
who provided outcomes at week eight (end of outpatient PR) but provided no data at week 
thirty-two (six months post-outpatient PR) maintained all the benefits of PR even at the sixth 
month period after the end of outpatient PR.  
BOCF is another type of single imputation approach that has been recommended by guidelines 
as an appropriate method of managing missing data (European Medicine Agency, 2010). It is 
used when it is reasonable to assume that the withdrawal of a participant from treatment could 
lead to deterioration of the condition or its return to the baseline level and that such patients 
derive no benefit from the treatment. This approach is reasonable for a COPD patient who did 
not attend adequate PR outpatient sessions and did not provide outcomes at the end of 
outpatient PR. It is also a reasonable approach for patients with COPD who provided outcomes 
at the end of outpatient PR, but did not provide follow-up data at the sixth month after the end 
of outpatient PR. 
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Based on these aforementioned reasons, the BOCF analysis was implemented for all missing 
data.  
a) Participants with no follow-up data at week eight in this study were assumed to have not 
improved from their baseline of day one. This is realistic because these participants did not 
attend the number of PR sessions adequate for achieving the minimum clinically significant 
improvement in walking ability i.e. attendance of at least eight sessions of PR (Sewell et al, 
2006). In the study reported in this chapter, the highest attendance by a patient that dropped 
out before end of the outpatient PR was five PR sessions and the lowest attendance was one PR 
session. 
b) Participants who provided follow-up data at week eight but provided none at week thirty-
two were assumed to have returned to their baseline outcome of day one. This is in line with 
previous studies which suggested that the benefits of PR are diminished from the sixth month 
post outpatient PR (Bestall et al., 2003).  
The ‘method effectiveness’ model is used in managing non-adherence to the trial protocol in an 
RCT (Mancour and Larmer, 2009). The method effectiveness model includes (a) the ‘per-
protocol’ analysis (in which only the patients who adhere to the assigned intervention are 
analysed) and (b) the ‘as treated’ analysis in which the patients who switch between arms of 
trial are analysed in line with whichever treatment they received. Where non-adherence by 
participants may be related to the intervention itself, the ‘per-protocol’ analysis could inflate the 
apparent benefit of an intervention and lead to erroneous conclusion that it was a superior 
therapy. For example, an intervention that is too demanding or one with unbearable side effects 
(Mancour and Larmer, 2009). The SRCT reported in this chapter is a pragmatic study. Drop-out 
is a common occurrence in studies that investigate audiovisual interventions in patients with 
COPD; Nguyen et al. (2008) (n=50, drop-out=36%), Petty et al. (2006) (n=214, drop-
out=18.7%). Any analysis which excludes non-completers is misleading in the context of the 
real healthcare setting (Haynes and Dantesa, 1987).  
On evaluating the SRCT reported in this chapter, it was recognised that a ‘per-protocol’ 
approach which excludes drop-outs from the analysis may prevent identification of possible 
deteriorative effects that the VBHEP may have on patients. For example, the possibilities of an 
excessive exercise regime which may compromise safe dosages or discourage appropriate 
compliance with the entire PR programme. All participants that were randomised were 
accounted for at the end of the study. In the SRCT, where the outcome at the end of outpatient 
PR or six months post-PR was not obtained due to drop out of a participant, the BOCF approach 
was used. The participants were stratified during randomisation and every participant in any 
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cohort of the trial finished their outpatient phase before the participants in another cohort 
commenced their outpatient phase. This made the possibility of any contamination of 
intervention very remote 
Based on these aforementioned reasons, the ‘as treated’ analysis was implemented. No patient 
was observed to switch between study arms, and accordingly, the risk of contamination was 
remote and non-completers were analysed using the BOCF protocol. 
 
7.2.3 POWER AND SAMPLE SIZE CALCULATIONS  
In order to calculate the sample size required for the SRCT to have a power of 80%, attempts 
were made to identify the MCID for each of the outcome measures of ESWT, SGRQ and MHLC.  
An abstract by Brouillard et al. (2007), later published in full (Pepin et al., 2011) identified a 
minimal clinically important difference (MCID) for ESWT following the use of a bronchodilator 
in 69 patients with COPD (mean FeV1=50) to be 65s or 95m. The authors also studied 132 
patients with COPD but were unable to identify the MCID following PR due to weak association 
between the anchors and the change in ESWT performance. Accordingly, Brouillard et al., 
(2007), along with Pepin et al., (2011) declared that the MCID for ESWT determined for one 
intervention may not be relevant to another. Therefore, the MCID for ESWT determined for 
patients with COPD following the use of Salmeterol was considered as not relevant to the study 
reported in this chapter. The MCID for the endurance shuttle walk test distance (ESWD) 
following PR in patients with COPD was identified by Waterhouse et al. (2006). Following six 
weeks of twice weekly PR, Waterhouse et al. (2006) compared pre to post pulmonary 
rehabilitation ESWD score in patients with COPD (n=161, male=54.7%, mean age=69, mean 
FeV1 =47%). The authors identified the relationship between changes in ESWD and patients 
self-assessment of improvement in their condition and they defined MCID in ESWD as 173m, 
standard deviation (SD) =180m. The authors did not report the MCID in terms of walk time 
(seconds).  
After the completion of the SRCT detailed in this chapter, Altenburg et al. (2015) (n=55, mean 
FeV1 =31.1%) published the MCID for the ESWT following PR in patients with COPD (and with 
chronic respiratory failure) as a range 154-164m (refer to section 9.3). The value reported by 
Altenburg et al. (2015) (i.e. 154-164m) is closer to that reported by Waterhouse et al. (2006) 
(i.e. 173m) and these magnitudes may suggest that the MCID reported by Pepin et al. (2011) (i.e. 
65s or 95m) is relevant to the intervention Salmeterol and not to PR.  
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The MCID of 173m (Waterhouse et al., 2006) was used in the SRCT reported in this chapter and 
the newly reported MCID by Altenburg et al. (2015) does not change the findings of the SRCT in 
this thesis (refer to section 7.5.3.1). 
The developers of the SGRQ (Jones et al. 1991; 1992) published the MCID as a 4 unit change in 
the total SGRQ scores (refer to section 2.5.8). The same value was confirmed by Schunemann et 
al. (2003). However these authors (Jones et al., 1991; 1992; Schunemann et al., 2003) did not 
publish the SD value for the reported MCID in SGRQ.  
Schunemann et al., (2003) identified the MCID by analysing the data of 84 patients with COPD 
who completed both the SGRQ and CRQ pre and post PR. The authors conducted a linear 
regression analysis and created a model in which changes in the CRQ scores were plotted, as 
independent variables, against changes in the SGRQ score as a dependent variable. Schunemann 
et al., (2003) concluded that the MCID for SGRQ is approximately a change of 4 units on the 
instrument. An attempt to contact the authors by email was not successful. Email contact was, 
however, established with the original author of the SGRQ (Jones et al., 1991). The design and 
intervention of the study reported in this chapter was described and a request was made to 
know the SD for SGRQ. In the personal communication, the author of the SGRQ responded that 
the SD for SGRQ appropriate to the study reported in this chapter is -/+13 (Jones, May 29, 
2014). 
A published standard deviation for MHLC could not be identified by the principal researcher. In 
a personal email communication, the author of MHLC indicated that there is no MCID identified 
so far for MHLC (Wallston, May 28, 2014 and May 30, 2014).  
To investigate whether the use of VBHEP results in a change in drop-out rates from outpatient 
PR, a sample size calculation was carried out. In doing this, the 51.72% drop-out in the 
observational study (reported in Chapter 6) was regarded as the baseline. The study reported in 
Chapter Six was conducted in a population of patients with COPD receiving PR provided by the 
same staffs in the same NHS trust as that in which the SRCT reported in this chapter was 
conducted. This SRCT defined a difference in drop out of 25% (e.g. 51.72% in non-video arm 
versus 76.72% in video arm) between the trial arms as significant.  
A sample size calculation was conducted using the primary outcome measure i.e. ESWD, with a 
MCID of 173m, (SD=180m), a study power of 0.80, an alpha of 0.05, and allowance was made for 
20% attrition of participants. Based on the methodology of the study (two arm RCT), forty-six 
(twenty-three in each arm) participants were required to be recruited into the SRCT of which at 
least thirty eight (nineteen in each arm) had to complete the study. By the end of the entire 
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SRCT (week thirty-two), there were twenty two participants in the video arm and twenty four in 
the non-video arm. This meant that the study was sufficiently powered - based on the primary 
outcome measure. 
A sample size calculation was also conducted using a secondary outcome measure for the trial 
(SGRQ) with MCID of 4 unit change in total SGRQ score (Jones, 1991; 1992), standard deviation 
13 (Jones, June 2, 2014) , a study power of 0.80, an alpha of 0.05 and allowing for 20% attrition. 
Based on the methodology of the study (two arm RCT), 398 participants (199 in each arm) were 
required to be recruited into the SRCT of which at least 332 (166 in each arm) were required to 
complete the study. By the end of the entire SRCT (week thirty-two), there were twenty two 
participants in the video arm and twenty-four in the non-video arm which meant that the study 
was underpowered - based on SGRQ as outcome measure.   
Further, a sample size calculation was conducted based on a 25% difference in the proportion of 
drop-out between the trial arms. Calculation indicated that a study with power of 0.80, an alpha 
of 0.05 would require fifty-eight participants in each arm of the RCT. By the end of the 
outpatient phase of the SRCT (week eight), there were twenty-three participants in the video 
arm and twenty seven in the non-video arm which meant that the study was underpowered 
based on a 25% difference in the proportion of drop-out between the two arms.  
 
7.3 STUDY METHODS 
The study setting was the PR unit of the Whittington Health NHS Trust. The PR programme was 
as detailed in section 6.4. 
Inclusion criteria for the study were 
-Individuals with a clinical diagnosis of COPD based on the patient’s spirometry, using the ERS 
definition (FEV1> or = 70% predicted value) (ERS, 1993; NICE, 2004) who have been referred to 
the Haringey PCT pulmonary rehabilitation programme. 
-Medical Research Council dyspnoea (MRC) scale three and above on referral to PR. MRC three 
is defined as ‘‘walks slower than contemporaries on level ground or has to stop for breathing 
when walking at own pace’. 
These inclusion criteria were in line with the NICE guidelines (NICE, 2004). 
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Exclusion criteria for the study were mostly the same exclusion criteria that would be applied to 
any PR participant. These were 
-Individuals with severe cardiac condition for which exercise is a contraindication. 
-Individuals with severe musculoskeletal condition that affects walking. 
-Individuals who have received PR or VBHEP in the previous six months. 
-Lack of good understanding of English (because the instructions in the video are in English 
language).  
- Individuals with MMSE score of less than 24. 
The study was a SRCT with two study arms (groups A and B). In line with guidelines (IMPRESS, 
2011; NICE, 2004), the setting was as described in Chapter Six of this report. 
The tool of the study was the Move-On-Up video.  
Based on the findings of the review in Chapter Two, the screening and outcome measures 
identified below were used in the study (Figure 7.1). 
 
 
 
 
Figure 7.1 Time course of the SRCT showing outcomes taken at various points of the study. 
 
During initial assessment at the PR centre, the following demographic data were obtained from 
every trial participant: 
- Age of participant  
- Years since COPD diagnosis 
 
During initial assessment at the PR centre, the following screening tools were completed by 
every trial participant: 
Day 0; 
MMSE, DSSI 
BASDEC, 
MRC, ESWT, 
SGRQ, 
MHLC  
Wk 4 of 
intervention; 
SGRQ 
Day 1; 
Intervention 
starts 
 
Wk 6 of 
intervention; 
Follick’s 
activity 
diary 
Wk 8 of 
intervention; 
ESWT, SGRQ, 
MHLC. End of 
intervention 
 
Wk 24 post 
intervention; 
ESWT, SGRQ, 
MHLC  
 
Wk 12 post 
intervention; 
SGRQ 
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- MMSE score to exclude individuals with possible dementia (MMSE score of less than twenty-
four). 
- Scores of depression (BASDEC), disease severity (MRC) and DSSI (social support) in order to 
be able to evaluate and compare the confounding factors in the two arms of the trial. 
During initial assessment at the PR centre, the following outcome measures were taken from 
every trial participant: 
- Measure of walking ability using the endurance shuttle walk test (ESWT). In line with exercise 
guidelines for COPD patients by Australian Lung Foundation (2008) and stress testing 
guidelines by the U.S. National Institutes of Health (2015), participants were asked not to eat a 
big meal, smoke or take caffeine drink in the hour before the walk test. They were also advised 
not to take any medication that may affect their performance.  
-Quality of life using the St George respiratory questionnaire (SGRQ) 
-Health Locus of Control using Multidimensional Health Locus of Control (MHLC) scales B and C. 
At the end of weeks eight and 32, at the PR centre, the following outcomes were evaluated for 
every trial participant: 
- Measure of walking ability using the endurance shuttle walk test (ESWT) 
- Quality of life using the St George respiratory questionnaire (SGRQ) 
- Health locus of control using the Multidimensional Health Locus of Control (MHLC) scales B 
and C. 
The SGRQ was completed by the study participants at the end of week four of the study (i.e. 
after four weeks of outpatient PR) and the same questionnaire was posted to the participants at 
home, which they completed at the end of week 20 of the study (i.e. 12 weeks after completion 
of outpatient PR). 
At the end of week six, all participants were given the modified Follick's diary of activity (Pitta 
et al., 2005; Moore, Berlowitz, Denehy et al., 2009) to complete at home over a period of one 
week. This was to determine a measure of their compliance with their home exercise 
programme. At the planning stage of the study, it was decided that every participant who failed 
to complete the diary appropriately on week seven would be provided with support and would 
be requested to repeat it in week eight. In order to preserve blinding, this support was made 
available through a member of the research team other than the principal researcher. On 
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analysis, none of the participants needed this support or failed to complete the diary 
appropriately on week seven. In order to preserve the blinding of the principal researcher, who 
was responsible for taking the outcome measures, he did not have access to the completed 
diaries until after the final assessments have been completed. 
 In addition, the data on attendance of patients at the PR sessions was compiled in order to 
investigate whether the concurrent use of VBHEP and PR results in a change in drop-out from 
outpatient PR. Based on the analysis of the literature (please refer to section 2.4), the SRCT 
defined completers as those participants who attended at least eight outpatient PR sessions 
(IMPRESS, 2011; Sewell et al., 2006).  
Potential participants were patients with COPD on the waiting list of the PR unit of Haringey 
PCT who met the inclusion criteria. The potential participants were contacted by the Haringey 
PCT pulmonary rehabilitation staff and were informed of the study. The details of patients who 
agreed to participate in the study were passed on to the principal researcher, who sent a 
participant information leaflet to each of them to provide more details of the study. The 
principal researcher telephoned the intending participants 48 hours after they received the 
information leaflet to answer any question they may have had. At least a further 24 hours was 
allowed between the phone call by the principal researcher and each participant's outpatient 
appointment. This was to enable an informed decision to be made by the patients about 
whether to participate in the study or not. At the hospital appointment, the principal researcher 
answered any query that an intending participant might still have had and they were advised 
further on what the intervention would be in each group, though at this stage, none of the 
participants was able to identify the group in which he or she would be placed. Each of the 
patients who still intended to volunteer for the study signed a consent form. 
 
Initial outcome measures were taken by the principal researcher, after which each participant 
was directed to move on to the next stage which involved randomisation and allocation of 
intervention (refer to section 7.3.1).  
In line with NICE guidelines (NICE, 2004; 2010) for the PR of patients with COPD, participants 
who were allocated to conventional outpatient PR (the non-video arm of the SRCT) were offered 
two supervised outpatient PR sessions weekly for eight weeks (refer to section 6.4 for details of 
the Haringey PCT pulmonary rehabilitation programme). They were advised to do at least one 
self-directed exercise session at home each week and that the duration of each self-directed 
home exercise session should be 15 to 30 minutes. Participants were advised that, during the 
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self-directed exercise session at home, they should do exercises similar to the ones that they do 
in the outpatient PR exercise sessions.  
Participants who were allocated to outpatient PR and VBHEP (the video arm of the SRCT) 
received two supervised outpatient PR sessions for eight weeks. They were advised to do at 
least one self-directed exercise session at home each week and that each self-directed home 
exercise session should be at least 15 to 30 minutes. The participants in the video arm were 
given the Move-On-Up exercise video on day zero. At the onset of their rehabilitation, they were 
advised by the independent researcher to use the exercise video for their self-directed, home-
based exercise sessions.  
At the end of eight weeks of outpatient PR, participants in both arms were asked to continue 
doing their self-directed exercises at home. 
 
7.3.1 RANDOMISATION, BLINDING AND MANAGEMENT OF THE RISK OF 
CONTAMINATION 
Computer randomisation was used to achieve the sequence of SRCT groups over the entire 
period of study. The randomisation was conducted by a researcher who was independent of the 
assessor (principal researcher) who took all the outcome measures. Randomisation was in 
strata. Each stratum consisted only of the participants in one arm of the study. The researcher 
who conducted the randomisation forwarded the results of the randomisation to a third 
researcher who was also independent of the assessor. This third researcher was responsible for 
delivering the appropriate intervention to every participant in line with the randomised 
allocation. Participants in each stratum started and finished the entire period of outpatient 
intervention before participants of another stratum began their period of outpatient PR. This 
was in order to avoid contamination of control participants in the intervention (Creswell, 2009).  
The randomisation process was effective as analysis of results (Table 7.3 and 7.4) demonstrated 
that there was no statistically significant difference in the presence of the confounding factors 
between the two trial arms  
Over the one year of recruitment into the SRCT, four cycles of PR were delivered in the Haringey 
PCT (later known as Whittington Healthcare NHS Trust). The groups were randomised in blocks 
such that, in any one year, there were equal numbers of groups in each arm of the study (two 
cohorts in each arm), but in a random order.  
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The blinding of the assessor was maintained as strongly as possible and the patients were 
encouraged not to divulge their group allocation to the assessor. At the entrance and various 
spots in the PR venue (where assessments took place) bold notices for participants were placed 
around which read ‘DO NOT TELL THE ASSESSOR WHETHER OR NOT YOU USE VIDEO OF 
EXERCISE AT HOME’. This was to prevent any communication that might reveal a participant’s 
group between the principal researcher (who was assessing for outcome measures) and the 
participants. This was to minimise any bias that might arise from the assessor having 
knowledge of what intervention each participant had received, particularly because if the 
allocation of one patient was known, the allocation of that cohort would be known. 
 
7.3.2 STUDY DURATION AND ETHICAL APPROVAL 
It was initially estimated that 32 referrals for patients with COPD could be received (per cycle of 
PR programme at Haringey PCT) and there could be four cohorts (i.e. 128 referrals) within the 
first ten months of recruitment. It was estimated that if 50% of the patients with COPD who 
were referred for PR at Haringey PCT were recruited into the study, it would take about ten 
months to recruit at least 46 (23 participants into each arm of the study). It was estimated that 
the last group would be in the study for a period of 32 weeks (about eight months). Therefore, 
the study was initially expected to take around one and half years from the commencement of 
recruitment. Additional time was added for other preparation and logistics. Ethical approval 
(Brent REC reference 09/H0717/65 dated October 2009) was therefore sought and received for 
two and a half years (October 2009 to March 2012).  
Recruitment of participants into the study commenced in January 2010 and, by October 2010, 
participants’ recruitment into the fourth cohort had ended. Recruitment of new participants 
was therefore stopped in October 2010, when the number of participants recruited had reached 
at least 23 in each arm, as in the initial estimate given by the power calculation. 
By the end of November 2010, the phase consisting of outpatient PR (initial eight weeks of the 
32 week study) ended in the fourth cohort. The sixth-month review of this cohort was carried 
out in May 2011, when the SRCT was considered as finished. 
The protocol for the study contained a plan for monitoring the trial by a Data Monitoring 
Committee. The study protocol indicated that serious adverse effects which are associated with 
participation in the study should be reported and investigated appropriately (US Department of 
Health and Human Services, 2007). The participants experiencing the adverse effects may then 
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be identified. The study would be stopped if participants in the intervention group (combined 
VBHEP and conventional PR group) manifested adverse effects that were not manifested in the 
control group (conventional PR only group). Throughout the study, no adverse effect was 
observed in any cohort.  
 
7.4 STATISTICAL CONSIDERATIONS 
The SRCT was designed with prior statistical support from the University of Hertfordshire 
Health Research and Development Support Unit (HRDSU).  
Intention-to-treat analysis was used in the study (refer to Section 7.2.2) and allowance was 
made for a 20% drop-out during the power calculation. For all of the statistical analyses, two-
tailed tests were carried out because it was acknowledged that if the intervention resulted in 
significant change, such change could be a beneficial or detrimental change (Altman, Machin, 
Bryant & Gardener, 2000). 
At the planning stage of the SRCT, it was intended that for the outcome measures of ESWD and 
SGRQ, which are continuous data, the paired t-test would be conducted to examine the 
probability of a change within each group (with regards to the quantitative variables tested) 
between baseline and relevant follow-up time. Also, it was intended that the un-paired t-test, 
also called the independent samples t-test, would be conducted to compare the two sets of 
quantitative data that were collected independently of one another (i.e. to compare the ESWT or 
SGRQ data of one arm of the study to the corresponding ESWD or SGRQ data from the other arm 
of the study). These were as advocated by Altman et al. (2000). 
However, after data collection and analysis, the Shapiro Wilk test of normality indicated that a 
significant proportion of ESWD and SGRQ data from the trial was not normally distributed. For 
example, Shapiro Wilk p =0.002 and 0.065 for ESWD data from non-video arm at weeks 8 and 
32 respectively (Appendix 7D).   
Relevant statistics literature (Altman et al., 2000; Motulsky, 2007; Murdoch University School of 
Chemical & Mathematical Sciences, 2009) and the statistical support unit of the University of 
Hertfordshire Health Research and Development Support Unit were consulted. The decision 
was made to analyse the continuous data that were taken as outcomes of intervention in the 
SRCT (ESWD and SGRQ) as well as the ordinal data (MHLC) with a non-parametric statistical 
tool.  
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Bart, Fligner and Notz (2009) suggested that when there are no extreme outliers, t-test analysis 
could be used with a sample size as low as five. However, other authors disputed this and 
argued that in a small sample size (described as ‘less than 50 or so’) (McDonald, 2014, p 124),  
the t–test can produce erroneous results, with significantly more than 5% risk of detecting an 
effect when there is none. It was recommended that when there are outliers, a non-parametric 
test should be considered (Altman et al., 2000). For a data set that is not suitable for parametric 
analysis due to outliers, the median was considered to be better than the mean as a measure of 
central tendency (Murdoch University School of Chemical & Mathematical Sciences, 2009). Also, 
the exact significance is more accurate than the asymptotic significance for a data set that is of 
small sample size, sparsely distributed, contains numerous ties or is unbalanced (Altman et al., 
2000; Motulsky, 2007).  The non-parametric tests that were used are robust because they 
compare the sum of ranks and are less likely than t-test parametric tools to indicate significance 
that is influenced by outliers (Altman et al., 2000; Mehta and Patel, 2011). Even when used in a 
situation where the distribution of data is normal, the Mann Whitney U test has efficiency of 
0.95 when compared with the independent t-test (Lehmann, 1999). 
Between-groups analysis was carried out using the Mann Whitney U test to compare the two 
sets of data that were collected independently of one another in order to compare a particular 
domain of the MHLC data of one arm of the study to the corresponding MHLC data from the 
other arm of the study. Inferences were made when a statistically significant change was 
observed in one group but not the other. Within-group analysis was carried out using the one 
sample sign test to examine the probability of a change within each group with regards to the 
variables tested between the baseline and relevant follow-up time.  
A two-by-two chi square test was conducted to evaluate any association between trial arm 
(video or non-video) and the completion of outpatient PR. 
The Spearman Rho correlation was conducted to investigate the relationship between the 
benefits from PR and baseline disease severity, psychosocial factors, walking ability and quality 
of life respectively, and to determine the correlation between the aforementioned baseline 
variables and participation in VBHEP(please refer to section 7.6).  
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7.4.1. CONFIDENCE INTERVAL AND MULTIPLE TESTING CORRECTIONS  
The confidence interval (CI) for measurement of treatment effect refers to the interval estimate 
within which the real effect size lies and it indicates the uncertainty of the sample in estimating 
the treatment effect due to sampling error (Altman et al, 2000; BMJ, 2012). Also, the values 
toward the limits of the confidence interval are less likely to be the population mean than the 
value at the center (Gardner & Altman, 1989). A 95% confidence CI means that if repeated 
samples are drawn from a population and 95% CIs are calculated for the mean of each of the 
samples, the population mean would be within the 95% of these CIs (Gardner & Altman, 1989). 
When the mean of an observed sample lies outside the values in the CI (e.g.  95% CI), such mean 
cannot reliably be assumed to be representative of the population at large, even when it appears 
to be significant in the sample observed (Yale University, 2014). 
Numerous researchers advised that a CI is superior to formal significance tests as the CI width 
represents the exactness of the point estimate when conducting statistical significance test of 
effect size (Altman et al, 2000; BMJ, 2012; Huck & Cormier, 1996; Sim & Reid, 1999). 
Significance testing provides information about the sample (a subset of the population) that is 
observed while CI provides information about the larger population. Effect sizes are regarded as 
statistically significant if it falls within the limits of the CI values and the CI does not include the 
value of zero (Altman et al, 2000; Hedges & Olkin, 1985; Schmidt, 1996). 
Bonferroni correction was made in the SRCT reported in this chapter. To identify the 
effectiveness of the new protocol of rehabilitation (outpatient PR concurrently with VBHEP), the 
difference in change in walking ability (ESWD), quality of life (SGRQ) and HLC between the 
experimental and the control group was evaluated at week 8 and 32.  To identify any significant 
difference in the change in ESWD or MHLC between experimental and control group following 
rehabilitation, the data on ESWD and MHLC that was collected in each arm at week one was 
compared with similar data collected in each arm at week 8 and week 32 of study.  For ESWD 
and MHLC, the use of the baseline data in the test of between group difference on two occasions 
(weeks 8 and 32) resulted in p value been set at 0.025 (i.e. 0.05 divided by 2). To identify any 
significant difference in the change in SGRQ between experimental and control group following 
rehabilitation, the data on SGRQ that was collected in each arm at week one was compared with 
similar data collected in each arm at weeks 4, 8, 20 and 32. The use of the baseline SGRQ data in 
(at weeks 4,8,20 and 32) resulted in p value been set at 0.0125 (i.e. 0.05 divided by 4) (Altman 
et al, 2000; Mundfrom et al., 2006).   
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Considering the reasons above, statistical significance and confidence interval (CI) for between 
group and within group analysis were set as follow: 
For ESWD results; p was set at 0.025, CI was set at 97.5% 
For MHLC results; p was set at 0.025, CI was set at 97.5% 
For SGRQ results; p was set at 0.0125, CI was set at 98.75% 
Where association between variables were investigated and deemed required by the literature 
(for example association between patient baseline scores and significant change in walking 
ability), Spearman rho correlation was conducted for ordinal outcomes that were non-
dichotomous (e.g. disease severity, social support and health locus of control) while 2x2 Chi-
square analysis was conducted for the dichotomous variable (depression in this case). Where 
correlation was conducted, the Bonferroni correction was applied as recommended by 
Mundfrom, et al. (2006) and Dunn (1961) i.e. the p value was divided by the number of 
variables. 
Nineteen variables were included in the Spearman rho correlation that was conducted in the 
SRCT. The variables are: 
-baseline ESWD scores 
- Magnitude of change in ESWD between baseline and week 8 (used to identify participants with 
clinically significant improvement in ESWD, based on a change of 173m between week 1 to 8 
changes in ESWD score) 
-  Magnitude of change in ESWD between baseline and week 32 (used to identify participants 
with clinically significant improvement in ESWD, based on a change of 173m between week 1 to 
32 changes in ESWD score) 
- 4 domains of baseline SGRQ scores  
-3 domains of baseline MHLC scale B 
-4 domains of baseline MHLC scale C 
-2 domains of DSSI score 
-MRC score 
-PR completion status 
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- Frequency of video-based home exercise session 
Applying Bonferroni correction, significance value p was set at 0.0026 (i.e. 0.05 divided by 19) 
Advice was sought from the statistical research support team at the University of Hertfordshire 
and the statistician confirmed the validity of these decisions.  
 
7.5 RESULTS  
7.5.1 DEMOGRAPHICS 
One hundred patients with COPD were referred to the Whittington Health NHS Trust during the 
recruitment period of the SRCT. They were all approached and 60 of them volunteered for the 
study.   
Of the 60 patients that volunteered, three patients were excluded (one with fascial irritation in 
the leg, one with arthritic pains and one with an MMSE score of 20). Fifty-seven participants 
were eventually randomized. Of the four cohorts of the study, two constituted the video arm of 
the SRCT and two constituted the non-video arm of the SRCT. The number of participants in the 
first, second, third and fourth SRCT cohorts respectively were 10, 17, 15 and 15. The first and 
third cohorts were the video arm (n=25 in total) and the second and fourth cohorts were the 
non-video arm (n=32 in total). 
Altogether, 11 participants dropped out post-randomisation (3 in the video arm, 8 in the non-
video arm). Of the 11 participants that dropped out, 7 (two in the video arm, five in the non-
video arm) dropped out within the initial eight weeks of the study (the outpatient PR stage) and 
an additional 4 (one in the video arm, three in the non-video arm) did not participate in the 
sixth-month follow-up assessment. The power calculation that was carried out allowed for a 
20% drop-out rate. The overall drop-out rate at eight weeks (the end of outpatient phase) was 
12.28% (7/57) and increased to 19.30% (11/57) at the 32nd week (the end of the maintenance 
phase) of the study. Consequently, the trial remained adequately powered at its completion to 
detect a significant between group difference in the change in ESWD. 
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3 excluded, 2 males,  2 
with severe 
musculoskeletal 
condition, 1 with MMSE 
=20 
60 volunteered, 31 males
Video arm at wk 1: 25 
patients (13 males, 4 mild,  
19 mod,  8 depressed)
57 randomised (29 males, 
12 mild,  38 mod, 15 
depressed 
Non-video arm at wk 1: 32 
(16 males, 8 mild,  19 mod, 
7 depressed)
At wk 8: 23 patients(13 
males,  4 mild,  17 mod, 6 
depressed )
At wk 8: 27 patients (13 
males, 7 mild,  15 mod, 3 
depressed)
At wk 32: 22 patients  (12 
males, 4 mild, 17 mod, 6 
depressed)
At wk 32: 24 patients (12 
males, 5 mild, 15 mod, 2 
depressed)
100 referred, all were 
approached
40 declined 
participation
 
                                      Figure 7.2 SRCT flowchart 
 
There was no statistically significant difference between the trial arms in the participant 
distributions of gender, mean age, MMSE score, depression scores, and social support scores 
(Table 7.4). It was observed that the COPD disease severity distribution was 16% (n=4) mild, 
76% (n=19) moderate, and 8% (n=2) severe in the video arm, and 25% (n=8) mild, 59.37% 
(n=19) moderate, and 15.63% (n=5) severe in the non-video arm. In comparison to the non-
video arm, there were fewer proportions of patients with mild COPD in the video arm, though 
there were also fewer proportions of patients with severe COPD in the video arm. Importantly, 
the differences in the distributions of disease severity were not statistically significant (Table 
7.3 and 7.4). 
Within-group analysis demonstrated that the drop-out rate in each arm of the study remained 
below 20% at the end of eighth week (8%, n=2 in video arm; 15.63%, n=5 in non-video arm). At 
the 32nd week, the participant drop-out rate in the video arm was 12% (3 out of 25). The 
participant drop-out rate in the non-video arm had increased to 25% (8 out of 32). However, 
the population of participants remaining in the study arms at week 32 was still more than the 
19 required to be in each arm at the completion of the trial (as identified in the power 
calculation).  
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7.5.2 BASELINE CHARACTERISTICS 
The trial arms were analysed for equality in baseline characteristics (Table 7.3 and 7.4). This 
baseline comparison served as a verification of the success of the randomization process.   
Shapiro Wilk tests of normality indicated that the data was not normally distributed in both 
arms in various outcome measures (Appendix 7B). Therefore, Mann Whitney U test was 
conducted for all data except gender (a nominal variable) for which Chi square analysis was 
conducted. The results indicated that there was no statistically significant difference in the 
baseline characteristics of the two groups because for the test in each outcome, the p value was 
greater than 0.05 (Table 7.3 and 7.4).  
 
 
Table 7.3 Comparison of baseline characteristics of video arm and non-video arm 
Trial arm Video (n=25) Non-video (n=32) 
Gender 13 Male = 52.00% 16 Male = 50.00% 
Median age 69 years 67 years  
COPD severity  4 mild = 16.00%, 19 
moderate = 76.00%, 2 
severe = 8.00%  
8 mild = 25.00%, 19 
moderate = 59.37%, 5 
severe = 15.63% 
Depression score 8 with depression (median 
score = 2.5) 
7 with depression (median 
score = 3.0)  
Median MMSE 28.00 26.00 
Median DSSI total 27.00 27.50 
Median social support  19.00 19.00 
Median social interaction  9.00 9.00 
Median years since diagnosis 4.00 5.00 
Median spirometry 0.55 0.58 
Median MHLC internal B 24.00 21.50 
Median MHLC chance B 21.00 22.00 
Median MHLC others B 21.00 22.00 
Median MHLC internal C 26.00 26.00 
Median MHLC chance C 22.00 22.00 
Median MHLC doctors C 15.00 13.50 
Median MHLC powerful others C 13.00 12.00 
Median ESW Distance (m) 172.93 211.05 
Median SGRQ symptom 76.50 75.26 
Median SGRQ activity 88.10 86.09 
Median SGRQ impact 75.52 77.72 
Median SGRQ total 77.15 78.72 
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Table 7.4a Mann-Whitney U Test of equality of baseline characteristics of the trial arms at 
baseline in the outcomes of age, spirometry, ESWT, disease severity, depression score and years 
since COPD was diagnosed. 
 
Outcome Age  COPD 
score 
COPD 
severity 
Depressio
n score 
Social 
interaction 
Social 
support 
ESWD Spirometry 
Exact sig. 
( 2 tailed) 
0.90 0.96 0.63 0.35 0.98 0.43 0.95 0.29 
 
Table 7.4b Mann-Whitney U Test of equality of baseline characteristics of the trial arms at 
baseline in the MHLC domains 
 
Outcome WK1 
internal 
B 
WK1 
chance 
B 
WK1 
powerful 
others B 
WK1 
internal 
C 
WK1 
chance C 
WK1 
doctors C 
WK1 
others C 
Exact 
sig.( 2 
tailed) 
0.15 0.10 0.99 0.86 0.54 0.37 0.19 
 
Table 7.4c Mann-Whitney U test of equality of baseline characteristics of the trial arms at 
baseline in the SGRQ domains 
 
 
Table 7.4d Gender SRCT arm cross-tabulation 
Gender  Video 
arm 
Non 
video 
arm 
Total 
Male Expected count 12.7 16.3 29 
Count 13 16 29 
Female Expected count 12.3 15.7 28 
Count 12 16 28 
Total Expected count 25 32 57 
Count 25 32 57 
 
Table 7.4e Chi-square tests of equality in gender distribution at baseline 
 Value Df Sig. (2-sided) 
Pearson chi-square 0.02 1 0.88 
N of valid cases 57   
 
The characteristics of the patients that were excluded from the SRCT based on exclusion criteria 
are indicated in Table 7.5 (also in Appendix 7C). For the excluded patients, only the gender, 
spirometry result and MMSE score during screening were available. The profile of the patients 
that were excluded from the trial was compared with that of the patients included in the trial. 
Outcome WK1 SGRQ 
symptom 
WK1 SGRQ 
activity 
WK1 SGRQ 
impact 
WK1 SGRQ 
total 
Exact sig.( 2 
tailed) 
0.99 0.65 0.37 0.71 
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The results indicated that between the two groups of patients, there was no statistically 
significant difference in the baseline characteristics and for the test in each outcome, the p value 
was greater than 0.05 (Table 7.5).   
Table 7.5a Comparison of the characteristics of the patients included in the SRCT and patients 
excluded from the SRCT 
Outcome  Patients excluded (N=3) Patients included (N=57) 
Gender 2 males (66.67%) 29 males (50.88%) 
Median MMSE 29.00 27.00 
Median spirometry 0.53  0.57 
 
 
Table 7.5b Mann-Whitney test of equality of characteristics of the participants included in trial 
and participants excluded from trial 
 
Outcome MMSE score Spirometry 
Exact Sig. (2 tailed) 0.78 0.82 
 
Table 7.5c Cross tabulation and comparison of gender distribution between the patients 
included in and excluded from the SRCT 
Gender  SRCT 
included 
SRCT 
excluded 
Total 
Male Expected count 29.5 1.6 31 
Count 29 2 31 
Female Expected count 27.6 1.5 29 
Count 28 1 29 
Total Expected count 57 3 60 
Count 57 3 60 
 
7.5d Chi square test of comparison of gender distribution between the patients included in and 
excluded from the SRCT 
 
 Value Df Sig. (2-sided) 
Pearson chi-square 0.29 1 1.00 
N of valid cases 60   
 
7.5.3 ANALYSIS OF CHANGES IN OUTCOME MEASURES 
For each of the outcome measures, analysis of between-group changes was carried out, followed 
by analysis of within-group changes. Repeated outcome measures over time were taken for 
ESWT, SGRQ and MHLC. The significance values quoted in the calculations for the outcomes and 
screening tools in this chapter were ‘adjusted p’ values as a result of the Bonferroni correction. 
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Tests were carried out with an overall 5% chance of rejecting the statistical hypothesis being 
tested when it is actually true. Thus, in any case where multiple testing was conducted, a 
Bonferroni correction was conducted as recommended by Altman et al. (2000) and Mundfrom, 
et al. (2006) (detailed in section 7.4.1 of this report).  
An overall confidence interval of 95% was applied with Bonferroni correction conducted as 
appropriate. The between- and within-group results are detailed in sections 7.5.3.1 and 7.5.3.2 
and Appendix 7E. 
A positive value of median change in ESWD indicates improvement in walking ability, a positive 
value of median change in a domain of MHLC indicates increase in locus of control in that 
domain and a negative value of median change in SGRQ indicates improvement in quality of life.  
 
7.5.3.1 BETWEEN-GROUP CHANGES IN OUTCOME MEASURES 
Between-group changes over time in ESWD 
Throughout the study, comparison of the two study arms using Mann Whitney test analysis 
indicated no clinically or statistically significant between-group difference in change in ESWD. 
All the median scores were outside the limits of the 97.5% CI (Table 7.6). 
 
Table 7.6 Change in ESWD scores 
 Median Difference p CI 
Baseline to week 8 220.94 0.21 -306.3, -131.8 
Baseline to week32 136.00 0.12 -185.83, -81.22 
 
Between-group changes over time in SGRQ  
Throughout the study, comparison of the two study arms using Mann Whitney test analysis 
indicated no clinically or statistically significant between-group difference in change in any 
domain of SGRQ. All the median scores were outside the limits of the 98.75% CI (Table 7.7a-
7.7d). 
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Table 7.7a Baseline to week 4 change in SGRQ scores 
 Median Difference p CI 
SGRQ symptom -15.46 0.91 8.45, 22.23 
SGRQ activity -19.38 0.45 13.33, 26.27   
SGRQ impact -24.80 0.88 17.38, 41.28 
SGRQ total -20.96 0.85 16.98, 34.73 
 
Table 7.7b Baseline to week 8 change in SGRQ scores 
 Median Difference p CI 
SGRQ symptom -18.69 0.15 11.36, 32.48 
SGRQ activity -23.92 0.02 14.49, 34.76   
SGRQ impact -27.24 0.02 17.31, 47.38 
SGRQ total -25.25 0.008 19.19, 39.67 
 
Table 7.7c Baseline to week 20 change in SGRQ scores 
 Median Difference p CI 
SGRQ symptom -24.75 0.10 18.70, 41.17 
SGRQ activity -26.18 0.06 20.91, 39.71 
SGRQ impact -39.91 0.054 24.45, 54.84 
SGRQ total -33.47 0.06 23.45, 46.43 
 
Table 7.7d Baseline to week 32 change in SGRQ scores 
 Median Difference p CI 
SGRQ symptom -10.55 0.055 5.61, 25.66   
SGRQ activity -14.13 0.03 8.062, 26.83 
SGRQ impact -16.52 0.02 10.44, 29.21   
SGRQ total -14.71 0.02 10.30, 27.12 
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Between-group changes over time in MHLC scale B and MHLC scale C 
The score for each item on the questionnaire MHLC scale B and scale C ranged from 1 (SD or 
strongly disagree) to 6 (SA or strongly agree). Higher scores in a particular domain of the 
questionnaire indicate a stronger belief in the domain (Wallston & Wallston, 1981). For 
example, if a repeated measure indicates a significant increase for an individual in the internal 
domain, it suggests an increase in those individuals’ beliefs in their own contribution to 
managing their health condition (refer to section 2.5.11 on the classification matrix of behavior).  
Throughout the study, comparison of the two study arms using Mann Whitney test analysis 
indicated no clinically or statistically significant between-group difference in change in any 
domain of MHLC scale B or MHLC scale C. For each of the domains, the median score either falls 
outside the limits of the 97.5% CI or zero is included in the 97.5% confidence limit (Table 7.8a 
to 7.8d). 
Table 7.8a Baseline to week 8 change in MHLC B scores 
 Median Difference p CI 
MHLC B Internal 7.00 0.38 -8.00, -1.99 
MHLC B Chance -3.00 0.004 1.999, 7.00   
MHLC B Powerful 
others 
5.00 0.08 -7.00, 0.999 
 
Table 7.8b Baseline to week 8 change in MHLC scores 
 Median Difference p CI 
MHLC C Internal 7.00 0.05 -7.00, -2.00 
MHLC C Chance -1.00 0.09 -7.00, -2.00   
MHLC C Doctors 2.00 0.08 1.00, 1.00 
MHLC C Others 1.00 0.34 1.00, 1.00 
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Table 7.8c Baseline to week 32 change in MHLC B scores 
 Median Difference p CI 
MHLC B Internal 6.00 0.43 -6.00, 1.00 
MHLC B Chance 0.00 0.52 0.00, 2.00   
MHLC B Powerful 
others 
5.00 0.05 -5.00, 1.00 
  
Table 7.8d Baseline to week 32 change in MHLC scores 
 Median Difference p CI 
MHLC C Internal 6.00 0.21 -8.00, 0.999 
MHLC C Chance 0.00 0.31 -8.00, 0.999   
MHLC C Doctors 1.00 0.18 -1.00, 1.00 
MHLC C Others 2.00 0.58 -2.00, 1.00 
 
 
Relationship between VBHEP and completion of outpatient PR 
The PR attendance data was revealed not to follow a normal distribution (Shapiro Wilks p=0.02 
video arm and 0.04 control arm). There was no association between trial arm (video or non-
video) and completion of outpatient PR (Pearson chi square=0.76, p=0.45, 95% CI = 0.41, 
13.04). 
Analysis of the cell frequencies indicated that 8.00% (2 out of 25) of the patients who were in 
the video arm dropped out, while 15.63% (5 out of 32) of the patients who were in the non-
video arm dropped out. The  7.63% difference in drop-out rate between the two arms was 
below the 25% set out at the planning stage of the study as what would be considered as 
significant.  
There was no statistically significant difference in the number of PR sessions attended by 
participants in the video arm compared to participants in the non-video arm (Mann Whitney U 
median difference =9.00, p=0.001, CI=-10.001,-6.001) 
 
 
175 
 
7.5.3.2 WITHIN-GROUP CHANGES IN OUTCOME MEASURES 
The primary comparisons of the SRCT were between the groups as detailed earlier. 
Nonetheless, the within-group comparisons were found to be interesting, as summarised below. 
Full results are presented in appendix 7E. 
Within-group changes over time in ESWD (primary outcome measure) 
Throughout the study, within-group analysis of ESWD demonstrated a statistically and clinically 
significant improvement in walking ability in the video arm (baseline to week 8 median 
difference=241.89m, p<0.0001, CI= 174, 410; baseline to week 32 median difference 181.08, 
p<0.0001, CI= 98, 326) and in the non-video arm (baseline to week 8 median 
difference=197.28m, p<0.0001, CI= 117, 306; baseline to week 32  median difference 122.40m, 
p<0.0001, CI= 67, 185). 
Within-group changes over time in SGRQ (secondary outcome measure)  
Throughout the study period, within-group analysis indicated a statistically and clinically 
significant improvement in QoL following PR in all SGRQ domains in both arms of the study 
(p<0.0125, CI = 98.75%) (Table 7.9a and 7.9b). 
 
Table 7.9a Change in SGRQ scores in video arm 
 Baseline to week 4 
Median Difference 
Baseline to week 8 
Median Difference 
Baseline to week 20 
Median Difference 
Baseline toweek 
32 Median 
Difference 
SGRQ symptom -17.07 -33.01 -37.25 -26.13 
SGRQ activity -12.57 -38.41 -38.69 -25.83 
SGRQ impact -32.20 -52.75 -55.30 -25.79 
SGRQ total -24.36 -47.77 -47.27 -33.29 
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Table 7.9b Change in SGRQ scores in non-video arm 
 Baseline to week 4 
Median Difference 
Baseline to week 8 
Median Difference 
Baseline to week 20 
Median Difference 
Baseline to week 
32 Median 
Difference 
SGRQ symptom -10.91 -15.81 -18.74 -8.43 
SGRQ activity -20.09 -19.40 -20.39 -7.54 
SGRQ impact -22.87 -20.40 -25.95 -11.56 
SGRQ total -17.99 -21.63 -23.65 -10.23 
 
Within-group changes over time in MHLC scale B and MHLC scale C (secondary outcome 
measure) 
Baseline to week 8 within-group analysis indicated a statistically significant median difference 
in the MHLC B of the video arm; internal domain = 8.00, chance domain =-6.00 (a reflection of 
reduced belief in the impact of ‘chance’ on the general health status), and ‘powerful others’ 
domain = 8.00. Baseline to week 8 within-group change in the MHLC B was statistically 
significant only in the internal domain in the control arm (median 7.00).  
In the video arm, baseline to week 8 within-group analysis indicated a statistically significant 
median difference only in the MHLC C; internal domain = 10.00, doctors domain =2.00, and 
‘others’ domain = 2.00. In the control arm, baseline to week 8 within-group analysis indicated a 
statistically significant median difference only in the MHLC C internal domain (median 4.00). 
In the video arm, baseline to week 32 within-group analysis indicated a statistically significant 
median difference only in the MHLC B; internal domain = 6.00 and powerful others’ domain = 
7.00. In the control arm, baseline to week 32 within-group change was not statistically 
significant in any MHLC B domain. 
In the video arm, baseline to week 32 within-group analysis indicated a statistically significant 
median difference only in the MHLC C; doctors domain = 2.00 and ‘others’ domain = 2.00. In the 
control arm, baseline to week 32 within-group change was statistically significant only in the 
MHLC C ‘others’ domain (median=1.00). 
Interestingly, the analysis suggests that at week 8 and 32 of the study, a significant increase in 
belief in doctors and ‘powerful others’ post PR was demonstrated only by participants in the 
video arm. 
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All MHLC analysis were conducted at levels of significance level p<0.025 and CI was set at 
97.5%. 
 
7.6 ANALYSIS OF RESULTS 
Generalisability of the findings from the SRCT 
Bjoernshave, Korsgaard and Nielsen (2010) conducted a Cochrane review of 26 RCTs of PR and 
indicated that only 12% of the studies described their sampling of all the patients contacted, 
including those who eventually did not participate in the study. The authors suggest that 
information on the participants who did not participate in a study can further enhance 
assessment of the external validity of the results of the study. One hundred patients with COPD 
were referred to the Whittington Health NHS Trust during the recruitment period of the SRCT. 
Sixty of them volunteered for the SRCT and these may be the more strongly motivated members 
of the population. It was not possible to obtain the data of the 40 patients who did not 
participate in the SRCT because the ethical approval that was granted for the study only allow 
the principal researcher to collect data from patients that did consent to participate in the study. 
Also, email and personal communication with the Whittington Health NHS Trust indicated that 
the required data on participation profile of these patients has not been kept and the trust has 
changed its patient database since the time in question (Whittington, 2014).  
 
However, of the sixty patients that volunteered for the SRCT, a comparison of those who were 
included, to those who were excluded (based on exclusion criteria) suggests no significant 
difference in baseline characteristics between the two groups (refer to Mann Whitney U and Chi 
square test, Section 7.5.2, Tables 7.3 and 7.4a to 7.4e).  
 
The incidence of depression in the patients who commenced PR in the study reported in 
Chapter Six (27.59%) is similar to that in the participants who were randomized in the SRCT 
(26.32%). Eighteen percent of the participants who completed outpatient PR in the SRCT and 
21.43% of the completers of PR in the study reported in Chapter Six demonstrated evidence of 
depression. 
The combined drop-out rate in the two arms of the SRCT at the eighth week of PR (12.3%) was 
lower than the drop-out rates of 15.74% (Garrod et al., 2004) and 27.40% (O’Neil et al., 2007) 
that were reported in previous studies of patients with COPD that attended twice weekly PR 
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sessions. The combined drop-out rate in the two arms of the SRCT at the sixth month after 
outpatient PR (the maintenance phase of the SRCT) was 19.3% and lower than the 36.2% drop-
out at the sixth month post-outpatient PR that was reported in the study by O’Neil et al. (2007). 
While the study reported in this chapter was a prospective SRCT, the study by Garrod et al. 
(2004) was a retrospective analysis of clinical service. The study by O’Neil et al. (2007) was a 
prospective, randomised, parallel-group trial but a high drop-out rate, with a lack of intention-
to-treat-analysis resulted in the study being underpowered. 
Types of errors associated with statistical analysis of a clinical trial are type I and type II errors. 
A type I error refers to the false rejection of a true null hypothesis, a situation in which the 
result leads to a conclusion that an intervention is effective when in fact it is not (Altman et al., 
2000). A type II error leads to a false negative outcome in which a trial fails to detect that the 
intervention works when in fact it does (David, 2004). Prevention of these types of error 
requires an effective combination of study power and statistical significance level. The power 
calculation that was carried out in the SRCT allowed for a 20% drop-out. The within-group 
analysis demonstrated that the drop-out in each arm of the study remained below 20% at the 
end of the eighth week (8% in video arm, 15.63% in non-video arm). The participant drop-out 
rate in the video arm remained below 20% at the end of the 32nd week of study. At 32nd week of 
the study, the participant drop-out rate in the non-video arm was 25% but the number of 
participants who remained in the arm at that stage (n=24) was still more than the 19 identified 
as being the minimum required to be in the study at completion,  during the power calculation. 
Thus, the study remained powered at 80% level throughout. 
There was no statistically significant difference in the distribution of confounding factors of 
COPD (depression, disease severity levels, and social support) between the two arms of the 
study (Tables 7.3 and 7.4a to 7.4e). 
The level of overall statistical significance (p<0.05), with application of Bonferroni correction as 
appropriate allowed the acceptance of a 5% chance of rejecting the statistical hypothesis being 
tested when it is actually true.  Confidence intervals of 95% were set as appropriate and only 
the median value from the observed sample which lies within the values in the 95% CI was 
accepted to be representative of the population at large (Yale University, 2014). 
Based on the aforementioned considerations, the findings from the primary outcome (ESWD) 
and MHLC data in the study reported in this chapter are believed to be generalisable. The 
findings from the SGRQ scores and drop-out rate are less generalisable because the study is 
underpowered based on these two outcome measures. 
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Ceiling and floor effects for primary outcome measures 
A ‘floor effect’ defines a situation when an outcome has a distinct lower limit for potential 
responses and a significant proportion of the participants’ scores are at or near this limit. A 
‘ceiling effect’ defines a situation when an outcome has a distinct upper limit for potential 
responses and a significant proportion of the participants’ scores are at or near this limit 
(Lewis-Beck, Bryman & Liao, 2004). The authors suggested that the existence of a ceiling or 
floor effect can impact negatively on the validity of research data when an instrument shows 
little or no difference its lower or upper limits (Lewis-Beck et al., 2004).  
The floor effect in the ESWT describes a situation in which a participant who commenced the 
test could not carry on beyond the initial warm-up duration of 90 seconds. The ceiling effect 
describes a situation in which a participant completed the initial warm up period of 90 seconds 
and completed the maximum 20 minutes of endurance walking. The floor effect on the SGRQ 
describes a participant who had SGRQ total score of zero while a ceiling effect describes a 
participant who had SGRQ total score of 100. The floor effect on the MHLC scales describes a 
participant who had a score of one in all the items on the MHLC scale (B or C) and a ceiling effect 
describes a participant who had a MHLC score of 6 in all the items on the MHLC scale.  
In the SRCT, none of the participants was affected by ceiling or floor effects in the outcome 
measures of ESWT, SGRQ or MHLC. 
During the ESWT, a rest period of 20 minutes was allowed between walks. After the rest period, 
the heart rate, blood oxygen saturation and Borg breathlessness scale were observed to return 
to pre-walk level between walks.  
Primary findings from the ESWD outcome 
The primary findings of the SRCT is that receiving VBHEP concurrently with outpatient PR has 
no additional clinically significant (173m) benefit in walking ability at the end of outpatient PR 
(eighth week of study) and at six months post-outpatient PR (p<0.025). This is in comparison to 
patients who received outpatient PR only. Previous studies by Moore, Fiddler, Seymour et al. 
(2009) (n=20, male=5), Petty et al. (2006) (n=174, male=122) and Yamanaka et al. (2009) 
(n=42, all males) indicated that a video-based home exercise programme is more effective than 
usual care (consisting of medication and verbal or written information alone) in improving 
exercise habit and QoL. However, none of these studies compared video based exercise 
programme with PR that has been established to be a necessary intervention in the 
management of PR (NICE, 2004; 2010). Further, the study by Yamanaka et al. (2009) recruited 
only males which limit the generalizability of the findings to female patients with COPD. While 
180 
 
video based exercise programme may offer benefits to patients who are not participating in PR 
(Moore, Fiddler, Seymour et al., 2009; Petty et al., 2006), this SRCT indicates that it brings no 
additional benefit to gains in walking ability when it is provided to patients who are already 
participating in PR. This finding informs practise. 
 Secondary findings from outcomes of SGRQ, MHLC and drop-out rate  
The secondary findings of the SRCT suggest that receiving VBHEP concurrently with outpatient 
PR may have no additional clinically significant benefits in the gains of QoL at the end of 
outpatient PR and at six months post-PR. This is in comparison to patients who received 
outpatient PR only. This finding may not be unequivocal because it is the result of a study that is 
underpowered in this particular outcome measure. Compared to the fifty-seven participants in 
this study, a RCT that would achieve a power of 0.80 (p< 0.05 and allowing for 20% attrition) 
would require 332 participants (166 in each arm) in order to demonstrate a statistically and 
clinically significant between group difference of four unit change in total SGRQ score (SD +/-
13) (Jones, 1991; 1992) (see also Section 7.2.3). While video based exercise programmes result 
in additional improvement in QoL in patients who are not participating in PR (Moore, Fiddler, 
Seymour et al., 2009; Petty et al., 2006), it would benefit practice to have a study to establish 
whether there are additional gains of QoL when VBHEP is provided to patients with COPD who 
are already participating in PR. 
The findings of the study reported in this chapter suggest that receiving VBHEP concurrently 
with outpatient PR may have no additional benefits of change in HLC at the end of outpatient PR 
and at 6 months post outpatient PR. This is in comparison to patients who received outpatient 
PR only. In practice, the factors that contribute to the quality of life of a patient with COPD could 
be considered as multidimensional. These include an individual  patient’s understanding of self-
management (internal factor), appropriate support by health team and others, as well as the 
ability to reduce the effects of chance situations such as the environment and changing weather 
(chance domains in MHLC scales B and C). The findings from this study suggested that receiving 
VBHEP concurrently with outpatient PR may have no additional benefits in improving patient’s 
locus of control in these various areas. These findings are in comparison to patients who 
received outpatient PR only.  
Findings from a one-to-one semi-structured interviews of patients with COPD (Moore et al., 
2012) (n=24, male-14) indicated that a patient’s locus of control can impact on participation in 
PR programme. Of the 24 participants, seven were completers of PR, four commenced PR but 
dropped out, twelve had never been referred for PR, (out of which three had initially declined 
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PR), and one had been referred for PR but never attended (Moore et al., 2012).  Hogg et al. 
(2012) interviewed patients with COPD (n=16, male=9), who had completed eight weeks of 
outpatient PR (time since completion of PR < 2 years) and identified that the inclination to 
exercise in the patients is related to prompting and companionship offered by PR staff. 
 
This SRCT concluded that receiving VBHEP concurrently with outpatient PR did not result in a 
significant difference in drop out from PR (defined in this study as a 25% difference in 
completers between the study arms) (p<0.05). Also, receiving VBHEP concurrently with 
outpatient PR did not result in a significant difference in the overall number of outpatient PR 
sessions attended by participants in each arm (p<0.05).  
Tertiary findings: Baseline variables that correlate with drop-out and with benefits from 
rehabilitation 
In the video arm and the non-video arm, there was no significant correlation between drop-out 
from PR and participant baseline walking ability (ESWD), quality of life (SGRQ domains), health 
locus of control (MHLC scores), social support (DSSI scores) or disease severity (MRC score) 
(based on adjusted p value <0.0026; refer to section 7.4.1). 
This finding is different from that reported by a larger study undertaken by Hayton et al. (2013). 
The aforementioned study centered upon 711 patients with COPD (557 commenced PR, 
161=drop out). Multiple logistic regression analysis demonstrated a significant negative 
correlation between individual patients’ walking ability and the drop out rate from PR 
(p<0.016). The subgroup analysis in the study reported in this chapter (n=25 in video arm, n=32 
in non-video arm) reduced the power of the study to detect correlation between baseline 
walking ability and rate of drop out in each subgroup. This may have been the reason why the 
correlations were not statistically significant. Further, the study by Hayton et al. (2013) was a 
retrospective analysis of clinical service and used the Intermittent Shuttle Walk test as the 
outcome measure of walking ability, while the study in this report is a prospective SRCT and 
used ESWT as the outcome measure of walking ability. Investigation into the association 
between baseline walking ability and drop out was, however, not the primary purpose of the 
PhD project detailed in this report. 
In order to analyse whether any of the baseline variables in patients with COPD have significant 
correlation with clinically significant improvements in walking ability following PR, Spearman 
Rho was conducted between ‘clinically significant improvement in walking ability’ and each of 
the baseline variables. Clinically significant improvement in walking ability was defined as a 
gain of 173m or more between baseline ESWD and ESWD at week eight of study or week thirty 
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two of study (Waterhouse et al., 2006). Clinically significant improvement at week 8 and at 
week 32 of the study was correlated with the baseline variables of the scores of ESWD, the four 
SGRQ domains, MRC, the two DSSI domain, three domains of MHLC scale B and the four MHLC 
scale C domains. Applying Bonferroni correction, p was set at 0.0026 (Appendix 7F).   
In the video arm, Spearman Rho analysis demonstrated that baseline walking ability has a 
strong and positive statistically significant correlation with the clinically significant 
improvement in walking ability at the end of the 8th week (r=0.82, p<0.001, 95% CI=0.63, 0.92) 
and 32nd week (r=0.78, p<0.001, 95% CI=0.56, 0.90) of study. The square of the r value was 0.67 
at the end of 8th week of study which suggests that the data explains the relationship in about 
67% of the population of study. The square of the r value was 0.61 at the end of 32nd week of 
study which suggests that the data explains the relationship in about 61% of the population of 
study. In the non video arm, analysis demonstrated that baseline walking ability has a strong 
and positive statistically significant correlation with clinically significant improvement in 
walking ability only at the end of the eighth week (r=0.65, p<0.001, 95% CI=0.39, 0.81) of study. 
The square of the r value was 0.42 at the end of 8th week of study which suggests that the data 
explains the relationship in about 42% of the population of study. 
This indicates that the greater the baseline walking ability, the better the gain of clinically 
significant improvements in walking ability.  
Spearman Rho indicated no statistically significant correlation between clinically significant 
improvements in walking ability following PR and other baseline variables investigated (based 
on adjusted p value of 0.0026) (Appendix 7F). 
In the video arm, chi-square analysis indicated no significant association between depression 
and clinically significant improvements in walking ability at week eight. In this arm, at week 32 
of the study, chi-square analysis indicated strong and statistically significant negative 
association between depression and clinically significant improvements in walking ability. 
Pearson Chi-Square was 9.035 (Phi value =0.60, 95% CI=0.38, 0.82, degree of freedom=1, n=25, 
p=0.003, 2- tailed). In the non-video arm, chi-square analysis indicated no significant 
association between depression and clinically significant improvements in walking ability at 
week eight and week thirty two of the study (p value set as <0.05).  
Some of the findings of the study reported in this chapter on baseline variables which have 
significant correlation with clinically significant improvements in walking ability following PR in 
patients with COPD are different from those reported by previous studies. Large observational 
studies of patients with COPD by Al-shair et al. (2009) (n=122, male=75, mean age=66 years) 
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and Spruit et al. (2010) (n=1795, age 40-75 years) reported significant negative correlation 
between severity of depression and benefits of walking ability from PR. A RCT by Berry, Jack, 
Adair & Zaccar (1999) (n=140, mean age 67.7 year) and a non-randomised retrospective study 
by Garrod et al. (2006) (n=74, mean age=68 year) reported significant negative correlation 
between COPD disease severity and each of improvement of walking ability and QoL following 
PR. The subgroup analysis in the study reported in this chapter (n=25 in video arm, n=32 in 
non-video arm) reduced the power of the study to detect association between baseline variables 
and significant improvements in walking ability in each subgroup. This may have been the 
reason why the associations between improvement of walking ability and some of the baseline 
variables were not statistically significant - in contrast to the findings of previous and larger 
studies. Investigation into the association between baseline variables and improvement in 
walking ability was, however, not the primary purpose of the PhD project. 
Tertiary findings: Effect of VBHEP on exercise habit and factors that influence the use of 
the exercise video 
A unit of self-directed exercise session in the study reported in this chapter was described as 
one that lasts for a minimum of 15 minutes. Compliance with home based self-directed exercise 
session was described as participation in minimum of at least one session for a minimum 
duration of fifteen minutes.  
A chi-square test conducted to evaluate the association between compliance with self-directed 
home exercise and participation in VBHEP (i.e. the trial arm of the study) demonstrated no 
statistically significant association between the two measures at p<0.05 (Pearson chi-square 
3.36, p=0.067). Based on the sample size in each arm and the compliance reported in the study 
arms (100% in the video arm versus 87.5% in the non-video arm) the study power is only about 
40%. Though the chi-square test was not statistically significant, it is an interesting observation 
that all of the participants in the video arm complied with at least once weekly self-directed 
home exercise programme compared with 87.5% (28 of the 32) of the participants in the non-
video arm. Also, the total units of self-directed exercise were considered (rather than the 
defined compliance of one unit and above).  A Mann Whitney U test demonstrated no significant 
difference in the number of units of self-directed home exercise sessions by participants in the 
video arm compared to the participants in the non-video group (median difference =9.00, 
p=0.001, CI=-10.001,-6.001). While p was 0.001, in the sample observed, the CI (-10.001,-6.001) 
indicated that the result could not be reliably assumed to be representative of the population at 
large.  
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Previous studies by Petty et al. (2006) suggested that participation in video based exercise 
programme significantly improved exercise habit compared to medical management alone.  
However, the study reported in this chapter is the first to compare patients who were receiving 
VBHEP (concurrently with outpatient PR) to patients who were receiving outpatient PR only. 
The finding of the study reported in this chapter is important to practise, especially since 
outpatient PR is already an established and necessary component of management of COPD. 
Various studies highlight the problem of non-compliance with different therapeutic 
interventions in patients with COPD. Though PR is an established intervention in the 
management of COPD (NICE, 2004), a previous randomised trial [O’Neil et al. (2007) (n=91)] as 
well as non-randomised studies [Garrod et al. (2006) (n=74); Singh, Smith, Hyland, & Morgan 
(1998) (n=267)] indicate that compliance with PR is poor. Cornford (2000) interviewed 
patients with COPD on oxygen therapy (n=24, mean age=69.7 year, male=11) to evaluate 
participants’ beliefs about oxygen therapy. The study identified that worries about dependency 
on oxygen reduced patients’ compliance with the use of oxygen. Earnest (2002) (n=27, mean 
age=69 year, male=13) interviewed patients with COPD on oxygen therapy using a semi-
structured questionnaire and participants completed SGRQ and Brief Symptom Inventory. The 
study found that personal factors such as a perception of the weight of the oxygen cylinder, 
isolation and inadequate relief of breathlessness from the user of oxygen influenced compliance 
with oxygen therapy. While various studies have highlighted factors that influence patients’ 
compliance with various interventions, knowledge of factors that influence the use of VBHEP in 
patients with COPD is lacking.  
Participants in the video arm were advised to document separately the home-based self-
directed exercise sessions during which they used the video, and the exercise sessions when 
they exercised without using the video. Data from completed modified Follick’s activity diary 
indicated that the median frequency of use of the exercise video at home by participants was 12 
units per week (each unit being at least 15 minutes) and the median frequency of self-directed 
exercise at home (including with and without the use of exercise video) was 17 units per week.  
Association between the overall duration of participation in video-based home exercise sessions 
and each of the baseline variables was investigated (at adjusted p value=0.0026). Analysis 
indicated a strong, negative and statistically significant correlation between overall duration of 
participation in the video-based exercise session at home and baseline MRC score (Spearman 
rho=-0.61, p=0.002, 95% CI= 0.28, 0.81). The square of the r value was 0.37 which suggests that 
the data explains the relationship in about 37% of the population of study. A strong, positive 
and statistically significant correlation was demonstrated between the overall duration of 
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participation in the video-based exercise session at home and the baseline score in the social 
interaction domain of the DSSI (Spearman rho=0.73, p=0.001, 95% CI= 0.47, 0.87). The square 
of the r value was 0.53 which suggests that the data explains the relationship in about 53% of 
the population of study (Appendix 7G).  
 This suggests that patients with mild COPD are likely to use the exercise video more frequently 
in VBHEP compared to patients with moderate or severe COPD. Also, patients with COPD who 
interact with others are likely to use the exercise video more frequently in VBHEP compared to 
those patients who are housebound or isolated. These findings corroborate the themes from the 
focus group study reported in Chapter 8 of this dissertation, which suggest that the frequency of 
use of the video relates to patients’ confidence in managing symptom severity, and that having 
social support (such as from relatives) may give users of the video the additional confidence to 
feel safe and the opportunity to surmount potential difficulties of managing electronic gadgets 
in this age group (Section 8.6). 
The results from the video arm demonstrate no significant correlation between the total units of 
self-directed home exercise sessions and a clinically significant improvement in walking ability 
at the end of outpatient PR (based on adjusted p value =0.0026).  
In the non-video arm, the median frequency of self-directed exercise at home as gathered from 
their modified Follick’s activity diary was 8 units per week (each unit being at least 15 minutes). 
There was no significant correlation between the total units of self-directed home exercise 
session and clinically significant improvement in walking ability at the end of outpatient PR 
based on adjusted p value = 0.0026).  
An important consideration relating to the findings on exercise habits in this study is that the 
data obtained with the use of the Modified Follick’s diary were collected over one week of the 
eight-week outpatient PR. Pitta et al. (2005b) compared time spent actively during daily life to 
functional exercise capacity in 50 patients with COPD (mean age=64 years) and 25 healthy 
individuals (mean age=66 years). Though, the study by Pitta et al. (2005b) used an 
accelerometer, rather than activity diary, which was used to monitor patients’ activity in the 
SRCT, reported in this chapter, Pitta et al. (2005b) suggested that monitoring at least two days 
of activity is sufficient for achieving reliable data. The SRCT reported in this chapter collected 
data over seven days of activity, which is more than the minimum of two days recommended, 
hence more representative of participants’ activities.  
Based on the findings from previous studies, the use of the modified Follick’s activity diary in 
this study offered a reliable tool to measure the participants’ exercise habits. Bertici, Fira-
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Mladinescu, Oancea & Tudorache (2013) observed patients with COPD (n=74 patients with 
COPD, mean age=63.5 years) for a period of seven days before and after six months of a three-
week PR programme. The study demonstrated a moderate correlation between pedometer and 
6MWT scores (r = 0.5-0.7). However, Sant’Anna et al. (2012) videotaped patients with COPD 
(n=30, mean age=67) executing protocols of movements (two slow and two fast 5-minute walks 
versus a routine of activities of daily living). The protocols of movements recorded by the 
pedometer were correlated with a video recording by way of criterion evaluation. The authors 
suggested that the pedometer demonstrated good reproducibility for step count at slow speed 
(r=0.79) and at fast speed (r=0.95) but significantly underestimated activity time. Another 
observational study of patients with COPD (Dyer et al., 2012) (n=28, mean age=69 years) used 
an accelerometer to monitor patients with COPD over two-day periods at the end of PR, and 
every six weeks post PR for 6 months. Dyer et al. (2012) indicated that the time spent standing 
and time spent walking as measured by the accelerometer had a poor correlation co-efficient 
with the incremental shuttle walk score (r=0.17 and r=0.23 respectively). A large study by 
Moore, Berlowitz, Denehy et al. (2009) was the only study that compared the pedometer against 
the activity diary for measurement of free living activity in patients with COPD. The authors 
recorded the physical activity of the patients (n=80, mean age=71 years) for seven consecutive 
days, with a pedometer and modified Follick’s activity diary concurrently. Eighteen percent of 
participants reported failure to comply with the instructions for pedometer use compared to 
5% who had incomplete diary data. 7.7% forgot to wear their pedometer, while 11.3% wore 
their pedometer in excess of seven days that was recommended by their clinician. The authors 
indicated that the modified Follick’s diary was more reliable as a measure of free-living activity 
in patients with COPD.  
 
7.7 CONCLUSION 
Based on the findings from the SRCT, the use of VBHEP together with outpatient PR by patients 
with COPD has no additive effect in improving walking ability or maintaining improvement in 
walking ability at 6 months post outpatient PR programme. Further, there was no significant 
difference in the drop out from outpatient PR between the participants who received the 
conventional PR and the participants who received combined VBHEP and the conventional PR.  
This finding is related to observations conducted between onset of outpatient PR and till six 
months post outpatient PR. Evidence from RCTs (Petty et al., 2006; Moore, Fiddler, Seymour et 
al., 2009) suggest that participation in video based exercise programme is associated with 
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greater exercise habit in patients who are not receiving PR. However, observation of patients in 
the study by Petty et al. (2006) was for 16 weeks and observation of patients in the study by 
Moore, Fiddler, Seymour et al. (2009) was for six weeks. None of the studies provided insight 
into the QoL or level of exercise activity by participants at six months into commencement of 
video based exercise programme. Also, the frequency of self-directed video based exercise 
programme by patients was described as four times weekly in the study by Moore, Fiddler, 
Seymour et al. (2009) and described as ‘’at least moderate aerobic exercise most days of the 
week’’ in the study by Petty et al. (2006). During the SRCT, participants were advised to use the 
exercise video at least once a week at home, for minimum of 15 minutes, in addition to 
attendance of twice weekly PR sessions. The median frequency of use of the exercise video at 
home by participants as gathered from their modified Follick’s activity diary was 12 units per 
week (each unit being at least 15 minutes). It is not certain that beyond six months post 
outpatient PR, patients would be participating in a self-directed video based exercise 
programme at an adequate level that could yield significant benefits of improvement in walking 
ability or QoL. A study that observe participant beyond six months post outpatient PR may 
inform on whether beyond six month post PR, continual participation in VBHEP, rather than 
not, would mean greater possibility of maintenance of benefits of PR . 
The participation in a video based exercise programme by patients with COPD who are not 
receiving PR should be encouraged as evidence indicates that it could result in significant 
improvement in QoL and exercise habit (Petty et al., 2006; Moore, Fiddler, Seymour et al., 2009). 
However, the findings of this study indicate that for patients with COPD who are already 
participating in PR, offering VBHEP has no additional benefit. 
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CHAPTER 8-EVALUATION OF PATIENTS’ EXPERIENCES 
OF USING THE MOVE-ON-UP VIDEO FOR HOME BASED 
EXERCISE PROGRAMME CONCURRENTLY WITH 
OUTPATIENT PULMONARY REHABILITATION 
PROGRAMME 
8.1 JUSTIFICATION  
This chapter reports on the focus group study that evaluated the experiences of patients with 
COPD who used the Move-On-Up video for VBHEP, concurrently with outpatient PR (namely, 
participants in the video arm of the SRCT). 
The Move-On-Up video was indicated for use in the management of patients with COPD (ACPRC, 
2006). The protocol of rehabilitation evaluated in Chapter 7, namely receiving VBHEP 
concurrently with outpatient PR, is a new protocol of rehabilitation and it would benefit 
practise to understand the experience of patients who have participated in such a protocol.  
Various qualitative studies have evaluated areas of patients’ expectation of, perception of and 
participation in inpatient and outpatient PR. Lewis, Bruton & Donovan-Hall (2014) used semi-
structure interviews to evaluate the lived experience of patients with COPD (n=25, participant 
age range 42 to 90 years) between referral to and commencement of PR. The investigators 
identified that patients with uncertainty due to lack of understanding of their diagnosis of COPD 
and dissatisfaction with their care experienced more panic attacks and that uncertainty about 
the potential benefits of PR may impact negatively on commitment to the participation in the 
programme.  
Arnold, Bruton and Ellis –Hillis (2006) studied factors relating to participation in outpatient PR 
and examined the subjective views of 20 patients with COPD (9 men, age range 45 to 85 years) 
using semi-structured interviews. The mix of participants in the study (16 completed PR, 2 
commenced PR but dropped out, 2 never attended PR) meant the study provided findings 
mainly about the reasons for starting and adhering to PR. The study identified that a positive 
influence by referring doctor, enjoyment of the PR sessions by patients and the fact that the 
programme (PR) took place in a group setting enhanced participation in PR by patients. These 
authors further identified that lack of social support, especially in the elderly was a factor that 
negatively impacted on participation. 
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Meis et al. (2014) interviewed clinicians (n=14, age range 24 to 52 years) and patients with 
COPD (n=13, age range 54 to 78 years) who participated in inpatient PR. Similar to the study by 
Lewis et al. (2014), Meis et al., (2014) suggested that the psychological, physical and socially 
limiting nature of COPD can be wearisome for patients with COPD and many patients struggled 
to accept their disease state, including limitations in daily activities. The study concluded that 
interactions with fellow patients who were struggling with similar difficulties and appropriate 
advice by clinicians, enabled patients to become more confident with their exercises. This 
finding is strengthened by the fact that focus groups and interview sessions were held at the 
beginning and the end of the PR. 
While various studies has investigated the experience of patients receiving outpatient PR, there 
is no study to date study that have evaluated the experience of patients who participated in a 
protocol of rehabilitation that combines VBHEP concurrently with outpatient PR. Therefore, the 
population of interest in this study were participants in the video arm of the SRCT and not the 
participants in the non-video arm. 
The focus group stage (as the final phase of the larger study) provided rich qualitative data on 
the experience and views of patients with COPD who have used the Move-On-Up video for 
VBHEP concurrently with outpatient PR. While there was an initial focus group (Chapter 4) 
which evaluated the suitability of the video for VBHEP, the participants in that focus group 
study were only required to watch the video and discuss their perception of the content. They 
were not required to have experienced participation in VBHEP concurrently with outpatient PR. 
Conversely, the participants in the focus group reported in this chapter were individuals who 
have used the video for VBHEP over extended period of time (up to 20 months) and who have 
participated in VBHEP concurrently with outpatient PR. The themes from participants in the 
focus group reported in this chapter may thus give insight into experiences unique to patients 
who receive the new protocol of rehabilitation (combination of VBHEP and PR). 
The SRCT reported in Chapter Seven recruited four cohorts; two cohorts into the video arm of 
the study and two cohorts into the non-video arm. Participants in the focus group study 
reported in this chapter were recruited entirely from the participants in the video arm of the 
SRCT (i.e. two of the four cohorts of the SRCT). 
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8.2 THE STUDY 
The research questioned: What are the experiences of patients with COPD who have used the 
Move-On-Up exercise video at home concurrently with outpatient PR? 
The objectives were to conduct focus group sessions involving patients with COPD who have 
used the Move-On-Up exercise video at home concurrently with outpatient PR and evaluate their 
experience of this protocol of rehabilitation. 
The aims of the study were to: 
(a) Evaluate whether patients’ experience of using the Move-On-Up for VBHEP met their 
expectations. 
(b) Compare patients’ adherence with the VBHEP during the 8 weeks of outpatient PR, with 
their adherence with the VBHEP post-outpatient PR.  
(c) Evaluate whether the video helped to reinforce the exercises learnt during the outpatient PR 
(d) Evaluate whether the video helped to sustain the motivation that patients have towards 
doing their exercises. 
(e) Evaluate whether the video helped to sustain the motivation that patients have towards 
attendance of the outpatient PR. 
Ethical approval was received for the focus group study (Hertfordshire REC reference 
11/EE/0139 of May 2011). 
 
8.2.1 SETTING 
The focus group sessions were carried out at the PR unit of the Whittington Health NHS Trust 
(formerly Haringey Teaching PCT). It is important to note that between the date of the 
submission of the application for the ethical approval and the date of the beginning of the focus 
group study reported in this chapter, the NHS Trust that hosted the study changed its name 
from Haringey Teaching Primary Health Care Trust to the Whittington Health NHS Trust. The 
staffs of the PR team of the Trust involved in the SRCT (Chapter 7) study were the same as those 
involved in the focus group study. Additionally, the PR protocol in the trust remained the same.   
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8.2.2 POPULATION AND RECRUITMENT 
The inclusion criterion was participation in the video arm of the SRCT reported in Chapter 7. 
Exclusion criteria were the same as were applied in the SRCT. In addition, participants of the 
SRCT who were not in the video arm of the SRCT were excluded. 
Purposive sampling was used in order to recruit patients who have experience of using the 
Move-On-Up video for VBHEP concurrently with outpatient PR. This is in accordance with the 
approach advanced by previous authors (Moule & Hek, 2011; Parahoo, 2006; Polit & Beck 
2006). All the participants (n=25) in the video arm of the SRCT were approached for 
recruitment by the hospital staff into the focus group study to make the sampling process valid.  
The hospital staff sent a package containing an invitation letter, a participant information 
leaflet, a contact detail slip and a stamped addressed envelope (SAE) to every patient who 
showed interest in participating in the study. Those interested in participating in the study sent 
the contact details slip back to the principal researcher. The principal researcher telephoned 
each intended participant to answer any question that he/she may still have. A further one week 
was allowed between the phone call and the participant’s appointment at the focus group 
venue, so as to enable an informed decision to be made by the participants regarding 
participation. Recruitment of the participants into the study continued until no further 
participant was available to participate in an additional focus group. A refund of the cost of 
public transport was offered to the participants and transportation arrangements were made 
available for the subjects with severe COPD who required such arrangement.   
 
8.3 INTERVIEW GUIDELINE DEVELOPMENT  
A focus group discussion guideline was specifically developed for the focus group (Appendix 
8B); which explored a number of areas of interest related to the suitability of the Move-On-Up 
video and it included all relevant items of the questionnaire detailed in Chapter 5. 
A copy of the group discussion guideline (Appendix 8B) was sent to a convenience sample of 
two patients with COPD who have used the Move-On-Up video for VBHEP to evaluate 
understandability of the focus group discussion guideline. The two patients were volunteers 
from the initial ten patients who responded to the invitation to participate in the focus group 
study (see Section 8.6 and Chart 8.1). These two patients were asked to indicate if any 
modifications were required to make it more readable or understandable as a discussion 
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guideline in a focus group session. Each patient indicated that the discussion guideline was an 
appropriate tool for the intended focus groups. These two patients were not included in the 
focus group sessions in order to avoid any participant bias due to prior knowledge.  
 
8.4 OUTCOME DATA 
Outcome measures in this focus group study were: 
 Tape recordings of the focus groups as transcribed by the principal researcher (Krueger, 
1995).  
 Independent records of verbal and non-verbal communications during the focus groups 
which was derived from the notes and observations of the sessions as documented by 
the independent researcher (Stewart et al., 2007).  
The transcript by the principal researcher was compared with the notes of the focus group 
sessions by the independent researcher to achieve credibility of the transcript (Polit & Beck, 
2006). 
 
8.4.1 MANAGEMENT OF BIAS 
In order to avoid selection bias, all participants in the video arm of the SRCT (n=25) were 
approached and efforts were made to have participants from each cohort of the video arm 
represented in the focus group study.  
The audio recording from the session were carefully transcribed by the principal researcher 
(moderator) and verified by the independent researcher against the notes of the focus group 
sessions by the independent researcher. Combining the verbatim transcript of the audio 
recording with the notes of the focus group sessions enhanced the credibility of the research 
because it was possible to check and ensure that the information provided by the participants 
retained its original meanings (Bryman, 2012). These actions made it possible to avoid a 
solitary account (of the expression of participants) by a single researcher, which could 
undermine the validity of the research (Guba & Lincoln, 1994).  
In order to ensure that blinding of the principal researcher in the SRCT (Chapter 7) was not 
compromised, recruitment into the focus group commenced only after the last outcome 
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measure from the last cohort of the SRCT had been taken. This ensured that no focus group 
participant was still actively involved in the SRCT or its follow up measure. 
8.5 METHODS 
Various research approaches were described in the literature about the constructivist 
philosophy of qualitative research including grounded theory, discourse analysis, 
phenomenology. Based on considerations similar to those described in section 4.5, a 
constructivist philosophy was considered as the most appropriate in this research. Creswell 
(2009) described a constructivist philosophy to qualitative research as that which is based on 
an advocacy or participatory assumption with an agenda to help marginalized peoples.  
Based on considerations similar to those detailed in section 4.5, the approaches of grounded 
theory, discourse analysis and phenomenological were rejected in this study in favor of a 
descriptive research approach using focus groups. 
 Further, it was considered that a descriptive research approach is appropriate for research into 
a subject where there is existing data from initial exploratory research (Stebbins, 2011). The 
discussion guideline in this study was informed to a degree by the data gathered in the earlier 
focus group study (reported in Chapter Four), in which an exploratory research approach was 
used (Elliot and Timulak, 2005; Stebbins, 2011).  The descriptive research ‘described’ the 
subjective experience of patients with COPD who have previously received PR concurrently 
with VBHEP.  
Descriptive research method can be inductive by generating new ideas from emerging data. 
While the emphasis in a deductive approach is on causality and starts with a hypothesis, the 
focus in an inductive approach is to evaluate new phenomena or previously researched 
phenomena from a different viewpoint (Bryman, 2006). While the focus group study reported in 
Chapter 4 used the approach to synthesise questionnaire items for a broader nationwide review 
of the video, the focus group reported in this chapter was conducted to describe the experiences 
of patients with COPD who have used the Move-On-Up exercise video at home concurrently with 
outpatient PR as such experiences may be related to the uniqueness of the new protocol of 
rehabilitation (combination of VBHEP and PR). The study method was inductive and the 
approach was descriptive (Stebbins, 2011). 
At the focus group appointment, the principal researcher answered further queries from the 
volunteers. Every participant was advised further that there would be an audio recording of the 
focus group session. This was in addition to a similar explanation contained in the participant 
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information leaflet sent to participants in the post as explained earlier. Each volunteer for the 
study signed a consent form. 
The roles of the moderator and the independent researcher were defined in line with 
documented recommendations (Canning, 2004; Morgan & Krueger, 1993) and were as 
described in section 4.5.3. The principal researcher adopted a dualist and objectivist position 
during the focus groups (Smith, Sparkes, Phoenix & Kirkby, 2012) in an attempt to prevent 
elements of researcher bias. Tape recording of the focus group session was conducted and this 
allowed the principal researcher to concentrate better on engaging participants in the focus 
group with minimal risk of losing the information been gathered (Sim, 1998). The principal 
researcher took the responsibility of initiating discussions on the topic of interest without 
creating a bias in the mind of participants e.g. topics of discussion were introduced as follows: 
Moderator (session 1), line 5 to 8:‘‘if I may start this way; what are your opinions of the 
knowledge of COPD and exercise as obtained from the video for your use at home?  In other 
words, using the video, what are your experiences of it, would you say it has provided you 
with adequate knowledge or do you have your reservations when you think about the 
amount of knowledge you obtained from the video?’’. 
A process of concurrent data analysis (Sim, 1998) was undertaken in which every session was 
transcribed and analysed prior to the subsequent focus group. The information gathered from 
the earlier focus groups was used to guide the discussion and seed questions in the later focus 
group or interview.  
The following steps were followed to obtain participants’ description of their experiences. 
Step 1- An initial list of items (suitability factors) that make a video suitable for VBHEP in the UK 
population of patients with COPD (identified in the earlier studies which evaluated the Move-On-
Up as reported in Chapters 3, 4 and 5) was used to produce the interview guideline containing 
the tentative areas of patients’ experience. 
Step 2 – Participants described their general experiences of using the exercise video for VBHEP 
concurrently with outpatient PR.  
Step 3- The focus group participants discussed their experience of receiving the VBHEP, which 
related to the tentative list in the interview guideline produced in Step 1. 
Step 4- The participants’ responses (from Steps 2 and 3) were examined and themes were 
identified. Some of the themes fell within the tentative areas of patient’s experience that were 
compiled and some of the themes in participants’ responses did not. 
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Step 5 - Items that were different from the previously listed areas of patients’ experience were 
examined. This was in order to identify any need to expand or modify the areas of patients’ 
experience initially listed in step 1 (for example, the impact of video as first contact before 
patients commence outpatient PR, impact of social support on compliance with VBHEP 
including the possible role of relatives in providing patients with technological support in the 
use of an exercise video). 
Step 6 - Participants in the subsequent focus group sessions discussed all the items identified 
from steps 1-5. Participants in the later focus groups therefore had more interview guidelines to 
discuss than the earlier groups (Bloor, 1978). This is important to note because the process of 
concurrent data analysis (Sim, 1998) made it possible for the principal researcher to identify 
new categories which were of interest to participants of the earlier focus group session. The 
new categories were added to the interview guideline of the subsequent focus groups (Bloor, 
1978). 
Step 7- These steps were repeated until no new items were identified and all existing items had 
been discussed. 
Following considerations similar to those detailed in Section 4.9, thematic analysis was 
regarded as the most suitable for the data analysis of the focus groups since it can be adapted to 
a wide varieties of data (interviews, focus groups or diaries) and it is not limited by any pre-
existing framework or sampling number (Boyatzis, 1998; Braun & Clarke, 2006; Wilkinson, 
2000).   
 
8.6 RESULTS AND ANALYSIS 
 Ten of the 25 participants initially indicated interest in the focus group study. Two agreed to 
participate in the piloting of the interview guideline for understandability (Section 8.3) and thus 
were not eligible for inclusion in the focus group sessions. Of the remaining eight, one agreed to 
participate in the focus group study but did not turn up on the day. Seven patients with COPD 
(four males, two patients with mild COPD, four patients with moderate COPD and one with 
severe COPD) eventually participated in the focus group study. The population of participants in 
the focus group study included patients from both cohorts of the video arm of the SRCT. 
Further, all of the participants completed PR as defined in the SRCT (Chapter 7). 
Three sessions were conducted. The first, second and third sessions lasted 58 minutes, 46 
minutes and 17 minutes respectively, making the cumulative duration of the sessions 121 
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minutes. Participant numbers were four, two and one in the first, second and third sessions 
respectively. While the first two sessions were focus groups (consisting of more than one 
participant), the third session consisted of one participant, making it effectively an individual 
interview. Further sessions could not be conducted because all patients in the population of 
interest had been approached already.  
 
25 in video arm 
of SRCT (13 male, 
4 mild, 19 mod, 
8 depressed)
10 showed 
interest in the 
focus group study
(6 males, 2 mild, 6 
mod and 2 severe, 
2 depressed)
2 participated 
in face validity 
phase (1 male, 
1 mod, 1 
severe, 1 
depressed)
1 did not show  
up at focus 
group (male, 
mod )
7 completed study
(4 males, 2 mild, 4 
mod, 1 severe and 
1 depressed)
 
Figure 8.1 Flowchart of participants from the video arm of the SRCT through to the follow-up 
focus group. 
 
After each focus group session, the principal researcher and the independent researcher met to 
discuss observations from the focus group session. The principal researcher also listened to the 
audio recording of each session and transcribed them. All these enhanced the accuracy and 
content representation of the data analysed. Analysis of the recordings from the focus groups 
were conducted to identify the key themes expressed by participants (Pope & May, 2009). 
The thematic analysis of the data collected at the focus group sessions was conducted and 
followed the same steps as in the analysis of the earlier focus group study in section 4.10. 
Themes refer to topics that pervade in a discussion (Sim, 1998; Steel, 2000).  The thematic 
analysis involved examination of the transcripts of recordings from the focus group sessions in 
three stages of coding (Braun & Clarke, 2006).  The researcher first identified themes in the 
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transcript including new themes that did not belong to any earlier known category. After the 
identification of themes, links and relationships between themes were examined. Subsequently, 
major themes were arranged into core ideas. Refer to sections 8.6.1 to section 8.6.4.       
8.6.1 GENERAL THEMES FROM THE FOCUS GROUPS 
Participants discussed their opinions on the knowledge of COPD and exercise as obtained from 
the video for their use at home with regards to whether it is adequate or inadequate. The video 
content was considered to provide adequate information on understanding COPD and the 
benefits of exercises. Some patients explained that there were parts of the video where the 
presenters were repeating the same thing over and over. 
Patient I (session 2), lines 13 and 14: ‘‘As for that, I do find it very informative. It has given me 
good information on what exercises I can do to improve myself, what to do when I am 
breathless, walking, and all that’’. 
Patient I (session 3), lines 8 to 11: ‘‘Yes, it’s very good. The video explained COPD very well, you 
know. They explain what could be wrong with your lungs and how it affects the breathings 
and so on and so forth. It’s a bit annoying as sometimes they keep going over things over 
and over again, but even then it explained the exercises very well. I am able to follow the 
exercises and do my bits and stop when I feel I want to’. 
Patient IV (session 1), line 11: ‘‘I particularly find it helpful for warm ups’’.  
The themes suggested that participants were able to understand the language used in the video 
and the language was appropriate for their level of understanding of their condition (COPD) 
Patient II (session 1), lines 23 and 24: ‘‘For someone like me, I think the explanations are 
oversimplified. Though, that could be useful for some people because we all have different 
abilities to understand things like this’. 
 Patient I (session 2), line 19: ‘‘The language is fine’’. 
Patient II (session 2), line 22: ‘‘Anyone can understand the languages used. I don’t think there 
are any strange terms’’. 
Participants discussed what their expectations were and compared them to what they 
considered as their needs that were met after using the video. There were indications from the 
themes that participants believed that the video met their expectations and improved their 
breathing and exercise habit.  
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Patient I ( session 1), lines 47 to 49: ‘‘Yes, it is not the same as the group sessions but, it helped 
me on those days when there is no group session and now that you people are yet to give me 
another opportunity of coming back (to outpatient group sessions) it has continued to 
help’’. 
Patient I (session 2), lines 63 to 65:‘‘I do the exercises about three times a week. I have since 
find my condition has improved a lot. I used to be on antibiotics every time. I hated it. But 
since I have been doing these exercises, I had less need for antibiotics. In fact, in the last ten 
months or so, I just used antibiotics about three weeks ago’’. 
Patient II (session 2), lines 72 to 74: ‘‘I have noticed improvements in my breathing. I now 
exercise for longer before I start to feel breathless, then I stop for a while. The exercises 
have helped a lot! Also, because I am able to manage my breathing better, I am more 
confident to push myself and do more’’.  
Patient I (session 3), lines 24 to 26: ‘‘Well, at the beginning, I did not really know what to 
expect. After watching it, I kind of know what it was meant to do for me or what I was 
meant to achieve with it. At the end of the day, I would say it met my expectation and helped  
me to be able to do some other things on my own’’. 
One of the participants suggested that he would normally exercise to a significant intensity in 
the PR group sessions but that he tended not to exercise as hard when using the video on his 
own. 
Patient IV (session 1), line 44 to 46: ‘‘While I would normally work myself harder and flat out 
at the group sessions, I rather, took things for granted with the video. Here (referring to the 
outpatient session), I believe I have to get the best before my time on each station is up but 
with the video, I believe I can do my exercises anytime. Fine, it has done some good but it is 
not like coming here’’. 
Individual participants described the proportion of the exercises included in the video that were 
helpful to their own particular needs at the time of undertaking exercise. The themes indicated 
that each participant regarded most or all of the exercises as appropriate  
Patient IV ( session 1), lines 62 and 63: ‘‘That’s right. I give each exercise a go because all of 
them are important for various reasons. I often get quite breathless but I plug on my 
oxygen and that makes me get better’’. 
199 
 
Patient I (session 3), lines 32 to 33: ‘‘I find most of it helpful. They make me get out of breath 
but I still cope doing them. I find out that my condition has improved a lot since doing 
them’’. 
Participants discussed whether watching the video and the information in the video on the 
benefits of exercise in the management of COPD affected how often they attended outpatient 
pulmonary rehabilitation, either by increasing or reducing their attendance. The participants 
suggested that the information participants obtained from the video may have enhanced their 
understanding of the benefits of PR and their preparedness to attend sessions. However, looking 
forward to meeting other patients in the exercise group session and the sense of competition 
may be a stronger factor that enhances attendance of PR sessions by patients.  
Patient IV (session 1), lines 68 to 72: ‘‘The information in the video is useful and lets us know 
the importance of exercises. Indirectly, that makes me appreciate the classes. But for me, 
the greater motivation for attending the class is because I look forward to meeting others 
who we exercise together. The video simply motivates my home exercises. The group 
exercises where you meet others with COPD are inspirational. It should be kept on, even if it 
means paying a small subscription’’. 
Patient II ( session 1), lines 75 to 77: ‘‘I think the video may have influenced my coming to 
classes. Yes, also the people you work with are important. You know when you come to the 
group, you see someone doing so much, then you too want to prove that you can do some, 
don’t  you? The sense of competition is good!’’ 
Patient I( session 2), lines 48 to 49:‘‘Somewhat, it does enhance the tendency to do your 
exercises including taking your group days very serious [ly]’’ . 
Patient (session 3), lines 37 to 39: ‘‘Well, I will say yes. In fact, there was a time at the day 
centre that I attend. They want to do exercises. I took it down there. There was this lady who 
just started doing exercises and a couple of others. They all joined in and everybody felt it 
was fantastic’’. 
Participants discussed their experience concerning the explanations and demonstration of the 
procedures of performing the exercises in the video, whether it had any impact on how well or 
how often they needed to do their exercises at home, either by increasing or reducing the 
number of times they exercise at home. Participants suggested that the video enhanced 
participants’ compliance with their exercises at home. 
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Patient I (session 1), lines 82 to 84: ‘‘You know when we are told to do our home bits, exercises; 
you may not do much until the next group day. You need [an] extra push to do your home 
exercises. This is where the video really helps. I think watching the video in a group would 
be great because then, maybe that could increase the motivation some more’’. 
Patient I, session 2, line 54- ‘‘The demonstrations stimulate you (to do exercise), don’t they?’’. 
Patient II, session 2, lines 55 to 56- ‘‘Yes! Sometimes when I am bored, I switch the video on 
and that makes me feel more like doing the exercises’’. 
Patient I (session 3), lines 45 to 46: ‘‘It explains to you over and over again with the view of 
making you understand the exercises more and more. That kind of makes you do them 
better and more often… Still, it is better to do it in a group because of the motivation of the 
group.’’ 
Participants discussed how often they did the exercises in the video compared to how often the 
video recommended that individuals should do the exercises.  They also discussed their 
experience in terms of increasing the amount of exercise they did over time (exercise 
progression). The themes suggested that although participants were still using the exercise 
video, the frequency of its use after each individual had completed the outpatient PR was less 
than the frequency of its use when the individual was still attending outpatient PR. The 
frequency at which each individual used the video continued to reduce as time went on, after 
completion of outpatient PR and the opportunity of group exercise sessions was no longer 
available. While the reduction in the frequency of use of the video for some participants was 
because there was altogether a reduction in their exercise habit, the reduction in the frequency 
of use of the video for some other participants may have been because they have an adequate 
understanding of their exercises and could exercise even without having to use the video. 
Patient IV (session 1), lines 99 and 100: ‘‘I used to do better with my video when I was 
attending the classes. I still use it, but attending the class from time to time used to make 
me stick more to it (video)’’. 
Patient II (session 1), lines 104 and 105: ‘‘I now use it (video) less. I could have loved to 
maintain the level of exercises through the gym but couldn’t afford the result. So, my 
exercise level has dropped’’. 
Patient II (session 2), lines 79 and 80: ‘‘For me, to be sincere, I don’t use it as much as I used to 
do. Maybe because I believe I now know the things I need to do’’. 
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Patient I (session 3), lines 55 and 56: ‘‘Just as I said, I used to do more when I first started 
using it. I was using it initially three times a week but later,it went down gradually to about 
once weekly”. 
Participants discussed how the use of the video in a home exercise programme impacted on 
their activities of daily living, whether it was difficult or easy to use the video or do the exercises 
recommended in it. Participants in the focus groups suggested that they were able to fit the use 
of the video into their other daily activities.  The ability of a patient to manage his or her own 
symptoms and incorporate exercise into the time of least discomfort is crucial to compliance 
with the use of the video. 
Patient II (session 1), line 110: ‘‘I do it in the morning before my day starts, otherwise I may 
not have the opportunity after that’’. 
Patient IV ( session 1), lines 111 and 112: ‘‘I do it, mostly in the morning because this is the 
time that I need it to keep me on. With my oxygen on, I can cope’’. 
Patient II ( session 1), line 113: ‘‘I do it in the morning. For me it is because that is the time my 
inhaler is most active’’. 
Patient I (session 1), lines 114 and 115: ‘‘I do it at various times of the day. Since I have it in the 
house, I fit it in around my activities. I don’t have [a] problem with that’’. 
Patient II ( session 2), lines 85 and 86: ‘‘It is fine. For me, I do it all right and I still carry on 
with my day. It fits in quite well to my programme. I often do it without even realising I am 
doing it. I just made it part of myself’’’. 
Patient I (session 3), lines 65 and 66: ‘‘I do not have [a] problem fitting it into my day. I usually 
do it in the afternoon because I am out in the morning most days of the week’’. 
In the discussion of the participants’ experience and opinions about the appropriateness of the 
exercises in the Move-On-Up video considering the equipment needed, it was evident that all the 
participants believed that they were able to do the exercises indicated without any limitation 
related to equipment needed.  
Patient I (session 1), line 120: ‘‘Most of the exercises are self-help. Walking, arm exercises’’. 
Patient II (session 2), lines 41 to 44: ‘‘All the exercises are appropriate for me. I think I am able 
to manage most of the exercises. I find the gardening quite interesting and helpful for me as 
an activity. I find the walking more challenging. I still do it and at least I now know what to 
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do when I get breathless. Sometimes, I stop and do my breathing exercises and continue till 
I finish’’. 
Patient II (session 2), line 92: ‘‘Everything in the video is home based. I like the walking. I like 
riding [a] bicycle outside in the open’’. 
Patient II ( session 2), lines 93 and 94: ‘‘It is okay. They asked you to use things like tomato 
can[s] and stuff like that. They are simple things. Nothing expensive (laugh)!’’. 
Patient I (session 3), lines 69 and 70: ‘‘It is okay. No major equipment needed. Walking or 
using things around the house as weights. Those are straightforward exercises’’. 
Participants in the focus group indicated that participants considered that they were able to do 
the exercises in the video safely, even in the absence of a clinician to supervise them. The 
themes indicated that the participants have sufficient understanding of what is considered as 
safe and appropriate limits of breathlessness or exertion. The themes from some participants 
suggested an understanding of what to do to enhance recovery from symptoms e.g. pacing their 
activities and the use of oxygen. 
Patient IV (session 1), line 127: ‘‘I always have my oxygen within reach. Do not overdo it- 
that’s the sense in it’’. 
Patient I (session 1), line 129: ‘‘Also, for me, I sometimes start with some sort of meditation 
to feel relaxed before getting on with it’’. 
Patient I (session 1), lines 135 to 136:‘‘if you do it long enough, you will get breathless. I do get 
reasonably breathless. That is not to say one should do too much. You can only do what you 
can do’’. 
Reflecting on the extent to which it is advised in the video that an individual should be 
breathless during exercise in order to derive health benefits from the exercises, participants in 
the focus group discussed their experiences of using the video (or doing the exercises as it 
recommends). Some participants considered the level of breathlessness that they experience 
during the outpatient PR session as a target level of breathlessness during the exercise session 
at home. 
Patient IV (session 1), lines 133 to 134:‘‘I think it also has to do with your mood. Sometimes in 
fact, I push myself way beyond, even on my own’’. 
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Patient II (session 2), lines 112 to 114: ‘‘I try to push , though I stop when I have to. I think I get 
reasonably breathless though. Look, I like to do it, I enjoy doing it but an hour for instance 
can be difficult for me. So I start and stop as required. But I get breathless enough’’. 
Patient I(session 2), line 115: ‘‘I push to a limit that I can. Just as I do in the classes’’. 
Patient (session 3), line 82: ‘‘I get quite breathless, though, I rest when I feel I can’t go any 
further’’.  
Participants discussed how long they were able to continue to exercise each time that they use 
the video (or do the exercises as it recommends) and the duration appear to vary between 
individuals and the duration by same individual vary according to limitations of symptoms. 
Altogether, participants demonstrated good understanding of how much exercise is required to 
achieve health benefits.  
Patient II (session 1), lines 142 to 143: ‘‘I usually have at least an hour to myself, sometimes 
more, of and on from one exercise to another. The video recommends walking and I take the 
dog on a long walk every morning’’. 
Patient III (session 1), line 145: ‘‘I do average of thirty minutes each time. Thirty minutes is for 
the whole session. Rest, jump up and down. That’s me done! (laugh)’’. 
Patient (session 3), line 82: ‘‘I don’t really time myself. I listen to my body and stop once I feel I 
am very breathless. I rest for a while and start again until I again feel breathless. I find it 
comfortable to manage myself that way’’. 
Furthermore, participants discussed how they managed to balance their ‘rest time’ with 
exertion time and it was evident that the participants were able to pace their exercise sessions 
safely, observing rest time inbetween exercises and as may be necessary based on severity of 
breathlessness. 
Patient I (session 1), line 146: ‘‘But there is a break in between my hour. I rest in between the 
exercises’’. 
Patient I (session 1), line 148: ‘‘I don’t do the stop watch sort of thing. I listen to my body’’. 
Patient II (session 1), lines 152 to 153: ‘‘You do the exercise until you are quite breathless then 
stop. The rest period is not monitored. You simply go to the next exercise when you feel you 
can. I don’t time myself’’. 
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8.6.2 NEW THEMES FROM THE FOCUS GROUPS, NOT IN EARLIER 
SUITABILITY FACTORS 
It was suggested that giving the video ahead of outpatient PR may help to prepare COPD 
patients for the group exercise as it provided some of the participants with important 
information on benefits of exercise for patients with COPD. 
Patient I (session 1), line 10: ‘‘I went through the video before going through the group 
exercises and it really prepared me for it’’. 
Patient III (session 1), lines 50 to 51: ‘‘it helped to prepare me for the group session. I think its 
good as first contact before you meet people in the group’’. 
Patient II (session 1), lines 52 to 53: ‘‘It also gives you that extra information you need to make 
up your mind whether to come or not’’. 
Some participants suggested that watching the video as a group could be beneficial and possibly 
more beneficial than watching it as an individual. 
Patient IV (session 1), lines 11 to 13: ‘‘I actually watched it from time to time and I say to 
myself; watching it in a group would be fantastic. We could learn together and have the 
opportunity to discuss. That will be even be more beneficial than just giving it to us to go 
and watch and use on your own’’. 
Themes from the focus group sessions suggested that activities such as walking a dog or 
belonging to an activity group in the community appear to enhance motivation to exercise.  
Patient II (session 1), lines 93 and 94: ‘‘We were told in the class to do exercises at home. So,I 
do the exercises every day. My dog is another motivation’’. 
Patient I (session 1), lines 102 and 103: ‘‘Now, the gym is my strength. I feel watching the video 
has enriched me because I now appreciate the need to continue doing something for 
myself’’. 
Patient I(session 2), lines 132 to 134: ‘‘Using the video at home has really helped me, it has 
helped very much, but I still feel doing the exercises along with other people as a group does 
pushes me to do more compared to when I am doing it on my own, alone at home. I like 
attending the group sessions!’’. 
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Having social support (such as from relatives) enhanced compliance with the video.  This 
appears to be because it gives users of the video the additional confidence to feel safe and it 
helps to overcome potential problems of managing electronic gadgets in this age group. 
Patient I (session 2), lines 86 to 90: ‘‘My knowledge of using electronic devices is limited. I am 
not too good with these things, iPhone etc. Though I have to get someone to help me to 
operate the video and I am now better at it, for example, I can now go to specific sections of 
the video’’. 
Patient II (session 2), lines 75 to 79: ‘‘It is fine. For me, I do it alright and I still carry on with 
my day. It fits in quite well to my programme. I often do it without even realising I am doing 
it. I just made it part of myself. My only problem is sometimes when I am not able to operate 
the machine, but anytime I feel lost, my grandson helps me to fiddle around with it and get 
it to work. Other times, really, I still carry on doing the exercises without playing the video 
itself’’. 
Patient I (session 2), lines 106 and 107: ‘‘It is still okay if you want to have someone there in 
case anything goes wrong. I do have my partner around sometimes. Though, without her, I 
still go on doing things within my limit’’. 
 
8.6.3 RELATIONSHIPS BETWEEN THEMES  
Frequent use of the video over time resulted in improvement in patient’s confidence in 
managing the exercises, pacing and ensuring safe use. 
Patient I (session 2), lines 67 and 6: ‘‘The more exercises, the better I get. Over time, I have 
been able to do more. Sometimes, I push myself even a bit more’’. 
Patient III (session 1), line 125: ‘‘The explanations are good enough. I start and stop at my 
own will’’. 
While there is evidence that use of the video is beneficial, patients still prefer the group exercise 
to using the video on their own.  
Patient II (session 2), lines 136 to 137: ‘‘I like attending the groups. Even now, I attend a group 
in my area and we organise different activities. The push is there when things are done in a 
group, than when you are doing it alone’’. 
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8.6.4 CORE IDEAS FROM THE FOCUS GROUP 
Patients were using the video about thrice weekly during the outpatient period. Having social 
support (such as from relatives) enhanced compliance with the video.   
The frequency of use of the video depends on patient’s fitness and symptom severity.  
Using the video may positively influence a patient’s uptake of the outpatient PR classes. There 
were suggestions for it to be used as a first contact tool ahead of the outpatient PR. 
Having a pet or belonging to an activity group in the community appeared to enhance 
motivation to exercise.  
Patients felt they were safe and were able to manage the use of the video at home. A sense of 
safety when using the video relates to patients’ ability to understand and manage their 
condition, and pace the exercises, as well as the presence of a relative or carer. 
For some patients, the duration of exercise activity on each session is guided by stated times. 
However, for others, the duration of exercises is determined simply by how they feel, such as 
breathlessness and other conditions.  
Twenty months after the video was first prescribed, patients were still using the video and 
expressing significant benefits. However, the home use by patients was diminishing over time; 
from about thrice weekly when it was first prescribed to about once weekly after the eight-week 
outpatient PR had ended. 
Patients expressed overall that they felt their expectations of the video were met, though they 
still prefer the PR group exercise sessions to using the video on their own. 
 
8.7 DISCUSSION 
While focus groups and individual interviews are independent data collection methods, their 
combination can enhance researchers' understanding of the phenomenon being investigated 
(Lambert & Loiselle, 2008). The reasons for combining the methods could be for the correlation 
of data (to compare and contrast emerging themes) or for integration of data, making efforts 
towards collecting adequate data (Creswell, 2009; Denzin & Lincoln, 1994; Lambert & Loiselle, 
2008).  
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Analysis of the data collected in this study demonstrated that the themes from the third session 
(an individual interview) showed no deviation from the themes from the first two sessions. This 
suggested that the group dynamics of the focus group sessions where there was some level of 
acquaintanceship among the participants did not obstruct the emergence of the individual 
perceptions in the focus group.  
The analysis of the data from this study demonstrated that the new PR protocol that combined 
VBHEP with an outpatient PR programme met patients’ expectations. All the patients explained 
that the VBHEP enhanced exercise habit and one particularly expressed that following VBHEP, 
there was reduced dependence on the use of antibiotics. The suggestion by some participants 
that, where possible, the video should be used as a first contact tool for patients with COPD to 
motivate them to attend PR is consistent with the findings of Petty et al. (2006) who indicate 
that patients who used an exercise video at home demonstrated a better conversion to an 
exercise habit, when compared to patients who received medical management only. 
Participants in the focus groups considered the language that was used to explain the exercises 
and other instructions in the video as appropriate for their level of understanding.  Participants 
generally expressed that ‘most’ or ‘all’ of the exercises included in the video were helpful to 
them, considering the levels of breathlessness that they experience. The discussion in the focus 
groups indicated that patients were able to progress their exercises at home. They appeared to 
have been able to use their understanding of the rate of perceived exertion (including their 
understanding of the Modified Borg scale of perceived exertion) to determine when to stop their 
exercises and observe a rest. Discussion in the focus groups indicated that participants 
confidently managed the exercises in the video safely.  
The availability of social support (including assistance from relatives), the ability to pace their 
own exercise and the ability to self-manage symptoms appeared to have enhanced compliance 
with the VBHEP. A previous focus group study involving 130 participants concluded that older 
adults, without family or friends who can manage technology, may lack the confidence required 
to manage digital information (Foley, 2004). While Arnold, et al. (2006) evaluated the 
experience of patients regarding participation in outpatient PR alone and the current focus 
group evaluated the experience of patients in outpatient PR combined with VBHEP, the findings 
in both studies suggest that the availability of social support may enhance the participation of 
patients with COPD especially the elderly in rehabilitation.  
Discussions in the focus groups suggested that a patient who is able to self-manage and control 
his/her disease symptoms is more likely to comply with the use of VBHEP. The VBHEP appeared 
to have enhanced patients’ participation in self-supervised exercises at home and participants 
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were still doing the VBHEP by the time that the focus group study was held. However, data from 
the study suggested that after the conclusion of the eight-week outpatient PR, by which time 
patients were no longer attending the group exercise sessions that PR offered, participation in 
VBHEP began to reduce from the initial thrice weekly to about once weekly. This finding is in 
agreement with the report of a previous meta-analysis of 44 studies (with 214 effect sizes) 
which concluded that exercising as a group in a class was superior to individual patients 
exercising at home (Burke et al, 2006). These authors conducted search of databases [PsycINFO 
(1887-current), PsycARTICLES, MEDLINE--OVID (1966-current), and SPORT Discus (1830-
current). The meta-analysis involved studies that directly compared the interventions of 
standard exercise classes (individuals exercising together in a group supervised by an 
instructor) versus true exercise groups (individuals exercising together in a group supervised 
by an instructor and involving defined team building strategy) versus home-based programme 
with contact by exercise instructor versus self-supervised home exercise programme. Direct 
comparison of change in physical activity post intervention indicated that participation in a true 
exercise group was significantly more effective than participation in standard exercise group (d 
= .73;p < .05), which in turn, was significantly more effective than participation in self-
supervised home exercise programme (d = .39;p < .05). Standard exercise class was minimally 
more effective than home-based programmes with contact by exercise instructor (d = .11), 
which in turn, was minimally more effective than self-supervised home exercise programmes (d 
= .26). However, neither of these last two effect sizes was significant (p > .05). 
One of the participants expressed a tendency to exercise to a more significant degree when in a 
PR group session than when alone, using the Move-On-Up exercise video. Also, this focus group 
study suggests that participation in VBHEP may have diminished from thrice weekly (when it 
was first prescribed) to once weekly (after completion of outpatient PR). This appear to confirm 
a large reduction from the median of 12 units per week (use of the exercise video at home) as 
obtained from the  modified Follick’s activity diary completed by the participants in the SRCT 
(Chapter 7) while they were still attending outpatient group exercise. This finding from the 
focus group is in agreement with the findings of previous studies which suggested that the 
psychological, physical and socially limiting nature of COPD can be wearisome for patients with 
COPD but that interactions with fellow patients in a group setting and appropriate advice by 
clinicians can enhance patients’ confidence with their exercise programme (Meis et al., 2014). 
While the patients in the study by Meis et al., (2014) participated in inpatient PR, which is 
different from this intervention, there were similarities in the findings of both studies which 
suggest that patients with COPD who are attending PR derive motivation from group sessions 
with other patients. 
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Interesting suggestions by some participants included that patients could come together to do 
the video-based exercise programme in a group setting and that this could enhance the benefits 
that they would derive from the video. There is evidence that respiratory patient support 
groups in the UK are supporting their members by establishing their own instructor-led 
exercise sessions in an effort to ensure that their members benefit from exercise programmes 
(Brent Breathe Easy Group, 2013; British Lung Foundation, 2013). A recent study suggested 
that patient support groups could be important in enhancing patients’ self-management skills 
(Bryant, Bang, Chew, Baik & Wiseman, 2013). Nine percent of respiratory patients received 
their initial teaching on inhaler techniques from non-clinician sources and 3% of patients 
receive the follow-up assessment of their inhaler technique from a respiratory support group, 
compared to 1% who received a similar follow-up from their pharmacist (Bryant et al, 2013). 
Exploring the use of a video-based exercise programme in patient support group settings may 
inform further development of such patient support group exercise sessions and its comparison 
to clinician-led group exercise sessions, though this did not fall within the scope of the current 
study. 
The low number of participants (n=7) in the study is a limitation. While an effort was made to 
recruit all 25 eligible participants from the SRCT, only seven of them eventually participated in 
the focus group study. It could not be established whether the seven who participated in the 
focus group actually represent the only proportion of patients in the video arm of the SRCT who 
were motivated and who used the video and did the exercises according to prescription. If this 
is the case, their view may not represent the experience of remaining patients in the video arm 
of the SRCT but who were not motivated to use the video as prescribed. 
 
8.8 CONCLUSION 
In line with the objectives of focus group study, which is to achieve an understanding of the 
perceptions, feelings and opinion of participants (Krueger, 1994), the focus groups reported in 
this chapter provided rich data on the experiences of patients with COPD who used the Move-
On-Up video for VBHEP, concurrently with outpatient PR.  
 
The findings from this study suggested that COPD patients were able to manage the VBHEP and 
no adverse effect was reported. It is important to consider exploring appropriate support from 
relatives and carers particularly when prescribing VBHEP to the older population of patients 
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with COPD.  In addition, having a pet or participating in an activity group in the community 
appeared to encourage exercise habit.  
Up to 20 months after the VBHEP was first prescribed, some patients were still doing the VBHEP 
and patients were still expressing significant benefit from it. However, after the 8 week 
outpatient PR ended, the use of exercise video at home started to diminish from about thrice 
weekly to about once weekly. Patients prefer group exercise sessions to exercising as an 
individual at home. 
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CHAPTER NINE- DISCUSSION OF ALL STUDIES 
This chapter reviews the areas of originality within the thesis. It summarises the findings of the 
multiple methodologies within the dissertation, how these are inter-related and how these 
relate to previously published research. The chapter includes details of the implications of this 
research to clinical practice and recommendations for future related research.  
 
9.1 AREAS OF ORIGINALITY  
This PhD research has made a significant and original contribution to academic knowledge in 
the area of pulmonary rehabilitation for patients with COPD since no previous study has 
investigated the following: 
 The relationship between uptake of outpatient PR and patient baseline measures of 
depression. 
 The effectiveness of the use of VBHEP together with outpatient PR in improving walking 
ability or in maintaining benefits of walking ability following outpatient PR.  
 The effect of receiving VBHEP concurrently with outpatient PR on drop-out from 
outpatient PR or the frequency of attendance of outpatient PR. 
 The relationship between overall duration of participation in video-based exercise 
sessions at home and baseline depression, HLC, MRC score or social support. 
 
9.2 FINDINGS FROM THE STUDIES 
This research set out to answer the following research questions:  
i) Is the Move-On-Up exercise video suitable for use in VBHEP as an adjunct to 
outpatient PR by the UK population of patients with COPD? 
ii) Are depression, social support, health locus of control or COPD disease severity 
confounding factors in the non-uptake of, or drop-out from PR? 
iii) Is the use of a VBHEP concurrently with outpatient PR more effective than 
outpatient PR alone in improving walking ability (measured with endurance 
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shuttle walk test) at the end of outpatient PR and in maintaining any significant 
benefit at six months post-outpatient PR? 
iv) Is the use of a VBHEP concurrently with outpatient PR more effective than 
outpatient PR alone in improving quality of life (measured with St George’s 
Respiratory Questionnaire) at the end of outpatient PR and in maintaining any 
significant benefit at six months post-outpatient PR? 
v) In comparison to outpatient PR alone, would using a VBHEP concurrently with 
outpatient PR result in a significant difference in change in health locus of 
control at the end of outpatient PR and at six months post-outpatient PR?  
vi)  Would using a VBHEP concurrently with outpatient PR result in a significant 
change in the drop-out rate from outpatient PR? 
vii)  What are the experiences of patients with COPD who have used the Move-On-Up 
exercise video at home concurrently with outpatient PR? 
The in-depth review of the Move-on-Up exercise video indicated that it is suitable as a tool for 
VBHEP as an adjunct to outpatient PR in the UK population of patients with COPD. This was the 
conclusion of the analysis of the video content against published guidelines and literature 
(Chapter 3), and the evaluation of patients with COPD and experienced respiratory clinician 
(Chapter 4 and 5). Further, the evaluation of the suitability of the video, using methodological 
triangulation, data triangulation and theory triangulation strengthened the credibility, 
dependability and conﬁrmability of the findings (Creswell, 2009; Shenton, 2004).  
The findings of the research reported in Chapter 6 where the participation profile of patients 
with COPD participating in PR programmes was examined, indicated that  
 Depression, social support, HLC or COPD disease severity was not a confounding factor 
of drop-out from PR (p<0.005).  
 Depression was the only variable identified to have an association with uptake of PR 
from all the variables investigated. The relationship was moderate (Phi value 0.32), 
statistically significant (p<0.05) and in a negative direction. 
 
The SRCT reported in Chapter 7, indicated within the findings that:  
 The use of VBHEP together with outpatient PR in patients with COPD has no additive 
effect in improving walking ability at the end of outpatient PR, or in maintaining any 
significant benefit at six months follow up.  
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 The use of VBHEP together with outpatient PR in patients with COPD has no additive 
effect in improving quality of life at the end of outpatient PR, or in maintaining any 
significant benefit at six months follow up.  
 In comparison to outpatient PR alone, using a VBHEP concurrently with outpatient PR 
did not result in a significant change in HLC at the end of outpatient PR or at six months 
follow up.   
 Using a VBHEP, concurrently with outpatient PR, did not result in a significant change in 
the drop-out rate from outpatient PR programme. 
 None of the factors regarding baseline walking ability, quality of life, depression or 
health locus of control (HLC) was demonstrated to influence participation in VBHEP in 
patients with COPD. There is a strong and statistically significant relationship which is 
in a negative direction, between overall duration of participation in video-based 
exercise sessions at home and baseline MRC score. There is a strong and statistically 
significant relationship which is in a negative direction between the overall duration of 
participation in video-based exercise sessions at home and social support (as indicated 
by the social interaction domain of the DSSI).  
 
The evaluation of the experiences of the patients with COPD undergoing concurrent VBHEP and 
PR reported in Chapter 8, determined that:  
 Patients with COPD experienced satisfaction with participation in VBHEP and no 
adverse effect was associated with participation.  
 Participants reported support from carers/relatives as particularly important in 
enhancing exercise habits.  
 Several months (up to 20) after its commencement, some patients with COPD were still 
participating in VBHEP, though it is noted that at the conclusion of post-outpatient PR, 
participation in VBHEP started to diminish from about thrice weekly to about once 
weekly.  
 Patients with COPD have a preference for group exercise sessions compared to 
exercising as an individual at home. 
 
The limitations of each of the studies were discussed in detail under the relevant chapters 
(sections 4.5.1, 4.11, 5.6, 6.8, 7.6 and 8.7). Participants in all of the studies experienced 
longstanding breathlessness consistent with COPD. Participants in the studies reported in 
chapters 5, 6, 7 and 8 completed MRC dyspnoea scale. Particularly, the studies reported in 
Chapters 4 and 5 advertised for individuals with diagnosis of COPD and this was emphasized in 
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the participants information leaflets (Appendix 4F and Appendix 5G), on the questionnaires 
(Appendix 5E) and at the focus groups (Appendix 4E). However, the diagnosis of COPD was not 
verified by formal spirometry in the studies reported in chapters 4 and 5 and it is possible that 
not all the patients recruited have COPD.  
Notably, numerous studies have identified under-usage of spirometry and inaccuracy of its use 
in the diagnosis of COPD in primary care. Lewis, Bruton and Donovan-Hall (2014) examined the 
lived experience of patients with COPD (n=25, participant age between 42 and 90 years) using 
semi-structured interview conducted between referral to and commencement of PR. 
Participants in the study were recruited on account of having COPD written on their PR referral 
and diagnosis was not necessarily confirmed by spirometry. These authors suggested that their 
inclusion criteria strengthened their study’s relevance to clinical practice. Joo, Au, Fitzgibbon, 
McKell and Lee (2011) (n=1052, male=283, age ≥35 years) demonstrated clinician bias in 
favour of conducting spirometry in patients with symptoms of exertional dyspnea and chronic 
cough rather than patients with current or past history of smoking and that diagnosis based on 
spirometry was accurate only in 50.9% of cases. Bednarek, Maciejewski, Wozniak, Kuca, and 
Zielinski (2008) (n=1960, male=764, aged>/= 40 years) demonstrated that limiting spirometry 
screening to only smokers could  result in 26% of cases been missed and limiting screening to 
only symptomatic patients could result in 32% missed cases. The authors identified 183 
patients with COPD of which only 18.6% of them had previously been diagnosed.  
Lastly, the findings from the focus group reported in Chapter 8 of this dissertation was in 
agreement with the findings from the focus group reported in Chapter 4 and questionnaire 
study reported in Chapter 5 in that all the studies indicated that participants identified the 
Move-On-Up video of exercise as meeting their expectations and as suitable for use in VBHEP.  
 
9.3 REFLECTIVE LEARNING, IMPLICATIONS OF FINDINGS TO CLINICAL 
PRACTICE AND FUTURE RESEARCH 
Reflective practice 
Various lessons were learned on reflecting upon the events during the entire programme of 
research. 
A study published after the completion of the SRCT detailed in this thesis (Altenburg et al, 2015; 
n=55, mean age=62, mean FeV1 =31.1%) reported MCID for the ESWT following PR in patients 
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with COPD (and with chronic respiratory failure) as a range (154-164m or 186-199s or 76- 
82%). The SRCT reported in this dissertation defined MCID for the ESWT as 173m (Waterhouse 
et al., 2006). 
There are important differences between the study by Altenburg et al. (2015) and that by 
Waterhouse et al. (2006). The study by Altenburg et al. (2015) was conducted in a Netherlands 
population compared with the study by Waterhouse et al. (2006) which was conducted in a UK 
population, and the Netherlands study was smaller in size (n=55 versus n=161 in the study by 
Waterhouse et al. (2006)). The patients in the study by Altenburg et al. (2015) participated in 
12 weeks of thrice weekly PR sessions compared with those in the study by Waterhouse et al. 
(2006) who participated in 6 weeks of twice weekly PR sessions. In the study by Altenburg et al. 
(2015), of the 55 participants an arm received only PR (n=24) while the other arm received a 
combination of PR and NIPPV (n=31), though these authors explained that analyses of the 
separate arms demonstrated similar associations. 
Considering the MCIDs of endurance shuttle walk tests that were reported in the three 
publications identified by the principal researcher (Altenburg et al., 2015; Pepin et a., 2011; 
Waterhouse et al., 2006), it was noted that the value of the MCID reported by Altenburg et al. 
(2015) (i.e. 154-164m or 76- 82%) is closer to that reported by Waterhouse et al. (2006) (i.e. 
173m or 68%). The magnitudes of the MCIDs reported by Altenburg et al. (2015) and by 
Waterhouse et al. (2006) may  further suggest that the MCID reported by Pepin et al. (2011) (i.e. 
65s or 95m) is relevant to the intervention Salmeterol and not to PR. The use of the MCID of 
endurance shuttle walk distance defined by Altenburg et al. (2015) however would not have 
changed the findings of the SRCT in this dissertation (refer to section 7.5.3.1). 
When reflecting on the focus group study reported in Chapter 8, it was considered that the 
themes obtained from the session where there was only one participant indicated no deviation 
from the themes obtained from the sessions where there were two or four participants. Two 
participants initially agreed to participate in the study but one did not attend. In retrospect, it 
may be that conducting one-to-one interviews at home (instead of focus group sessions at 
venues away from participants’ homes) would have led to an increase in the number of study 
participants. As section 8.6 and 8.7 reveal, however, there are clear agreements between the 
findings of this focus group study and the findings of the SRCT (the larger study).   
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Implications of findings to clinical practice and future research 
The findings of this research may serve to inform practice and future research in numerous 
ways. Findings from Chapter 6 where the participation profile of patients with COPD 
participating in PR programmes was examined, suggest that:  
 It may be appropriate to assess patients with COPD for depression at the point of 
referral to PR programme and not only at the start of the programme. The identification 
of depression at this stage of assessment may indicate additional need for support to 
increase the probability that a patient with COPD would attend the initial PR 
assessment.   
 Investigation into whether management of depression results in a significant difference 
in the uptake of PR would be a useful topic for further research by therapists and 
medical practitioners, especially since Chapter 6 investigated association between 
participation in PR and the baseline variables, not effect of baseline variables on 
participation in PR. The findings from the chapter demonstrated an association between 
uptake of PR and participants’ baseline depression status. However, this finding is not 
indicative of a cause-effect relationship and the investigation of cause-effect relationship 
was not the aim of the study. 
The current practice of participation in a video-based exercise programme by patients with 
COPD who are not receiving PR is indicated to result in significant improvement in QoL and 
exercise habit (Moore, Fiddler, Seymour et al., 2009; Petty et al., 2006). However, the findings 
from the SCRT in Chapter 7 indicate that participation in VBHEP concurrently with outpatient 
programme may not result in additional benefit of walking ability.  
Future studies should compare participation in VBHEP against participation in outpatient PR 
only. Studies by Petty et al. (2006) and Moore, Fiddler, Seymour et al. (2009) compared the use 
of exercise video to usual care which may have included written or verbal information. The 
SRCT reported in chapter 7 compared the effectiveness of the use of VBHEP together with 
outpatient PR in improving walking ability or in maintaining benefits of walking ability 
following outpatient PR. An RCT that compares participation in VBHEP against participation in 
outpatient PR only would add to the body of knowledge. However, there could be ethical 
challenges to such study since participants in the video arm of such study would be denied PR; 
an intervention which is established to be beneficial in improving exercise tolerance and QoL.  
The SRCT (Chapter 7) indicated that participation in VBHEP concurrently with PR resulted in no 
additional benefits of improvement in walking ability compared with outpatient PR only. 
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However, the SRCT was underpowered in the domains of SGRQ quality of life tool. The 
qualitative research findings in Chapter 8 suggested that participation in VBHEP resulted in the 
benefits of reduced use of antibiotics. The low number of participants (n=7) in the qualitative 
study is a limitation and the participants may have been the more motivated patients, however, 
the findings should be investigate in a wider group.   
9.4 CONCLUSION  
The findings from this research indicate that non-uptake and drop-out from PR by patients with 
COPD is high and that the presence of depressive symptoms may be associated with reduced 
probability of uptake of PR in patients with COPD. Findings from the current research 
demonstrated that the Move-On-Up exercise video is suitable for use in VBHEP as an adjunct to 
outpatient PR in patients with COPD. While the use of an exercise video at home may confer 
significant benefit of improvement in QoL and exercise habit to patients with COPD who are not 
receiving PR (Moore, Fiddler, Seymour et al., 2009; Petty et al., 2006), concurrent participation 
in VBHEP with outpatient programme confers no additional benefit of walking ability.   
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APPENDIX 3A: CORRESPONDENCE WITH DEVELOPERS OF THE ‘MOVE-ON-
UP’ EXERCISE VIDEO GIVING CONSENT TO THE USE THE VIDEO IN THE 
RESEARCH. 
RE: PROPOSAL AND DRAFT QUESTIONNAIRES 
December 6, 2006 
From: Alice.Bennett@bra.boehringer-ingelheim.com To: rgarrod@hscs.sgul.ac.uk CC: 
advicepool2005@yahoo.co.uk Kamlesh.Sheth@bra.boehringer-ingelheim.com     
Hi Rachel 
I have discussed Ade’s proposal with Kamlesh (our Medical Advisor) and you’re right as the 
video is in the public domain there is no issue with Ade using it in his study and we are happy 
for him to include it within his research. 
As you know we are looking at ways to evaluate the video in the future, but I think this will take 
time to agree and will be initiated by BI/Pfizer, so for the purposes of Ade’s research it probably 
makes sense for him to continue with it independently to any discussions we have. 
Of course if Ade is interested in getting involved in our evaluation separately then that would be 
great.  
I hope this is OK and stands as an ‘official’ approval, if you need any other documentation from 
me please let me know. 
  Best regards 
Alice 
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APPENDIX 3B: 2008 DATABASE SEARCH STRATEGY FOR EVALUATING THE 
SUITABILITY OF THE ‘MOVE-ON-UP’ VIDEO FOR VBHEP 
This appendix describes the source for the literature reviews detailed in chapters 3 (unless 
indicated otherwise).  
Databases consulted in the process were:  
PUBMed 
SCOPUS (officially named as SciVerse) 
CINAHL (Cummulative Index to Nursing and Allied Health Literature)  
 PEDro (Physiotherapy Evidence Database)  
Database: PubMED  
Limitation of publication year: May 2003 –August 2008 
Search term: COPD and pulmonary rehabilitation (in TITLES and ABSTRACT) - 1243 
Limiting to studies in human, published in English-1213 
Search within the 1213 ‘exercis* and education’ (this was to exclude studies investigating other 
interventions e.g smoking cessation, oxygen intervention) 126 
Limited to RCTs- 7 
Search term: COPD and respiratory exercis* limited to May 2003- August 2008 (in TITLES and 
ABSTRACT) -812 
Limiting to studies in human, published in English-808 
Search within the 808, limiting to studies that investigated exercise and education (to exclude 
studies investigating other interventions e.g smoking cessation, oxygen intervention) - 89 
Limited to RCTs- 6 
Database: SCOPUS  
Limitation of publication year: May 2003 –August 2008 
Search term: COPD and pulmonary rehabilitation (in TITLES and ABSTRACT) - 893 
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Limiting to studies in human, published in English-688 
Limiting to journals -681 
Search within the 681 ‘exercis* and education’ (this was to exclude studies investigating other 
interventions e.g smoking cessation, oxygen intervention) 192 
Limiting to RCTs- 61 
Search term: COPD and respiratory exercis* (in TITLES and ABSTRACT)-832 
Limiting to studies in human, published in English-672 
Limiting to journals- 667 
Search within the 667 ‘exercise and education’ (this was to exclude studies investigating other 
interventions e.g smoking cessation, oxygen intervention) 138 
Limiting to RCTs- 20 
Database: CINAHL Plus 
Limitation of publication year: May 2003 –August 2008 
Search term: COPD and pulmonary rehabilitation (in TITLES and ABSTRACT)-2341 
Limiting to studies in human, published in English- 329 
Limiting to journals- 281 
Limiting to RCTs- 6 
Search term: COPD and respiratory exercis* (in TITLES and ABSTRACT)-31 
Limiting to studies published in English- 24 
Limiting to studies published in journals-18 
Limiting to RCTs-1 
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Database: PeDro  
Limitation of publication year: May 2003 –Augusts 2008 
Search term: COPD and pulmonary rehabilitation (in TITLES and ABSTRACT)-173 
Limited to RCTs-73 
Search term: COPD and respiratory exercis* (in TITLES and ABSTRACT)- 244 
Limited to RCTs-38 
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APPENDIX 3C: TWENTY RCTS EXCLUDED FROM THE CRITICAL REVIEW OF PUBLICATIONS ON PR (BETWEEN 2004 
AND 2008) IN THE EVALUATION OF THE MOVE-ON-UP  VIDEO AGAINST RESEARCH PUBLICATIONS 
Reference Reason(s) for exclusion 
Bösch, Feierabend & Becker, 
2007 
Article in German. No full text available in English. 
Casaburi et al., 2005 Both arms of the study received PR. Study investigated effectiveness of the use of tiotropium when received in addition to PR. 
The study did not evaluate any PR exercises. Advice on medications does not fall within the content analysis of the Move-On-Up 
exercise video, as reported in Chapter Three. 
De Blok et al., 2006 Both arms of the study received PR. Study evaluated effectiveness of adding ‘physical activity counselling’ intervention to 
conventional PR. Physical activity counselling in the study involved each participant in the intervention arm receiving a 30-
minute session of activity counseling two weeks prior to commencement of PR and at weeks one, five and seven of the eight-
week PR. The study did not evaluate any PR exercises separately. 
Deacon et al., 2008 Both arms of the study received PR. Study investigated effectiveness of dietary creatine when received in addition to PR. The 
study did not evaluate any PR exercises. Nutritional advice does not fall within the content analysis of the Move-On-Up video, 
as reported in Chapter Three. 
Faage, & Larsen, 2004 No full text available in English. The pages of this publication (i.e. pages 153 to 158) in the relevant online journal were not 
accessible. 
Gadoury et al., 2005 The study compared usual care to a package of ‘self-management care’ which included education on management of 
exacerbation. The study did not evaluate any PR exercises. 
Gohl et al., 2006 Article in German. No full text available in English. 
Kaplan et al., 2004 The study evaluated the use of two generic and two disease specific QoL questionnaires in PR. The study did not evaluate any 
PR exercises. 
Lolak et al., 2008 Both arms of the study received PR. Study investigated effectiveness of progressive muscle relaxation (PMR) when received in 
addition to PR. The study did not evaluate any PR exercises. PMR does not fall within the content analysis of the Move-On-Up 
video, as reported in Chapter Three. 
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Maltais et al., 2005 Report of the rationale of an RCT and the RCT findings were later reported in the publication by Maltais et al., 2008. 
Puente-Maestu et al. (2003) The study was an evaluation of a maintenance programme of exercise between two groups, each of which participatedin 
different types of rehabilitation programme.  The study was not an evaluation of an item of PR separately. 
Puhan et al., 2004 This ia only a report of the rationale of an RCT and the RCT findings were later reported in the publication by Puhan et al., 
2006. 
Ruize de Ona Lacasta et al., 
2004 
Two variables co-existed in the two arms of the study at the same time. Participants in the supervised exercise arm also 
received exercise regimen of higher intensity compared to participants in the self-supervised exercise arm. Therefore, it may 
be difficult to establish if the difference in change in outcome measures between the two arms was due to the difference in 
exercise intensity or rehabilitation protocol i.e. supervised versus unsupervised exercise protocol. 
Sridhar et al., 2008 The study compared a nurse-led ‘care package’ against usual care. The nurse-led ‘care package’ included home visits and 
monthly telephone calls in addition to PR. The study did not evaluate an item of PR separately. 
Steele et al., 2008 All arms in the study received PR. The study evaluated exercise adherence in an arm that received PR in addition to weekly 
phone calls, home visits and the use of a pedometer.  
Varga, Boda & Somfay, 2005 Article in Hungarian. No full text available in English. 
Wen & Gao, 2008 Article in Chinese. No full text available in English. 
Wu et al., 2006 Article in Chinese. No full text available in English. 
Xie, Zhu, Cui & Liu (2003) Article in Chinese. No full text available in English. 
Zhang et al., 2008 Article in Chinese. No full text available in English. 
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APPENDIX 3D: FORTY-SIX RCTS INCLUDED IN THE CRITICAL REVIEW OF PUBLICATIONS ON PR (BETWEEN 2004 AND 
2008) IN THE EVALUATION OF THE MOVE-ON-UP  VIDEO AGAINST RESEARCH PUBLICATIONS  
Evaluation of RCTs that investigated effectiveness of outpatient PR. 
RCT 
reference 
Population  Study aim Intervention Outcomes Main findings including 
between-group 
comparisons 
PEDro score and 
other comments 
Barakat et 
al., 2008 
COPD, n=80 (67 
males). Mean 
FeV1=42.8+/-7.6%. 
To evaluate 
outpatient PR using 
SGRQ, 6MWT and 
BODE. 
14-week outpatient PR 
versus routine medical 
review. 
6MWT, SGRQ and 
BODE index taken at 
baseline and at week 
14. 
Outpatient PR arm 
demonstrated 
significantly higher 
improvement in SGRQ 
and 6MWT (p<0.05) 
compared to control. 
PEDro score 
=6/10. BODE index 
has no known 
MCD. No blinding 
of assessors in the 
study. 
Guell et al., 
2006 
COPD, n=40 
enrolled, aged 65+/-
8 years. All male. 
To assess the effect 
of PR on 
psychosocial 
morbidity, 
functional exercise 
tolerance and 
HRQoL in patients 
with COPD. 
16 weeks PR versus control.  6MWT, CRQ, revised 
symptom checklist, 
Millon behaviour 
health inventory 
(MBHI) taken at 
baseline and at week 
16. 
PR group demonstrated 
significantly greater 
gain (compared to 
control group) in 
6MWT, QoL (CRQ), 
psychosocial domains 
of MBHI and symptoms. 
PEDro score=5/10. 
All participants 
were male. 
Karapolat 
et al., 2007 
COPD, n=54 (46 
males) recruited, 49 
completed (43 
males). Mean 
FeV1=54.9%. 
To evaluate short-
term benefit of 
outpatient PR in 
COPD. 
8-week outpatient PR versus 
no rehabilitation. 
6MWT, SGRQ, 
dyspnoea visual 
analogue scale 
(DVAS), pulmonary 
blood analysis and 
pulmonary function 
test taken at baseline, 
at 8th week and at 12th 
week (i.e. 4th week 
post-PR). 
Rehabilitation group 
demonstrated 
significantly higher 
improvement in 6MWT 
and DVAS (at 8th week) 
and SGRQ at 8th and 
12th week (p<0.05). 
PEDro score=6/10, 
DVAS has no MCD. 
Intention-to-treat 
analysis was not 
conducted. No 
blinding of 
assessors 
Lindsay et COPD, n=50 (38 To evaluate whether Tiotropium therapy plus six- FeV1, 6MWT, CRQ There was no PEDro score= 
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al., 2005 males), mean 
FeV1=0.85 
litre/minute, mean 
age=69.7 years. 
multidisciplinary PR 
has additional 
benefit over 
tiotropium therapy 
in managing COPD. 
weekly PR (experimental 
arm) versus tiotropium 
therapy alone (control arm). 
Peak Visual Analogue 
Scale (PVAS) measure 
of breathlessness 
were taken at 
baseline and at 6th 
week, 12th week and 
3rd month. 
significant difference 
between groups in 
improvement in 6MWT, 
PVAS and CRQ 
(p<0.05). Both arms of 
the study demonstrated 
significant 
improvement in all the 
outcome measures 
(p<0.05). 
3/10. PVAS has no 
defined MCD. 
Blinding of 
assessors was not 
conducted. 
Authors conducted 
intention-to-treat 
analysis. 
Man et al., 
2004 
COPD, n=42 (17 
males). Mean 
FeV1=39.2%. 
To evaluate effects 
of PR early post-
hospital discharge 
after acute 
exacerbation of 
COPD. 
8-week early outpatient PR 
versus no rehabilitation. 
ISWT, SGRQ, CRQ and 
SF-36 taken at 
baseline and at 3 
months post-hospital 
discharge.  
Rehabilitation group 
demonstrated 
significantly higher 
improvement in ISWT, 
SGRQ, CRQ and mental-
component of the SF-
36.  
PEDro score=5/10. 
No blinding of 
assessors. 
Mineo et al., 
2004 
COPD, n=60, All 
with emphysema, 
none with giant 
bullae, dominant 
bronchitis or 
bronchiectasis. 
To evaluate effects 
of lung function 
reduction surgery 
against outpatient 
PR on QoL. 
6 weeks PR versus lung 
function reduction surgery. 
6MWT, SF-36, 
Nottingham Health 
Profile (NHP), SGRQ, 
FeV1taken at baseline 
and at 6th month post-
intervention (PR or 
lung function test). 
Participants who had 
lung reduction surgery 
demonstrated 
significantly greater 
improvement in 6MWT, 
NHP score, SGRQ and 
FeV1 (p<0.05). Both 
groups showed 
significant 
improvement in QoL 
and exercise capacity at 
6th month (p<0.05).  
PEDro score=6/10. 
All participants 
have emphysema 
and no clinically 
dominant chronic 
bronchitis. FeV1. 
indices of 
hyperinflation are 
better correlates of 
activity than FeV1 
(O’Donnell & 
Laveneziana, 
2006). 
Paz-Diaz et 
al., 2007 
COPD, n= 24, all 
with severe COPD. 
To determine the 
impact of outpatient 
PR on depression 
and dyspnoea in 
8-week outpatient PR versus 
control (routine review 
including visit to physician 
every 3 weeks). 
Beck depression 
inventory (BDI), State 
trait anxiety 
inventory, MRC score 
and SGRQ taken at 
Participants in PR 
group demonstrated 
significantly greater 
improvement in BDI, 
SGRQ and MRC 
PEDro score=4/10. 
Control group 
(n=14) is 
predominantly 
male (n=12) while 
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patients with COPD. baseline and at week 
8. 
(p<0.05). 6 of the 10 
participants in the 
rehabilitation 
group were male. 
Petersen et 
al., 2007 
19 moderate to 
severe patients with 
COPD (6 males), 
FeV1=31+/-1. 
Twenty healthy 
subjects, 10 males. 
To investigate 
effects of regular 
exercise on systemic 
inflammation, 
exercise tolerance 
and QoL. 
Nine (of the 19) patients had 
7 weeks of twice weekly PR 
and were compared to the 
COPD control (n=10) and 
healthy subjects. 
SGRQ, ISWT, ESWT, 
FeV1 taken at baseline 
and at week 7. 
Between-group 
difference in change in 
SGRQ scores was not 
significant. Between-
group difference in 
change in change in 
ISWT and ESWT were 
significant. 
PEDro score-5/10. 
Individuals with 
smoking pack 
years >20years 
were excluded 
which limits the 
generalizability of 
the results. With 
10 in COPD 
training arm, study 
was under-
powered to detect 
MCD in SGRQ. 
      Mean PEDro 
score=5.0. 
Comparison of review with recommendation in the Move-On-Up video: The video recommended for home use by its makers. This study was not evaluating its use 
in the outpatient unit. 
 
Evaluation of RCTs that investigated effectiveness of home-based PR. 
RCT 
reference 
Population Study aim Interventions Outcomes Main findings 
including 
between-group 
comparisons. 
PEDro score and 
other comments 
Boxall et al., 
2005 
60 patients with 
severe COPD, all 
housebound were 
recruited, 46 (26 
males) completed.  
To assess the effects 
of a 12-week home-
based PR in 
housebound 
patients with COPD. 
12-week PR (intervention 
arm) versus usual medical 
care (control). 
6MWT, SGRQ, Borg 1-10 at 
baseline and 12th week. Also, 
number of hospital re-
admission and length of stay 
at re-admission. 
Intervention 
arm 
demonstrated 
improvement 
that is 
significantly 
PEDro 
score=5/10. 
23.3% of 
participants 
dropped out (due 
to reasons 
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greater than 
that of the 
control arm in 
6MWT, SGRQ, 
Borg scale of 
breathlessness 
and length of 
stay at 
readmission(p
<0.05).  
including inability 
to cope with 
exercises, 
hospitalization, 
and death) and the 
study did not 
conduct intention-
to-treat analysis. 
Inclusion criteria 
required 
participants to be 
60 years and 
above and all 
participants had 
severe COPD. 
These factors may 
limit the 
generalizability of 
the findings of the 
study. 
Guell et al., 
2008 
COPD, n=57 
recruited, 51 
completed. Mean 
FeV1=38.2%, mean 
age=64.5 years. 
To compare the 
effects of home-
based PR and 
hospital outpatient 
PR in patients with 
COPD. 
8-week outpatient PR versus 
unsupervised home exercise 
programme. 
Respiratory muscle function-
PImax, maximal expiratory 
pressure PEmax, 6MWT and 
CRQ taken at baseline, at the 
end of 8th week of PR and at 
6th month post-PR. 
 
Hospital group 
had 
significantly 
higher 
improvement 
in CRQ 
compared to 
home group. 
Both groups 
demonstrated 
significant 
improvement 
in PImax, PEmax, 
6MWT and 
CRQ (p<0.05). 
PEDro 
score=7/10. Study 
participants were 
all males. No 
intention to treat. 
No blinding of 
assessors. 
Maltais et COPD, n=252 (140 To evaluate whether Home-based versus hospital CRQ dyspnoea subscale at 1 No significant PEDro 
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al., 2008 males, mean 
FeV1=44.5%). 
home-based PR is as 
effective as 
outpatient hospital-
based PR in patients 
with COPD. 
outpatient-based PR. year. difference 
between 
improvement 
in CRQ scores 
between the 
two arms 
(p<0.05). Both 
arms 
demonstrated 
significant 
improvement 
in dyspnoea 
(p<0.05). 
score=8/10. The 
study participants 
were provided 
with exercise 
bikes for home-
based exercise. It 
is not a routine 
practice in the UK 
to buy exercise 
bikes for patients.  
Murphy et 
al., 2005 
COPD, n =31 
recruited, 26 (17 
males) completed. 
Mean FeV1=40%. 
To investigate the 
outcomes of 
supervised home 
exercise programme 
received 
immediately on 
discharge post-
COPD exacerbation. 
6 weeks home-based PR 
versus control (standard 
care without any 
rehabilitation). 
ISWT, 3-minute step test, 
SGRQ, maximal voluntary 
isometric contraction taken at 
baseline and 6th week. 
Supervised PR 
group had 
significantly 
higher 
improvement 
in ISWT, SGRQ 
and muscle 
strength 
(p<0.05). 
PEDro 
score=4/10. The 
home exercise 
programme 
involved visit by a 
physiotherapist 
and the result 
cannot be 
extrapolated to 
self-directed home 
programme.  
Oh (2003) COPD, n =34 
recruited, 23 (14 
males) completed. 
Mean FeV1=43%. 
 
To examine the 
effects of a home-
based PR program 
on lung function, 
dyspnea, exercise 
tolerance, and 
quality of life in 
patients with 
moderate to severe 
chronic lung 
disease. 
8-week home-based PR 
program versus educational 
advice only. 
FeV1%, Borg score, 6MWT, 
CRQ score measured before 
and at 8 weeks, post 
programme. 
 
At the end of 
8th week, the 
PR group 
demonstrated 
significantly 
lower 
exertional 
dyspnea and 
significantly 
higher increase 
in 6MWT, and 
CRQ score 
PEDro score=4. Of 
the 34 
participants, the 
30 were randomly 
assigned to 
experimental and 
control group 
while the last 4 
were assigned to 
experimental 
group to preserve 
against drop out. 
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 (p<0:05). 
There was no 
significant 
between group 
differences in 
FeV1%. 
 
This action meant 
21% of 
participants in 
experimental 
group were not 
randomized. Also, 
the study suffered 
32% drop-out and 
authors did not 
conduct intention 
to treat analysis. 
Also, lack of 
blinding of 
assessor was a 
major risk of bias. 
Resqueti et 
al., 2007 
COPD, n=38 (35 
males) enrolled, 29 
completed. Mean 
age 68+/-6 years, 
mean FeV1=28.6%. 
To evaluate short-
and medium-term 
effects of 
domiciliary PR for 
patients with COPD. 
8 weeks of supervised home 
exercise programme versus 
8 weeks of unsupervised 
home exercise programme. 
The maintenance phase 
(post-8-week PR to 6th 
month post-PR) involved 
once-monthly phone call to 
the supervised home-
exercise group. 
FeV1, 3-minute walk test 
(3MWT), CRQ, taken at 
baseline, post-home exercise 
programme and 6th month. 
Supervised PR 
group had 
significantly 
higher 
improvement 
in 3MWT and 
CRQ (p<0.05). 
PEDro 
score=5/10. Study 
suffered 23.7% 
drop-out and did 
not use intention-
to-treat. All 
participants in the 
control arm were 
male and 84.2% of 
participants in 
intervention arm 
were male. The 
result may not be 
generalizable to 
females. 
      Mean PEDro 
score= 5.5 
Comparison of review with recommendation on use of the Move-On-Up video: The video is recommended for home use by its makers. 
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Evaluation of RCTs that investigated effectiveness of community-based PR. 
RCT 
reference 
Population Study aims Interventions Outcomes Main findings 
including 
between-group 
comparisons. 
PEDro score and 
other comments 
Elci et al., 
2008 
COPD, n=78 (67 
males), mean 
age=58.9+/-10.1 
years. 
To examine the 
applicability and 
efficacy of a PR 
programme in a 
community hospital 
without a specialist 
PR service.  
One face-to-face exercise 
sessions and subsequently, 
once weekly phone call (PR 
group) for a period of 3 
months versus control (no 
exercise) group. 
6MWT, SF-36, SGRQ, HADs, 
FeV1, taken at baseline, 1st, 2nd 
and 3rdmonth. 
PR group 
demonstrated 
improvements 
that were 
significantly 
higher than that 
of the control 
group in 6MWT 
(at 3rd month), 
SGRQ, SF-36 and 
HADs (at 2nd and 
3rd month). 
P<0.05. 
PEDro 
score=3/10. 
Assessors in the 
study were not 
blinded to 
participants’ 
allocation.  
Elliot et al., 
2004 
43 patients (23 
males) with 
moderate to severe 
COPD. 
To compare the 
efficacy of a 
community-based 
exercise programme 
with standard 
hospital outpatient 
PR programme. 
3-month hospital-based PR 
(exercise & self-
management education) 
versus 3-month community-
based exercise programme. 
6MWT and CRQ taken at 
baseline and at 3 months. 
At 3 months, 
there was no 
significant 
between-group 
difference in 
6MWT or CRQ. 
Both groups 
demonstrated 
significant 
improvement in 
CRQ score and 
only hospital PR 
group 
demonstrated 
significant 
improvement in 
PEDro 
score=5/10. The 
participant 
number in the 
community PR 
group (n=9) was 
low such that 
that arm of the 
study was 
underpowered 
to detect 
significant 
change in the 
outcome 
measures. Also, 
the unbalanced 
nature of the 
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6MWT.  arms (hospital 
PR=22, 
community 
PR=9) may have 
affected the 
result. 
      Mean PEDro 
score=4 
Comparison with content of the Move-On-Up video: The video recommended for home use by its makers. The study reported in this chapter was not evaluating its 
use in the outpatient unit. 
 
Evaluation of RCTs that investigated strengthening exercises in PR. 
RCT 
reference 
Population Study aim Interventions Outcomes Main findings 
including 
between-group 
comparisons. 
PEDro score and 
other comments. 
Alexander, 
Phillips & 
Wagner, 
2008 
COPD, n=27 (16 
males) recruited, 
n=20 (14 males) 
completed. 
Completers mean 
age= 69+/-9. FeV1 
below 60%. 
To compare the 
effects of a strength-
training-enhanced 
programme versus 
conventional PR 
programme.  
8-week traditional PR 
programme (in addition to 
strength training) versus 8-
week traditional PR only. 
 Test of 1 repetition maximum 
(RM) muscular strength, 
senior fitness test 
(physiological characteristics 
associated with activities of 
daily living) and 6MWT taken 
at baseline and week 8. 
There was no 
significant 
between-group 
difference in 
changes in 
6MWT and 
senior fitness 
test. Strength 
training group 
demonstrated 
significantly 
higher 
improvement in 
1 RM seated leg 
press (p<0.05). 
PEDro 
score=4/10. 
Drop-out was 
high (25.9%) 
and the study 
conducted no 
intention to treat 
analysis. 
Kongsgaard COPD, n=18 
recruited mean 
To evaluate the 
effects of heavy 
12-week progressive 
resistance training (training 
FeV1, quadriceps cross-
sectional area, isometric knee 
 At 3-month, self-
reported health 
PEDro 
score=4/10. All 
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et al., 2004 FeV1= 46+/-3.4, 
ages 65-80 years. 
All male, n= 13 
completed. 
resistance exercise 
in elderly males 
with COPD. 
group) versus 12 week 
breathing exercise only 
(control arm). 
extension strength, maximal 
gait speed, stair-climbing 
time, isometric trunk flexion 
and a Danish self -reported 
health and ADL questionnaire 
completed at baseline and at 
week 12.  
and ADL, stair 
climbing time 
and quadriceps 
cross-sectional 
area were 
significantly 
higher in the 
training group 
compared to 
control group 
(p<0.05). 
participants 
were male and 
number of 
participants was 
low (n=13). 
Drop-out was 
high (27.9%) 
and intention-to-
treat was not 
conducted. 
Mador et al., 
2004 
COPD, n=32 
recruited, n= 24 
completed, for 
completers, mean 
age =71 years, 
mean 
FeV1=41.8%. 
To compare the 
effects of endurance 
training only to 
endurance plus 
strength training.  
8-week endurance plus 
strength training (combined 
group) versus 8 weeks of 
endurance-only training. 
6MWT, CRQ, cycle ergometry 
endurance exercise test and 
muscle strength 
measurements conducted at 
baseline and at week 8. 
At 8 weeks, there 
was no 
significant 
change in 6MWT 
or CRQ between 
the two arms. 
The increase in 
muscle strength 
was significantly 
greater in the 
combined group 
than in the 
endurance only 
group. 
PEDro 
score=6/10. All 
participants 
were non-
smokers, though 
this is not a 
general 
requirement for 
participation in 
PR in many PR 
services. 
O’Shea, 
Taylor & 
Paratz, 2007 
COPD, n=54 (21 
males), mean 
FeV1=51%. 
To investigate 
whether a 12-week 
predominantly 
home-based 
strength exercises 
reduce 
impairments, 
activity limitation 
and participation 
restriction in 
patients with COPD 
12 weeks of progressive 
resistance exercises 
(experimental group) versus 
no exercise (control) group. 
6MWT, dynamometry muscle 
strength test conducted at 
baseline and week 12 and 
week 24 (12 weeks post-
intervention). 
Experimental 
group 
demonstrated 
significantly 
greater 
improvement in 
dynamometry 
muscle strength 
than control 
group at week 
12. No other 
PEDro 
score=7/10. Two 
of the three 
exercise sessions 
per week were 
home-based. The 
study conducted 
intention-to-
treat analysis. 
However, drop-
out between the 
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and whether the 
gains are 
maintained 12 
weeks after end of 
the programme. 
significant 
difference in 
between-group 
change in 
outcomes. 
groups varied 
widely (25.9% in 
experimental 
group versus 
11.1% in control 
group). 
Phillips, 
Benton & 
Wagner, 
2006 
COPD, n=24 
recruited, 22 
randomized, final 
analysis 
conducted for 19 
participants (5 
males), mean FeV1 
=37.6%. 
To investigate the 
effect of single set 
resistance exercises 
on strength and 
functional fitness in 
PR patients. 
Endurance training (ET) 
group received 8 weeks PR 
consisting of endurance 
training only and strength 
training (ST) group received 
8 weeks ET plus resistance 
training. 
Strength testing (1 RM), 
senior fitness test and 6MWT 
conducted at baseline and 
week 8. 
ST group 
demonstrated 
significantly 
greater 
improvement in 
6MWT and 
muscle strength 
test (chest press 
and leg press) 
than the control 
group at week 
12. 
PEDro 
score=4/10. 
Intention-to-
treat was not 
conducted and 
there was no 
blinding of 
assessors. 
      Mean PEDro 
score=5. 
Comparison with the content of the Move-On-Up video: Strength exercises are included in the video e.g. biceps bend. 
 
Evaluation RCT that investigated endurance exercises in PR. 
RCT 
reference 
Population Study aim Intervention. Outcomes Main findings 
including 
between-group 
comparison. 
PEDro score 
and other 
comments 
Arnadottir et 
al., 2006 
COPD, n=63 were 
randomized, 42 
completed (21 
males), Mean FeV1 
To compare the 
effects on 
endurance and 
strength training on 
exercise capacity 
8 weeks of ET (endurance + 
resistance + calisthenics 
training) versus 8 weeks of 
RT (resistance + calisthenics 
Peak exercise capacity 
(incremental cycle ergometer 
test), Borg CR-10 and Borg 
rate of perceived exertion 
(RPE), 12-minute walk test, 
In favour of the ET 
group, there was 
between-group 
difference in 
change in peak 
PEDro 
score=4/10. 
Intention-to-
treat was not 
conducted 
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=37.5%. and QoL in patients 
with COPD. 
training) SGRQ and HADs conducted at 
baseline, week 8, 6th and 12th 
month post-training. 
exercise capacity 
(at week 8), Borg 
CR-10 (at 8th week 
and 6thmonth 
post-training) and 
RPE (at week 8, 6th 
month post-
training and 12th 
month post-
training). There 
was no significant 
between-group 
difference in 12-
minute walk test, 
SGRQ or HADs at 
all points. 
despite drop 
out of 33.3% 
which weakens 
the reliability 
of the findings. 
      PEDro score = 
4. 
Comparison with the content of the Move-On-Up video: Endurance exercises are included in the video, with particular emphasis on walking. 
 
Evaluation of RCT that investigated upper extremity exercises in PR. 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons. 
PEDro score 
and other 
comments 
Holland et al., 
2004 
COPD, n=38 (24 
males), mean FeV1 
=36.6%. 
To compare the 
effects of upper limb 
and lower limb 
training 
(experimental 
group) with that of 
lower limb (control) 
6 weeks of UL training 
involving unsupported 
upper limb endurance 
training (experimental 
group) versus 6 weeks of LL 
training (control group). 
Incremental unsupported 
upper limb exercise test 
(ULET), 6MWT and CRQ 
conducted at baseline and at 
week 6. 
Experimental 
group 
demonstrated an 
improvement in 
ULET which was 
significantly 
higher than that 
the change in the 
PEDro 
score=7/10. 
There is no 
defined MCD 
for incremental 
unsupported 
upper limb 
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training alone. control group. 
There was no 
significant 
between-group 
difference in 
6MWT and CRQ. 
exercise test. 
   .   PEDro 
score=7/10. 
Comparisons with recommendations in the Move-On-Up video: Upper extremity exercises are included in the video.  
 
Evaluation of RCTs that investigated lower extremity exercises in PR. 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons. 
PEDro score 
and other 
comments 
Casaburi et 
al., 2004 
COPD, n=53 
randomised, all 
male, n= 47 
completed, mean 
FeV1 =40%. 
To determine the 
effects of 
testosterone 
supplementation, 
with or without 
resistance training 
on body 
composition and 
muscle function in 
men with COPD. 
Subjects were randomized 
to one of the following 4 
groups: placebo + no 
training (P) versus 
testosterone + no training 
(T) versus placebo + 
resistance training (R=lower 
limb strengthening 
exercises) versus 
testosterone + resistance 
training (TR). 
Body composition analysis, 
muscle strength and 
fatiguability and cycle 
ergometer endurance test 
taken at baseline and at week 
10. 
Patients in group 
R demonstrated 
increase in body 
composition (lean 
leg weight) and 
muscle strenght 
(leg press1 RM) 
that is significantly 
greater (p<0.05) 
than that 
demonstrated by 
participants in the 
placebo (P) group. 
There was no 
significant 
between-group 
difference in cycle 
ergometer 
PEDro 
score=5/10. 
Participants 
were all men 
and this limits 
the application 
of the findings 
to females with 
COPD. Low 
number of 
participants in 
the R and P 
groups ((n=11 
in each) and 
lack of blinding 
of assessors 
were some 
weaknesses of 
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endurance test 
taken at baseline 
and at week 10.  
 
the study. 
Hoff et al., 
2007 
COPD, n=12 (8 
males), mean 
FeV1=36.2%, mean 
age 61.7 year. 
To evaluate the 
impact of short term 
maximal strength 
training (MST) in 
patients with COPD. 
Attendance of 8 week 
strength training sessions 
(MST group) versus control 
(modest unsupervised 
regular activity). 
1 RM leg press, FeV1 and 
mechanical efficiency using 
cycle ergometry conducted at 
baseline and week 8. 
MST group 
demonstrated 
improvements 
that were 
significantly 
greater than that 
in the control 
group in 1 RM leg 
press, FeV1 and 
mechanical 
efficiency (p<0.05) 
at week 8. 
PEDro score= 
6/10. Low 
number of 
study 
participants, 
hence not 
adequately 
powered. FeV1 
is an artificial 
manoeuver and 
does not 
correlate with 
outcomes such 
as dyspnoea, 
health related 
QoL or exercise 
capacity. 
      Mean PEDro 
score = 5.5 
Comparison with recommendations in the Move-On-Up video: Lower extremity exercises are included in the video. 
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Evaluation of RCTs that investigated breathing exercises in PR. 
 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons 
PEDro score 
and other 
comments 
Beckerman 
et al., 2005 
COPD, n=42 (32 
males), mean FeV1 
=42.5%. 
To evaluate the long 
term benefits of IMT 
on inspiratory 
muscle strength, 
exercise capacity 
QoL, primary care 
use and 
hospitalization.  
1 year IMT (IMT group) 
versus control. 
At 3rd, 6th, 9th and 12th month, 
measures of spirometry, 
inspiratory muscle strength, 
Borg CR-10, 6MWT, SGRQ, 
primary care use and hospital 
admission were taken. 
The IMT group 
demonstrated 
significantly larger 
improvement 
compared to the 
control group in 
inspiratory muscle 
strength and 
6MWT (at 3rd, 6th, 
9th and 12th 
month; p<0.01), 
SGRQ (at 6th, 9th 
and 12th month; 
p<0.01) and Borg 
CR-10 at 9th month 
(p<0.05). There 
was no significant 
difference in 
spirometry, 
hospital 
admissions or 
primary care 
utilization 
between the 
groups at any 
point. 
 
PEDro 
score=5/10. 
The 
intervention 
group received 
a considerably 
more intensive 
protocol of IMT 
which involved 
supervised 
outpatient IMT 
training for a 
month 
followed by 11 
months of 
home training 
verified daily 
by telephone 
calls and by 
weekly home 
visits. Blinding 
of assessors 
strengthened 
the findings of 
the study. 
Faager, 
Stahle & 
COPD, n=32 (12 
males), mean peak 
To evaluate how 
spontaneously used 
ESWT using spontaneous 
PLB versus ESWT without 
ESWT, pulse oximetry (SPO2), 
Borg CR-10, peak expiratory 
ESWT result 
(using PLB) was 
PEDro 
score=5/10. A 
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Larsen, 
2008 
expiratory flow at 
rest= 247+/-
85litre/minute. 
pursed lip breathing 
(PLB) affects 
walking endurance 
walking endurance, 
oxygen saturation 
and dyspnoea in 
patients with COPD. 
PLB. flow and FeV1 conducted pre-
walk and immediately post-
walk, 5 minutes and 10 
minutes post-walk. 
37seconds (16%) 
larger than ESWT 
(without PLB) 
(p<0.01). There 
was significantly 
positive absolute 
difference in SPO2 
in favour of pursed 
lip breathing 
(p<0.05). 
 
cross-over RCT 
with each 
participant 
performing 
two walk tests 
in random 
orders on the 
same day; 
ESWT with PLB 
versus without 
PLB. However, 
the two tests 
were 
conducted at 
least 15 
minutes apart. 
While this 
study reported 
a between 
group 
difference of 
16% in ESWT, 
the MCD for 
ESWT has been 
reported as 
68% (SD 60) 
(Waterhouse, 
Walters, Clarke 
& Lawson, 
2006). 
Garrod et 
al., 2005 
COPD, n=69 
recruited, n=48 
completed, mean 
FeV1=44.3+/-18.4%, 
mean age 68. 
To examine the 
effects of PLB 
during exercise in 
patients with COPD 
who did not 
spontaneously 
ISWT using spontaneous 
PLB versus ISWT without 
PLB. 
ISWT, SPO2 and end exercise 
respiratory rate (RR) pre-
walk and immediately post-
walk. Also recovery time post-
walk. 
ISWT result (using 
PLB) was only 
4.9m (95% CI was 
2.8-6.9) larger 
than ISWT 
(without PLB) and 
this is short of the 
PEDro 
score=4/10. A 
cross over RCT 
with each 
participant 
performing 
two walk tests 
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perform PLB.  MCD for ISWT. 
There was 
significant 
reduction in end 
exercise RR and 
recovery time. 
(p<0.01). 
in random 
orders; ISWT 
with PLB 
versus without 
PLB. However, 
the two tests 
were 
conducted at 
least 20 
minutes apart. 
Magadle et 
al., 2007 
COPD, n=34 (26 
male), mean 
FeV1=45.5%, mean 
age =65.6 years. 
To examine the 
effects of adding 
inspiratory muscle 
training (IMT) to PR 
in patients with 
COPD. 
12 weeks general PR 
exercises plus 6 months IMT 
(IMT group) versus 12 
weeks general PR exercises 
plus 6 months sham IMT 
(control group). 
6MWT, SGRQ, Borg CR-10, 
spirometry (FeV1 and FVC) 
and inspiratory muscle 
strength (PImax) taken at week 
12 and at 6th month post PR. 
At week 12, there 
was significant 
improvement in 
6MWT (p<0.01) 
and at 6th month 
post PR, there was 
significant 
improvement in 
SGRQ, Borg CR-10 
and PImax, all in 
favour of the IMT 
group. 
PEDro 
score=7/10. 
Drop-out was 
20.6% and 
intention-to-
treat analysis 
was not 
conducted. The 
significant 
between-group 
differences in 
6MWT at week 
12 were not 
evident at 6th 
month post-
IMT. 
 
Norweg et 
al., 2005 
COPD, n=43 
randomized (13 
males), mean 
FeV1=55.9%, mean 
age=75.3 years. 
To evaluate the 
short-term and 
long-term effects of 
combining activity 
training or lectures 
to exercise training 
on quality of life, 
functional status 
10 weeks exercise training 
alone (E) versus 10 weeks 
exercise training plus 
activity training (EA) versus 
10 weeks exercise training 
plus lecture series (EL). 
Activity training was defined 
as ‘‘a structured behavioural 
6MWT, CRQ, Modified 
Pulmonary functional status 
and dyspnoea questionnaire 
(PFSDQ-M) and COPD self-
efficacy scale administered at 
baseline, 6th, 12th, 18th and 24th 
week. 
There was 
significantly larger 
improvement in 
CRQ total (at week 
6) and PFSDQ-M 
outcomes (at 
weeks 6 and 12) 
for participants in 
PEDro 
score=3/10. 
The study did 
not report 
between-group 
comparisons of 
FeV1 at 
baseline due to 
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and exercise 
tolerance. 
intervention that 
emphasized dyspnea 
management strategies, 
especially breathing 
combined with supervised 
activity exertion’’. 
the EA group 
compared to EL 
(p<0.05). There 
was significantly 
larger 
improvement in 
PFSDQ-M 
outcomes (at week 
12) for 
participants in the 
EA group 
compared to E 
(p<0.05. There 
was no significant 
difference 
between the 
various groups in 
6MWT or COPD 
self-efficacy at 6th, 
12th, 18th or 24th 
week. 
missing data in 
49% of 
participants. 
This makes it 
impossible to 
evaluate COPD 
severity 
distribution in 
the study arms. 
At baseline, 
participants in 
the EA group 
demonstrated 
better QoL 
(CRQ) than 
participants in 
the EL group 
(p<0.01). There 
was 19% 
(during 
rehabilitation 
stage) and 43% 
(before 24th 
week) drop-out 
rate and no 
intention-to-
treat analysis. 
Puente-
Maestu et 
al. (2003) 
 
COPD, n =26 
recruited, 23 (19 
males) completed. 
Mean FeV1<50%. 
 
To examine the 
effects of specific 
expiratory muscle 
training (SEMT) on 
expiratory muscle 
performance, 
exercise 
performance and 
the sensation of 
breathlessness in 
3 months of SEMT daily, six 
times weekly, each session 
lasting 30 minutes 
(experimental group) versus 
training with very low load 
(control group) 
 
6MWT, expiratory muscle 
strength, expiratory muscle 
endurance,  Mahler baseline 
dyspnea index (BDI) and the 
transition dyspnea index post 
exertion, maximal inspiratory 
pressure (Pimax), maximal 
expiratory pressure (Pemax) 
conducted before and within 1 
In favour of the 
SEMT group, there 
was significant 
between group 
difference in 
expiratory muscle 
strength, 
expiratory muscle 
endurance, 6MWT 
(p < 0.05). 
PEDro score=6. 
The study had 
a good 
completion 
rate (88.5%). 
However, an 
unusually high 
proportion of 
participants 
(83% ) was 
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patients with COPD. 
 
week post training. 
 
Between groups 
difference in the 
dyspnea index was 
not statistically 
significant.  
 
male and this 
may limit the 
generalisability 
of the findings 
to females with 
COPD. 
Sykes et al., 
2005 
COPD, n=40 (34 
males), ages 60 to 80 
years. 
To investigate the 
effects of including 
IMT in a 4-week 
inpatient PR. 
4-week PR plus IMT (IMT 
group) versus 4-week PR 
only (control group). 
6MWT, peak oxygen 
consumption (VO2peak) and 
CRQ at baseline and at 4th 
week. 
IMT group 
demonstrated 
improvement in 
VO2-peak that is 
significantly larger 
compared to that 
in the control 
group (p<0.05). 
PEDro 
score=7/10. 
The study 
ensured 
blinding of 
assessors 
which 
strengthened 
the findings of 
the study. 
      Mean 
score=5.3 
Comparison with the content of the Move-On-Up video: Breathing retraining is included in the ‘Move-On-Up’ video, especially pursed lip breathing. The use of IMT 
is not routinely recommended as part of PR. 
 
Evaluation of RCT that investigated training intensity in PR. 
 
RCT 
reference 
Population Study aim Intervention. Outcomes Main findings 
including 
between-group 
comparisons. 
PEDro score 
and other 
comments 
Bjorshave & 
Korsgaard, 
2005. 
COPD, n=124 
invited, n=10 
randomised, n=20 
(10 males) 
completed, mean 
FeV1=34.8%, mean 
To compare the 
effects of a 4-week 
home-based low 
and middle intensity 
frequency training 
programme in 
4 weeks of either high 
intensity (30 step/minute x 
15 minute and high intensity 
walk for 15 minute, 5 
days/weekly) versus 4 
weeks of low intensity (15 
FeV1, SF-36, standardized 
treadmill walk test conducted 
at baseline and at 4 weeks. 
Significantly 
higher 
improvement in 
walking time in 
favour of middle 
intensity exercise 
PEDro 
score=4/10. 
With 35.5% 
drop-out, the 
lack of 
intention to 
287 
 
ages = 62.6 years. patients with 
moderate to severe 
COPD. 
 
step/minute x 15 minute 
and quiet pace walk for 15 
minute, 2 days/weekly). 
 
group (p<0.01). 
No significant 
between group 
difference in SF-36 
and FeV1. 
treat analysis is 
a weakness of 
the study. 
      Mean PEDro 
score=4 
Comparison with the content of the Move-On-Up video: The advice in the video is for a patient to exercise to a point of Borg 3 to 4 on Borg scale 1 to 10, for 30 
minutes or more, three times weekly.  
 
Evaluation of RCT that compared interval to continuous training in PR. 
 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons 
PEDro score 
and other 
comments 
Arnardottir 
et al., 2006 
COPD, n=100 
included, n=60 (9 
males) completed, 
age range 43-80 
years. Mean FeV1= 
34%. 
To compare the 
effects of interval 
training (I) (3 
minute) with 
continuous training 
(C). 
16 weeks I training; 3 
minute of >/=80% of 
baseline peak exercise 
intensity (Wpeak) 
interspersed by 3 minutes of 
30-40% Wpeak versus 16 
weeks of C training (>/=65% 
Wpeak). 
Outcomes of incremental cycle 
ergometer test, 12 minute 
walk test, CRQ, HADs, SF-36 
taken at baseline and 16th 
week. 
There was no 
significant 
difference 
between the two 
study arms in the 
any of the 
outcome measures 
(p<0.05). 
PEDro 
score=5/10. 
Weaknesses of 
the study 
included a drop 
out of 40% and 
lack of 
intention to 
treat analysis. 
Also, the 
patients who 
dropped out 
had more sere 
COPD.  
Puhan et al., 
2006  
COPD, n=98, 
FeV1/FVC<70% 
predicted. 
To examine whether 
interval exercise is 
no less effective 
3 weeks supervised PR 
involving continuous 
exercise >/= Wpeak (C 
CRQ, 6MWT at baseline and 
post-PR. 
Between-group 
difference in CRQ 
(-0.05) and 6MWT 
PEDro 
score=8/10. 
The strength of 
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than continuous 
exercise session and 
whether it is 
tolerated better by 
patients with COPD.  
group) versus 3 weeks 
supervised PR involving 
interval exercise of 2 
minutes unloaded pedalling 
followed by pedalling with 
increments of 25 watts 
every 10 seconds until 
unable to maintain pedalling 
frequency of 50/minute (I 
group).  
(1.1m) were not 
significant. 47.9% 
of participants in 
the I group versus 
24% of 
participants in the 
C group adhered 
to their protocol. 
the study 
included the 
use of 
intention-to-
treat analysis 
and blinding of 
assessors. 
Vogiatzis et 
al., 2005 
COPD, n=19 (16 
males), 
FeV1=41.6%) 
predicted. 
To investigate the 
response to interval 
exercise (IE) 
training by 
examining changes 
in morphologic and 
biochemical 
characteristics of 
the vastus lateralis 
and compare the 
changes to that 
obtained after 
constant load (CL) 
exercise. 
3 week exercise- intensity 
124% Wpeak for 30s work 
period interspersed by 30s 
rest for 45 minutes (IE 
group) versus 3 week 
exercise- intensity 75% 
Wpeak for 30min/day (CL 
group). Participants 
exercised for 3 days/week 
Change in type I and II fibers 
cross sectional area, muscle 
capillarization and cycle 
ergometer exercise capacity 
conducted at baseline and at 
3rd week. 
There was no 
significant 
difference 
between the 
groups in the 
outcome 
measures. 
PEDro 
score=6/10. 
Low number of 
participants 
and 
participants 
were 
predominatly 
male (84%). 
These factors 
limit the 
generalizability 
of the findings 
of the study.  
      Mean PEDro 
score=6.3 
Comparison with the content of the Move-On-Up video: The advice in the video was not specific to either continuous or interval exercise. Users of the video are 
advised to exercise to a point of Borg 3 to 4 on Borg scale 1 to 10, for 30 minutes or more, three times weekly.  
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Evaluation of RCT that investigated progression of exercise in PR. 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons 
 PEDro score 
and other 
comments 
Alexander & 
Bento, 2008 
COPD, n=20, mean 
age=68 years 
To compare 
strength and 
functional fitness 
outcomes between 2 
single-set resistance 
trainings of different 
intensity 
progressions in 
elderly PR patients 
to identify if there is 
a threshold effect 
for training 
intensity. 
All participants received 
same load of 8 weeks of 1 set 
of 8 -15 repetitions of 5 
exercises. Rapid progression 
(RP) arm had 5% to 10% 
load increase immediately 
after a session where 10 
repetitions were completed 
while delayed progression 
(DP) arm had 3 to 5 Ibs load 
increase following 2 
consecutive sessions where 
12 repetitions were 
completed. 
Chest press, arm curl and lift 
& reach test conducted at 
baseline and at week 8. 
RP arm 
demonstrated 
improvement in 
the outcomes of 
chest press, arm 
curl and lift & 
reach test that 
were significantly 
higher than that 
demonstrated by 
the DP (p<0.05) 
PEDRo 
score=3/10. 
Participant 
number was 
low and there 
is no known 
MCD for the 
outcomes used 
in the study.  
Comparison with the content of the Move-On-Up video: It is recommended in the video that its users should aim to increase the amount of exercise that they do 
over time. 
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Evaluation of RCTs that investigated effect of varying the number of supervised PR sessions 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons 
PEDro score 
and other 
comments 
Carrieri-
Kohlman et 
al., 2005 
COPD, n=103 (46 
males), mean age 
66+/-8, 
FeV1=44.8+/-14% 
predicted.  
To assess the 
differences in the 
long-term outcomes 
of dyspnoea, 
exercise 
performance, health 
related QoL and 
health resource 
utilization following 
a self-management 
programme with 3 
different doses. 
Self-management 
programme plus walking 
exercise and biweekly nurse 
telephone calls (DM) versus 
DM plus 4 supervised 
exercise sessions over 2 
months (DM-exposure) 
versus DM plus 24 
supervised exercise sessions 
over 2 months (DM-
training). 
6MWT, incremental & 
endurance treadmill exercise 
test, CRQ, SF-36 and Borg-
CR10 conducted at baseline, 
2nd, 4th, 6th and 12th month. 
There was no 
significant 
difference 
according to 
groups in 
improvement in 
6MWT. DM-
training group 
demonstrated 
significantly 
greater 
improvement 
(p<0.05) than DM-
exposure and DM 
group in Borg-
CR10 and 
treadmill walk 
time (at 2nd, 6th& 
12th month), CRQ 
(at 2nd) and SF-36 
(at 4th month).  
PEDro 
score=6/10. 
115 patients 
were 
randomized 
but data was 
presented for 
103 patients.  
Nguyen & 
Carrieri-
Kohlman, 
2005 
COPD, n=103 (46 
males), mean age 
66+/-8, 
FeV1=44.8+/-14% 
predicted. 
To assess the effects 
of 3 versions of 
dyspnoea self-
management 
programme on 
depression in 
patients with COPD. 
Self-management 
programme plus walking 
exercise and biweekly nurse 
telephone calls (DM) versus 
DM plus 4 supervised 
exercise sessions over 2 
months (DM-exposure) 
versus DM plus 24 
supervised exercise sessions 
Centre for epidemiological 
studies depression scale (CES-
D), 6MWT, incremental & 
endurance treadmill exercise 
test, CRQ and SF-36 conducted 
at baseline, 2nd month. 
 
There was no 
significant 
difference 
according to 
groups in 
improvement in 
CES-D and 6MWT. 
DM-training group 
demonstrated 
PEDro 
score=5/10. 
115 patients 
were 
randomized 
but data was 
presented for 
103 patients. 
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over 2 months (DM-
training). 
significantly 
greater 
improvement 
(p<0.05) than DM-
exposure and DM 
group in treadmill 
walk time and CRQ 
at 2nd month. 
O’Neil et al., 
2007 
COPD, n=91 (61 
males) 
randomised, 66 
(46 males) 
completed. Mean 
FeV1 =41.33%. 
To compare the 
effects of twice-
versus once-weekly 
supervised PR on 
exercise capacity 
QoL in patients with 
COPD. 
6 weeks of twice-weekly 
supervised PR versus 6 
weeks of once weekly 
supervised PR. 
ISWT, ESWT, CRQ scores 
measured at baseline, week 6, 
2 months and 6th month of 
study. 
There was no 
significant 
difference 
between the study 
arms in 
improvement in 
outcomes of ISWT 
and CRQ (p<0.05). 
There was 
significant 
difference in 
outcome of ESWT. 
However, this 
between-group 
difference in 
ESWT had been 
present at baseline 
and continued to 
be present at week 
6, month 2 and 
month 6 of study. 
PEDro 
score=6/10. 
Drop-out of 
27.5% and no 
intention-to-
treat-analysis 
are weaknesses 
of the study. 
The proportion 
of drop-out 
resulted in the 
study being 
underpowered. 
The trend in 
improvement 
in ESWT 
suggested a 
relationship 
between 
baseline 
exercise 
capacity and 
improvement 
in exercise 
capacity 
following PR. 
      Mean PEDro 
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=5.7 
Comparison with exercise sessions as recommended in the Move-On-Up video: It is recommended in the video that individuals should observe exercise sessions of 
3 to 4 times a week. 
Evaluation of RCT that investigated length of PR programme. 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons 
PEDro score 
and other 
comments 
Sewell et al., 
2006 
 COPD, n=100 (56 
males), mean age 
70 years, mean 
FeV1 1.13litre. 
To evaluate whether 
4 weeks PR 
programme is 
equivalent to a 7 
week PR at 
equivalent time 
points of 7 weeks 
and 6 months. 
4 weeks of twice-weekly 
supervised PR sessions (4-
wk-PR-group) versus 7 
weeks of twice-weekly 
supervised PR sessions (7-
wk-PR-group). 
The ISWT, ESWT, CRQ and 
BPQ (breathing problem 
questionnaire). 
 
At the 7 week 
point, the 4-wk-
PR-group only 
demonstrated 
greater 
improvement in 
ESWT that was 
statistically 
significant 
(p=0.02) 
compared to the 7-
wk-PR-group. At 
6th month post-PR, 
there was no 
significant 
difference in 
outcome between 
the groups. 
PEDro 
score=6/10. 
The authors 
suggested that 
the awareness 
that their 
supervised PR 
programme is 
limited to 4 
weeks may 
have 
influenced the 
degree of 
motivation and 
participation 
by participants 
in the 4-wk-PR-
group, hence 
the higher 
improvement 
in outcome 
demonstrated 
at 7th week.  
      Mean PEDro 
score = 6 
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Comparison with exercise sessions as recommended in the Move-On-Up video: The video is available for continuous use at home. 
 
Evaluation of RCTs that investigated effect of repeating PR programme. 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons. 
PEDro score 
and other 
comments 
Romagnoli et 
al., 2006 
 COPD, n= 29, 
males=19 mean 
FeV1=36.5%, were 
recruited. All 
completed 
inpatient PR, 32 
completed 6th 
month 
assessment, 29 
(19 males) 
completed 12th 
month 
assessment. 
To investigate the 
optimal frequency 
of delivering PR and 
evaluate whether 
repeating PR more 
frequently would 
lead to similar long 
and short term 
physiological gains 
and decreases the 
burdens of 
hospitalization. 
Both arms participated in 
inpatient PR (2 weeks, 6 
sessions/week). Group 1 
participated in 2nd and 3rd PR 
programme (outpatient) at 6 
and 12 month post-
discharge. Group 2 
participated in only 2nd PR 
programme (outpatient) at 
12 months post-discharge. 
Maximal inspiratory pressure, 
maximal expiratory pressure, 
6MWT, 10-point Borg scale, 
SGRQ, number of 
hospitalization and number of 
days on admission. 
Both groups had 
similar significant 
improvement in 
6MWT post 
inpatient PR 
(p<0.05), but both 
groups had lost 
the gains at 6 
months post 
inpatient PR. 
Significantly larger 
number of 
patients in group 2 
experienced 10 
days or more of 
hospitalization 
(p<0.05). 
PEDro score-
5/10. Though 
participants 
were 
randomised, 
There was no 
blinding of 
assessors or 
concealment of 
allocation. 
      Mean PEDro 
score=5 
Comparison with exercise recommendations in the Move-On-Up video: The video is available for continuous use at home. 
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Evaluation of RCTs that investigated effect of audiovisual stimuli on training outcomes in patients with COPD. 
RCT 
reference 
Population Study aim Intervention Outcomes Main findings 
including 
between-group 
comparisons 
PEDro score 
and other 
comments 
Bauldoff et 
al., 2005 
COPD (moderate 
to severe), n=30 
(13 males), mean 
FeV1 41.27+/- 
18% predicted, 
mean age 63+/-11 
years. 
To determine the 
feasibility of 
distractive auditory 
stimuli (DAS) used 
during an upper 
limb training (UET) 
programme on 
perceived dyspnoea, 
functional 
performance, and 
health-related QoL. 
In addition, to 
determine the 
appropriate music 
tempo used during 
the UET. 
UET for 15 minutes 3-5 
times/week using moderate 
DAS versus UET for 15 
minutes 3-5 times/week 
using slow DAS versus 
control group (UET for 15 
minutes 3-5 times/week but 
no DAS). 
University of California 
Shortness of Breath 
Questionnaire (UCSD SOB), 
SGRQ, 6 Minute Peg and Ring 
Board Count (6MPRB) taken 
at baseline and 4th week. Also, 
self-report daily log. 
 
Compared to the 
control group, 
each of the 
moderate and 
slow DAS groups 
demonstrated 
significantly 
higher 
improvements in 
6MPRB counts 
(p<0.05). There 
was no significant 
difference in 
6MPRB scores 
between the 
moderate and 
slow DAS groups. 
There was no 
significant 
difference 
between the 
groups in the 
SGRQ and 
perceived 
breathlessness 
scores. 
PEDro 
score=5/10. 
There is no 
known MCD for 
6MPRB count. 
The study 
suffered from 
failure to 
achieve 
blinding of 
therapists or 
assessors.  
Liu et al., 
2008 
COPD, n=48 (all 
male), mean age 
=72.1 year. Mean 
To evaluate the 
clinical efficacy, 
compliance and 
applicability of a 
Daily endurance walk at 
80% maximal capacity by 
following the tempo of music 
recorded on a mobile phone 
ISWT, FeV1 and SF-12 
measured at baseline and 
weeks 4, 8, 12 and 52.  
Compared to 
control group, the 
mobile phone 
group 
PEDro 
score=4/10. 
The 
participants in 
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FeV1 =45.6%. home-based 
exercise training 
programme added 
to music from a 
mobile phone. 
(mobile phone group) 
versus daily endurance walk 
at 80% maximal capacity 
without mobile phone music 
(control group). 
demonstrated 
significantly 
higher 
improvement in 
ISWT (at 12 and 
52 week) and SF-
12 (at 12 and 52 
week) (p<0.01). 
There was no 
significant change 
in FeV1 in either 
group. 
this study were 
all males which 
may limit the 
generalizability 
of the findings. 
There was no 
blinding of 
assessors.  
Nguyen et al., 
2008 
COPD, n=50 (33 
males), 
FeV1/FVC<70%. 
To test the efficacy 
of two dyspnoea 
self-management 
programmes in 
patients with COPD. 
 
Dyspnoea self-management 
(education, self-
management skill training 
and independent exercise) 
delivered as 
internet/personal digital 
assistant based (eDSMP) 
versus same programme 
delivered face-to-face 
(fDSMP). 
CRQ, 6MWT and exercise 
habit diary measured at 
baseline, 3rd and 6th month of 
programme. 
Both groups 
demonstrated 
significant 
improvement at 
3rd and 6th month 
in CRQ, 6MWT and 
exercise habit. 
There was no 
significant 
between-group 
difference in the 
outcomes. 
PEDro 
score=6/10. 
Though, the 
study 
conducted 
intention-to-
treat analysis, 
drop-out was 
high (36%). 
Also, there was 
no blinding of 
assessors. 
Petty et al., 
2006 
COPD, n=214 
randomised, 174 
completed the 
study (120 males, 
mean age=70 
years). 
To compare the 
effects of a library of 
pulmonary 
rehabilitation 
videotapes versus 
an older videotape 
and usual care on 
quality of life in 
persons with COPD.  
Videotape according to 
COPD disease 
level/psychological state of 
motivation (customised 
videotape) versus standard 
videotape (2 tapes on PR 
exercises and education) 
versus control group (usual 
care from physician which 
may have included written 
or verbal information). 
Fatigue impact scale (FIS), 
Seattle Obstructive Lung 
Disease questionnaire (SOLQ) 
and SF-36 measured at 
baseline, 4th, 8th and 16th 
week.  
At 16th week, the 
customised 
videotape group 
demonstrated 
significant 
improvement in 
emotional function 
and coping skills 
domains of the 
SOLQ, compared 
to participants 
who received 
PEDro 
score=3/10. 
There was 20% 
drop-out and 
there was no 
intention-to-
treat analysis.  
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standard video or 
their usual care 
from their 
physician (which 
may have included 
written or verbal 
information) 
(p<0.05). Also, 
participants in the 
individually-
customized 
videotape group 
demonstrated 
significantly larger 
improvement in 
the physical 
function domains 
of the SOLQ, 
compared to 
participants who 
received usual 
care (p<0.05) but 
not when 
compared to 
participants who 
received standard 
video (p=0.069). 
There was no 
between-group 
significant 
difference in other 
outcome 
measures. 
      Mean PEDro 
score=4.5 
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Comparison with exercise recommendations in the Move-On-Up video: The video contains audio and video stimulation in terms of sounds and images of individuals 
demonstrating the exercises.
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APPENDIX 4A: ETHICAL APPROVAL FOR FOCUS GROUP STUDY THAT 
EVALUATED SUITABILITY OF THE MOVE-ON-UP VIDEO FOR VBHEP 
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APPENDIX 4B: INTERVIEW GUIDELINE FOR FOCUS GROUPS THAT 
EVALUATED SUITABILITY OF THE MOVE-ON-UP VIDEO FOR VBHEP 
GUIDELINES FOR CONDUCT OF THE FOCUS GROUP DISCUSSION 
 
A) DOUBLE CHECK THAT EVERYONE IS READY, RECORDER IN PLACE ETC. 
 
B) WELCOME PARTICIPANTS AND GIVE OVERVIEW OF THE CONSTITUTION OF THE 
MEMBERSHIP OF THE FOCUS GROUP e.g we have here all members of COPD support group 
or e.g.we have here consultant chest physician, experienced respiratory nurse(s), 
physiotherapist(s), etc. Do not mention names. 
 
C) INFORM ON THE AIM OF THE FOCUS GROUP. 
 
D) INFORM PARTICIPANTS OF EXPECTED TIME FRAME (1 HOUR, 10 MINUTES 
 
E) INFORM PARTICIPANTS THAT YOU ARE RECORDING ON TAPE 
 
F) COLLECT INFORMATION & CONSENT FORM FROM THOSE THAT HAVE NOT RETURNED IT. 
 A to F to be conducted within the first 7 minutes. 
 
F) PROCEED TO OPEN DISCUSSION OF THE QUESTIONS. THE PERSON WRITTING RESPONSES 
AND REACTIONS SHOULD START EACH QUESTION ON DIFFERENT PAGE. THIS PHASE IS 
EXPECTED TO TAKE 60 MINUTES i.e. average of 5 minutes for each question.  
 
FACILITATOR EXTENDS THANKS TO PARTICIPANTS- 1 MINUTE. 
  
QUESTIONS FOR OPEN DISCUSSION SESSION ON:  
 
MEMBERS OF COPD SUPPORT GROUPEVALUATION OF 'MOVE ON UP' COPD VIDEO FOR HOME 
USE   
(1) How would you rate the knowledge of COPD and exercise as obtainable from the video for 
patients use at home? 
(2) How would you rate the explanations on the causes of COPD and self management contained 
in the video for patients? 
(3) What proportion of the exercises would you describe as relevant to COPD? 
(4) How would you rate the exercises in the video for the varying levels of weakness as may be 
witnessed by COPD patients of different COPD severity at different times? 
(5) How would you rate the recommended duration of the exercise per session as contained in 
the video? 
 (6) How would you rate the advice on exercise how much exercise the patient should do during 
each session as contained in the video? 
(7) How would you rate the advice on ‘rest’ during exercise session as contained in the video? 
(8) How would you rate the choice of exercises contained in the video for safe performance 
when patients do them at home in the absence of a clinician? 
(9) How would you rate the explanations and demonstration of the procedures of performing 
the exercises as contained in the video? 
(10) How would you rate the entire duration of the video? 
(11) How would you rate the level of motivation derivable from the explanations and 
demonstrations on COPD rehabilitation as contained in the video? 
(12) How would you rate the language of instruction in the video for targeted population of 
patients? 
FACILITATOR EXTENDS THANKS TO PARTICIPANTS- 1 MINUTE. 
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APPENDIX 4C: ONLINE DISCUSSION AND EXCHANGE SESSION ON CLINICIAN 
PROFILE PER PR PROGRAMME IN THE UK 
CLINICIAN RATIO PER PULMONARY REHABILITATION PROGRAMME 
http://www.csp.org.uk/icsp/topics/clinician-ratio-pulmonary-rehabilitation-programme 
 
Posted by ademolaadekunle on 16 Jul, 2007 at 9:35pm  
recommendations, 4 comments  
Dear all, 
We will like peoples views as well as personal experience of the ratio/distribution of clinician per 
pulmonary rehabilitation programmes in UK. Present literature has been as far as identifying the overall 
programme organisation e.g. in a UK study,100% of programmes reported having a physiotherapist as 
member of the team, 77% had a nurse as member and 76% had a respiratory physician.  
However, we are interested in knowing what is the average number of physiotherapist per programmeor 
average number of nurses per programme?  
I would be grateful for your contribution and thank you for your time. 
Replies 
 
Respondent 1 on 27 Jul, 2007 at 8:37am  
We run a multi-discpliniary programme delivered by our team members. The overall responsibility 
belongs to the physiotherapist and they are present for all sessions. Talks are delivered by physio (8 
sessions), dietician1(1session), OT(once a week for 15 minutes at the end of a talk for relaxation and 3 
seperate sessions to look at coping with anxiety and long term illness) Nurse (1 session) Support worker 
(1 session) Lead for expert patient programmme (1 session). Always present for each session is a 
physiotherapist and at least 1 support worker but an additional support worker may attend depending 
upon the dependency of the group. 
We use to have input from the respiratory consultant but he tended to duplicate talks that were delivered 
by the physio and most times turned up 30 - 40 minutes late which we felt reflected badly on the 
programme. 
We have any where between 10-15 patients at a time on the programme and take up to three on oxygen 
Hope this is the information you were looking for 
 
 
Respondent 2 on 27 Jul, 2007 at 10:01am  
Clinical practice is 1 physio/ staff to 8 patients, from research point of view or when patients are mild we 
will go up to 10 - 14 patients per staff member.Ultimately this cannot and should not be rigid, it will 
depend on the physical abilities of patients in the group, if mild they may need very little supervision, in 
the community there may be less support/more patients. 
Realistically we should be doing a risk assessment, what is the capability of the gym, how many people 
can safely and adequately exercise there. Remember, risk assessment goes both ways, rehab is a VERY 
SAFE and EFFECTIVE treatment, what is the risk to the patient of NOT receiving adequate treatment if 
unrealistic/ too rigid ratios are set. If I were a patient I would sue the hospital if my rehab did not run 
(classes cancelled) on the grounds there were not enough staff. I would want evidence that there was a 
significant risk associated with running rehab with fewer members of staff- and you would find it hard 
pushed to find that. Patients need rehab at the moment we are barely touching the surface of need. 
 
Respondent 3 on 1 Aug, 2007 at 12:08pm  
We work on the recommendation of 1:8 staff to patient ratio for the exercise sessions. However it's much 
easier to work with a smaller number in reality so i try to have a PTA and a volenteer at times. Our nurses 
only input into the education sessions. 
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Respondent 4 on 2 Aug, 2007 at 9:21am  
Our rehab programme is community based. It is a rolling programme around Angus and we run 2 classes 
concurrently. Our staff:pt ratio is usually about 1:5 and we have a resp specialist nurse and physio in 
attendance most sessions. We find this model works very well for overall pt management as we have 
complimentary skills, and feedback from pts has been very positive - our average attendance rate for the 
groups over 3 years is over 80%. We use different professionals as guest speakers and use staff flexibly 
according to the needs of the group to minimise downtime. 
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4D: PERMISSION FROM BRITISH LUNG FOUNDATION TO APPROACH 
MEMBER BREATHE EASY GROUPS FOR PARTICIPATION IN EVALUATION OF 
VIDEO FOR VBHEP 
From: Susan Oguntoye<Susan.Oguntoye@blf-uk.org> 
To: a.adekunle@herts.ac.uk 
Date: Monday, 11 August 2008 15:13:37 +0100 
Subject: Contacts for your ‘Move on up’ research 
Dear Adekunle,  
Apologies for the delay with this. I have been a little preoccupied with a few things.  
Re. your research, please speak to the Bromley group who as I mentioned in our phone conversation have 
encountered the video already. 
You may be best served by going around and visiting groups, explain during these visits what you do and 
then get their consent to partake in your research. Here the group contacts for some groups that may be 
open to your research: 
Bromley Margaret Gregory 0208 777 0574  margaretgregory@ukgateway.net 
<mailto: radhica.ramoutarseepaul@newhamhealth.nhs.uk> 
Enfield  Pam Blake 0208 245 8113 stanblake@@blueyonder.co.uk 
<mailto: joji.joseph@newhamhealth.nhs.uk> 
Greenwich Helen Jefford 0208 836 8657 helen.jefford@greenwichpct.nhs.uk 
<mailto: Lynda.haggis@kingsch.nhs.uk > 
Havering Susan Haworth 01708 783 034 
<joji.joseph@newhamhealth.nhs.uk> 
Kingston Bill Peare 0208 948 4419 patbillpeare@btinternet.com; William.peare@sky.com 
<mailto: chazlerigg@hotmail.com> 
Paddington Cassie Lee 0207 886 2349 Cassandra.lee@imperial.nhs.uk 
< mailto: chazlerigg@hotmail.com> 
Southwark Frank Vissicchio 0207 252 8562 
<mailto: matthew.wilde@rtpct.nhs.uk> 
Tower Hamlets Ron Coverson 0207 515 9602 coverson@coverson.co.uk 
<mailto: Kirsty.barnes@rtpct.nhs.uk> 
Wandsworth Hilton Persaud 0208 393 3471 
 
I hope this helps. Unfortunately, I will stop working for the BLF from the 20th August so please get back to 
me before then should you need further information. 
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Regards, 
Susan Oguntoye 
Development Officer- London 
British Lung Foundation 
73-75 Goswell Road 
London 
EC1V 7ER 
Tel 020 7688 5557 
Mob 07792 767356 
Fax 020 7688 5555 
 
Help us to make a difference. 
Sign the British Lung Foundation Charter, calling for better diagnosis, treatment and care for people 
affected by lung disease, by visiting http://www.lunguk.org/media-and-campaigning 
/britishlungfoundationcharter.htm 
2008 ING New York Marathon-Take on the challenge and become part of the BLF team. For more 
information call Caz Jennings on 0207 688 5581 or email events@blf-uk.org 
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APPENDIX 4E: TRANSCRIPT OF THE FOCUS GROUP SESSIONS THAT 
EVALUATED THE SUITABILITY OF THE ‘MOVE-ON-UP’ EXERCISE VIDEO FOR 
USE IN VBHEP  
Session 1: Stevenage clinician focus group session (North Hertford).Date- 03-11-2008, 
1.00pm. In attendance- Principal researcher- Moderator, independent researcher and 5 other 
clinicians (Nurse; a female, Occupational therapist-OT; a female, Physiotherapist I; a male, 
Physiotherapist II; a female, Physiotherapist III; a female) 
Moderator- Good morning everybody. This is the clinician focus group session for the review of 
video of COPD exercise. We are here in Hertford. I will start by thanking you for giving your 
time, I really appreciate that. To start with, just out there (indicating through the double door) 
to the right is the ladies and gents. And in the event of, unlikely event of any fire, basically, we 
would all exit there (indicating to the front entrance of the building). Em, I will just proceed by 
informing us of the aim of the session. Actually, we are here today to, from different individuals 
and perspectives, having watched the video- to kind of give our opinion with regards to the use 
of this exercise video by COPD patients at home for pulmonary rehabilitation programme. The 
expected time frame is 1 hour, 10 minutes and we will not exceed that. I will start by saying; 
from your idea of an ideal video-based exercise programme by COPD patients, what do you 
think of or how do you see the Move-On-Up video? 
OT- Good and professional in making but not ideal in some areas.  
Moderator- I want you to, I mean what are your thoughts, when you were watching it; you 
were thinking this is a video; this is the patient population who would be using it and coming 
from that perspective. 
Physiotherapist I –The overall stuff is good. 
Moderator - Now, I mean in the area of information, what kind of information about the effect 
of exercises on COPD do you think most COPD patients want or need to know. Would you say 
the video has got enough of that , or you would say probably more needed, how much of it 
would you say is contained in the video? 
OT- There is a lot of it by the doctor. 
Nurse-Lots of repetitions. 
Moderator- The exercises in the video, quite a number of them.  Altogether, looking at the 
effectiveness of exercises in COPD; what do you feel about the effectiveness of exercises chosen 
in the Move-On-Up video? 
Physiotherapist II- Difficult to say good balance of upper and lower limb exercises. But they 
didn’t no progression.  
Physiotherapist III- But they didn’t say why they selected those exercises. 
Moderator- And the selection of exercises, are they right or not, or a little more should have 
been added or its just enough in terms of arriving at an effective programme? 
Physiotherapist II- The exercises are okay – they did walking outdoor, etc. It is more to do with 
the progression. 
Moderator- Hmm- okay in terms of the proportion of exercises that are suitable for COPD, now 
different patients are at different stages of the disease and my question is what progression of 
the chosen exercise are applicable. Since we know there are the mild, the moderate and the 
severe COPD patients and each of these stages; the patient would be looking at participating in 
the programme. So what proportion of the exercises, could be applicable to these different 
stages of COPD? 
Physiotherapist III- Begining with, you watch your breathlessness, warned to watch  
Moderator- So we are looking at the vast majority of the exercises, or maybe less than half or 
half? 
Physiotherapist II- say 75% suitable for majority. 
Physiotherapist I- Yes 
306 
 
Nurse- Yes 
Moderator- I think here, we are coming to something very important. Since the video is being 
given to patients to use at home, it is slightly different from a hospital based or community 
based programme where the clinicians are with these patients. What do you think about the 
safety of a patient doing the chosen exercises in the absence of a clinician? Are they just- not too 
difficult which they should be able to carry out on their own or would it be something not safe 
or are we looking at just ideal? 
Physiotherapist I-They are safe enough. 
Nurse- Yeah. 
Physiotherapist I- Just safe on their own. 
Nurse- Yeah. 
Moderator- Now if you are talking about the exercises in the video, what do you think about the 
recommended amount? Is it just appropriate or not enough, including the intensity, the duration 
of exercises: as in how long to do it, how often to do it? 
Physiotherapist II- Each patient can identify where they fit, weight by weight, you can 
progress. 
Physiotherapist I- A tin of 500 gram is too low. 
Moderator- What about the duration? 
Physiotherapist III- I think they said half an hour, 3 to 4 days weekly. 
Nurse- I think there were clear messages about exercise intensity. 
Moderator- Okay, now because this is a home programme, let’s look at it from the point of 
motivation. When you think about the motivation desirable to help patient in complying with 
home based programme, what comes to your mind about the Move-On-Up? Is it just okay or is 
there anything you can think of that you would do more or less of? 
Physiotherapist I- Very positive and reassuring! But I think all the patients look too well. 
Moderator- Now to communication and demonstration in the video, how do you feel about the 
way of communication in the video? 
Nurse- the language, no jagons, communication is clear.  
Physiotherapist I- practical advises were given, sometimes pictures going over voice, too much 
talking at times.  
Moderator – I will just like to hear from you other things other than those we’ve mentioned 
earlier, basically that will make you choose the Move-On-Up video for use in home based 
exercises by COPD patients/ 
Physiotherapist I- It’s the only one we know.  (all laugh). Patients see that it’s not scary 
exercises (laugh).      
Nurse- Open patients mind to go through the door and attend pulmonary rehabilitation. 
Moderator- What other things, I mean apart from the ones we’ve mentioned. What other  
things do you think would make you not to recommend it to a patient? Or basically what are the 
things you think you would do more or less of? 
Physiotherapist III- Maybe another video different one for different COPD severity level. 
Chorus- Yes-  
Moderator-That is being very very useful. Thank you very much. I think we touched practically 
everything we want to. it is good I have been able to get some other areas from you. Thank you 
very much for your time. You are very very much appreciated.  
Participants responded- Thank you too.  (Laughs!) 
END OF SESSION- 
DURATION- 42 minutes 
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Session 2: Bromley COPD patients focus group session (London). 
Date- 18-11-2008, 1.30pm 
In attendance- Principal researcher- Moderator, independent researcher and 4 patients (Patient 
I; a female, Patient II; a male, Patient III; a male, Patient IV; a female) 
Moderator- Thank you very much, I welcome everybody here to the focus group session in 
which we are discussing the use of Move-On-Up exercise video for use in home based exercises 
by COPD patients in UK. Like I said, the aim of the session is to have opinion of patients who are 
the end users of the video on various points.  I am going to start by saying what are your ideas of 
an ideal video for home based exercise for COPD patients? What will you be looking out for. 
Patient III- I will be looking out for exercises that will improve my breathing and I find in the 
video they seem to concentrate on the whole of the body. 
Patient IV- (looking towards patient III in disapproval) I get a lot of muscle pain so I need 
something also to keep my muscles more subtle, you know, not too much ache when I get out of 
breathe. 
Patient I- Well, I am not as I used to, muscle wasting, this is why I need exercise   
Moderator- Any other thing? 
No response  
Moderator- Well basically, let’s come down to information.What kind of information on the 
effects of exercise on COPD do you think most COPD patients would want to know and how 
much of this would you say the Move-On-Up video gives? 
Patients III- Yeah, the information there is quite reasonable because exercise seems to be 
number 1 priority not just for the lungs but for the heart as well and they (video) 
tell you the same. 
Patient IV- What they need to tell people so that they don’t get frightened, when you get out of 
breath, you are not harming yourself, it doesn’t hurt you to get out of breath. It is in the aspect of 
the video. I think when you first get out of breath, you’ve been in the hospital, when you come 
out, you get breathless, you stop doing it, you get frightened. That’s what they(in the video) tell 
you. 
Moderator- And what do you feel about the effectiveness of the exercises? You know those 
exercises you see in the video, what do you feel about them, the ones in Move-On-Up? How do 
you see those set of exercises? 
Patient IV- I think they are great.  
Patient III- I think the video is a bit too long. 
Patient II- No! (reacting to the response of Patient III) 
Patient III- I’ll say 20 minutes to half an hour. 
Moderator- Is that talking about the length of the exercises? 
Patient IV- But there was no need to explain it all. I think they (the explanations) could have 
been at the end. Then, there could have been, just complete the exercises, no talking, go from 
one exercise to the other, so you go through it a bit quicker.  
Patient I- Now I think, when you know exactly what you’re doing, you know how not to do it 
too much. 
Patient IV- I still like having the video on while doing the exercises but I don’t want to hear all 
the stuff each time I do it, so I push the fast forward (button on the videoplayer). 
Patient II- You could do that. 
Patient IV- Yes that is what I did. 
Patient III- It’s all down to how you package the exercises, doing it alone or with someone else, 
you know. 
Patient II- But I love doing my own thing alone. 
Patient III- It’s really appropriate. 
Moderator- I mean, talking in terms of doing it in group or alone, now we are looking at a video 
which people are given to use at home, we are looking at the motivation aspect of it and 
basically with regards to this particular video, what amount of motivation would you say is 
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derivable from it? Would you say just enough? Is it very much? Is it not enough? What, what are 
your opinions in terms of the motivation. 
Patient II- I think the motivation to keep through the exercise rather than just sit around, I 
think the motivation is good. See some people need motivating but me, nobody tells me. 
Patient I- Think there should still be a bit of supervision so as to be guided properly, at what 
point to change anything. That is why it is not wise to do it on your own. 
Patient II- I do my exercises. Because of the breathing, I exercise with a 9 inches fan. I couldn’t 
do it without a fan. 
Moderator- Now what about the amount of exercise, I mean 
Patient II- Too long! 
Moderator- What would you say about the amount of exercises recommended, I mean the 
information in the video about how much you should do, how much rest you should have in 
between (exercises), things like that. What do you think about the information on how much 
you should do as recommended in the video? 
Patient II- Like I said, the British Lung Foundation and the British Heart Foundation and they 
say between 20 minutes and half hour. 
Patient I- I think if you work within your own pace. 
Patient III- The video takes an hour for me.  
Patient I- They (the video) did say it. 
Patient IV- Yes, they did say it- yeah. And like I said if you don’t listen to all this; what is exactly, 
what is exactly good for you, you just do the exercises, you do plenty of it. You have to keep 
going forward with the video. 
Patient III- No pain, no gain.    
Patient I- But that is not right. We’ve been told that all the time. 
Moderator- Now very importantly, we all know COPD is a condition in which how much it 
affects an individual vary from how much it affects another individual and if we are looking at 
that point, I’ll say looking at how you feel from one day to another and even same day, how you 
feel in the morning might be different from how you feel in the evening, emhow much of the 
exercises do you think you are able to do? What proportion of the exercises do you think you 
are able to do at these different times? 
Patient II- Mid-morning. 
Patient IV- Not evening, but when I have done it, I feel I can do more, and I keep going. 
Patient I- And I do it as soon as I get up. 
Moderator- Now, I am talking about proportion. I just want to have a good idea, let’s say this is 
a whole lot of exercises in the video, what proportion of the exercises is suitable for different 
COPD patients with different levels of breathlessness or different levels of exercise ability? 
Would you say vast majority of the exercises or would you say a good amount or maybe less 
than half or quite a lot of the exercises? 
Patient II- For me, standing is the problem. If I stand and hold on to something. 
Patient IV- It is a good video to start you on exercises you know because they are not strenuous 
yeah! 
Patient III- Like I said, that video takes about an hour. 
Patient I- But you can tailor it to your own need! 
Patient III- Yeah. 
Moderator- Now all these exercise in the video as demonstrated, and basically with regards to 
the communication in the video, the demonstrations, the language and the communication? 
Patient III- Very nice 
Patient II- Yeah. 
Patient I- Yeah. 
Moderator- Now, we are looking at it from the angle of; people are doing it at home, which is 
slightly different from people doing it maybe in the hospital. What do you think of safety of the 
patients doing it in the absence of the clinician? 
Patient II- I think they are safe. 
Patient III- I don’t think they would do any harm. 
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Moderator- Any other thing anybody feels? 
No response 
Moderator- I would like to hear what other things than the ones we have mentioned that you 
like about the Move-On-Up video. The things that would make you choose to use it for home 
based exercise? 
Patient I- I think I can wake up in the morning and just go on and do it. 
Patient III- Except too long. 
Patient IV- Music and good dancing at the end. That would be so good. 
Patient IV- They can put it in into a sequence. Now I am starting and stopping it because I don’t 
want to listen to all the explanations 
Moderator- What about the language in the video and the communication, the demonstrations-  
Patient IV- That’s alright. 
Patient I- Yes. All right. 
Moderator- Now I will just ask at this point, other than those mentioned earlier, are there any 
concern about the Move-On-Up video which you think you will want to voice or is there 
anything you can think of that you would do more or less of? 
Patient I- …The neck exercises, that is the one I will not do because I’ve got bad pain. 
Patient IV- I think that is what you’ve got to do. Go through the video and see what you can do 
and what you can’t. 
Moderator- And are there information in the video around the safe things to do? 
Patient IV- Huh, Hmm (shaking his head affirmatively). 
Patient III- In my opinion, I could spend like 10 minutes to show you by doing exercises, what 
they do to the lung. 
Moderator- That is very nice to hear from you all and thank you very much for participating in 
the focus group. 
Patient III- Thank you very much for giving us the opportunity to look at that video in our 
homes, to say our opinion. 
Moderator- Thank you very much. Thank you so much. 
END OF SESSION- 
DURATION- 25 minutes 
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Session 3: Chase-side, (Enfield) clinician focus group session (Enfield). 
Date- 21-11-2008, 1.00pm 
In attendance- Principal researcher- Moderator, independent researcher and 4 other clinicians 
(Nurse; a female, Occupational therapist-OT; a female, Physiotherapist I; a female, 
Physiotherapist II; a male) 
Moderator- Thank you very much, we are happy and very glad to have the pleasure of the 
company of you all; a team of very experienced respiratory clinicians. Thank you. Why we are 
here today is, we just want to discuss in terms of evaluation of Move-On-Up video for use in 
video-based exercise at home by COPD patients and if I would just start generally by saying ; 
what is or are your idea(s) of an ideal video for home based exercises by COPD patients. 
Basically, what would you be looking out for? 
OT- DVD, not video? 
Moderator- OK, we’ve got this in DVD format and we’ve got it in video format. Basically, what 
are you going to be looking out for in the components, the use of it? Yeah. 
Physiotherapist I- I think it needs to be set up in sections or whatever, so they could see 
different sections of different types. So they know what are the advices and exercises. And then 
the exercises used to be easy to access in separate sections of the video they could access easily. 
OT- You can currently do that in the main menu; you could change and go to each section at a 
time. 
Physiotherapist II- I think the video as it is now is a bit on the high level for the patients. You 
probably need something more sub-acute unfortunately, when they are not as good as those 
people in the video. A little bit more of chair based exercises. Something to start with and then 
they can put the rest into it afterwards. 
OT- And it is not very clear what group of people the video is made for. I think the people we see 
at home with COPD are moderate to severe. So our patients are often those who need oxygen 
regularly. Those wearing oxygen and doing exercises- that sort of thing could be incorporated. 
And I said, it’s obviously difficult having one video for moderate and one video for severe, but 
we only need say within same film, for this one (section) is for people that have moderate, this 
one (section) for severe. You also want your severe people to actually get up and do something. 
Nurse- No, I think that is actually contained in that section called walking. They actually get up 
walking. Though, they still need to exercise. I know you said if we have different sections in the 
same DVD, but I still think personally, we better have one video, I thought the introduction was 
very good. The introduction why exercise; all these explanatory stuff in one tape, the next one. 
Now in the next video, have exercises and as you say, have the mild to moderate to severe ones, 
going out walking and then have a separate tape for the house bound that are unable to go out 
so they still have access to exercise. So I think they need to break it like that.   
OT- In a triple video packed together called “chat to breathe” (Laugh). 
Nurse- No, no. I think it’s better separated so that the professional involved could then say this 
is take that.  
Moderator- I mean what kind of information about the effect of exercise on COPD do you think 
most COPD patients would want to know – I mean how much of this would you say the Move-
On-Up video gives? 
Physiotherapist I - I think the doctor that talked at the beginning gives quite good explanation 
at the beginning. 
Nurse- I think it’s good the patients took part actually. The patients expressing themselves, to 
some degree they see doctors all the time, they like to see other people. 
Physiotherapist I– I think it’s good the way X (the presenter) kept reiterating; be breathless, - 
they felt scared getting breathless.  
Moderator- What, I’m trying to get exactly what you’re, you’re saying. It’s good the way she (the 
presenter in the video) has mentioned about? 
OT- She keeps, during the exercise, saying it’s okay to be breathless. 
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Physiotherapist II- They probably need more and more of that sort of information, in terms of 
just giving some confidence 
Nurse- Yeah. 
Physiotherapist II- It’s alright to be anxious, it’s alright to be breathless but not gasping for 
breath. It’s alright to do as much as you can. It’s alright to keep moving. Because most of them 
are really terrified about doing stuffs like that. 
OT- And also need to say you don’t have to see the whole exercises breaking at once. I think the 
main thing we are concerned about is how to keep our patients motivated to keep doing 
exercises everyday because they do it once, they panic because they are out of breath, they say 
“Oh, that is not going to help me!”. So I think the fact she is saying to them you need to be doing 
it everyday, you don’t need to do the whole tape. 
Nurse- I think the patient need to be quite self-motivated to do the tape. To set aside you know, 
create some time to actually follow that em. 
Physiotherapist I- Do you know a patient that’is actually done it? 
OT- I can think of one, do you know Mr. 
Nurse- Sh! Sh! Sh! (reminding the OT not to mention patients name) 
OT- Ok.Mr O, Mr O(whispered into the nurse’s ears). 
Nurse- Alright (nodding in recognition). 
OT- Yes, he did it. I told him the benefits of some sort of pulmonary rehab and I gave it to him. 
He started doing it regularly and he’s got a lot from it! So it’s interesting. 
Moderator- Thank you very much.  This is taking us to another question which we will just like 
to talk about. Now you’ve seen the different exercises in the video; arm, leg, and other range of 
exercises. What do you feel about the effectiveness of chosen exercises in the Move-On-Up? 
Physiotherapy I- I think the exercises they’ve chosen are actually quite good. I think there are 
good varieties of upper limb, lower limb, but I don’t think just four issues of those exercises can 
do much good. And I don’t think, if I remember correctly, there is nothing very specific about 
progressive in number of exercises.  I don’t think few repetitions is actually enough. I think It’s 
okay to start but some of those patients should be doing ten, twenty of some of those I think. I 
mean 4 or 5 could be fine for some of the patients we see, you know; only mobilizing indoor, 
can’t manage stairs, that sort of thing. 
Moderator- - So you think the 4 or 5 would be good for. 
Physiotherapist I- To start with, yes. 
Physiotherapist II- To start with. 
Physiotherapist I- That needs to be progressed.  
OT- I think it is difficult. Is it not to make a general case about thatem? 
Moderator- Now, there are recommendations on amount of exercises, how much you should do 
in a week or things like that. Em, what would you say about the amount of exercises 
recommended in the video? 
Nurse- I think the presenter in the video said something about 3 to 4 times. 
Physiotherapist II- Yeah 
OT- Yeah, yeah but it wasn’t stressed.  
Nurse- It was there but I don’t think it was reiterated like some other things. 
OT- I think in a way at the beginning where they flashed up the key points like a power point 
presentation, like you know; if you want to do this breathing exercise, if short of breath, how 
you should do, it was there. 
Moderator- Em, now in terms of proportion of exercise in that video, that is or let me frame it in 
a different way. What do you think is the proportion of the exercises, of all the exercises in the 
video, different types of them, what proportion of them is suitable for the different COPD 
patients with different levels of breathlessness? You know we’ve got the mild, moderate, severe 
ones but looking at the exercises as a whole, what proportion of it exactly would you say is 
suitable for the different levels of breathlessness. 
Physiotherapist II- Most of the exercises are in standing. 
OT- Have you got the booklet here? 
Physiotherapist I- Yeah, most are sitting to stand. Yeah. 
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Moderator- Now in this particular video, would you say the vast majority, would you say a good 
amount of the exercises, would you say half, maybe less than half, more? 
Physiotherapist II- I think they need to do more chair based exercises. Majority of the exercises 
are in standing up. 
Nurse- I think we all guys see moderate to severe patients. Because they are really in that 
hospital. However, I think the DVD itself could actually help. I think it’s very ‘middle of the road’ 
OT- The DVD is good. 
Nurse- That would not be challenging enough for mild to moderate and too challenging for 
moderate to severe. 
Moderator- What do you mean by ‘middle of the road’ in terms of proportion? 
Nurse- It would get the ones on the mild side of moderate or the. 
Physiotherapist I- The introduction is general. It is not graded. 
Moderator- When you say middle of the road, are you saying half, are you saying in terms of 
percentage? 
OT- Seventy percent, Seventish. 
Nurse- Fifty. 
Moderator- Any other opinion? 
No response 
Moderator- Now, lets talk about safety. In terms of em, what do you think about the safety of a 
patient doing the chosen exercises in the absence of the clinician? Basically, they are going to be 
probably using it at home, is a different thing from being with us in the hospital, doing it in our 
presence. What do you think about the safety? Have you got anything to say? Are they just okay 
or any concern? 
OT- There is something on there that says; if you get more breathless, they are all going to get 
more breathless! It says, if you get chest pain or tightness, if you’re dizzy or clammy, 
increasingly wheezy- they are all going to get increasingly wheezy! If your joints and muscles, if 
you feel very tired, it is a kind of. 
Nurse- I think they are very satisfactory. When standing, they’re told to hold on to something. 
OT- I just think that could be such that won’t want to push themselves. Again, it’s about balance. 
Nurse- But it’s without the clinician. It’s difficult. Isn’t it? 
OT- Yeah, yeah. It’s safe enough. 
Physiotherapist I- It should say something about if using drugs. 
Moderator- You said something about when they are standing. 
OT- Yeah, they are standing to do, that thing, just make sure that are. They should be obvious 
but you never know. 
Physiotherapist II- Or footwear. They tell them waters, be rehydrated. 
Nurse- All on the side of caution. Isn’t it 
Moderator- Now when you think about the motivation desirable in order to help in complying 
with home based exercise. What comes to your mind about the Move-On-Up video? Is it just 
okay or is there anything that you can think of that you would do more or less of? 
Physiotherapist I- I think motivation is always a problem, isn’t it? Whenever they set patient 
exercises, then compliance is always a problem. 
OT- In the beginning, it’s very good in the beginning. It’s very positive. You need somebody 
pushing them- common! You need somebody pushing them verbally. 
Physiotherapist I- I think the presenter in the video was doing some of that. 
OT- Yeah. 
Nurse- I think the diary, that is a good thing. 
OT- Do you think? 
Nurse- I think with the diary, they need to show it to somebody, then they are going to have 
more incentives. 
OT- Because when there’s no one they’re going to show it to, that is the problem. So maybe if 
you say to them, I’ll come back in 2 months, 3 months and check how far they’ve gone or take 
the diary to the GP. 
Nurse- Or the practice nurse or respiratory consultant or the chest clinic to say common. 
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Physiotherapist I- They need to be accountable. Don’t they? 
OT- Yeah, then they are more likely to do it and they can monitor the improvement and they 
encourage them, say; your breathlessness score was this. 
Moderator- Now, how do you feel about the way of communication? I mean, the 
communication in the video, the language, the demonstrations, I mean what are your opinions? 
Physiotherapist I- It’s okay. 
Nurse- I think a bit too much of the video presenter. 
OT- Does it really matter if the video presenter is an expert patient? 
Moderator- You mean doing the introductions? 
OT- Or doing the exercises with the patients? 
Moderator- Other than these things which we have discussed, I will like to hear from you other 
things which you like about the Move-On-Up video. The things that will make you chose to use it 
for video-based exercise programme at home? 
OT- I like the diary and I like the little booklet. They’ve got the little booklets with pictures in it, 
is all well laid out. 
Physiotherapist II- I think they should bring out more booklets. Some patients don’t use DVD 
so the diary and the booklets are useful.  
Nurse- But also, what about the younger COPD patients? 
Moderator- Sorry? 
Nurse- I say we are getting much younger COPD patients as well? 
Moderator- I will say that is taking us to the next question which is in the area of what are 
other things which you think with regards to the Move-On-Up, what are the other things which 
you think you will probably do more or less of? You’ve just said something about the age, okay? 
Nurse- I’m just saying that we have seen more of the younger age groups as well and I don’t 
think that (the video) keeps such person motivated at all. 
Moderator- You think the tape is more in the area of people that are. 
Nurse- 70 or 80 or late 60s upwards whereas recently, we are getting people who are under 
60s. 
OT- What about, the presenter who represents a generation. 
Nurse- Some of these, more varieties to suit the lesser able and the more able patients. 
Physiotherapist II- The standing up exercises for the more able and the chair based exercises 
needed for the less able. 
OT- Inhalers, nebulizers, oxygens: all need to go in there. What is your opinion? 
Moderator- Well, probably, I am here as a moderator 
Laugh!  
Moderator- I must say it’s being quite exciting and interesting because you have been coming 
up with various, various ideas which I don’t think it’s easy to put together. 
OT- Are you doing, by asking practitioners? 
Moderator- Well, we are having different sessions and in these different meetings, we are 
having a variety clinicians; nurses, physiotherapists, OTs, physicians and this we really hope will 
give us a variety of ideas coming from different professional background and it goes towards the 
evaluation. 
OT- Okay. 
Moderator- You mentioned something about functional activities? 
Physiotherapist II- More chair based exercises. 
Physiotherapist I- I know that the whole point of the tape is talking about exercises but they 
(patients) might want to save their energy in the morning to do something in the evening. There 
is not anything about energy conservation. The DVD can not replace pulmonary rehabilitation. 
According to NICE guidelines, all patients diagnosed with COPD should have some 
rehabilitations. 
Moderator- Thank you very much. I must say you’ve been really and quite helpful and in the 
last 1 hour or so, you’ve been giving us a very good range of ideas and all these would be very 
useful for us. Thank you very much for your time. The time you spent watching the DVD and the 
314 
 
time you’ve spent sitting here doing the evaluation. We’ve come to the end of the focus group 
now. Thank you. 
Laugh! 
OT- Should I press stop? 
Moderator- Yes! 
Laugh! 
END OF SESSION 
DURATION- 40 minutes 
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Session 4: Hornchurch COPD patients focus group session (Essex). 
Date- 25-11-2008, 12.30pm 
In attendance- Principal researcher- Moderator, independent researcher and 4 patients (Patient 
I; a male, Patient II; a female, Patient III; a female, Patient IV; a female) 
Moderator- Good afternoon to every one of us here. It is with pleasure that we welcome you. 
Thank you for coming. We are here to have a focus group session where we would be discussing 
on evaluation of the Move-On-Up exercise video for use by COPD patients for programme of 
home exercise. If I would just start by asking what are your ideas of an ideal video for 
programme of home exercise? What are the things you would be looking out for? 
Patient III- Initially, I wouldn’t do something as I would sit down. I saw my doctor yesterday. 
She was very keen on me starting this, so I didn’t do any of this until then. At same time, I did a 
bit this morning and holding on to a chair or wall or something, I could probably manage 
without falling of. 
Moderator- But then, you went through it? 
Patient III- Yeah. I think I’ll probably be able to manage it. 
Patient I- Encourage me to do some exercises and I think if I over, the exercises themselves are 
good. 
Patient III- What impressed me is that they said “don’t be afraid of getting breathless”. Yeah, 
because I have heart problem and lung problem, so between the two of them, I don’t know 
which one I am being breathless with. So being breathless mean I have to stop. My heart starts 
racing off. But this morning, I was breathless, I was alright, I wasn’t so worried about it (smiling 
broadly). 
Patient II- I very much sit in the arm chair. I get out through the doorstep and become 
breathless and have to sit back again. I just thought what I have to do and then start doing the 
video. And I did the exercises with them as they were saying it and I managed about 3 days 
going with the exercises and I’ve stopped just slouching along in the house slippers. I put proper 
shoes on in the home and I’m quite fit physically and mentally. I walk properly as I am using my 
muscles; I am not slouching along in the house slippers because I don’t have in the house with 
them. I’m just slouching, but this video made me buckle shoes and walk with them. I find the 
breathing exercises wonderful. Because I find it hard to relax because of panting. I think I am 
better now. I am able to control the aspect of my breathing and I’m so much more relaxed. 
Moderator- Em, I mean basically, you’ve all come from different directions. Some of us talking 
about the motivation, some of us talking about the exercises. That takes us to the next question. 
What kind of information about the effect of exercise on COPD do we think most COPD patients 
would be looking for and would want or need to know. And how much of these would you say 
the Move-On-Up video gives? 
Patient II- To relax my breathing and controlling it. For me anyway, you see I still try to move. I 
try to move. I try to do things for myself. I just sit in the chair and feel tired and I just slouch 
along and I am sitting for the best part. But I think if I carry on doing this, which I am trying to 
do, I think I’ll be good. 
Patient III- What makes it quite interesting with breathing is; you don’t think about breathing, 
you just breathe. But if you think about it, you know you are doing the exercises, you have to 
think about it. And you can continue thinking normally instead of those chaos. I think it would 
be beneficial. 
Patient IV- That is right because you are not using, you see I breathe through my mouth most of 
the time. I’ve got to breathe through my mouth, it relaxes me. 
Patient II- The more you it, the better. 
Moderator- What about the amount of exercise? 
Patient IV- The amount? 
Moderator- Yes. 
Patient IV- Half an hour a day. 
Moderator- Half an hour a day? 
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Patient IV- Yes. 
Patient II- I’ve done it as long as they keep going. I’ve done it with them. 
Patient III- But if I understand, I didn’t time it. 
Patient I- As you get stronger, then you can do more 
Patient III- If I go through the whole video, I won’t get to the end. 
Patient IV- Oh well, if you get out of breath, stop! 
Patient III- Exactly. There is a confusion here between what the paper (enclosed with the 
video) says and the video says. I think that  needs resolving. 
Moderator- What is it that you find confusing? 
Patient III- Well, do you calculate the breathing level (Borg breathlessness) after each exercise 
or at the end of it all? 
Patient IV- It is at the end of each. 
Patient III- Then it ought to be added on top here (indicating the top of the paper instructions). 
Patient II- It is after each exercise. At the end of doing that, then you think; what’s  your 
breathing like is and you decide. 
Patient IV- If you look at it, each exercise is different. 
Moderator- In terms of the exercise intensity, in terms of how much exercise is indicated in the 
video, in terms of the duration that you are meant to do the exercises as in the video, em, what 
are your opinions? Thinking about what the video says about how much exercise you should do 
and how long you should do the exercises, what are your opinions? 
Patient I- It general sentence says 4 to 6 times (repetitions). Obviously, that’s for initial. You 
should be able to do more. 
Patient II- And I’ll think they leave it to your own. Where you used to be say breathless 5 today, 
you may be able to be 2 later. It’s just the initial one.  
Patient IV- I think it depends on the individual. If you find the heavy exercises  
As breathless as he (Patient II) says, and I find I get somewhat severe breathlessness with the 
things (exercises) that I do, and I suppose that it is what it’s all about. At the end of it all, I will 
say 4 for breathlessness. 
Patient I- Four? That’s another bad score for a beginner. 
Patient III- It is just all about, you don’t have to do it and hurt yourself because if you hurt 
yourself, you are not going to do it! 
Moderator- Okay, what about the proportion of exercise in the video, some neck, some arm 
exercises, some leg exercises. Now, of these loads of exercises, what proportion would you say is 
suitable for COPD patients? 
Patient II-It must be all over your body. The varieties makes the difference. 
Patient IV- Because you are breathless, you’ve been sitting and doing nothing, no exercise, this 
was before I got the video and so I find all my joints, my neck, my shoulder stiff. Now, I’ve been 
doing this (video exercises) a few times, I ‘m using my legs. That is alright. If you are sitting 
there thinking of these whole tiredness, you won’t be doing nothing. 
Patient II- You might be doing 5 or 6 now, then three weeks time, you might be doing 10. 
Moderator- We all know COPD comes with, we all get breathless differently at different times. 
We can be more breathless than we were yesterday. So we are looking at us being on a different 
level of breathlessness on different days. Looking at these different levels we might find 
ourselves or different levels of breathlessness we might find ourselves, what proportion of these 
exercises would you say apply to all these different levels? Is it much of these exercises, is it 
about half of them, is it more or is it less? 
Patient II- You would get breathless with all of them. 
Moderator- What I’m trying to say is this; let’s say all the exercises are 100%, the different sort 
of exercises, can we say what percentage of these exercises would be applicable to the different 
levels of breathlessness we might find ourselves on different days? Would you say large 
proportion of the exercises can be done at any time, would you say large proportion of the 
exercises can be done at any time or?   
Patient I - Yeah 
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Patient II- Unless you have infection and you couldn’t do any of them. I would be able to do 
them.  
Moderator- So let’s say what %age of the exercises would be applicable at different times? 
Patient I- I’ll say you don’t just stick to one exercise. You do all the varieties of the exercise. I’ll 
say 75% of them. 
 Patient III- Yeah. 
Patient I- One of the benefits with the video is; when I had heart surgery, I went to the hospital 
and they gave me sitting exercises. I went out of the hospital, I couldn’t remember how to do 
them. But seeing the exercises, you could do them much better when you actually see someone 
doing it. 
Patient IV- That’s right. 
Patient III- That is great benefit. 
Moderator- Now in that case, are you talking about the communication, I mean this is one of the 
areas I want us to look into. In this video, the pattern of communication, how do you feel it has 
been? 
Patient III- Excellent! 
Patient IV- Yes 
Moderator- The language, the demonstration? 
Patient III- Excellent 
Patient I- Yeah 
Patient II- Yeah. 
Patient IV- X (the presenter) as she speaks, she used minimum language and it works very well. 
Patient III- And I think as you get older, you need the motivation as well. 
Patient II- Oh, I actually down the road walked out of the house to the post office. 
Patient III- Did you? 
Moderator- You walked out of the house? 
Patient IV- Yes, I did!  
Moderator- To the post office? 
Patient IV- (Laugh). Yes, I did! I actually took my stick, as I open the door, got to the main road, 
trying to cross; the bus coming, then I lost my confidence. 
Moderator- You did mention something about motivation. Because this is a piece of video 
which people get from the clinician, they take home to use, which is slightly different from a 
situation where we are all in the hospital together doing this together. So to get people to do this 
at home would be a bit challenging and as such, motivation is an area where we would really 
want to know what are your opinions. In this particular video, what do you think about the 
motivation level that you could get? 
Patient II- You get more confidence from it. 
Patient III- I am very pleased with the video. It is highly motivational. 
Moderator- What about safety? What about safety of the exercises being done at home em.if I 
could come again, what do you think about the safety patient doing the chosen exercises in the 
absence of the clinician? 
Patient IV- In terms of safety, you’ve only got to be sensible with yourself. Haven’t you? 
Patient IV- Take it easy with yourself. You don’t have to do all. You could hurt yourself. Say do it 
in fives (5s), then sixs (6s), sevens (7s). 
Patient III- Hold on to something. 
Patient IV- As you continue doing it, watching the video, doing it with them and then I could 
start doing it on my own, timing myself. 
Patient III- Is it the intention that based on your study, to modify the production? 
Moderator- Actually, what we are doing is not, I am not one of those that produced the video 
and what we are basically doing is as an independent body evaluating the video. And what we 
want in this case is the opinion of the end users which is the people using it at home. So what 
comes out of this is to reflect how you (the patients) perceive the video. And apart from all  
these we have mentioned, is there any other thing, I mean I will personally want to hear from 
you what are things other than the ones we have mentioned earlier that you like about the 
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Mover-On-Up video, I mean those things that would make you choose to use it for home 
exercise. 
Patient IV- Say it again choose. 
Moderator- Apart from the things which we have mentioned, I will like to hear from you other 
things which would make you choose to use this video for home based exercises. I know we 
have discussed some points but are there others which you will want us to know? 
Patient I- It gets me to move. 
Patient II- It is an open outlet for me. I hope to make a better life for myself than sitting in chair 
and feeling sorry for myself. 
Patient III- I’ll like to be able to walk out and have a couple of drinks in the evening. 
Moderator- Now what about the other way round? I know we’ve discussed a lot of things. Do 
you have other things, other than what we have mentioned earlier, other things which you think 
is there, anything you can think of which you think you will do more or less of as different from 
what is in the video? 
Patient II- Oh now I won’ try gardening. 
Patient I- I would like to do a bit of gardening but it’s not easy for me now. 
Patient III- Say we have any friend who are interested, would they be able to get into it (video) 
even if say for a trial? 
Moderator- We are giving this video out for people to feedback on. 
Patient IV- It is a survey 
Moderator- We are not giving it out as a treatment tool in which case we are not able to say 
“take, go and use it”. That is not what we are able to do because we are doing this within strict 
ethical guidelines. However, using it by any person, you can always approach your GP, your 
physiotherapist, your nurse, I mean who is involved in managing your COPD and through those 
means, people are able to get it as something to be prescribed or to use. So if you have such 
people, of course, they only need to speak with their GP. 
Well, I must say we really appreciate that you’ve given your time today, you’ve given your time 
watching the video (about 1 hour, 10 minutes) and. 
Patient II- Now what have we got to do after, everybody? 
Moderator- Now what we are doing is only one-off. For each of us, we are only participating 
once and you wouldn’t have to come back for this. 
Patient III- Do we keep the DVD? 
Moderator- Yes!  
Participants- Laugh. 
Moderator- Please it’s all yours. You’ve been so great and we really thank you for your time. 
Participants (chorused)- Thank you. 
Moderator- Practically, we have come to the end of the focus group. Thank you. 
END OF SESSION- 
DURATION- 36 minutes 
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Session 5: Kingston focus group session (Surrey). 
Date- 28-11-2008, 12.30pm 
In attendance- Principal researcher- Moderator, independent researcher and 6 patients (Patient 
I; a female, Patient II; a male, Patient III; a female, Patient IV; a male, Patient V; a female, Patient 
VI; a female) 
Moderator- Thank you all for coming to this focus group session. It is a pleasure having you 
around. In the next 1 hour, 1hour.10 minutes, we would actually be discussing on the evaluation 
of the Move-On-Up exercise video as a exercise video for home use in patients with COPD. And if 
I may just start by saying what are your ideas of an ideal video for home based exercise 
programme for COPD patients.     
Patient VI- I think the actual video is very good for people that are at home. You know, getting 
started is a good idea.   
Patient II- Good varieties.  
Patient IV- Good varieties yeah, getting on the right mode of intervention. 
Patient III-Yeah, yeah. 
Patient I-I like the simplicity. 
Patient VI- Yeah. 
Patient II- Yeah. 
Patient I- I mean the simplicity was there, exercise clearly demonstrated and em. 
Moderator- Now if you are looking at a exercise video for home use by COPD patients, what 
kind of information about the effects of exercises do you think should be in such a video? And 
just how much of these would you say you have seen in the Move-On-Up video? 
Patient III- Some of the things I do, I don’t know why I do it, I don’t know what I do but that 
(video)explained it and I thought it was good. 
Patient IV- Yeah, shows you what muscles are 
Patient V- For each movement 
Patient IV- Yeah, I thought that was brilliant. 
Moderator- Now you have an idea more of what you are doing?  
Patient IV- Absolutely, yeah, yeah. I mean we quite like to know why we are doing something. 
Patient IV- They show you the neck exercises and that by physiotherapist and to get all your 
muscles to relax. All their muscles are tight and their shoulders, actually stopping them from 
breathing. 
Patient V- Yeah. 
Patient I- And that is good. 
Patient VI- I think the introduction by the doctor, the professor, very good, very exciting. 
Moderator- Now what would you say about the amount of exercises recommended in the 
video? I mean in terms of how much one should do, or how long one should do the exercises for. 
So as contained in the video, what, what do you think? 
Patient II- I start off with I minute, then I go 1 minute, 30 seconds, then I go to 2 minutes by 
progressing my fitness. 
Patient VI- I think they say that do it four times but. 
Patient V- I think the idea is: how many times a week could you do it? That is the theory. How 
many times are you going to have to sit down, put it in and actually physically do it on your 
because when you are by yourself, you really don’t have the motivation. You have to make the 
effort to do it. But if you wind it on, bypassing the talking, you can actually take half an hour. So 
it doesn’t take that long.  
Patient VI- Yes. 
Patient V- So it doesn’t take that long. Just do the exercises. On the other hand, once you’ve 
done it a few times, you can actually remember it. 
Patient II- You won’t have to use it 
Patient V- You don’t have to use it. 
Patient V- I was thinking actually, if you write it down, just stick it on the wall. 
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Patient VI- Or maybe include 2 CDs, one with the talk from the Professor, about the 
introduction to it, possibly one from doctor, X (presenter). But the actual exercise should start 
within a few minutes of the short talk by X (presenter) and then you could do it. 
Moderator- Well, because there is quite a lot of exercises in the video, if you look at it, it’s got 
some like leg exercises, arm exercises and different ones like that. Now coming from the 
background of your idea of COPD: some days less breathless than others, some days more 
breathless than others. What do you think is the proportion of the exercises that is suitable for 
the different levels of breathlessness that you would see? 
Patient II- About half an hour. The more you do it, the more you do it, the fitter you’re going to 
be and the more active you become doing it afterwards. So, you are using your muscles. Because 
if you’re not doing any exercise, you loose your muscles.  
Patient VI- There are different levels of exercises. You’ve got one for people that are not able or 
would never be able to go out. These are the people that are doing the neck, the shoulder, things 
they can actually do by sitting down in the chair. Then you’ve got the next step which is the one 
standing up by the mantle piece raising their legs, some people would never be able to do that. 
Patient V- Bear in mind, we are all going to get older! Laugh!.      
Patient IV- In a away, do what you can do and then remember what they always taught us, as 
soon as you start puffing around, stop! 
Patient VI- I don’t mind getting out of breath 
Patient IV- No. 
Patient II- It’s all in that video. 
Patient VI- I think the more you do it, the less breathless you become. 
Patient II- Oh yeah. You know I find that really strange, really hard, then I couldn’t keep up with 
the pace of the video because I quite easily. 
Patient V- The sit-to-stand in the video, they were sitting on the edge of the chair. We do it by 
our back to the chair. 
Patient VI- Yeah, I noticed that and I think that is something sort of more far into it. 
Patient II- I used to do it but now,  I have become sort of ill that I can’t do it I can’t do it, the 
rowing boat, that sort of things. It is embarrassing for me. In any way, shape or form, I wouldn’t 
be able to do it. 
Patient V- (speaking to Patient VI) People understand that you have to sit down. 
Patient I- But these here, they say alright, let’s start go out walking around. I can do that. 
Moderator- Really, that is the question I am trying to get across in terms of let’s say: the whole 
lot of exercises in the video  represent a 100%, and we are all at different levels of 
breathlessness, 
Patient I- That’s right 
Patient V- Yes. 
Moderator- But for everybody, are we looking at: we are able to do at least this percentage or 
this proportion of it regardless of where each person is, either it’s slightly breathless, or is very 
very breathless? Each individual, what would you say is the proportion of the exercises that 
you’ll still be able to do in this whole lot? Would you say? 
Patient V- How much of the exercises in the video? 
Moderator- Yes. I mean let’s put it. 
Patient VI- For me 50% 
Patient II- I can probably do most of it. 
Patient V- I would say most of it.  
Patient III- I don’t think there is a problem with any of it 
Patient V- It’s just how many times you are going to do it. 
Patient III- Yeah. 
Patient IV- I can do all of it without getting breathless, at the moment. 
Moderator- So I mean, let’s come to the area of safety then, especially if you are looking at: this 
is a DVD or CD which we give to people to use at home. It’s a different scenario from when we 
are in the hospital and we are doing this exercise with the clinician, next to us. So an area which 
I’ll want us to discuss is: what do you think in terms of the patient doing the chosen exercises in 
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the video. Especially look at the chosen exercises in the video. To you, how do you find them and 
what do you think about the safety of doing it in the absence of the clinician? 
Patient V- I don’t think there is a risk. They are not that difficult. 
Patient VI- You’ve got two stages of exercise here. There are people that’s never done it before 
and you just introduce them. There, you’ve got two levels of exercises. The first one, I could 
imagine anybody could do that without getting themselves hurt. The second one, where they 
were walking around the street, all sort of things like that, that’s the one. 
Patient II- No they are sitting room exercises, they all seems very gentle. 
Patient VI- No, no, you walk round the, that’s alright but the second half of it, I wouldn’t do that. 
Patient II- There are the sitting room exercises, the kitchen exercises, the tins are been used 
and I think let’s do two of each, let’s do these three and then four. If you just do four of those, in 
a long time, you are doing eight. 
Patient VI- Like going and walking up the stairs, I find that, couldn’t do it and you stop within 
people’s capability because it is left to them to decide how far at a time. 
Patient III- And they did give a guideline in there. 
Patient VI- Yeah, when to stop. Yeah. 
Patient VI- I thought it is okay. 
Patient III- You know at the times when you go somewhere, at Surbiton, I tried going on the lift, 
and then I thought no, no. I will attack the stairs.  
 
One of the participants knocks on the table considering that participants were talking to one 
another and not directly to the moderator. The moderator responded that he was interested in 
their conversation and that he was observing and notes of their conversations was been taken.  
 
Moderator- No please, don’t stop. As you are saying it, I am picking everything you are saying. I 
find it very very helpful and useful. I just want you to come up with everything you can in this 
area we are discussing. And it’s been quite useful, I must say. 
Patient V-Alright. 
Patient III- Okay. 
Moderator- I mean another thing I was actually going to ask is in terms of motivation. I mean 
when you think about the motivation desirable for you to be able to comply with a home 
exercise programme because then you are doing it at home. 
Patient VI- I think the thing is trying to get time to do it. If you could get two or three things 
instead of. 
Patient III- I think if  you could motivate yourself, say to do it for a month, say two or three 
times a week and then. 
Patient II- I was going to say, certain programme (on television) that’s the time I do my own: 
watching East Ender, Emeradale, or. I do it every time East Ender is on. If you watch and do it, or 
whatever programme you like,  
Patient IV- That would make you. 
Patient III- Write it down, you don’t laminate the instructions. Write it down, do it. 
Moderator- Okay, how do you word it? 
Patient III- You have it written down, just the details; the legs, the arms, whatever, sit-to-stand. 
Moderator- So if you are talking in terms of the motivation that is required to do these 
exercises at home, what comes to your mind with the Move-On-Up video? Is it just okay or is 
there anything you can think of that you will do more or less of? Looking at the motivation. 
Patient II- I think the exercises are okay. Very well balanced. 
Patient VI- It’s all balanced. 
Patient I- It covers both aspects from beginning to first, right through it. 
Patient III- It does help if you’ve got the right message. It was really motivational. 
Moderator- Would you say you get some sort of enthusiasm looking, I mean watching or doing 
the Move-On-Up video or is there anything you will say you will do more or less of? 
Patient III- From the motivation? 
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Moderator- In terms of putting on the video in your home to the exercises, looking at watching 
it, either the music in it, the demonstrations in it? 
Patient VI- I think what said is that if you want to do an exercise video, you need the right kind 
of music. That place where they keep saying come-on-up, that actually annoys me.  
Laugh. 
Patient II- You need the right kind of music at the background, to give you the incentive. 
Patient III- To give you a bit of boost. 
Patient II- Yeah. To make you feel motivated. 
Patient IV- They mentioned Shiatus and Tai-chi. 
Moderator- Okay, that’s fine. Let’s come on and just discuss about the communication. Now 
how do you feel about the way of communication in the video? The language, the 
demonstration? 
Patient VI- The language and demonstrations are quite good. 
Others- Yeah, yeah!! 
Patient II- I watched a lot of you see, I’ve got a couple of, these other ones actually relaxes you , 
makes you feel very. 
Patient V- I like the explanations. 
Moderator- Now, I will like to hear from you what are other things apart from the ones we’ve 
been discussing, what are the other things that you like about the Move-On-Up video that will 
make you choose to use it for home exercise programme? 
Patient III- What will make us use it? 
Moderator- Yes, what other things apart from what we’ve discussed do you like about the 
Move-On-Up video which would make you think: okay, this is the kind of thing I will use for 
home exercise programme? 
Patient VI- That is what I said, you don’t need the introduction. It’s so long, the introduction. 
But if you just switch it on, get up and do what they’ve done. 
Patient II- Yes, but just wind it on. 
Patient VI- But a lot of people won’t. Sometimes, I do that 
Patient II- But the DVD might be better. You tip down, you tip it down to main exercise, the DVD 
might be better. 
Patient VI- A lot of the elderly people would love the DVD but they don’t know how to do it. 
Moderator- Is that to say you find it easier in the DVD format? 
Patient III- Well, I’ve got the  DVD,I haven’t got the video. 
Patient II- At least, the DVD is better. 
Patient VI- A lot of time, the DVD, yeah but when you have to press it on, you have to keep 
pressing the button. 
Patient II- Have you got the DVD? 
Patient IV- The only trouble you know is the. 
Patient VI-That is what I am saying; I think they are not going to bother. If you are watching the 
introduction, you thought about it, you talk about it, you probably sit down and watch it yeah. 
From that point on, anytime you switch the video on, you wouldn’t want to watch the 
introduction. It’s far easier if you have a video telling you all about the video, all about the 
exercises, why you choose to do it and then you have another video which you put in when 
you’re trying to do the exercise. 
Patient IV- I do the DVD. 
Patient VI- When you switch it on, well, a lot of people won’t mess around with DVD and things 
like that, fast forward. 
Patient III- Most people have got a remote control. 
Patient VI- A lot of old people doesn’t understand the television and video and 
Patient III- Then, they are not going to us it at all. 
Patient VI- Well, I think they would. 
Patient III- So you want the exercises on its own? 
Patient VI- On its own, on its own, separate from the introduction. 
Patient II- But then find someone to do it for you. 
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Patient III- You can separate it, if you get someone to do it for you. 
Patient VI- I mourn about it, I feel produce this video, they could directly produce it that way, 
have the introduction, have the exercise, choose yourself. 
Patient II- You can copy it yourself and choose yourself. You can copy on your computer. 
Patient VI- For most people, it’s beyond them. You are asking people to come to do, you’re 
actually going to try and get them to. 
Patient V- I don’t know if Ade is interested in this. 
Moderator- I mean yeah, I mean I am. I am definitely interested. I mean the other arm of the 
question which I would like to ask really is – other than what we have discussed, what are other 
things which you think for the Move-On-Up video, you will do less of or you’ll do more of. In 
other words, do you have any other comment? 
Patient III- Most of us would if you want us to. 
Moderator- Is there anything that you think should have been done differently? 
Patient II- No. 
Patient III- No. 
Patient VI- No, it is well balanced. 
Patient III- If you want to separate it, separate it! 
Patient II- He wants two DVDs. 
Patient VI- Yes please! 
Laugh! 
Patient VI- The introduction is important but I wouldn’t want to hear it every time I put the 
video on. It bores me. I actually want to put the video on, if you put it on and start fast 
forwarding it, I wouldn’t bother about it. If you put the video on, half an hour for the Eastender 
em., and you start pressing the buttons, doesn’t work. You’ll be out by with Eastender by the 
time you get the video right. 
Laugh! 
Patient II- If youhave the video done at home, with a friend, you’re more likely to do it. I am 
sure that is the key. And you’ll take the time to do it. 
Patient VI- I think sleep, we all end up with pain and the rib aching. This sort of exercises on the 
muscles gets it all going.  
Moderator- Em, really, I would say thank you very much to all of you for your time. You’ve 
given quite a lot of information. We don’t know how many pages we’ve been writing on.  It’s 
been really loads of information we will really find helpful. Thank you very much for your time 
watching the video. Thank you for your time you’ve spent here. 
Patient IV- Do you want the video back? 
Moderator- The DVD is yours. It’s your copy. It’s free. 
Patient V- What are you actually studying? 
Patient II- Physiotherapy. 
Patient V- Alright. 
Moderator- And this is actually part of the programme of study and what we are doing, which 
we have just done part of it now, is evaluating the Move-On-Up video itself, looking at it as 
something to be used at home by COPD patients for home exercise programme. 
Patient III- How many Breathe Easy groups have you done? 
Moderator- Em, we’ve been going from centre to centre and this is the third session we would 
be holding with members of the BreatheEasy groups and it’s been fantastic. I would still like to 
say thank you very much. 
END OF SESSION- 
DURATION- 45 minutes 
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Session 6: Newham clinician focus group session (London). 
Date- 06-01-2009, 1.00pm 
In attendance- Principal researcher- Moderator, independent researcher and 5 other clinicians 
(Consultant chest physician; a male, Nurse I; a female, Nurse II; a female, Nurse III; a female, 
Nurse IV; a female, Nurse V; a female) 
Moderator-Thank you very much, I welcome everybody here. It is a pleasure having you 
around. Why we are having this session, and here with us a team of experienced respiratory 
clinicians, is to evaluate the Move-On-Up exercise video for home based exercise programme, 
video-based exercise programme at home by COPD patients. If I will just start by saying; from 
your point of view, what are your ideas of an ideal video for home based exercise programme 
for COPD patients? Generally, what are the things you’ll be looking out for or what are the things 
you’ll consider as ideal that will make such video suitable. 
Physician- It has to be very simple has straightforward instructions about the importance of 
the exercise. Then, to do one step at a time to make sure patients are following the instructions 
and are doing the exercises 
Nurse II- The exercises in it need to be realistic, that they are not too strenuous. According to 
their MRC score. 
Moderator- Not too strenuous exercises? 
Physician – The difficulty of one DVD for all the patients is just that you’re not tailoring the 
exercises according to the patient. In the hospital, you can see what each patient can do and you 
can tailor their type of exercises and the time of exercise according to your patient. But in the 
DVD, it’s not different. 
Moderator- Thank you. Now is there any other thing you’ll want to mention? 
No response 
Moderator- If I just go to the next one, this is basically, what kind of information about the 
effect of exercise on COPD do you think most COPD patients would want to know or need to 
know and how much of this do you think or would you say the Move-On-Up video gives. 
Another participant enters the room and joins the discussion. 
Moderator- Sorry, for the benefit of the last person that‘s just, turning to the person that has 
just entered- Sorry, we’re just not mentioning names because the tape is running on. Thank you 
for coming, thank you for your time. Why we are here as I have just said is we want to have a 
focus group session to where we would be evaluating the Move-On-Up looking at its suitability 
for use in home based video exercise programme and what I’ve just asked now is, what kind of 
information about the effect of exercise on COPD do you think most COPD patients would want 
to know and how much of these would you say the Move-On-Up video gives?    
Moderator turned facing the entire group 
Nurse II- Some breathing control-they need to exercise to point of breathlessness. That’s very 
important. 
Moderator- Breathing control? 
Nurse II- Yeah. They are scared of breathlessness. 
Physician - Reassurance to patients that breathlessness during exercise is something normal 
and something we expect and they shouldn’t get panicky when this happens. I think from the 
importance of pulmonary rehabilitation, it’s correlation in outcome as the second best after stop 
smoking, so to pass this information because most patients rely on inhalers, on the antibiotics. 
Studies have shown that pulmonary rehabilitation, when properly given to patients gives the 
best result after stop smoking. 
Moderator- OK. Any other information? 
Nurse III- That they need to exercise to point of breathlessness. Most of them as soon as they 
start getting breathless, they normally stop. 
Moderator- Thank you. Now you’ve watched the video and quite a number of exercises there. 
Now the exercises that were chosen in this video, what do you think of about the effectiveness 
of those chosen exercises? What are your opinions about the effectiveness? 
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Nurse II- They have to improve the strength of the chest muscles. 
Physician- I see that there is a lot of introduction. As if there are two DVDs in one. The first one 
of them is like speaking to the patients about doing the exercises, the breathlessness and so on. 
That is the first part. The second part which is actually doing the exercises with the patient. I 
think the design of the DVD for some of the patients is a bit confusing because if you would like 
those patients for example give them a DVD to just play and do the session one by one, you don’t 
expect the patient to do half an hour of introduction every time. You need to go-this is the DVD 
for breathing exercise. 
Moderator- So different DVDs? 
Physician- Yes. 
Moderator -I’m just trying to get what you are saying, if that’s what you mean. Two different 
DVDs; one for introduction,  
Physician- and one for actual exercises which they need to do every time. And then to do a 
strata in the second DVD. To go in chapters. If I’m seeing a patient in outpatient, and say the 
breathlessness score is say 1 or 2 or 3, you say you need to do chapters 1, 2, 3 exercises. Those 
who have got better tolerance, you say they can do this or that, so we know from the beginning 
when they go home that this is for me and this is not for me. I can do this and this one, clear 
instructions about what they can do and what they can not do and for how long and how many 
times. It is not that obvious on the DVD. 
Nurse II- And this would be including their oxygen. Some of them with oxygen, some without 
oxygen. 
Moderator- Okay, I understand what you mean. Okay, basically you are looking at something 
which different levels of COPD severity can use. Okay, what would you say  about the exercise. 
For there to be a result after using the DVD or doing the exercise, we are looking at definite 
amount of exercise that would make it kind of deliver what the clinician wants. From the 
content of the video, what are your opinions or what do you have to say about the amount of 
exercises recommended? In terms of intensity in terms of duration. 
Physician- Like I said, the intensity and duration is for all the COPD patients who can do all of 
them but you can not ask a patient of scale of 6 to do all, and they would just put the DVD on a 
shelf in their bedroom and never do it. So if you want to be realistic with this, you need to do it 
in separate chapters as I said and you need to tailor it according to a patient otherwise, the way 
it’s designed like this, I don’t think anyone would do it except the one who have got mild COPD 
can go ahead and do all of it. 
Moderator- So it is more suitable for the mild COPD patients according to your assessments of 
the amount of exercises and the content. 
Physician- Yeah, too long and too intense for a severe COPD patient 
Nurse III- Especially, in Newham, I mean most of our patients are sort of severe cases. 
Moderator- Any other thing you have to say about the DVD. 
No response 
Moderator- Okay, now what do you think is the proportion of the exercises that is suitable for 
different COPD patients with different levels of breathless? Now, I think 
You’ve touched this a bit but to make it clearer, for a COPD patient, how they feel today might be 
different from how they’ll feel the next day, whether mild, moderate or severe. And even same 
day, their breathlessness can change. Now what proportion of the exercises that is in the video 
would you say is suitable for the different COPD patients and different levels of breathlessness? 
Putting the whole exercises into context of say 100%, what proportion of it do you think 
practically, most COPD patients can do? I mean regardless of looking at , definitely they will 
have varying levels of breathlessness, at any point in time, depending on their breathlessness, 
how much or what proportion of the exercises do you think they will still be able to do? Any 
opinion? 
Nurse I- That would depend on their MRC. 
Physician- Exactly, exactly, depending on their MRC. For example, for mild COPD, they’ll be able 
to do 100%, severe COPD would do maximal 10% to 15%. 
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Moderator- You think the severe would only be able to do 10% to 15% of the content.  Okay. 
Em, the next point is one which has to do with the setting in which this DVD is meant to be used. 
It is a home, it’s meant to be used for home programme, for home based exercise. In the context 
of this, it is slightly different from a situation where they come to the outpatient or community 
pulmonary rehab and they are doing these exercises in the presence of a clinician. So safety is 
what we are looking at here. What do you think about the safety of a patient doing the selected 
exercises in the absence of a clinician, do you see anything, do you think its just okay or do you 
think there is any issue? Just from your own opinion as you’ve watched the DVD and looking at 
the chosen exercises. 
Physician- Where holding on to a can of beans, 400g and to put maybe one of them would fall 
on their head (laugh!). I think it would be quite unsafe to do that. Its if you put the proper words 
if you do that much, you have to stop. Just the different scenario, if you’re having chest infection, 
consult your doctor first, those kind of information. 
Nurse III- Yeah, you do like to say on the cover like if they’re having chest infection, 
Moderator- So more information on the precautions which the patient need to take.  
Nurse III- Yeah. 
Physician- To be more obvious on the DVD.  
Moderator- Em, now, what about the motivation aspect of it. The motivation , how motivating 
is the DVD, the Move-On-Up DVD to be used at home by COPD patients. Because when you give 
home programme, there is always an issue around compliance and to get appreciable 
compliance, then you’re looking at some level of motivation. The DVD, with the language in it, 
the demonstrations in it, with the overall, either the background or the way the message is 
being passed across or the people in it, from different angles, what are your opinions, how 
motivating? 
Physician- The first half of the DVD is suppose to increase their motivation. It’s suppose to tell 
them about the importance of doing their exercises and to see the difference in a patient. It’s 
supposed to motivate the patients to use the DVD. But on the other hand, it’s too long, sorry to 
say, it’s too boring for the patient to go through this all the time. So the motivation would 
depend on the person giving them the DVD, so to introduce it to them and to have this one for 
information, either to make the information shorter in a more attractive way or to give them 2 
different DVDs and then concentrate on exercising with it all the time. 
Moderator- So the aspect of having another patient another patient, you consider that 
motivating, but the issue of having to play it each time they want to use the DVD, you think that ? 
Physician- These are wrong introductions but once they are motivated, the actual exercise. And 
maybe you need somebody a bit younger and more attractive (laugh). 
Nurse III- Like yourself (referring to the physician laugh)  
Nurse III- Like a celebrity  
Moderator- Okay, a well known person. 
Nurse I- Like in the British Lung Foundation magazine, they have some persons 
Moderator- In that sense, you are looking at someone well known who has COPD or? 
Nurse III- No I think someone well known who has COPD because I think then he can relate to 
other patients. Not someone who doesn’t know anything about COPD or breathlessness. A well 
known who has COPD. 
Moderator- What are the other things that you think might contribute to the motivation of the 
patient when they use the DVD. What are the other things you think might make them to use it? 
Nurse II- Yeah, you see this would make them do it, go out more, isn’t it. Maybe it could make 
them, oh, I can go out a little bit, so you then motivate them to have a better outlook or positive 
outlook to life and their own illness because sometimes, how they view their illness. 
Physician- The idea of the DVD is to use at home. 
Nurse II- Yeah, so that they can do more around the house as well, isn’t it. They are scared, 
sometimes, the uncertainty or fear. 
Physician- You don’t expect them to carry it around the house? 
Nurse- II- Oh, you don’t carry DVD but, it will give them the impetus you know, positive mind 
set. 
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Moderator- OK. What about communication? What about the language of instruction, the way 
the message is being passed across, do you think the target population would comprehend it or 
em…to put it in another way, how do you feel about the way of communication in the DVD from 
your own point of view? 
Physician- Some parts of the DVD, introduction is okay for anyone to understand. The other 
partit might have been easier to go through the exercises in sections, how your arm muscles 
affect your breathing and then to go to scenario. The first one, just the information they 
understand and the communications would have been better if they say exercises and its 
importance and how to do it slowly. 
Moderator- What other aspects of the communication do you have particular comment on: the 
background, in terms of people in it, how would the patients see them, would that communicate 
anything or do you think there are better ways of/ You’ve mentioned part of it anyway, like 
getting other people who are well known who have got COPD. Are there other things that can 
improve the communication or as it is okay, do you think it is okay?  
No response 
Moderator- Now apart from the things we have mentioned, are there other things you think 
looking at the DVD you’ll do more or less of or that you’ll do differently? I know you’ve 
mentioned things around having it in different sections for different COPD severity and the 
introduction differently from the exercises. Are there other things you think you’ll do more or 
less of to make it more suitable at home for this patient group? 
Physician- I think we’ve mentioned the most important things. 
Moderator- Are there particular positives in this DVD? Are there things which you think would 
make you use it or choose the DVD for a patient as a suitable DVD? Are there things which you 
think are appropriate? 
Physician- As it is? 
Moderator- Yes 
Nurse III- I think it depends on the patient to see they are the sort of patient with the things 
that were mentioned. As it is now, I think you have to choose your patient. 
Physician- The idea to give something to patients to take home is a great idea. It’s just the how. 
Moderator- I think that is just about all the points I’ve got down here and I’ll say thank you for 
your time. Thank you for the time you must have spent watching the DVD and even for your 
time coming down here. Thank you very much.  
Participants chorused- Thank you very much.    
 
END OF SESSION- 
DURATION- 25 minutes 
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APPENDIX 4F: LETTER TO PARTICIPANTS IN THE FOCUS GROUPS ON 
EVALUATION OF 'MOVE ON UP' COPD VIDEO FOR USE IN VIDEO BASED 
EXERCISE AT HOME  
DATE      
                  LETTER TO PARTICIPANTS FROM COPD SUPPORT GROUP 
 
Dear  
RE- FOCUS GROUP SESSION ON EVALUATION OF 'MOVE ON UP' COPD VIDEO FOR USE IN VIDEO 
BASED EXERCISE AT HOME  
ETHICS PROTOCOL NUMBER: HEPEC/08/08/68 
We are inviting you to take part in a research project. Before you decide, it is important for you to 
understand why the research is being done and what you would have to do. Ademola Adekunle (Research 
Physiotherapists),  
Professor Tim Watson and Mrs Fiona Schreuder (research supervisors) 
will be carrying out the research. Please take the time to read the information on the following pages 
carefully and, if you wish, discuss it with relatives and friends. Take your time to decide whether or not 
you wish to take part. 
If, when you have read the information sheet you are interested in taking part in this study, please 
complete the reply slip and return it to the Principal Researcher/Research Physiotherapist in the SAE 
provided with this letter. Please, give a contact phone number on which a member of the research team 
can call you. When we call you, please, ask any questions you have and we will try to explain and answer 
your queries. Remember that you do not have to participate in this study. Furthermore, you would be free 
to leave the study at any time and there would be no need for you to give a reason. 
Your routine medical care would not be affected in any way. I suggest that you keep this letter so that you 
can show it to anyone concerned with your medical care as a patient.  
Please don’t hesitate to contact us on one of the numbers if you have any questions. 
 
Yours sincerely 
Research Physiotherapists - Ademola Adekunle (02089895164, a.adekunle@herts.ac.uk) 
Research supervisors: Professor Tim Watson (01707284970, t.watson@herts.ac.uk)                                                                                                                             
                                    Mrs Fiona Schreuder (f.m.schreuder@herts.ac.uk) 
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What is the purpose of the study? 
This is a study to evaluate ‘move on up' COPD video for home use by COPD patients. We hope the results 
of this study will help with the treatment of people with COPD. The researcher Ademola Adekunle will be 
carrying out this research as part of a PhD. 
What is the evidence of the video? 
The video of exercise for COPD patients was developed by Boehringer Pfizer in association with St George 
School of Physiotherapy and Association of Chartered Physiotherapists in Respiratory Care. This study 
aims to use the opinion of patients and clinicians to evaluate the content of the video of exercise as a tool 
for pulmonary rehabilitation.  
WHY HAVE I BEEN CHOSEN? 
You are being asked to participate, as we are looking for adults who have COPD (who have some 
problems with breathlessness and physical activities) and with good understanding of verbal explanation 
in English. This study hopes to recruit altogether up to 8 members of COPD client group in each of up to 3 
COPD client focus group sessions. 
Who is organizing the study? 
A research team based in University of Hertfordshire is organizing the study. Ademola Adekunle  is the 
research Physiotherapist and Professor Tim Watson and Mrs Fiona Schreuder  are the research 
supervisors.  
DO I HAVE TO TAKE PART? 
You are free to decide whether or not to take part in this study, and you can leave it at any stage, without 
giving a reason and without it making any difference to your normal treatment. You are under no 
obligation to take part.  
What sort of study is this? 
is study is a focus group discussion session.  
What would happen to me if I take part? 
If you decide to take part, you would receive in the post information about when and where the 
discussion session would take place, a consent form and a copy of the DVD which you should watch ahead 
of the focus group meeting. The “move-on-up” video of exercise is about 1 hour, 5 minute in duration. 
There would be at least a week between the time you would receive the DVD and the day of the focus 
group session. You would be required to attend a session with other members of Breathe easy client 
group making a total of up to eight in the group.  
The focus group session would take place in a community centre or similar non-NHS venues in your 
locality. The research team would offset the cost of public transportation incurred by you. The entire 
focus group session would last about 1 hour, 10 minutes. Completed consent forms would be collected at 
the focus group session. During the session, we would ask of your valued opinion on suitability of the 
“move-on-up” video of exercise for home video based exercise programme in UK COPD patients. This part 
of the focus group session would be recorded on a tape. This would later be transcribed. The outcome of 
the focus group would also inform the content of a questionnaire for a forthcoming national survey 
evaluating the video. The eventual information obtained from this study may help us to improve 
pulmonary rehabilitation management of COPD patients in the future.   
Are there other ways of treating COPD? 
Yes, there are other ways of treating COPD including the use of medications. However, without pulmonary 
rehabilitation, maximal benefits of treatment may not be received by a patient. Therefore, guidelines 
based on research evidence suggested that pulmonary rehabilitation is a necessary part of management 
programme for COPD.  Also outpatient, centre based and home based pulmonary rehabilitation are 
330 
 
indicated to be effective in management of COPD. We are carrying out a study to see if there would be 
additional benefit of doing video based exercises at home concurrently with hospital based pulmonary 
rehabilitation over doing hospital based pulmonary rehabilitation only. As part of the bigger study, this 
focus group aim to evaluate the “Move –On-Up” video of exercises for its suitability to pulmonary 
rehabilitation programme in UK. The focus group would also inform the content of a questionnaire for a 
forthcoming national survey evaluating the video. The eventual information obtained from this study may 
help us to improve pulmonary rehabilitation management of COPD patients in the future.   
Would my taking part in the study be kept confidential? 
No-one except the named researchers would have access to your details and no identifying details would 
be published. If you wish we would provide you with a summary of the final results. All information, 
which is collected during the course of the research, would be kept strictly confidential within the 
confines of the law.  
GP Notification. 
Participating in this study does not require you to use any intervention or do anything that could 
compromise any treatment you might be receiving from your GP. Therefore, we are not required to notify 
your GP of your participation.  
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? 
The results of the study will be presented to therapists working with patients with COPD and submitted 
for publication in relevant journal. We suggest that you keep this letter and a copy of the consent form in 
case you need to show it to anyone concerned with your medical care. 
Contacts for further information 
For any further information, you can contact a member of the research team or the independent person. 
Below are their names and phone numbers: 
Research Physiotherapists - Ademola Adekunle (02089895164, a.adekunle@herts.ac.uk) 
Research supervisors: Professor Tim Watson (01707284970, t.watson@herts.ac.uk)                                                     
.                                                                           
                                    Mrs Fiona Schreuder (f.m.schreuder@herts.ac.uk) 
WHO HAS REVIEWED THE STUDY? 
The Health and Emergency  Profession Research Ethics Committee  at the University of Hertfordshire has 
approved the study.  
ETHICS PROTOCOL NUMBER: HEPEC/08/08/68 
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FOCUS GROUP SESSION ON EVALUATION OF 'MOVE ON UP' COPD VIDEO FOR USE IN VIDEO 
BASED EXERCISE AT HOME  
(Ethics Protocol Number: HEPEC/08/08/68) 
 
 
 
 
CONTACT DETAIL SLIP 
 
I would be interested in taking part in this study and i agree to be contacted by the 
research team. 
 
 
Name: _______________________________________ 
 
Telephone Number: ____________________________ 
 
 
 
Please, return this slip to 
 
Adekunle Ademola, 
Community Respiratory Team, 
Block L1, 
St Ann`s Hospital, 
St Ann`s Road, London. 
N15 3TH 
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APPENDIX 5A: ETHICAL APPROVAL FOR NATIONWIDE SURVEY EVALUATING 
SUITABILITY OF MOVE-ON-UP FOR VBHEP 
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APPENDIX 5B: EXTENSION OF ETHICAL APPROVAL FOR NATIONWIDE 
SURVEY EVALUATING SUITABILITY OF MOVE-ON-UP FOR VBHEP 
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APPENDIX 5C: RANDOMISATION TABLE FOR MEMBER BREATHE EASY 
GROUPS TOWARDS PARTICIPATION IN NATIONWIDE EVALUATION OF 
MOVE-ON-UP VIDEO FOR VBHEP 
COUNTRY B/EASY GROUP B/EASY REGION RAND Rand II 
 England  Peterborough London & South 71 1 SELECT 
England  Aylesbury Vale London & South 50 2 SELECT 
England  Thurrock London & South 64 4 SELECT 
England  Brighton London & South 44 4 SELECT 
England  Southampton London & South 13 4 SELECT 
England  North Herts London & South 57 4 SELECT 
England  Hammersmith & Fulham London & South 51 7 SELECT 
England  Daventry Midlands 28 2 SELECT 
England  Derby & District Midlands 8 2 SELECT 
England  Mansfield & Ashfield  Midlands 20 2 SELECT 
England  Stafford Midlands 16 2 SELECT 
England  Bassetlaw  Midlands 3 4 SELECT 
England  Aire Valley North 30 1 SELECT 
England  Bradford North 14 1 SELECT 
England  Gateshead North 20 1 SELECT 
England  Northallerton North 23 1 SELECT 
England  Grimsby North 18 2 SELECT 
England  Salford North West 9 1 SELECT 
England  Tameside & Glossop North West 12 1 SELECT 
England  Bolton North West 4 2 SELECT 
England  West Cumbria North West 6 2 SELECT 
England  Liverpool South North West 9 4 SELECT 
England  Bristol South West 22 2 SELECT 
England  Weymouth South West 16 3 SELECT 
England  Windon South West 9 4 SELECT 
England  Helston South West 11 5 SELECT 
England  Cornwall South West 1 6 SELECT 
Scotland Aberdeen Scotland 10 1 SELECT 
Scotland Dalkeith & Bonnyrigg Scotland 1 1 SELECT 
Scotland Dundee Scotland 14 1 SELECT 
Wales Aberystwyth Wales 8 1 SELECT 
Wales Bridgend Wales 9 2 SELECT 
Northern 
Ireland Derry Northern Ireland 1 2 SELECT 
England  Worthing London & South 76 7 SELECT 
England  Tunbridge Wells London & South 71 11 SELECT 
England  Cannock Midlands 22 4   
England  Dewsbury & District North 20 3   
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England  Warrington North West 4 6   
England  Blackdownhills South West 9 7   
England  Spelthorne London & South 58 14   
England  Kesington & Chelsea London & South 8 14   
England  Southend London & South 35 15   
England  Ashford London & South 53 16   
England  Enfield London & South 33 16   
England  Essex London & South 7 17   
England  Wandsworth London & South 6 18   
England  Bedford London & South 59 18   
England  Bexley London & South 60 19   
England  Welwyn & Hatfield London & South 47 20   
England  Winchester Rural London & South 24 25   
England  Colchester London & South 25 25   
England  Norwich London & South 74 25   
England  Watford London & South 54 26   
England  Windsor London & South 70 26   
England  Cantebury London & South 44 26   
England  Harlow & Epping London & South 54 27   
England  Harwich & Dovercourt London & South 22 28   
England  New Forest London & South 7 29   
England  Saffron Walden London & South 25 30   
England  Dacorum London & South 16 31   
England  Medway London & South 24 31   
England  Milton Keynes London & South 6 32   
England  Islington & Haringey London & South 43 34   
England  Havering London & South 57 36   
England  Horsham & Crawley London & South 65 36   
England  Bromley London & South 63 36   
England  Romsay London & South 5 38   
England  Greenwich London & South 77 39   
England  West Herts London & South 45 41   
England  Merton & Sutton London & South 10 42   
England  Isle of Wight London & South 6 42   
England  Ipswich London & South 8 43   
England  Thanet London & South 30 44   
England  Haven London & South 13 44   
England  Buckinghamshire London & South 77 46   
England  Mid Sussex London & South 9 46   
England  Southwark London & South 54 46   
England  Twickenham London & South 54 47   
England  Clacton London & South 57 48   
England  Brent  London & South 7 49   
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England  Newham London & South 40 49   
England  Maldon London & South 4 51   
England  Tower Hamlet London & South 28 52   
England  Kingston London & South 49 52   
England  Croydon London & South 61 52   
England  Islington & Haringey London & South 58 53   
England  Chichester London & South 21 55   
England  Reading London & South 32 56   
England  Luton & District London & South 21 60   
England  Great Yarmouth & Waveney London & South 25 61   
England  Guildford London & South 58 62   
England  Woking London & South 16 62   
England  Epsom London & South 51 62   
England  North Norfolk London & South 14 63   
England  Banbury London & South 60 64   
England  Camden London & South 5 66   
England  Barking & Dagenham London & South 71 66   
England  Chelmsford & District London & South 11 67   
England  Barnet London & South 9 67   
England  Cambridge London & South 69 68   
England  Hounslow London & South 29 69   
England  Middlessex London & South 12 70   
England  Portsmouth & District London & South 29 70   
England  Fenland London & South 48 71   
England  Fleet London & South 2 72   
England  Hertford London & South 35 74   
England  Braintree & District London & South 38 76   
England  Warwick & District Midlands 12 5   
England  Boxton Midlands 3 8   
England  Louborough Midlands 30 10   
England  Telford & District Midlands 3 10   
England  North Staffordshire Midlands 23 11   
England  Sulihull Midlands 3 11   
England  IikestonHereford Midlands 12 12   
England  Grantham Midlands 18 13   
England  North-west Leicestershire Midlands 11 13   
England  Northampton Midlands 3 15   
England  Chesterfield Midlands 25 16   
England  Sutton & Coldfield Midlands 22 17   
England  Walsall Midlands 7 17   
England  Glenfield Midlands 26 18   
England  Ross on Wye Midlands 10 19   
England  Nottingham West Midlands 6 21   
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England  Nottingham South Midlands 4 24   
England  Dudley & District Midlands 30 25   
England  Birmingham South Midlands 4 29   
England  Lincoln Midlands 3 29   
England  North Nottingham Midlands 21 29   
England  Nottingham Midlands 17 29   
England  Malvern & Wocester Midlands 21 30   
England  Redditch & Bromsgrove  Midlands 23 30   
England  Rotherham North 4 3   
England  Scarborough North 2 3   
England  Teesside North 14 3   
England  Redcar & East Cleveland North 4 8   
England  Wallsend North 9 9   
England  Bansley North 4 11   
England  Darlington North 25 11   
England  Hartlepool North 20 11   
England  Leeds East North 9 14   
England  York North 21 21   
England  Goole North 3 22   
England  Scunthorpe North 27 22   
England  Doncaster North 5 23   
England  Halifax North 1 23   
England  South Tyneside North 8 23   
England  Newcastle North 22 24   
England  Sheffield South North 7 24   
England  Harrogate North 8 25   
England  Ashington North 30 27   
England  Durham North 3 27   
England  Haltwhistle North 8 29   
England  Leeds & District North 13 29   
England  Pontefract North 9 29   
England  Sherburn in Elmet North 26 30   
England  Preston North West 26 8   
England  Blackburn and Accrington North West 1 11   
England  Morecambe North West 10 11   
England  Wirral North West 7 12   
England  Halton North West 14 13   
England  Chesterfield North West 26 15   
England  Fylde and Wyre North West 23 16   
England  Oldham North West 7 18   
England  Blackpool North West 16 19   
England  South Chesire North West 4 19   
England  Newton Heath North West 19 20   
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England  Wigan & Leigh North West 24 20   
England  Kendal North West 26 21   
England  St. Helens & Knowsley North West 3 21   
England  Rochdale North West 9 22   
England  West Lancs & Southport North West 9 22   
England  Central Manchester North West 16 23   
England  Bury North West 6 24   
England  Liverpool North North West 3 25   
England  Stockport North West 7 25   
England  Gloucester South West 22 7   
England  Bournemouth South West 2 8   
England  Guernsey South West 23 8   
England  North Cornwall South West 8 8   
England  North Wiltshire South West 14 8   
England  Tewkesbury South West 8 8   
England  Bristol Withywood South West 23 9   
England  Bath South West 9 10   
England  Penzance South West 7 12   
England  Plymouth South West 2 12   
England  North Devon South West 14 13   
England  Taunton South West 20 15   
England  Weston Super Mare South West 19 15   
England  East Devon South West 24 16   
England  Teignmouth South West 20 16   
England  Torquay South West 1 16   
England  Braunton and District  South West 16 18   
England  Clevedon South West 4 19   
England  Salisbury South West 22 20   
Scotland North Ayrshire Scotland 6 1   
Scotland Clyde Valley Scotland 1 3   
Scotland Borders Scotland 8 4   
Scotland Edinburg Scotland 1 4   
Scotland East Kilbride Scotland 15 5   
Scotland North Glasgow Scotland 5 5   
Scotland Forth valley Scotland 4 8   
Scotland Oban Scotland 13 8   
Scotland Dunfries Scotland 1 10   
Scotland Dunfermline Scotland 8 10   
Scotland Kirkcaldy Scotland 10 10   
Scotland Perthshire Scotland 14 11   
Scotland North Lanarkshire Scotland 4 12   
Scotland Renfrewshire Scotland 13 15   
Wales Bangor Wales 18 2   
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Wales Llanidloes  Wales 4 2   
Wales Torfaen  Wales 6 2   
Wales Llynfi Valley  Wales 3 4   
Wales Abergavenny Wales 10 6   
Wales Anglesey Wales 7 8   
Wales Llanelli Wales 21 9   
Wales Pontypridd & Rhondda  Wales 12 9   
Wales Merthyr Tydfil  Wales 2 10   
Wales Neath Valley  Wales 13 12   
Wales Caldicot Wales 14 13   
Wales Swansea Bay  Wales 19 13   
Wales Wrexham & District  Wales 18 14   
Wales Ystrad Mynach & Bargoed  Wales 13 14   
Wales Cardiff  Wales 7 17   
Wales Kinmel Bay & District  Wales 16 17   
Wales Mold Wales 21 18   
Wales Newport  Wales 20 18   
Wales Carmarthen  Wales 16 21   
Northern 
Ireland Causeway Northern Ireland 1 4   
Northern 
Ireland Belfast Northern Ireland 3 5   
 
Two Breathe Easy groups were excluded from the main questionnaire survey. These included the 
Bromley Breathe Easy group (London & South) whose members were involved in the piloting stage of the 
questionnaire and the Tower Hamlet Breathe Easy group (London & South) whose members were 
receiving PR in a hospital where the principal researcher was a staff during the period of the research 
 
Breathe Easy groups that participated eventually were 
Wandsworth (England) 
Dalkeith Midlothian (Scotland) 
Dundee (Scotland) 
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APPENDIX 5D: RANDOMISATION TABLE FOR UK PR SERVICES TOWARDS 
PARTICIPATION IN NATIONWIDE EVALUATION OF MOVE-ON-UP VIDEO FOR 
VBHEP 
RANDOMISATION PHASE BY PHASE 
Country PR Service SHA rand select 
England Bishop Auckland General  NHS North East 1 select 
England 
City General Hospital, Stoke-on-
trent NHS West Midlands 1 select 
England Derriford Plymouth NHS South West 1 select 
England Doncaster Royal Infirmary  NHS Yorkshire & The Humber 1 select 
England Eastbourne District General  NHS South East Coast 1 select 
England George Eliot Nuneaton, Warwick NHS West Midlands 1 select 
England Gloucestershire Royal Infirmary  NHS South West 1 select 
England Halton General Runcorn NHS North West 1 select 
England Harrogate, England  NHS Yorkshire & The Humber 1 select 
England Ipswich NHS East of England 2 select 
England Kettering, Northamptonshire NHS East Midlands 1 select 
England Kings College London NHS London 3 select 
England King Edward VII Windsor NHS South East Coast 1 select 
England 
Kings Mill Sutton-in-Ashfield, 
Nottinghamshire  NHS East Midlands 1 select 
England 
Macclesfield District General 
Hospital, Chesire NHS North West 1 select 
England Medway District Gillingham, Kent NHS South East Coast 1 select 
England Newham London NHS London 1 select 
England North Manchester General  NHS North West 1 select 
England Northern General Sheffield NHS Yorkshire & The Humber 1 select 
England Queens Hospital, Romford NHS London 1 select 
England Queen Elizabeth Gateshead NHS North East 1 select 
England 
Queen Elizabeth II Welwyn Garden 
City NHS East of England 2 select 
England Royal Bournemouth  NHS South West 1 select 
England Royal Free, London NHS North West 1 select 
England Russell Hall Hospital, Dudley NHS West Midlands 1 select 
England Southampton General Southampton NHS South Central 1 select 
England St Alban City Hospital, Hertfordshire NHS East of England 1 select 
England St James University Leeds NHS Yorkshire & The Humber 1 select 
England Chelsea and Westminster NHS London 1 select 
Scotland Glasgow Royal Infirmary  NHS Greater glasgow & clyde 1 select 
Scotland St Johns West Livingston NHS Lothian 2 select 
Scotland Kings Cross Hospital, Dundee NHS Tayside 1 select 
Wales Royal Glamorgan, Pontyclum 
Bhondda Cynon Teaching Local 
Health Board 2 select 
Wales 
Camarthen Prince Philip Hospital, 
Lianelli Hywel Dda NHS Trust 1 select 
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Northern 
Ireland Craigavon Area Hospital Health & Social Board 1 select 
 
Non-participating PR Service following 
randomization 
1st Replacement attempt: Appropriate PR 
services from the randomisation table 
City General Hospital, Stoke-on-trent Good Hope Sutton  
Derriford Plymouth Freeman Newcastle Upon Tyne 
Doncaster Royal Infirmary  
 
Friarage Northallerton, North Yorkshire 
Eastbourne District General  Queen Elizabeth the Queen Mother Margate 
George Eliot Nuneaton, Warwick Moseley Hall Hospital, Birmingham 
Gloucestershire Royal Infirmary  Great Western Swindon 
Halton General Runcorn Hope Salford 
Ipswich Luton & Dunstable Luton  
Kings College London- this service was involved 
in the development of the video. Therefore the 
service is replaced with the next appropriate on 
the table-  
 
King Edward VII West Sussex 
Macclesfield District General Hospital, Chesire Manchester Royal Infirmary  
Medway District Gillingham, Kent Queen Marys Kent 
Newham London Oldchurch Romford 
Northern General Sheffield Pontefract 
Queens Hospital, Romford Queens Elizabeth Hospital, Woolwich, London 
Queen Elizabeth Gateshead 
 
South Tyneside District South Shield 
Royal Bournemouth  Royal Cornwall    
Southampton General Southampton St Marys Isle of Wight 
St Alban City Hospital, Hertfordshire West Suffolk Bury St Edmunds 
Chelsea and Westminster Barnet  
St Johns West Livingston Edinburgh Royal Infirmary 
Royal Glamorgan, Pontyclum Prince Charles Hospital Merthyr Tydfil 
Camarthen Prince Philip Hospital, Lianelli Withybush Hospital, Haverfordwest 
 
 
Non-participating PR Service during 
1streplacement attempt 
2nd Replacement attempt: Appropriate PR 
services from the randomisation table 
Good Hope Sutton  New Cross Wolverhampton 
Friarage Northallerton, North Yorkshire Hartlepool, England 
Queen Elizabeth the Queen Mother Margate Royal Surrey County Guilford 
 
Moseley Hall Hospital, Birmingham Princes Royal Telford (Shropshire) 
Great Western Swindon Poole  
Hope Salford Lancashire Teaching Hospital, Preston 
Queen Marys Kent St Peters Chertsey 
Oldchurch Romford Royal Brompton London 
Queens Elizabeth Hospital, Woolwich, London St Mary, Praed Street, London 
South Tyneside District South Shield Sunderland Royal Sunderland 
Royal Cornwall    Royal Devon & Exeter Exeter 
St Marys Isle of Wight St Mary’s Portsmouth/Queen Alexandra, 
Portsmouth 
West Suffolk Bury St Edmunds Princess Alexandra, Harlow 
Withybush Hospital, Haverfordwest West Wales General Dyfed 
 
Non-participating PR Service during 3rd Replacement attempt: Appropriate PR 
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2ndreplacement attempt services from the randomisation table 
New Cross Wolverhampton Queen`s Burton on Trent 
Hartlepool, England Huddersfield Royal Infirmary  
Lancashire Teaching Hospital, Preston Leighton Crewe 
St Peters Chertsey St Richards Chichester 
Royal Brompton London St Georges, London 
Sunderland Royal Sunderland North Tees General Stockton on Tees, Newcastle 
Princess Alexandra, Harlow Southend Hospital, Essex 
West Wales General Dyfed Wrexham Maelor Wrexham 
Poole Royal Victoria Infirmary Newcastle Upon Tyne is 
the same team as Freeman Hospital, Newcastle. 
Therefore, the next appropriate hospital to Royal 
Victoria Infirmary is 
Somerset PCT, Hendford Lodge 
 
Non-participating PR Service during 3rd 
replacement attempt 
4th Replacement attempt: Appropriate PR 
services from the randomisation table 
Southend Hospital, Essex Hemel Hempstead 
St Georges, London St Helier, Sutton 
Wrexham Maelor Wrexham University Hospital of Wales 
Somerset PCT, Hendford Lodge St Paul's Medical Centre, Cheltenham 
Queen`s Burton on Trent Salford Royal Hospital, Hope Hospital, Salford 
 
Three PR services were ecluded from the main national survey. These included the Haringey Teaching 
Primary Care Trust (later became Whittington Hospital NHS Trust) PR service which was involved in the 
piloting stage of the questionnaire, the Kings College London PR service was involved in the development 
of the exercise video and the Royal London Hospital (which had the same PR team under the Tower 
Hamlet primary Care Trust) where the principal researcher was a staff during the period of the study. 
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APPENDIX 5E: QUESTIONNAIRES FOR EVALUATION OF 'THE MOVE ON 
UP'EXERCISE VIDEO. 
QUESTIONNAIRE FOR EVALUATION OF 'MOVE ON UP' COPD VIDEO FOR  COPD  PATIENTS  
(ETHICS NUMBER HEPEC/03/09/73 
 
Instruction This questionnaire survey is being done as a nationwide review of the “Move-On-
Up” exercise video by COPD patients (i.e. people with long standing and progressive 
breathlessness). This is to examine how suitable the video is for video-based exercise at home 
by COPD patients. The information obtained from this study may help us to improve future 
treatment of COPD patients through exercises and disease management education to improve 
breathlessness, reduce anxiety, increase exercise ability and quality of life. Completing the 
questionnaire is expected to take about 10 minutes. 
Ademola Adekunle (Research physiotherapist) is carrying out the survey while Professor Tim 
Watson and Mrs Fiona Schreuder are the research supervisors. The researcher Ademola 
Adekunle will be carrying out this research as part of a PhD in Physiotherapy.  
Please, take the time to decide if you wish to participate and discuss it with others that you feel 
necessary.  You can ask us any questions you have and we will try to explain and answer your 
queries (our contact details are included below). Please remember that you do not have 
toparticipate in this study and there would be no need for you to give a reason if you decide not 
to take part. 
Confidentiality of participants is guaranteed. The enclosed return envelope is marked with a 
code which indicates which Breathe Easy group you are linked to. This is to help us to work out 
which Breathe Easy groups have responded – it will not tell us who you are. No questionnaires 
are marked and so we will not be able to tell who the completed papers are coming from. 
For any information, you can contact any of the individuals below 
Research Physiotherapist; Ademola Adekunle, 02089895164, a.adekunle@herts.ac.uk 
Research Supervisors : Professor Tim Watson, 01707284970, t.watson@herts.ac.uk 
Mrs Fiona Schreuder, f.m.schreuder@herts.ac.uk  
 
Instruction 
You are requested to return the completed questionnaire in the envelope provided before 
__/__/ 2009 
Personal Data- 
1) Please indicate your age group from the list below 
20-29    
30-39     
40-49    
50-59    
60-69    
70-79    
80 and above   
2) Gender 
Male   
Female   
 
3) Educational level : what is the highest level of formal educational qualification that you 
have? 
Degree   
Diploma  
A Level   
O Level/ GCSE  
Others   
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4) How many years ago were you diagnosed of COPD?   
2 years or less   
3 - 4 years   
5-6 years   
7-8 years   
9-10 years   
More than 10 years  
5) How much is your breathing and activity affected by your COPD? 
I only get breathless with strenuous exercise       
I get short of breath when hurrying on the level or up a slight hill.   
I walk slower than people of the same age on the level because of breathlessness or have to stop 
for breath when walking at my own pace on the level                     
I stop for breath after walking 100yards or after a few minutes on the level  
I am too breathless to leave the house.      
 
What do you think about the ‘Move on Up’ Video? 
Please tick which of the responses below you think best applies to the corresponding question 
  Very 
Inadequate 
Inadequate Adequate Very 
Adequate 
6 How would you rate the 
knowledge of COPD and exercise 
as obtained from the video for 
your use at home? 
    
7 How would you rate the 
explanations on the benefits of 
exercise in the management of  
COPD as contained  in the video? 
    
8 How would you rate the 
explanations and demonstration 
of the procedures of performing 
the exercises in the video? 
    
9 How would you rate the level of 
motivation derivable from the 
explanations and 
demonstrations on COPD 
rehabilitation in the video? 
    
10 How adequate is the advice on 
including exercises within your 
activities of daily living? 
    
 
Please tick which of the proportion below in percentage(%) you agree apply to the 
corresponding question 
  Few Some Most All 
11 What proportion of the exercises included in the 
video would be helpful to you? 
    
12 What proportion of the exercises in the video would 
you be able to perform within the limits of your 
breathlessness? 
    
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Please tick which of the responses below you think best applies to the corresponding question 
 
  Very 
Inappropriate 
Inappropriate Appropriate Very 
Appropriate 
13 How would you rate 
the recommended 
duration of the 
exercise per session? 
    
14 How would you rate 
the advice on the 
level of physical 
exertion during each 
particular exercise?  
    
15 How would you rate 
the advice on 
increasing amount 
of exercise you 
should do over time 
(exercise 
progression)? 
    
16 How would you rate 
the advice on how 
often you should 
exercise? 
    
17 How would you rate 
the advice on ‘rest’ 
during the exercise 
session? 
    
18 How would you rate 
the choice of 
exercises for safe 
performance when 
you do them at home 
without somebody 
to supervise you?  
    
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Please tick which of the responses below you think best applies to the corresponding question 
 
  Very 
Inappropriate 
Inappropriate Appropriate Very 
Appropriate 
19 How would you rate 
the language used to 
explain the exercises 
and other 
instructions in the 
video?  
    
20 How would you rate 
the length of the 
video? 
    
21 How appropriate are 
the exercises for 
home use 
considering the 
equipment needed? 
    
 
 
THANK YOU FOR COMPLETING THE QUESTIONNAIRE 
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QUESTIONNAIRE FOR EVALUATION OF 'MOVE ON UP’ COPD VIDEO FOR CLINICIANS 
(ETHICS NUMBER HEPEC/03/09/73 
 
Introduction 
 The aim of this questionnaire is to do a nationwide review of the “Move-On-Up” exercise video 
by clinicians managing COPD. A participating clinician is required to have 2 years experience of 
involvement in managing COPD patients/ pulmonary rehabilitation. This is to consider the 
video’s suitability for video-based exercise at home by UK population of COPD patients. The 
eventual information obtained from this study may help us to improve pulmonary rehabilitation 
management of COPD patients in the future. Completing the questionnaire is expected to take 
about 10 minutes. 
Ademola Adekunle (Research physiotherapists) is carrying out the survey while Professor Tim 
Watson and Mrs Fiona Schreuder are the research supervisors. The researcher Ademola 
Adekunle will be carrying out this research as part of a higher degree in Physiotherapy.  
Please, take the time to decide if you wish to participate. You can ask us any questions you have 
and we will try to explain and answer your queries. Please remember that you do not have 
toparticipate in this study and there would be no need for you to give a reason if you would 
rather not participate. 
Confidentiality of participants is guaranteed. The envelope enclosed is marked with a code 
indicating from which NHS pulmonary rehabilitation service an envelope is being returned 
from. This is to assess response rate from the various participating strategic authorities and 
ensure our data collection is not leaving out a population that has been selected by chance 
selection process. It offers the opportunity to be able to send reminders where necessary. 
However, no questionnaire is marked; hence individual responses can not be isolated. 
For any information, you can contact any of the individuals below 
Research Physiotherapist: Ademola Adekunle, 02089895164, a.adekunle@herts.ac.uk 
Research Supervisors:Professor Tim Watson, 01707284970, t.watson@herts.ac.uk 
Mrs Fiona Schreuder, f.m.schreuder@herts.ac.uk  
Instruction  
You are requested to return the completed questionnaire in the envelope provided before __/__/ 
2009. 
 
Personal Data- 
1) Please indicate your profession from the list below 
 Clinical psychologist   
 Exercise physiologist  
 Nurse   
 Occupational therapist            
 Physician   
 Physiotherapist  
 Others  
 
2) Gender  
Male   
Female   
 
3) How many years experience have you working with COPD patients?   
2-3                     
4-5                 
                     6-7                     
                     8-9                     
     10 and above                 
 
 
348 
 
 
Video evaluation data 
Please tick which of the responses below you agree apply to the corresponding question 
  Very 
Inadequate 
Inadequate Adequate Very 
Adequate 
4 How would you rate the 
knowledge of COPD and 
exercise as obtainable  
from the  video for patients 
use at home?       
    
5 How would you rate the 
explanations on the benefits 
of exercise in the 
management of COPD as 
contained in the video for 
patients?                
    
6 How would you rate the 
explanations and 
demonstration of the 
procedures of performing the 
exercises as contained in  the 
video?     
    
7 How would you rate the level 
of motivation derivable from 
the explanations and 
demonstrations on COPD 
rehabilitation as contained in 
the video? 
    
8 How adequate are advice on 
structuring exercises into 
activities of daily living to  
ensure compliance?                                          
    
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Please tick which of the proportion below in percentage(%) you agree apply to the 
corresponding question 
  1%-25% 26%-50% 51%-75% 76% -100% 
9 What proportion of the 
different types of exercises 
that are relevant to COPD 
would  you say is contained 
in the video?             
    
10 What proportion of the 
exercises  in the video would 
you describe as  
relevant to mild COPD  
patients?                 
    
11 What proportion of the 
exercises  in the video would 
you describe as  
relevant to moderate COPD 
patients?          
    
12 What proportion of the 
exercises in the  video would 
you describe as relevant to 
severe COPD patients?                                 
    
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Please tick which of the responses below you think best applies to the corresponding question 
  Very 
Inappropriate 
Inappropriate Appropriate Very 
Appropriate 
13 How would you rate 
the               
recommended 
duration of 
theexercise per 
session as contained  
in the video?                                         
    
14 How would you rate 
the advice  on 
exercise intensity as 
contained 
 in the video?                                          
    
15 How would you rate 
the advice on 
exercise progression 
as contained in  the 
video?                                              
    
16 How would you rate 
the advice on  
frequency of 
exercise as 
contained inthe 
video?                                             
    
17 How would you rate 
the advice on ‘rest’ 
during exercise 
session as contained 
in the video?                          
    
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Please tick which of the responses below you think best applies to the corresponding question 
 
  Very 
Inappropriate 
Inappropriate Appropriate Very 
Appropriate 
18 How would you rate 
the choice of 
exercises contained 
in the video for safe 
performance when 
patients do them at 
home in the absence 
of a clinician? 
    
19 How would you rate 
the language of 
instruction in the 
video for targeted 
population of 
patients?                           
    
20 How would you rate 
the entire duration 
of the video 
    
21 How appropriate are 
the choice of 
exercises for home 
programme  
considering the 
equipment needed?       
    
 
THANK YOU FOR COMPLETING THE QUESTIONNAIRE 
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APPENDIX 5F: QUESTIONNAIRES RESPONSES FOR EVALUATION OF 'THE 
MOVE ON UP'EXERCISE VIDEO. 
Table 1: Results of the national survey in questionnaire items on both patient and clinician questionnaires 
Video item Clinicians  Patients with 
COPD 
Proportion of participants that considered the language used 
to explain the exercises and other instructions in the video as 
appropriate 
96.7%, 
n=60 
98.4%,  
n=59 
Proportion of participants that considered the overall length 
(in time) in the video as appropriate 
92.0%, 
n=57 
96.7%, 
 n=58 
Proportion of participants that considered the knowledge of 
COPD and exercise obtainable from the video as adequate 
93.5%, 
n=58 
96.7%,  
n=58 
Proportion of participants that considered the level of  
motivation derivable from the explanations and  
demonstrations on COPD rehabilitation in the video as 
adequate 
87.1%, 
n=54 
96.7%, 
 n=58 
Proportion of participants that considered the explanation and 
demonstration on procedures of performing the exercises in 
the video as adequate 
96.7%, 
n=60 
96.7%, 
 n=58 
Proportion of participants that considered the exercises safe 
for performance by patients without physical presence of the 
clinician 
95.2%, 
n=59 
100%, n=60 
Proportion of participants that considered the advice on 
structuring exercises within patient’s activities of daily living 
as adequate 
90.3%, 
n=56 
98.4%,  
n=59 
Proportion of participants that considered the exercises in the 
video as appropriate for home based exercise programme 
considering the equipment required 
98.4%, 
n=61 
98.4%, 
 n=59 
Proportion of participants that considered the 
recommendation of in the video on duration of exercise per 
session as adequate 
96.7 %, 
n=60 
100%, 
 n=60 
Proportion of participants that considered the 
recommendation in the video on exercise intensity as adequate 
95.1%, 
n=59 
100%,  
n=60 
Proportion of participants that considered recommendation in 
the video on exercise progression as adequate 
90.3%, 
n=56 
96.7%,  
n=58 
Proportion of participants that considered the 
recommendation in the video on rest during exercise session 
as adequate 
96.8%, 
n=60 
100%,  
n=60 
Proportion of participants that regarded the video as suitable 
in the advice on how often a patient should exercise 
100%, 
n=62 
100%,  
n=60 
Proportion of participants that considered the explanation of 
the benefits of the exercises as adequate 
98.4%, 
n=61 
98.4%,  
n=59 
 
 
Table 2: Results of the national survey in questionnaire items that on clinician questionnaires only 
 
Video item Clinicians  
Proportion of clinicians that believed most or all of the 
exercises are relevant to mild COPD patients 
79.0%, n=49 
Proportion of clinicians that believed most or all of the 
exercises are relevant to moderate COPD patients 
90.3%, n=56 
Proportion of clinicians that believed most or all of the 
exercises are relevant to severe COPD patients 
83.8%, n=52 
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Table 3: Results of the national survey in questionnaire items that on patient questionnaires only 
 
Video item Patients 
Proportion of  patients with COPD that indicated that most or all 
of the exercises included in the video would be helpful to them 
93.3%, n=56 
Proportion of patients with COPD that indicated that they can 
perform most or all of the exercises in the video within the 
limits of their breathlessness 
96.7%, n=58 
 
Table 4: Comparison of responses of ‘suitable’ and ‘very suitable’ from clinician respondents 
Video item Suitable Very suitable 
The language used to explain the exercises and other 
instruction in the video as appropriate 
53.2%, 
n=33 
43.5%, n=27 
The overall length (in time) in the video as appropriate 72.6%, 
n=45 
19.4%, n=12 
Knowledge of COPD and exercise obtainable from the video. 75.8%, 
n=47 
17.7%, n=11 
Suitability of the explanation and demonstrations on benefits 
of the exercises for patients with COPD 
77.4%, 
n=48 
21.0%, n=13 
Suitability of the explanation and demonstration on 
procedures of performing the exercises in the video. 
40.3%, 
n=25 
56.5%, n=35  
The level of  motivation derivable from the explanations and 
demonstrations on COPD rehabilitation in the video  
32.3%, 
n=20 
54.8%, n=34 
Suitability of the choice of exercises for patients to perform 
without physical presence of the clinician 
62.9%, 
n=39 
32.3%, n=20 
Suitability of the advice on structuring exercises within 
patient’s activities of daily living  
43.5%, 
n=27 
46.8%, n=29 
Suitability of the recommendation in the video on duration of 
exercise  
75.8%, 
n=47 
21.0%, n=13 
Suitability of the recommendation in the video on exercise 
intensity  
79.0%, 
n=49 
16.1%, n=10 
Suitability of the recommendation in the video on exercise 
progression  
75.8%, 
n=47 
14.5%, n=9 
Suitability of the recommendation in the video on rest during 
exercise session  
71.0%, 
n=44 
25.8%, n=16 
Suitability of the advice in the video on how often a patient 
should exercise 
79.0%, 
n=49 
21.0%, n=13 
Suitability of the exercises in the video for home based exercise 
programme considering the equipment required 
59.7%, 
n=37 
suggested 
MOST 
38.7%, n=24 
suggested ALL 
Adequate amount of the different types of exercises for 
patients with COPD 
59.7%, 
n=37 
30.6%, n=19 
Proportion of exercises believed to be relevant to the needs of 
a mild COPD patients 
30.6%, 
n=19 
suggested 
MOST 
48.4%, n=30 
suggested ALL 
Proportion of exercises believed to be relevant to the needs of 
a moderate COPD patients 
54.8% , 
n=34 
suggested 
MOST 
35.5%, n=22 
suggested ALL 
Proportion of exercises believed to be relevant to the needs of 
a severe COPD patients 
67.7%, 
n=42 
suggested 
MOST 
16.1%, n=10 
suggested ALL 
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Table 5: Comparison of responses of ‘suitable’ and ‘very suitable’ from patient respondents 
Video item Suitable Very suitable 
The language used to explain the exercises and other 
instructions in the video as appropriate 
26.7%, n=16 71.7%, n=43 
The overall length (in time) in the video as appropriate 46.7%, n=28 50.0%, n=30 
Knowledge of COPD and exercise obtainable from the video. 36.3%, n=22 60.6%, n=36 
Suitability of the explanation and demonstrations on benefits 
of the exercises for patients with COPD 
25.0%, n=15 73.3%, n=44 
Suitability of the explanation and demonstration on 
procedures of performing the exercises in the video. 
30.0%, n=18 66.7%, n=40 
The level of  motivation derivable from the explanations and 
demonstrations on COPD rehabilitation in the video  
31.7%, n=19 64.5%, n=39 
Suitability of the choice of exercises for patients to perform 
without physical presence of the clinician 
50.0%, n=30 50.0%, n=30 
Suitability of the advice on structuring exercises within 
patient’s activities of daily living  
33.3%, n=20 65.0%, n=39 
Suitability of the recommendation in the video on duration of 
exercise  
56.7%, n=34 43.3%, n=26 
Suitability of the recommendation in the video on exercise 
intensity  
46.7%, n=28 50.0%, n=30 
Suitability of the recommendation in the video on exercise 
progression  
38.3%, n=23 61.7%, n=37 
Suitability of the recommendation in the video on rest during 
exercise session  
43.3%, n=26 56.7%, n=34 
Suitability of the advice in the video on how often a patient 
should exercise 
44.1%, n=26 55.9%, n=34 
Suitability of the exercises in the video for home based exercise 
programme considering the equipment required 
36.7%, n=22 61.7%, 38 
Proportion of  the exercises included in the video which would 
be helpful to me 
58.3% , n=35 
SUGGESTED 
MOST 
35.0%, n=21 
SUGGESTED ALL 
Proportion of the exercises in  the video that I would be able to 
perform within the limits of your breathlessness 
55.0%, n=33 
SUGGESTED 
SOME 
41.7%, n=25 
SUGGESTED 
SOME 
 
Table 6: Clinician profiles versus median score of perception of suitability of exercise video for VBHEP as 
adjunct to outpatient PR (1= ‘very unsuitable’, 2= ‘unsuitable’, 3= ‘suitable’, 4= ‘very suitable’). 
Suitability domain Nurses Physician Physio-
therapist 
Others Total 
Knowledge of COPD and Exercise in the video 3 3 3 3 3 
Suitability of the language used in the video to 
the target population  
3 3 4 3 3 
Explanation on benefits of Exercise  3 3 3 3 3 
Explanation and demonstration of procedure 
of doing exercise 
3 4 4 3 4 
Motivation derivable from video 3 4 4 2 4 
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Advice on structuring exercise intop activities 
of daily living 
3 3 4 3 3 
Proportion of the different types of exercises 
for patients with COPD contained in the video 
3 3 3 4 3 
Proportion of exercises relevant to patients 
with mild COPD 
4 3 3 4 3 
Proportion of exerciseds relevant to patients 
with moderate COPD 
3 3 3 4 3 
Proportion of exercises relevant to patients 
with severe COPD 
3 3 3 4 3 
Suitability of the recommended duration of 
exercises per session 
3 3 3 3 3 
Suitability of advice on exercise intensity 3 3 3 3 3 
Suitability of the advice exercise progression 3 3 3 3 3 
Suitability of the advice on frequency of 
exercise sessions 
3 3 3 3 3 
Suitability of the advice on rest in-between 
exercises 
3 3 3 3 3 
How safe the choosen exercises are for home 
programme 
3 3 3 3 3 
Appropriateness of the choice of exercises 
considering equipment required 
3 3 3 3 3 
Appropriateness of the entire duration of the 
video 
3 3 3 2 3 
 
Table 7: Patient profiles versus median score of perception of suitability of exercise video for VBHEP as 
adjunct to outpatient PR (1= ‘very unsuitable’, 2= ‘unsuitable’, 3= ‘suitable’, 4= ‘very suitable’). 
 
Suitability domain Patients 
with 
mild 
COPD 
Patients 
with 
moderate 
COPD 
Patients 
with 
severe 
COPD 
Total 
Knowledge of COPD and Exercise in the video 4 4 3 4 
Suitability of the language used in the video to 
the target population 
4 4 3 3 
Explanation on benefits of Exercise  4 4 3 4 
Explanation and demonstration of procedure 
of doing exercise 
4 4 3 4 
Motivation derivable from video 4 4 3 4 
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Advice on structuring exercise into activities 
of daily living 
4 4 3 4 
Proportion of the different types of exercises 
in the video that is useful for patients 
3 3 3 3 
Proportion of the different types of exercises 
in the video that patient can do within limits of 
the breathlessness that patient experiences 
from day to day 
4 3 3 3 
Suitability of the recommended duration of 
exercises per session 
4 3 3 3 
Suitability of advice on exercise intensity 4 3 3 4 
Suitability of the advice on increasing amount 
of exercise 
4 4 3 4 
Suitability of the advice on how often patient 
should exercise 
4 4 4 4 
Suitability of the advice on rest in-between 
exercises 
4 4 3 4 
How safe the chosen exercises are for home 
programme 
4 3 3 3 
Appropriateness of the choice of exercises 
considering equipment required 
4 4 3 3 
Appropriateness of the entire duration of the 
video 
4 4 3 4 
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APPENDIX 5G: INVITATION TO PARTICIPATE IN QUESTIONNAIRE SURVEY 
ON EVALUATION OF 'MOVE ON UP' VIDEO FOR HOME USE 
LETTER TO BREATHE EASY COORDINATOR 
24 July 2015 
Breathe Easy UK, 
………………… 
Dear Breathe Easy Coordinator, 
 
INVITATION TO PARTICIPATE IN QUESTIONNAIRE SURVEY 
ON EVALUATION OF 'MOVE ON UP' COPD VIDEO FOR  HOME USE . Ethics Number: 
HEPEC/03/09/73 
We are inviting the members of Breathe Easy to take part in a research project. Before you decide, it is 
important for you to understand why the research is being done and what you would have to do.  
This questionnaire survey is being done as a nationwide review of the “Move-On-Up” video of exercise by 
COPD patients (i.e people with long standing and progressive breathlessness). This is to examine 
how suitable the video is for video based exercise at home by UK population of COPD patients. The 
eventual information obtained from this study may help us to improve future treatment of COPD patients 
through exercises and disease management education to improve breathlessness, reduce anxiety, 
increase exercise ability and quality of life.  
Research physiotherapist Ademola Adekunle will be carrying out the research. Research supervisors are 
Professor Tim Watson, Mrs Fiona Schreuder. The researcher Ademola Adekunle will be carrying out this 
research as part of studies for PhD degree in Physiotherapy. Completing the questionnaire is expected to 
take about 10 minutes. The study is approved by the University of Hertfordshire School of Health & 
Emergency Professions Ethics Committee reference HEPEC/03/09/73 
Your Breathe Easy chapter is one of thirty-five Breathe Easy chapters chosen by chance selection of all 
breathe easy chapters in UK. Members of Breathe Easy group in such chapter are accessed through the 
group coordinator. The research team would seek volunteers from the group members to complete 
questionnaires evaluating the suitability of the “Move-On-Up” video of exercise for video based home 
exercise programme for COPD patients in UK. Also the members of the Breathe Easy group would be 
provided with names and contact details of members of the research team they can contact to discuss the 
study and have any query answered. Attached is a copy of the questionnaire. 
If, after reading the information sheets, your Breathe Easy group is interested in taking part in this study, 
please complete the reply slip below and return to us before…….2009 when we would start sending out 
questionnaires to participating Breathe Easy groups. The response on the reply slip would give us 
information on your willingness to participate, the number of your members with COPD, the required 
number of questionnaires, SAEs and copies of the DVD (if you have volunteer members who have not 
watched the DVD already). 
Confidentiality of participants is guaranteed. Completed questionnaires would be returned by the 
participating members directly to the research team in a SAE enclosed with the questionnaires. Each 
envelope that would be sent out with each questionnaire would be marked with a code to indicate from 
which Breathe Easy group the envelope is being returned from. This is to assess response rate from 
various participating regions and ensure our data collection is not leaving out a population that has been 
selected by chance selection process. It will offer us the opportunity to be able to send reminders where 
necessary. However, no questionnaire is marked; hence individual responses can not be isolated. All 
completed questionnaires returned to the researcher would be collated for analysis. 
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Please, take the time to decide if you wish to participate and discuss it with others that you feel necessary.  
Please you can ask us any questions you have and we will try to explain and answer your queries. Please 
remember that you do not have to participate in this study and there would be no need for you to give a 
reason.  
Please, you are required to return the reply slip before………2009. Once we receive your reply slip 
indicating your willingness to participate, we would send the questionnaires to the contact person 
indicated in your reply slip.  
Please don’t hesitate to contact us on one of the members of the research team if you have any questions. 
Yours sincerely, 
Research Physiotherapists –  
Ademola Adekunle (02089895164), a.adekunle@herts.ac.uk 
Research Supervisors-Professor Tim Watson (01707284970), t.watson@herts.ac.uk 
Mrs Fiona Schreuder, f.m.schreuder@herts.ac.uk  
 
REPLY SLIP 
 
Section A-Details of your Breathe Easy group 
Name of group: 
Address: 
Contact person: 
Telephone: 
E-mail: 
Number of members in your group (who have COPD)……. 
Number of volunteer members in your group (who have COPD and who have not watched the Move-On-
Up DVD already: 
 
Please, you are required to return this reply slip before………2009. 
 
Kindly return to- Ademola Adekunle Research Physiotherapist, School of Health & Emergency 
Professions, University of Hertfordshire, College Lane Campus, Hatfield, Hertfordshire.  AL10 9AB.Tel-
02089895164.   E-mail- a.adekunle@herts.ac.uk  
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APPENDIX 6A: COPY OF HONOURARY CONTRACT (AND EXTENSION OF 
CONTRACT) AT HARINGEY PCT (LATER KNOWN AS WHITTINGTON HEALTH 
NHS TRUST) TO CONDUCT STUDIES 
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Copy of extension of honourary contract at Haringey PCT (later known as Whittington 
Health NHSTrust) to conduct studies 
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APPENDIX 6B: LONE WORKER POLICY FOR STUDY TITLED FACTORS 
AFFECTING UPTAKE OF PR IN PATIENTS WITH COPD 
Lone Working Policy For Study On ‘FACTORS AFFECTING THE UPTAKE OF PULMONARY 
REHABILITATION’. Haringey Primary Care Trust, Version 1,July 2007 
 
1.0Introduction 
The Pulmonary Rehabilitation Uptake Study aim to achieve an acceptable standard of safe working 
practice for all staff working in the community.  Every member of the research team has a responsibility 
to be safety conscious not just for himself/herself but also other members of the team, and to actively 
ensure that personal risks to safety are identified as early as possible during visits, to ensure that 
appropriate strategies are formulated and risks minimised. 
The following procedures are in place to ensure the safety of all staff.  Members of the research team 
should ensure that they adhere to them at all times.  Any issues that arise as a result of this policy should 
be raised with the principal researcher or a member of the supervisory team. 
The nature of data collection may in total or in part involve lone working. This policy is intended to 
provide minimum standards and guidelines for every members of the research team working alone in the 
community.  Every member of the research team has individual responsibility to act on threats or 
perceived threat to personal safety. This may include information sharing within and externally to the 
team, terminating a patient’s visit and the member of research team in the community (in this case the 
principal researcher) always keeping a member of the supervisory team briefed of situations.  
2.0 Risk assessment of perceived danger 
Risk assessment is designed to identify perceived level of risk when staff is working alone.  Following 
identification of risk, appropriate strategies must be sought to protect staff. 
Examples of such strategies may be meeting/seeing the patient in a day centre or outpatient department 
(by agreeing a time to coincide with an outpatient appointment), visiting in the morning only, visiting in 
pairs where possible or agreeing with the patient that their pet will be in another room for all 
intervention sessions. 
Risk assessment is a continuous process whereby safe working procedures must be reviewed on an 
ongoing basis by the member of the research team involved. A comprehensive risk assessment form must 
be completed at the earliest point in process to ensure that risks are identified if possible prior to staff 
lone working. 
3.0 Responsibilities of members of research team 
A member of the research team is responsible for taking reasonable care of himself/herself or others who 
may be affected by his/her acts or omissions.   
A member of the research team is required to abide by the guidelines of lone working regarding health 
and safety issues, including any risk assessment which specifies control measures and safe working 
procedures for lone working. 
It is the responsibility of the member of the research team visiting the patient (in this case the principal 
researcher) to ensure that the risk assessment form is completed for a patient before visit. 
3.1 Recording details of visits 
The principal researcher would record the details of the visit in the agreed system.  
The following information must be recorded: 
Patient`s name. 
Address/ location and contact telephone number of appointment (e.g. client address, day centre address). 
If returning to the office, expected time of arrival. 
If not returning to the office, exact time arranged to call a member of the supervisory team 
3.2 Making arrangements with the supervisors 
When not returning to the office following a visit in the community, the principal researcher must notify a 
member of the supervisory team that he has completed the visit safely. 
In the absence of the supervisors, the principal researcher should contact the departmental office. 
All telephone numbers necessary will be stored in the phone for the principal researcher and the 
supervisors.  
3.3 Instructions in the event that a member of the team does not signal their safety 
The supervisors should expect the principal researcher to signal his safety by the agreed method within 
30 minutes of the specified time. If the supervisor has not heard from the principal researcher by this 
time, he/she will proceed to make enquiries as below. 
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Step one: The supervisor will telephone the staff member on his mobile to ascertain his 
whereabouts and expected time of leaving. If the supervisor does not establish the principal researcher’s 
safety and whereabouts he/she will then proceed to the next step. 
Step two: The supervisor will telephone the patient’s home or their family / carers / venue of last 
meeting and check if the principal researcher is still there, or what time they completed the visit and 
departed.  If he/she is satisfied with the response and believes the principal researcher to be safe, she will 
return to step one and make contact with the principal researcher directly. 
Step three: If through step two, the supervisor still can not establish the safety of the principal 
researcher, he/she will wait another 30 minutes and if the principal researchers safety has still not been 
established, the Police should be contacted. Give details of the principal researcher, the location of their 
visit, the details of the supervisor and departmental office. The police will decide if any further action is 
warranted. Write down the name of the person you speak to and the time of your call. 
.                    At this stage, if the situation is deemed to be serious and the staff member felt to be at risk, the 
supervisor or the department staff should contact the relevant unit in the University and the principal 
researcher’s home to report the incident. 
 
4.0 Training 
All staff should complete the conflict resolution training (course on management of violence and 
aggression course) before commencing work or as soon as practicable after commencing work. 
5.0 Personal safety  
Staff must have access to a mobile phone. 
Staff must maintain general standards of personal safety, for example, not taking valuable personal items 
on visits, not walking through poorly lit places, etc. 
 
6.0 Incident reporting 
6.1 Dangerous situations 
If a situation occurs in which a member of the team/principal researcher perceives himself/herself to be 
in immediate danger and need to alert the rest of the team to his/her situation, the member of the 
research team/principal researcher will tell the patient or family that he/she is running late and 
therefore need to call the office and ask them to warn the next patient. When speaking to a member of the 
team on the telephone, the member of the research team/principal researcher will ask them to call Mr 
Lane Hatfield, to warn them that he is likely to be late. Also the a member of the research team/principal 
researcher will ask person receiving the message to call him back immediately after speaking with Mr 
Lana Hatfield so he could know the new time arrangement.  This message will effectively notify the 
supervisor or the office that the member of the research team/principal researcher is in danger and 
instruct them to dial 999, requesting Police assistance and that of any other of the Emergency Services 
deemed necessary. Also the fact that the individual that poses danger to the member of the research 
team/principal researcher knows that the member of the research team/principal researcher is expecting 
a call back may delay or deter him from starting any form of aggression. 
 
6.2 Incidents and near-misses 
All incidents and near misses should be reported to a member of the supervisory team. In the case of 
serious incidences, for example, personal attack, the police may need to be informed. 
Following an immediate response to a situation an incident reporting form should be completed. 
Further action to be taken depends on the nature and severity of the incident.  A member of the research 
team/principal researcher should feel confident that he/she will be supported following safety 
disturbances and that such event would be taken seriously. 
Confidential staff details list. 
Research Physiotherapists 
Ademola Ademola, email a.adekunle@herts.ac.uk, Tel- 02085053361 
Mobile- 07886217410 
Research supervisors 
Professor Tim Watson, email t.watson@herts.ac.uk, Tel-01707284970) 
Mrs Fiona Schreuder, email f.m.schreuder@herts.ac.uk, Tel-01707284971 
 
Police and Ambulance 
Emergency number 999.  
 Police Community Safety telephone number 020 7275 4750 
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APPENDIX 6C: NRES AND R&D ETHICAL APPROVALS FOR STUDY TITLED 
FACTORS AFFECTING UPTAKE OF PR IN PATIENTS WITH COPD 
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APPENDIX 7A: NRES AND R & D ETHICAL APPROVALS FOR STUDY TITLED 
EFFECT OF VIDEO-BASED EXERCISE PROGRAMME ON WALKING ABILITY 
AND MAINTENANCE OF BENEFITS OF OUTPATIENT PR IN COPD PATIENTS 
Brent Medical Ethics Committee 
Room 019, Level 7 Maternity Block 
Northwick Park Hospital 
Watford Road 
Harrow 
Middlesex 
HA1 3UJ 
 
Telephone: 020 8869 3805  
Facsimile: 020 8869 5222 
09 October 2009 
 
Professor Tim Watson 
Research Supervisor 
University Of Hertfordshire 
School of Health & Emergency Professor 
University Of Hertfordshire 
College Lane, Hatfield, Herts 
AL10 9AB 
 
 
Dear Professor Watson 
 
Study Title: EFFECT OF VIDEO-BASED EXERCISE PROGRAMME ON WALKING 
ABILITY AND MAINTENANCE OF BENEFITS OF OUTPATIENT 
PULMONARY REHABILITATION IN COPD PATIENTS 
REC reference number: 09/H0717/65 
Protocol number: 1 
The Research Ethics Committee reviewed the above application at the meeting held on 28 September 
2009. Thank you for attending to discuss the study. 
 
Ethical opinion 
Mr. Ademola Adekunle attended the meeting on your behalf. The Chair welcomed him and asked for a 
brief explanation of the proposed study and the main ethical issues in his opinion. In addition the Chair 
informed him that a letter would be sent following the meeting, which would set out the Committee's 
discussion and any amendment required to the documentation.   
Mr Adekunle informed the committee that the study is being undertaken in conjunction with the 
pulmonary rehabilitation team in the hospital. A member of the team will mention the study to the 
patient.  
The Chair asked Mr Adekunle to clearly explain the recruitment process. Mr Adekunle replied that the 
team administrator or team nurse will mention the study to the patient and ask if they are interested. If 
the patient is interested then they will be asked for their consent to give contact details to Mr Adekunle. 
He will then ring the patients and arrange for them to attend an assessment meeting. Before the patients 
attend the assessment the PIS will be sent to them in the post and they will have 48 hours to decide 
whether they want to join the study or not. The Chair noted that the PIS will be sent to the patients before 
the appointment.  
The committee asked for further clarification as to whom exactly would mention the study to the patient 
and Mr Adekunle confirmed that it would be the team nurse or physiotherapist.  
The Chair asked Mr Adekunle whether the personal data that he is proposing to keep for 3 years will be 
anonymised and Mr Adekunle confirmed that it would be.  
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The members of the Committee present gave a favourable ethical opinion of the above research on the 
basis described in the application form, protocol and supporting documentation, subject to the conditions 
specified below. 
Ethical review of research sites 
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see “Conditions 
of the favourable opinion” below). 
Conditions of the favourable opinion 
The favourable opinion is subject to the following conditions being met prior to the start of the study. 
Management permission or approval must be obtained from each host organisation prior to the start of 
the study at the site concerned. 
For NHS research sites only, management permission for research (“R&D approval”) should be obtained 
from the relevant care organisation(s) in accordance with NHS research governance arrangements.  
Guidance on applying for NHS permission for research is available in the Integrated Research Application 
System or at http://www.rdforum.nhs.uk. Where the only involvement of the NHS organisation is as a 
Participant Identification Centre, management permission for research is not required but the R&D office 
should be notified of the study. Guidance should be sought from the R&D office where necessary. 
Sponsors are not required to notify the Committee of approvals from host organisations. 
It is responsibility of the sponsor to ensure that all the conditions are complied with before the start of 
the study or its initiation at a particular site (as applicable). 
Approved documents 
The documents reviewed and approved at the meeting were: 
Document  Version  Date   
Covering Letter   26 August 2009   
REC application   28 July 2009   
Protocol  1    
Investigator CV   19 August 2009   
CV for Adekunle Ademola Olusegun   21 July 2009   
CV for Kola Akinlabi   21 August 2009   
Participant Consent Form  1    
Letter of invitation to participant  1-Inc 
Information 
Sheet & Reply 
Slip  
  
GP/Consultant Information Sheets  1  26 August 2009   
Letter confirming honorary contract   25 July 2008   
Copy of Certificate of registration - The Chartered Society of 
Physiotherapy  
 01 May 2006   
Sample Diary/Patient Card  Activity 
Diary-
Haringey PCT  
  
MRC dyspnoea scale     
Questionnaire: BASDEC     
Questionnaire: MMSE     
Questionnaire: St George's respiratory questionnaire (SQRG)     
Questionnaire: Multidimensional Health Locus of Control     
Questionnaire: Duke Social Support Index     
Copy of "move on up" video     
Permission to use Video   06 December 2006   
Permission to use activity diary   19 June 2009   
Permission to use Duke Social support index   01 May 2009   
Permission to use SQRG   24 April 2009   
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Cablestar invoice   19 March 2008   
MMSE kit - shipping document   30 July 2009   
Letter re data management committee   20 August 2009   
Letter re data management committee   20 August 2009   
FAQ - MHLC scales   03 August 2009   
Intellectual Property Agreement   21 May 2007   
Candidate registration for research degree   05 August 2008   
 
Membership of the Committee 
The members of the Ethics Committee who were present at the meeting are listed on the attached sheet. 
Statement of compliance  
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics 
Committees (July 2001) and complies fully with the Standard Operating Procedures for Research Ethics 
Committees in the UK. 
After ethical review 
Now that you have completed the application process please visit the National Research Ethics Service 
website > After Review 
You are invited to give your view of the service that you have received from the National Research Ethics 
Service and the application procedure. If you wish to make your views known please use the feedback 
form available on the website. 
The attached document “After ethical review – guidance for researchers” gives detailed guidance on 
reporting requirements for studies with a favourable opinion, including: 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Progress and safety reports 
 Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light of changes in 
reporting requirements or procedures. 
We would also like to inform you that we consult regularly with stakeholders to improve our service. If 
you would like to join our Reference Group please email referencegroup@nres.npsa.nhs.uk. 
09/H0717/65 Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project 
Yours sincerely 
Dr Kofi Anie 
Chair 
Email: Mona.Shah@nwlh.nhs.uk 
Enclosures: List of names and professions of members who were present at the meeting and 
those who submitted written comments 
“After ethical review – guidance for researchers” [SL-AR2 for other studies] 
Copy to: Adeola  Akano, Haringey Integrated Community Therapy, Stuart Crescent, Wood 
Green, London, N22 5NJ 
 
Angela Williams, North Central London Research Team, Research Governance 
Team, Room 3 -17, 3rd Floor, West Wing, St Pancreas Hospital, St Pancreas Way, 
NW1 0PE. 
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Brent Medical Ethics Committee 
Attendance at Committee meeting on 28 September 2009 
Committee Members:  
Name  Profession  Present   Notes    
Mr Suresh Akula  Retired Civil Servant  Yes    
Mr Sinan Alsaffar  Pharmacist  No    
Dr Kofi A Anie  Clinical Psychologist  Yes    
Mrs Sunder Chita  Manager  Yes    
Dr C Bernard Colaco  Consultant 
Rheumatologist  
No    
Dr Neeta Ghosh-Chowdhury  General Practitioner  No    
Dr Sanober Haque  Doctor of Medicine  No    
Ms Homa Syeda Hasan  Bioethics Adviser  Yes    
Mr Maurice Hoffman  Work Placement Advisor  No    
Mr  Paul James  Chief Audiologist  No    
Dr Wing May Kong  Consultant Physician and 
Honorary Senior Lecturer  
No    
Mrs Shaheda Lakha  Oncology and Clinical 
Trials Pharmacist  
No    
Mr Adeyemi Olagbegi  Clinical Pharmacology 
Study Data Manager  
Yes    
Miss Vashti Ragoonanan  Specialist Nurse - 
Haematology  
Yes    
Mr Howard Woolfson  Senior Exam Invigilator  Yes    
Miss Ourania Xeniou  Clinical Trial Site Manager  No    
Miss Zainab Yate  Research & Performance 
Officer  
Yes    
Also in attendance:  
Name  Position (or reason for attending)   
Mrs  Alka Bhayani  Ethics Administrator   
Mrs Mona  Shah  Senior Coordinator   
Written comments received from:  
Name  Position   
Dr Sanober Haque  Doctor of Medicine   
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APPENDIX 7B: TEST OF EQUALITY OF OUTCOME MEASURES AT BASELINE 
BETWEEN THE TRIAL ARMS 
Table 1: Key to abbreviations used in appendices for chapter 7. 
Abbreviation/exam
ple of measure 
abbreviated 
Key 
WK1 MHLC 
Powerful Others B 
Baseline measure (week 1)of powerful others domain of scale B of the 
Multidimensional Health Locus of Control. Similar abbreviation is applied to 
other measures e.g WK1SGRQsymptom. 
ESWD difference 
Wkx-y 
Difference between endurance shuttle walk distances (ESWD) recorded at week 
x and ESWD recorded at week y. For example, ESWD difference wk 1-32 means 
the difference between ESWD recorded at week one and ESWD recorded at 
week thirty-two. 
MHLC Scale 
domain difference 
WKx-y 
Difference between the scores of the Multidimensional Health Locus of Control 
(MHLC) scale (C as appropriate), domain (e.g. internal, chance) recorded at week 
x and the score of the same domain of MHLC form recorded at week y. For 
example, MHLC C chance difference Wk1-32 means the difference between the 
score of the chance domain of the MHLC form C recorded at week 1 and the 
score of the same domain of the same form recorded at week 32. 
SGRQ domain 
difference WKx-y 
Difference between the score of the particular domain of the St Georges 
respiratory questionnaire (SGRQ) recorded at week x and the score of the same 
domain of the SGRQ recorded at week y. For example, SGRQ activity difference 
WK1-4 means the difference between the score of the activity domain of the 
SGRQ recorded at week 1 and the score of the same domain of the SGRQ 
recorded at week 4. 
 
 
Table 2: Shapiro Wilk Tests of Normality at baseline 
 
SRCTArm 
Shapiro-Wilk 
 Statistic Df Sig. 
Gender video arm .639 25 .000 
non video arm .638 32 .000 
Age video arm .902 25 .021 
non video arm .973 32 .579 
COPDseverity video arm .770 25 .000 
non video arm .726 32 .000 
SocialInteraction video arm .937 25 .127 
non video arm .895 32 .005 
SocialSupport video arm .824 25 .001 
non video arm .869 32 .001 
DSSItotal video arm .845 25 .001 
non video arm .945 32 .106 
WK1MHLC internalB video arm .951 25 .267 
non video arm .945 32 .105 
WK1MHLCchanceBlabel video arm .928 25 .077 
non video arm .947 32 .120 
WK1MHLCPowerfulOther
sB 
video arm .898 25 .017 
non video arm .933 32 .048 
WK1MHLC internalC video arm .942 25 .169 
non video arm .977 32 .713 
WK1MHLCchanceC video arm .910 25 .030 
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non video arm .901 32 .006 
WK1MHLCdoctorsC video arm .916 25 .042 
non video arm .928 32 .035 
WK1MHLCOthersC video arm .936 25 .122 
non video arm .914 32 .015 
WK1ESWDistance video arm .914 25 .038 
non video arm .919 32 .020 
WK1SGRQsymptom video arm .952 25 .280 
non video arm .953 32 .180 
WK1SGRQactivity video arm .922 25 .056 
non video arm .887 32 .003 
WK1SGRQimpact video arm .925 25 .068 
non video arm .875 32 .001 
WK1SGRQtotal video arm .932 25 .095 
non video arm .894 32 .004 
MMSEScore video arm .922 25 .058 
non video arm .890 32 .003 
DepressionCategory video arm .590 25 .000 
non video arm .511 32 .000 
Sprirometry video arm .914 25 .037 
non video arm .866 32 .001 
YearsSinceCOPD video arm .930 25 .088 
non video arm .947 32 .122 
 
Tables 3a to 3l: Mann-Whitney Test Statistics and frequency statistcs and ranks 
Table 3a: Test Statistics 
 Age COPDscore COPDseverity DepressionScore 
Mann-Whitney U 392.000 397.000 372.500 341.500 
Exact Sig. (2-tailed) .901 .963 .627 .349 
 
Table 3b: Test Statistics (cont.) 
 
SocialInteractio
n SocialSupport DSSItotal 
WK1MHLC 
internalB 
WK1MHLCchan
ceBlabel 
Mann-Whitney U 398.000 351.000 362.500 310.000 399.500 
Exact Sig. (2-tailed) .977 .426 .550 .149 .997 
 
Table 3c: Test Statistics (cont.) 
 
WK1MHLCPowe
rfulOthersB 
WK1MHLC 
internalC 
WK1MHLCchan
ceC 
WK1MHLCdoct
orsC 
WK1MHLCOthe
rsC 
Mann-Whitney U 399.000 389.000 362.000 344.000 319.500 
Exact Sig. (2-tailed) .990 .863 .544 .365 .194 
 
Table 3d: Test Statistics (cont.) 
 
WK1ESWDistan
ce 
WK1SGRQsymp
tom 
WK1SGRQactivi
ty 
WK1SGRQimpac
t WK1SGRQtotal 
Mann-Whitney U 395.500 399.000 371.500 344.000 376.000 
Exact Sig. (2-tailed) .946 .990 .647 .373 .708 
 
Table 3e: Test Statistics (cont.) 
 Spirometry YearsSinceCOPD 
Mann-Whitney U 334.000 397.000 
Exact Sig. (2-tailed) .292 .965 
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Table 3f: Frequencies statistics 
SRCTArm Age COPDscore COPDseverity 
DepressionScor
e 
video arm N Valid 25 25 25 25 
Missing 0 0 0 0 
Median 69.0000 3.0000 2.0000 2.5000 
non video arm N Valid 32 32 32 32 
Missing 0 0 0 0 
Median 67.0000 3.0000 2.0000 3.0000 
 
Table 3g: Frequency statistics (cont.) 
SRCTArm 
SocialInteractio
n SocialSupport DSSItotal 
WK1MHLC 
internalB 
video arm N Valid 25 25 25 25 
Missing 0 0 0 0 
Median 9.0000 19.0000 27.0000 24.0000 
non video arm N Valid 32 32 32 32 
Missing 0 0 0 0 
Median 9.0000 19.0000 27.5000 21.5000 
 
 
Table 3h: Frequency statistics (cont.) 
SRCTArm 
WK1MHLCchanc
eBlabel 
WK1MHLCPowe
rfulOthersB 
 WK1 MHLC 
internal C 
WK1MHLCchanc
eC 
video arm N Valid 25 25 25 25 
Missing 0 0 0 0 
Median 21.0000 26.0000 24.0000 22.0000 
non video arm N Valid 32 32 32 32 
Missing 0 0 0 0 
Median 22.0000 26.0000 23.0000 22.0000 
 
3i: Frequency statistics (cont.) 
SRCTArm 
WK1MHLCdocto
rsC 
WK1MHLCOther
sC 
WK1ESWDistan
ce 
WK1SGRQsympt
om 
video arm N Valid 25 25 25 25 
Missing 0 0 0 0 
Median 15.0000 13.0000 172.9300 76.5000 
non video arm N Valid 32 32 32 32 
Missing 0 0 0 0 
Median 13.5000 12.0000 211.0500 75.2600 
 
Table 3j: Frequency statistics (cont.) 
SRCTArm 
WK1SGRQactivit
y 
WK1SGRQimpac
t WK1SGRQtotal MMSEScore 
video arm N Valid 25 25 25 25 
Missing 0 0 0 0 
Median 88.1000 75.5200 77.1500 28.0000 
non video arm N Valid 32 32 32 32 
Missing 0 0 0 0 
Median 86.0850 77.7150 78.7150 26.0000 
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Table 3k: Frequency statistics (cont.) 
SRCTArm 
DepressionCate
gory Spirometry YearsSinceCOPD 
video arm N Valid 25 25 25 
Missing 0 0 0 
Median .0000 .5500 4.0000 
non video arm N Valid 32 32 32 
Missing 0 0 0 
Median .0000 .5850 5.0000 
 
Table 3l: Ranks of variables 
 SRCTArm N Mean Rank Sum of Ranks 
Age video arm 25 29.32 733.00 
non video arm 32 28.75 920.00 
Total 57   
COPDscore video arm 25 28.88 722.00 
non video arm 32 29.09 931.00 
Total 57   
COPDseverity video arm 25 30.10 752.50 
non video arm 32 28.14 900.50 
Total 57   
DepressionScore video arm 25 26.66 666.50 
non video arm 32 30.83 986.50 
Total 57   
SocialInteraction video arm 25 29.08 727.00 
non video arm 32 28.94 926.00 
Total 57   
SocialSupport video arm 25 30.96 774.00 
non video arm 32 27.47 879.00 
Total 57   
DSSItotal video arm 25 30.50 762.50 
non video arm 32 27.83 890.50 
Total 57   
WK1MHLC internalB video arm 25 32.60 815.00 
non video arm 32 26.19 838.00 
Total 57   
WK1MHLCchanceBlabel video arm 25 29.02 725.50 
non video arm 32 28.98 927.50 
Total 57   
WK1MHLCPowerfulOthersB video arm 25 29.04 726.00 
non video arm 32 28.97 927.00 
Total 57   
WK1MHLC internalC video arm 25 29.44 736.00 
non video arm 32 28.66 917.00 
Total 57   
WK1MHLCchanceC video arm 25 30.52 763.00 
non video arm 32 27.81 890.00 
Total 57   
WK1MHLCdoctorsC video arm 25 31.24 781.00 
non video arm 32 27.25 872.00 
Total 57   
WK1MHLCOthersC video arm 25 32.22 805.50 
non video arm 32 26.48 847.50 
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Total 57   
WK1ESWDistance video arm 25 29.18 729.50 
non video arm 32 28.86 923.50 
Total 57   
WK1SGRQsymptom video arm 25 28.96 724.00 
non video arm 32 29.03 929.00 
Total 57   
WK1SGRQactivity video arm 25 30.14 753.50 
non video arm 32 28.11 899.50 
Total 57   
WK1SGRQimpact video arm 25 26.76 669.00 
non video arm 32 30.75 984.00 
Total 57   
WK1SGRQtotal video arm 25 28.04 701.00 
non video arm 32 29.75 952.00 
Total 57   
Spirometry video arm 25 26.36 659.00 
non video arm 32 31.06 994.00 
Total 57   
Years since COPD diagnosis video arm 25 29.12 728.00 
non video arm 32 28.91 925.00 
Total 57   
 
 
Table 4a to 4b: Crosstabs of gender versus SRCT arm 
 
Table 4a: Gender SRCTArm Crosstabulation 
 
SRCTArm 
Total video arm non video arm 
Gender Male Count 13 16 29 
Expected Count 12.7 16.3 29.0 
female Count 12 16 28 
Expected Count 12.3 15.7 28.0 
Total Count 25 32 57 
Expected Count 25.0 32.0 57.0 
 
Table 4b: Chi-Square Tests of gender versus SRCT arm 
 Value Df Exact Sig. (2-sided) 
Pearson Chi-Square .022 1  
Fisher's Exact Test   1.000 
N of Valid Cases 57   
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APPENDIX 7C: COMPARISON OF BASELINE CHARACTERISTIC OF 
PARTICIPANTS INCLUDED IN THE SRCT TO THE PARTICIPANTS EXCLUDED 
IN THE SRCT. 
Mann-Whitney TestTable 1a: Test Ranks 
 SRCTInclusionExclusionLa
bel N Mean Rank Sum of Ranks 
Spirometry SRCTIncluded 57 30.63 1746.00 
SRCTExcluded 3 28.00 84.00 
Total 60   
MMSEScore SRCTIncluded 57 30.32 1728.00 
SRCTExcluded 3 34.00 102.00 
Total 60   
 
Table 1b: Test Statistics 
 Spirometry MMSEScore 
Mann-Whitney U 78.000 75.000 
Exact Sig. (2-tailed) .815 .782 
 
Table 1c: Test statistics (cont.) 
SRCTInclusionExclusionLabel MMSEScore Spirometry 
SRCTIncluded N Valid 57 57 
Missing 0 0 
Median 27.0000 .5700 
SRCTExcluded N Valid 3 3 
Missing 0 0 
Median 29.0000 .5300 
 
Table 2a: Cross tabulation of gender distribution between patients included in and 
excluded from the SRCT 
 
SRCTInclusionExclusionLabel 
Total SRCTIncluded SRCTExcluded 
Gender Male Count 29 2 31 
Expected Count 29.5 1.6 31.0 
female Count 28 1 29 
Expected Count 27.6 1.5 29.0 
Total Count 57 3 60 
Expected Count 57.0 3.0 60.0 
 
Table 2b: Chi-Square Tests of gender distribution between patients included 
in and excluded from the SRCT 
 
Value Df 
Exact Sig. (2-
sided) 
Pearson Chi-Square .285a 1 1.000 
Fisher's Exact Test   1.000 
N of Valid Cases 60   
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APPENDIX 7D SHAPIRO WILK TEST OF  DISTRIBUTION OF CHANGE IN 
OUTCOME MEASURES IN THE SRCT 
Shapiro Tests of Normality 
 
SRCTArm 
Shapiro-Wilk 
 Statistic Df Sig. 
ESW Distance difference 
WK1-8 
video arm .924 25 .063 
non video arm .882 32 .002 
ESWDistance difference 
WK1-32 
video arm .889 25 .010 
non video arm .938 32 .065 
SGRQsymptom difference 
WK1-4 
video arm .956 25 .335 
non video arm .910 32 .011 
SGRQactivity difference 
WK1-4 
video arm .911 25 .032 
non video arm .904 32 .008 
SGRQimpact difference 
WK1-4 
video arm .988 25 .989 
non video arm .933 32 .046 
SGRQtotal difference 
WK1-4 
video arm .968 25 .584 
non video arm .938 32 .066 
SGRQsymptom difference 
WK1-8 
video arm .951 25 .258 
non video arm .924 32 .026 
SGRQactivity difference 
WK1-8 
video arm .875 25 .005 
non video arm .882 32 .002 
SGRQimpact difference 
WK1-8 
video arm .887 25 .010 
non video arm .958 32 .246 
SGRQtotal difference 
WK1-8 
video arm .861 25 .003 
non video arm .951 32 .150 
SGRQsymptom difference 
Wk1-20 
video arm .966 25 .545 
non video arm .903 32 .007 
SGRQ activity difference  
WK1-20 
video arm .963 25 .487 
non video arm .856 32 .001 
SGRQimpact difference 
WK21-20 
video arm .916 25 .041 
non video arm .947 32 .121 
SGRQtotal difference 
WK1-20 
video arm .934 25 .110 
non video arm .925 32 .028 
SGRQsymptom difference 
WK1-32 
video arm .943 25 .175 
non video arm .926 32 .030 
SGRQactivity difference 
WK1-32 
video arm .933 25 .104 
non video arm .921 32 .022 
SGRQimpact difference 
WK1-32 
video arm .927 25 .076 
non video arm .956 32 .216 
SGRQtotal differrence 1-
32 
video arm .896 25 .015 
non video arm .964 32 .353 
MHLC  B internal 
difference wk 1-8 
video arm .904 25 .023 
non video arm .967 32 .425 
MHLC  B Internal 
difference wk1-32 
video arm .970 25 .654 
non video arm .950 32 .148 
MHLC B chance diference 
wk1-8 
video arm .976 25 .788 
non video arm .969 32 .482 
MHLC  B chancedifference  
wk1-32 
video arm .949 25 .241 
non video arm .966 32 .399 
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MHLC B powerfulothers 
differenc wk1-8 
video arm .918 25 .046 
non video arm .949 32 .135 
MHLC B powerful others 
difference  w1-32 
video arm .957 25 .362 
non video arm .950 32 .140 
MHLC C internal 
difference difference wk1-
8 
video arm .940 25 .146 
non video arm .963 32 .329 
MHLC C internal 
difference wk1-32 
video arm .962 25 .448 
non video arm .939 32 .072 
MHLC Cchancedifference 
wk 1-8  
video arm .958 25 .368 
non video arm .926 32 .030 
MHLC C chancedifference 
wk1-32 
video arm .959 25 .389 
non video arm .915 32 .016 
MHLC C doctorsdifference 
wk1-8 
video arm .934 25 .110 
non video arm .966 32 .392 
MHLC C doctorsdifference 
wk1-32 
video arm .943 25 .171 
non video arm .958 32 .243 
MHLC C doctors 
difference wk1-8 
video arm .930 25 .087 
non video arm .976 32 .664 
MHLC C  others wk1-32 video arm .926 25 .069 
non video arm .951 32 .157 
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APPENDIX 7E: BETWEEN AND WITHIN GROUP ANALYSIS OF OUTCOME 
MEASURES FROM THE SRCT. 
SRCT between group differences with confidence intervals 
 
Table 1: Mann Whitney test of between group analysis of change in ESWD. 
 
 
 
 
 
Table 2: Mann Whitney test of between group analysis of change in MHLC between week 1 and 
week 8. 
Outcome MHLC 
Internal B 
Difference 
Wk 1-8 
MHLC 
chance B 
Difference 
Wk 1-8 
MHLC 
powerful 
others B 
Difference 
Wk 1-8 
MHLC 
Internal C 
Difference 
Wk 1-8 
MHLC 
chance C 
Difference 
Wk 1-8 
MHLC 
doctors C 
Difference 
Wk 1-8 
MHLC 
others C 
Difference 
Wk 1-8 
Mann 
Whitney 
test 
345.50 225.00 291.50 278.00 295.50 293.50 341.00 
Exact sig.( 
2 tailed) 
0.38 0.004 0.08 0.05 0.09 0.08 0.34 
Median 
score 
7.00 -3.00 5.00 7.00 -1.00 2.00 1.00 
 
Table 3: Mann Whitney test of between group analysis of change in MHLC between week 1 and 32. 
Outcome MHLC 
Internal B 
Difference 
Wk 1-32 
MHLC 
chance B 
Difference 
Wk 1-32 
MHLC 
powerful 
others B 
Difference 
Wk 1-32 
MHLC 
Internal C 
Difference 
Wk 1-32 
MHLC 
chance C 
Difference 
Wk 1-32 
MHLC 
doctors C 
Difference 
Wk 1-32 
MHLC others C 
Difference Wk 
1-32 
Mann 
Whitney 
test 
350.50 359.50 279.00 321.50 336.50 316.50 366.00 
Exact sig.( 
2 tailed) 
0.43 0.52 0.05 0.21 0.31 0.18 0.58 
Median 
score 
6.00 0.00 5.00 6.00 0.00 1.00 2.00 
 
 
Outcome ESW Distance difference  
Wk1-8 
ESW Distance 
difference  Wk1-32 
Mann Whitney U test 321.00 302.00 
Exact sig.( 2 tailed) 0.21 0.12 
Median score 220.94 136.00 
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Table 4: Mann Whitney test of between group analysis of change in SGRQ between week 1 and 4. 
Outcome SGRQ symptom 
Difference WK1-4 
SGRQ activity 
Difference WK1-4 
SGRQ impact 
Difference WK1-4 
SGRQ total 
Difference WK1-4 
Mann Whitney 
test 
393.00 325.50 390.00 388.00 
Exact sig.( 2 
tailed) 
0.91 0.45 0.88 0.85 
Median score -15.46 -19.38 -24.80 -20.96 
 
Table 5: Mann Whitney test of between group analysis of change in SGRQ between week 1 and 8. 
Outcome SGRQ symptom 
Difference WK1-8 
SGRQ activity 
Difference WK1-8 
SGRQ impact 
Difference WK1-8 
SGRQ total 
Difference WK1-8 
Mann Whitney 
test 
309.50 256.00 256.50 237.00 
Exact sig.( 2 
tailed) 
0.15 0.02 0.02 0.01 
Median score -18.69 -23.92 -27.24 -25.25 
 
Table 6: Mann Whitney test of between group analysis of change in SGRQ between week 1 and 20. 
Outcome SGRQ symptom 
Difference WK1-20 
SGRQ activity 
Difference WK1-
20 
SGRQ impact 
Difference WK1-20 
SGRQ total 
Difference WK1-20 
Mann Whitney 
test 
298.00 281.50 280.00 283.00 
Exact sig.( 2 
tailed) 
0.10 0.06 0.054 0.06 
Median score -24.75 -26.18 -39.91 -33.47 
 
Table 7: Mann Whitney test of between group analysis of change in SGRQ between week 1 and 32. 
Outcome SGRQ symptom 
Difference WK1-32 
SGRQ activity 
Difference WK1-
32 
SGRQ impact 
Difference WK1-32 
SGRQ total 
Difference WK1-32 
Mann Whitney 
test 
281.00 266.50 258.50 256.50 
Exact sig.( 2 
tailed) 
0.055 0.03 0.02 0.02 
Median score -10.55 -14.13 -16.52 -14.71 
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ESWD p significant at 0.025 (because baseline data was tested at weeks 8 and 32). Minimum clinically 
significant difference is a change of 173m. 
ESWD WEEK 8: p=0.21, Median 220.9, CI= (-306.3,-131.8).  
ESWD WEEK 32: p=0.12, Median 136.0, CI= (-185.83,-81.22).  
 
MHLC p significant at 0.025 (because data was tested at weeks 8 and 32). There is no defined minimum 
clinically significant difference 
MHLC Internal B WEEK 8, p=0.38, Median 7.00, CI= (-8.000,-1.999).  
MHLC Internal B WEEK 32, p=0.43, Median 6.00, CI= (-6.00, 1.00).  
 
MHLC Chance B WEEK 8, p=0.004, Median -3.00, CI= (1.999, 7.00).  
MHLC Chance B WEEK 32, p=0.52, Median 0.00, CI= (0.00, 2.00).  
 
MHLC Powerful others B WEEK 8, p=0.08 Median 5.00, CI= (-7.00, 0.999).  
MHLC Powerful others B WEEK 32, p=0.05 Median 5.00, CI= (-5.00, 1.00)  
 
MHLC Internal C WEEK 8, p=0.05, Median 7.00, CI= (-7.00,-2.00).  
MHLC Internal C WEEK 32, p=0.21, Median 6.00, CI= (-8.00, 0.999).  
 
MHLC Chance C WEEK 8, p=0.09, Median -1.00, CI= (-7.00,-2.00).  
MHLC Chance C WEEK 32, p=0.31, Median 0.00, CI= (-8.001, 0.999).  
 
MHLC Doctors C WEEK 8, p=0.08, Median 2.00, CI= (-1.00, 1.00).  
MHLC Doctors C WEEK 32, p=0.18, Median 1.00, CI= (-1.00, 1.00).  
 
MHLC Others C WEEK 8, p=0.34, Median 1.00, CI= (-1.00, 1.00).  
MHLC Others C WEEK 32, p=0.58, Median 2.00, CI= (-2.000, 1.00).  
 
SGRQ p significant at 0.0125 (because baseline data was tested at weeks 4, 8, 20 and 32). Minimum clinically 
significant difference is a change of -4. 
SGRQ Symp WEEK 4 p=0.91, Median -15.46, CI (8.45, 22.23)  
SGRQ Symp WEEK 8 p=0.15, Median -18.69, CI (11.36, 32.48)  
SGRQ Symp WEEK 20 p=0.10, Median -24.75, CI (18.70, 41.17)  
SGRQ Symp WEEK 32 p=0.055, Median -10.55, CI (5.612, 25.66)  
 
SGRQ Activity WEEK 4 p=0.45, Median -19.38, CI (13.33, 26.27)  
SGRQ Activity WEEK 8 p=0.02, Median -23.92. CI (14.49, 34.76)  
SGRQ Activity WEEK 20 p=0.06, Median -26.18, CI (20.91, 39.71) 
 SGRQ Activity WEEK 32 p=0.03, Median -14.13, CI (8.062, 26.832) 
  
SGRQ Impact WEEK 4 p=0.88, Median -19.38, CI (17.38, 41.28)  
SGRQ Impact WEEK 8 p=0.02, Median -23.92, CI (17.31, 47.38)  
SGRQ Impact WEEK 20 p=0.054, Median -26.18, CI (24.45, 54.84)  
SGRQ Impact WEEK 32 p=0.02 Median -14.13, CI (10.44, 29.21)  
 
SGRQ Total WEEK 4 p=0.85, Median -19.38, CI (16.98, 34.73)  
SGRQ Total WEEK 8 p=0.01, Median -23.92, CI (19.19, 39.67)  
SGRQ Total WEEK 20 p=0.06, Median -26.18, CI (23.45, 46.43)  
SGRQ Total WEEK 32 p=0.02 Median -14.13 CI (10.30, 27.12)  
 
Mann-Whitney Test comparing total duration of self supervised exercise between the two arms. p significant 
at 0.05 
 Median difference in total duration of self supervised exercise =9, p=0.001, CI= (-10.001,-6.001) 
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SRCT within group differences with confidence intervals (not primary result of 
interest) 
 
            Table 8: One sample sign test analysis of within group change in ESWT. 
 
 
 
Table 9: One sample sign test analysis of within group change in MHLC between week 1 and 8. 
 
Outcome MHLC 
Internal B 
Difference 
Wk 1-8 
MHLC 
chance B 
Difference 
Wk 1-8 
MHLC 
powerful 
others B 
Difference 
Wk 1-8 
MHLC 
Internal C 
Difference 
Wk 1-8 
MHLC 
chance C 
Difference 
Wk 1-8 
MHLC 
doctors C 
Difference 
Wk 1-8 
MHLC 
others C 
Difference 
Wk 1-8 
Video arm 
Exact sig.( 2 
tailed) 
<0.0001 0.003 0.003 <0.0001 0.052 <0.0001 0.008 
Median score 
for video 
arm 
8.00 -6.00 8.00 10.00 -2.00 2.00 2.00 
Non video 
arm Exact 
sig.( 2 tailed) 
<0.0001 0.56 0.11 0.001 0.84 0.69 0.31 
Median score 
for non video 
arm 
7.00 0.001 1.50 4.00 0.00 0.00 0.001 
 
Table 10: One sign test of within group analysis of change in MHLC between week 1 and 32. 
Outcome MHLC 
Internal B 
Difference 
Wk 1-32 
MHLC 
chance B 
Difference 
Wk 1-32 
MHLC 
powerful 
others B 
Difference 
Wk 1-32 
MHLC 
Internal C 
Difference 
Wk 1-32 
MHLC 
chance C 
Difference 
Wk 1-32 
MHLC 
doctors C 
Difference 
Wk 1-32 
MHLC 
others C 
Difference 
Wk 1-32 
Video arm 
Exact sig.( 2 
tailed) 
0.01 0.82 0.01 0.13 0.83 0.004 0.008 
Median 
score for 
video arm 
6.00 0.001 7.00 9.00 0.00 2.00 2.00 
Non video 
arm Exact 
sig.( 2 
tailed) 
0.052 0.66 0.29 0.09 0.52 0.19 0.01 
Median 
score for 
non video 
arm 
4.50 0.001 0.50 4.00 0.50 0.50 1.00 
 
Outcome ESW Distance 
difference  Wk1-8 
ESW  
Distance difference  
Wk1-32 
Video arm Exact sig.( 2 
tailed) 
<0.0001 <0.0001 
Median score for video 
arm 
241.89 181.08 
Non video arm Exact sig.( 
2 tailed) 
<0.0001 <0.0001 
Median score for non 
video arm 
197.28 122.40 
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Table 11: One sign test of within group analysis of change in SGRQ between week 1 and 4. 
Outcome SGRQ symptom 
Difference WK1-4 
SGRQ activity 
Difference WK1-4 
SGRQ impact 
Difference WK1-4 
SGRQ total 
Difference WK1-4 
Video arm Exact 
sig.( 2 tailed) 
<0.0001 <0.0001 <0.0001 <0.0001 
Median score for 
video arm 
-17.06 -12.57 -32.20 -24.36 
Non video arm 
Exact sig.( 2 
tailed) 
<0.0001 <0.0001 <0.0001 <0.0001 
Median score for 
non video arm 
-10.91 -20.09 -22.87 -17.99 
 
Table 12: One sign test of within group analysis of change in SGRQ between week 1 and 8. 
Outcome SGRQ symptom 
Difference WK1-8 
SGRQ activity 
Difference WK1-8 
SGRQ impact 
Difference WK1-8 
SGRQ total 
Difference WK1-8 
Video arm Exact 
sig.( 2 tailed) 
0.003 0.001 <0.0001 <0.0001 
Median score for 
video arm 
-33.01 -38.41 -52.75 -47.77 
Non video arm 
Exact sig.( 2 
tailed) 
<0.0001 <0.0001 <0.0001 <0.0001 
Median score for 
non video arm 
-15.81 -19.40 -20.40 -21.63 
 
Table 13: One sign test of within group analysis of change in SGRQ between week 1 and 20. 
Outcome SGRQ symptom 
Difference WK1-20 
SGRQ activity 
Difference WK1-
20 
SGRQ impact 
Difference WK1-20 
SGRQ total 
Difference WK1-20 
Video arm Exact 
sig.( 2 tailed) 
<0.0001 <0.0001 <0.0001 <0.0001 
Median score 
for video arm 
-37.25 -38.69 -55.30 -47.27 
Non video arm 
Exact sig.( 2 
tailed) 
<0.0001 <0.0001 <0.0001 <0.0001 
Median score 
for non video 
arm 
-18.74 -20.39 -25.95 -23.65 
 
Table 14: One sign test of within group analysis of change in SGRQ between week 1 and 32. 
 
Outcome SGRQ symptom 
Difference WK1-32 
SGRQ activity 
Difference WK1-
32 
SGRQ impact 
Difference WK1-32 
SGRQ total 
Difference WK1-32 
Video arm Exact 
sig.( 2 tailed) 
0.001 <0.0001 <0.0001 <0.0001 
Median score 
for video arm 
-26.13 -25.83 -25.79 -33.29 
Non video arm 
Exact sig.( 2 
tailed) 
0.002 0.01 0.002 0.002 
Median score 
for non video 
arm 
-8.43 -7.54 -11.56 -10.23 
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Video arm 
 
ESWD p significant at 0.025 (because baseline data was tested at weeks 8 and 32). Minimum clinically 
significant difference is a change of 173m. 
ESWD WEEK 8: p<0.0001, Median 241.89, CI= (174, 410).  
ESWD WEEK 32: p<0.0001, Median 181.08, CI= (98, 326).  
 
MHLC p  significant at 0.025 (because baseline data was tested at weeks 8 and 32) 
There is no defined minimum clinically significant difference. 
MHLC Internal B WEEK 8, p<0.0001, Median 8.00, CI= (5.00, 11.50) 
MHLC Internal B WEEK 32, p=0.01, Median 6.00, CI= (2.50, 10.00). 
 
MHLC Chance B WEEK 8, p=0.003, Median -6.00, CI= (-11.50,-3.00)  
MHLC Chance B WEEK 32, p=0.82, Median 0.001, CI= (-5.50, 2.50) 
 
MHLC Powerful others B WEEK 8, p=0.003 Median 8.000, CI= (3.50, 10.00) 
MHLC Powerful others B WEEK 32, p=0.01 Median 7.00, CI= (3.00, 9.50) 
 
MHLC Internal C WEEK 8, p<0.0001, Median 10.00, CI= (5.50, 11.50) 
MHLC Internal C WEEK 32, p=0.13, Median 9.00, CI= (3.00, 12.00) 
   
MHLC Chance C WEEK 8, p=0.052, Median -2.00, CI= (5.50, 11.50) 
MHLC Chance C WEEK 32, p=0.83, Median 0.00, CI= (-3.00, 12.00) 
 
MHLC Doctors C WEEK 8, p<0.0001, Median 2.00, CI= (1.00, 4.00) 
MHLC Doctors C WEEK 32, p=0.004 Median 2.00, CI= (1.00, 3.50) 
 
MHLC Others C WEEK 8, p=0.008, Median 2.00, CI= (1.00, 4.00) 
MHLC Others C WEEK 32, p=0.58, Median 2.000, CI= (0.50, 4.00) 
 
SGRQ p significant at 0.0125 (because baseline data was tested at weeks 4, 8, 20 and 32). Minimum clinically 
significant difference is a change of -4. 
SGRQ Symp WEEK 4 p<0.0001, Median -17.06 CI (-29.90, -4.80) 
SGRQ Symp WEEK 8 p=0.003, Median -33.01, CI (-39.70, -10.20) 
SGRQ Symp WEEK 20 p<0.0001, Median -37.25, CI (-46.80, -19.10) 
SGRQ Symp WEEK 32 p=0.001, Median -38.69, CI (-39.90, -8.10)  
 
SGRQ Activity WEEK 4 p<0.0001, Median -12.57, CI (-36.10, -6.30)  
SGRQ Activity WEEK 8 p=0.001, Median -38.41, CI (-50.90, -18.80)  
SGRQ Activity WEEK 20 p=0.0001, Median -38.69, CI (-52.60, -22.30)  
SGRQ Activity WEEK 32 p<0.0001, Median -25.83, CI (-38.80, -12.90)  
 
SGRQ Impact WEEK 4 p<0.0001, Median -32.20, CI (-44.10, -14.10)  
SGRQ Impact WEEK 8 p<0.0001, Median -57.25, CI (-59.20, -22.00)  
SGRQ Impact WEEK 20 p<0.0001, Median -55.30, CI (-67.40, -27.60)  
SGRQ Impact WEEK 32 p=0.02 Median -14.13, CI (-51.90, -14.60)  
 
SGRQ Total WEEK 4 p<0.0001, Median -24.36, CI (-37.50, -10.50)  
SGRQ Total WEEK 8 p<0.0001, Median -47.77, CI (-52.60, -20.80)  
SGRQ Total WEEK 20 p<0.0001, Median -47.27, CI (-57.50, -23.60)  
SGRQ Total WEEK 32 p<0.0001, Median -33.29, CI (-46.80, -13.90)          
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Non-video arm 
 
ESWD p significant at 0.025 (because baseline data was tested at weeks 8 and 32). Minimum clinically 
significant difference is a change of 173m. 
ESWD WEEK 8: p<0.0001, Median 197.28, CI= (117, 306)  
ESWD WEEK 32: p<0.0001, Median 122.40, CI= (67, 185) 
 
MHLC p  significant at 0.025 (because baseline data was tested at weeks 8 and 32) 
There is no defined minimum clinically significant difference. 
MHLC Internal B WEEK 8, p<0.0001, Median 7.00, CI= (3.50, 9.00) 
MHLC Internal B WEEK 32, p=0.52, Median 4.50, CI= (-1.50, 7.00) 
 
MHLC Chance B WEEK 8, p=0.56, Median 0.00, CI= (-4.00, 2.00) 
MHLC Chance B WEEK 32, p=0.66, Median 0.00, CI= (-5.50, 2.50) 
 
MHLC Powerful others B WEEK 8, p=0.11 Median 1.50, CI= (-0.50, 6.00) 
MHLC Powerful others B WEEK 32, p=0.29 Median 0.50, CI= (-0.50, 5.00) 
 
MHLC Internal C WEEK 8, p=0.001, Median 4.00, CI= (1.00, 8.00) 
MHLC Internal C WEEK 32, p=0.09, Median 4.00, CI= (0.00, 7.00) 
   
MHLC Chance C WEEK 8, p=0.84, Median -00, CI= (5.50, 11.50) 
MHLC Chance C WEEK 32, p=0.52, Median 0.50, CI= (0.00, 7.00) 
 
MHLC Doctors C WEEK 8, p=0.69, Median 0.00, CI= (-1.00, 2.50) 
MHLC Doctors C WEEK 32, p=0.19 Median 0.50, CI= (0.00, 2.00) 
 
MHLC Others C WEEK 8, p=0.31, Median 0.00, CI= (-0.50, 3.50) 
MHLC Others C WEEK 32, p=0.01, Median 1.00, CI= (0.50, 3.50) 
 
SGRQ p significant at 0.0125 (because baseline data was tested at weeks 4, 8, 20 and 32). Minimum clinically 
significant difference is a change of -4. 
SGRQ Symp WEEK 4 p<0.0001, Median –10.91 CI (-33.30, -6.20) 
SGRQ Symp WEEK 8 p<0.0001, Median –15.81, CI (-24.70, -9.20) 
SGRQ Symp WEEK 20 p<0.0001, Median -18.74, CI (-36.70, -9.10) 
SGRQ Symp WEEK 32 p=0.002, Median –8.43, CI (-18.90, -2.40)  
 
SGRQ Activity WEEK 4 p<0.0001, Median -20.09, CI (-38.90, -10.30)  
SGRQ Activity WEEK 8 p<0.0001, Median -19.40, CI (-25.60, -9.20)  
SGRQ Activity WEEK 20 p<0.0001, Median -20.39, CI (-37.00, -12.90)  
SGRQ Activity WEEK 32 p=0.01, Median –7.54, CI (-22.40, -3.10)  
 
SGRQ Impact WEEK 4 p<0.0001, Median -22.87, CI (-47.10, -13.30)  
SGRQ Impact WEEK 8 p<0.0001, Median -20.40, CI (-31.70, -10.50)  
SGRQ Impact WEEK 20 p<0.0001, Median -25.95, CI (-43.30, -18.90)  
SGRQ Impact WEEK 32 p=0.02 Median -11.56, CI (-26.20, -3.90)  
 
SGRQ Total WEEK 4 p<0.0001, Median -17.99, CI (-42.10, -12.80)  
SGRQ Total WEEK 8 p<0.0001, Median -21.63, CI (-26.60, -11.00)  
SGRQ Total WEEK 20 p<0.0001, Median -23.65, CI (-38.60, -17.10)  
SGRQ Total WEEK 32 p<0.0001, Median -10.23, CI (-22.40, -5.00)  
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APPENDIX 7F FACTORS THAT CORRELATE WITH BENEFITS FROM PR 
INTERVENTION 
Table 1: SRCT video arm- Correlation between baseline factors (ESWD, SGRQ, MHLCand DSSI) and 
significant improvement in walking ability (n=25, significance at 0.0026). 
 
Clinically 
significant 
improvement at 
wk 8 
Clinically 
significant 
improvement 
at wk 32 
 COPDseverity Correlation 
Coefficient 
-.325 -.459* 
Sig. (2-tailed) .113 .021 
N 25 25 
SocialInteraction Correlation 
Coefficient 
.307 .467* 
Sig. (2-tailed) .136 .018 
N 25 25 
SocialSupport Correlation 
Coefficient 
.130 .177 
Sig. (2-tailed) .537 .398 
N 25 25 
WK1MHLCnternalB Correlation 
Coefficient 
.261 .246 
Sig. (2-tailed) .208 .235 
N 25 25 
WK1MHLCchanceBl
abel 
Correlation 
Coefficient 
-.058 -.185 
Sig. (2-tailed) .783 .376 
N 25 25 
WK1MHLCPowerful
OthersB 
Correlation 
Coefficient 
.111 -.102 
Sig. (2-tailed) .596 .628 
N 25 25 
WK1MHLCnternalC Correlation 
Coefficient 
.047 -.017 
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Sig. (2-tailed) .825 .936 
N 25 25 
WK1MHLCchanceC Correlation 
Coefficient 
-.110 -.219 
Sig. (2-tailed) .599 .292 
N 25 25 
WK1MHLCdoctorsC Correlation 
Coefficient 
.100 -.023 
Sig. (2-tailed) .635 .914 
N 25 25 
WK1MHLCOthersC Correlation 
Coefficient 
.111 .023 
Sig. (2-tailed) .598 .915 
N 25 25 
WK1ESWDistance Correlation 
Coefficient 
.820* .782* 
Sig. (2-tailed) .000 .000 
N 25 25 
WK1SGRQsymptom Correlation 
Coefficient 
.064 .285 
Sig. (2-tailed) .763 .167 
N 25 25 
WK1SGRQactivity Correlation 
Coefficient 
-.128 .124 
Sig. (2-tailed) .542 .555 
N 25 25 
WK1SGRQimpact Correlation 
Coefficient 
-.324 -.056 
Sig. (2-tailed) .115 .791 
N 25 25 
WK1SGRQtotal Correlation 
Coefficient 
-.162 .101 
Sig. (2-tailed) .440 .632 
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N 25 25 
 
Table 2: SRCT non video arm-Correlation between baseline factors (ESWD, SGRQ, MHLC and DSSI) 
and significant improvement in walking ability (n=32, significance at 0.0026). 
 
Clinically 
significant 
improvement at 
wk 8 
Clinically 
significant 
improvement 
at wk 32 
 COPDseverity Correlation 
Coefficient 
-.441* -.292 
Sig. (2-tailed) .012 .105 
N 32 32 
SocialInteraction Correlation 
Coefficient 
.155 .282 
Sig. (2-tailed) .397 .117 
N 32 32 
SocialSupport Correlation 
Coefficient 
-.049 .229 
Sig. (2-tailed) .791 .207 
N 32 32 
WK1MHLCnternalB Correlation 
Coefficient 
.106 .109 
Sig. (2-tailed) .565 .553 
N 32 32 
WK1MHLCchanceBl
abel 
Correlation 
Coefficient 
.153 .095 
Sig. (2-tailed) .402 .606 
N 32 32 
WK1MHLCPowerful
OthersB 
Correlation 
Coefficient 
.044 -.123 
Sig. (2-tailed) .810 .503 
N 32 32 
WK1MHLCnternalC Correlation 
Coefficient 
.007 .060 
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Sig. (2-tailed) .971 .746 
N 32 32 
WK1MHLCchanceC Correlation 
Coefficient 
-.092 -.099 
Sig. (2-tailed) .615 .591 
N 32 32 
WK1MHLCdoctorsC Correlation 
Coefficient 
-.152 -.253 
Sig. (2-tailed) .405 .162 
N 32 32 
WK1MHLCOthersC Correlation 
Coefficient 
.086 -.049 
Sig. (2-tailed) .641 .788 
N 32 32 
WK1ESWDistance Correlation 
Coefficient 
.648* .440* 
Sig. (2-tailed) .000 .012 
N 32 32 
WK1SGRQsymptom Correlation 
Coefficient 
-.098 .010 
Sig. (2-tailed) .592 .955 
N 32 32 
WK1SGRQactivity Correlation 
Coefficient 
.035 .046 
Sig. (2-tailed) .851 .801 
N 32 32 
WK1SGRQimpact Correlation 
Coefficient 
-.125 -.028 
Sig. (2-tailed) .494 .879 
N 32 32 
WK1SGRQtotal Correlation 
Coefficient 
-.078 .035 
Sig. (2-tailed) .671 .849 
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N 32 32 
 
SRCT video arm-Relationship between baseline depression status and significant improvement in 
walking ability (n=25). 
 Video arm- relationship at week 8 
Table 3a: 2 by 2 contingency table of depression status versus significant improvement in walking 
ability 
 
Clinically significant 
improvement at week 8 
Total not significant Significant 
DepressionCategory Non-depressed 4 13 17 
Depressed 5 3 8 
Total 9 16 25 
 
Table 3b: Chi-Square Tests of depression status versus significant improvement in walking 
ability 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 3.586a 1 .058   
N of Valid Cases 25     
 
Table 3c: Symmetric Measures 
 Value Approx. Sig. 
Nominal by Nominal Phi -.379 .058 
Cramer's V .379 .058 
N of Valid Cases 25  
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Video arm-correlation at week 32 
Table 4a: 2 by 2 contingency table of depression status versus significant improvement in walking 
ability 
 
Clinically significant 
improvement at week 32 
Total not significant significant 
DepressionCategory Non-depressed 4 13 17 
Depressed 7 1 8 
Total 11 14 25 
 
Table 4b: Chi-Square Tests of depression status versus significant improvement in walking 
ability 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 9.035 1 .003   
N of Valid Cases 25     
 
Table 4c: Symmetric Measures 
 Value Approx. Sig. 
Nominal by Nominal Phi -.601 .003 
Cramer's V .601 .003 
N of Valid Cases 25  
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SRCT non-video arm-Correlation between baseline depression status and significant improvement 
in walking ability (n=32). 
Non-video arm at week 8 
Table 5a: 2 by 2 contingency table of depression status versus significant improvement in walking 
ability 
 
 
 
 
 
 
 
 
 
Clinically significant 
improvement at week 8 
Total not significant Significant 
DepressionCategory Non-depressed 11 14 25 
Depressed 4 3 7 
Total 15 17 32 
 
Table 5b: Chi-Square Tests of depression status versus significant improvement in walking 
ability 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .379a 1 .538   
N of Valid Cases 32     
 
Table 5c Symmetric Measures 
 Value Approx. Sig. 
Nominal by Nominal Phi -.109 .538 
Cramer's V .109 .538 
N of Valid Cases 32  
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Non-video arm at week 32 
Table 6a: 2 by 2 contingency table of depression status versus significant improvement in walking 
ability 
 
Clinically significant 
improvement at week 32 
Total not significant significant 
DepressionCategory Non-depressed 15 10 25 
Depressed 5 2 7 
Total 20 12 32 
 
Table 6b: Chi-Square Tests of depression status versus significant improvement in walking 
ability 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .305 1 .581   
N of Valid Cases 32     
 
Table 6c: Symmetric Measures 
 Value Approx. Sig. 
Nominal by Nominal Phi -.098 .581 
Cramer's V .098 .581 
N of Valid Cases 32  
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APPENDIX 7G FACTORS THAT CORRELATE WITH PARTICIPATION IN SELF- 
DIRECTED VIDEO-BASED HOME EXERCISE SESSION 
 
SRCT video arm- Correlation between baseline factors (ESWD, SGRQ, MHLC and DSSI) and weekly 
frequency of participation in video based home exercise session (n=23, significance at 0.0026) 
 
Total duration of 
participation in video-
based home exercise 
session 
Spearman's rho COPDseverity Correlation Coefficient -.609* 
Sig. (2-tailed) .002 
N 23 
SocialInteraction Correlation Coefficient .729* 
Sig. (2-tailed) .000 
N 23 
SocialSupport Correlation Coefficient .300 
Sig. (2-tailed) .164 
N 23 
WK1MHLCnternalC Correlation Coefficient .312 
Sig. (2-tailed) .147 
N 23 
WK1MHLCchanceC Correlation Coefficient .072 
Sig. (2-tailed) .743 
N 23 
WK1MHLCdoctorsC Correlation Coefficient .384 
Sig. (2-tailed) .071 
N 23 
WK1MHLCOthersC Correlation Coefficient .067 
Sig. (2-tailed) .763 
N 23 
WK1ESWDistance Correlation Coefficient .458 
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Sig. (2-tailed) .028 
N 23 
WK1SGRQsymptom Correlation Coefficient -.147 
Sig. (2-tailed) .504 
N 23 
WK1SGRQactivity Correlation Coefficient -.201 
Sig. (2-tailed) .359 
N 23 
WK1SGRQimpact Correlation Coefficient -.171 
Sig. (2-tailed) .434 
N 23 
WK1SGRQtotal Correlation Coefficient -.168 
Sig. (2-tailed) .444 
N 23 
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APPENDIX 8A: NRES AND R&D ETHICAL APPROVALS FOR STUDY TITLED 
EVALUATION OF PATIENTS’ EXPERIENCE OF USING ‘MOVE-ON-UP’ VIDEO 
FOR HOME BASED EXERCISE PROGRAMME CONCURRENTLY WITH 
OUTPATIENT PR PROGRAMME 
NRES Committee East of England - Hertfordshire 
Victoria House 
Capital Park 
Fulbourn 
Cambridge 
CB21 5XB 
 
 Telephone: 01223 597733  
Facsimile: 01223 597645 
24 May 2011 
Mr Ademola Adekunle 
Research Physiotherapist/Principal researcher 
Haringey Teaching Primary Care Trust 
School of Health & Emergency Profession 
University of Hertfordshire 
College Lane, Hatfield 
AL10 9AB 
Dear Mr Adekunle 
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399 
 
For non-NHS sites, site management permission should be obtained in accordance with the procedures of the 
relevant host organisation.  
 
Sponsors are not required to notify the Committee of approvals from host organisations 
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reporting requirements or procedures. 
We would also like to inform you that we consult regularly with stakeholders to improve our service. If 
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APPENDIX 8B: INTERVIEW GUIDELINE FOR STUDY TITLED EVALUATION OF 
PATIENTS’ EXPERIENCE OF USING ‘MOVE-ON-UP’ VIDEO FOR HOME BASED 
EXERCISE PROGRAMME CONCURRENTLY WITH OUTPATIENT PR 
PROGRAMME 
FOCUS GROUP DISCUSSION GUIDELINE  FOR FOCUS GROUP EVALUATING PATIENTS’ 
EXPERIENCE OF USING 'MOVE ON UP' VIDEO FOR HOME BASED EXERCISE PROGRAMME 
CONCURRENTLY WITH OUTPATIENT PULMONARY REHABILITATION PROGRAMME.VERSION 2, 
MAY 2011.  ETHICS NUMBER:  
PART 1 
a) Introduction 
Principal researcher will introduce participants e.g we have here COPD patients who were participants of 
the study which is evaluating the experience of COPD patients who used the “Move-On-Up” exercise video 
for home based exercise programme concurrently with outpatient PR. Names of participants would not 
be mentioned. 
b) Consenting 
Participants will be informed that any personal information obtained as a result of their participation in 
the study will be treated as confidential and will not be made publicly available 
They will be informed that they are not obliged to take part in the study and may withdraw at any time 
without the need to justify their decision and without affecting them in any way. They will be advised that 
there will be audio recording of the focus group session. Each volunteer for the study will sign a consent 
form which will be collected by the principal researcher. 
 
PART 2  
a) Focus group discussion stage 
What are your opinions on the knowledge of COPD and exercise as obtained from the video for your use 
at home? Please, comment on whether it is adequate or inadequate. What can you say about the language 
used to explain the exercises and other instructions in the video considering your level of understanding 
of your condition (COPD)? 
When the video was first given to you, what were your expectations? Also, if you are to reflect on your 
expectations and COMPARE your expectations to what you feel after using the video, how much of the 
expectation can you say was met? 
As an individual, can you describe the proportion of the exercises included in the video that was helpful to 
your own particular needs, considering the levels of breathlessness you experience? 
When you had the information in the video on the benefits of exercise in the management of COPD, did 
the information have any effect on how often you needed to attend outpatient pulmonary rehabilitation 
either by increasing or reducing your attendance? 
What can you say about the explanations and demonstration of the procedures of performing the 
exercises in the video? Did it have any impact on how well or how often you needed to do the exercises at 
home either by increasing or reducing the number of times you exercise at home? 
What can you say about how often you do the exercises in the video COMPARED to how often the video 
recommend that you should do them?  Also, what was your experiencing in terms of increasing the 
amount of exercise you do over  time (exercise progression)? 
What can you say about how often you use the video (or do exercises as it recommends) during the 8 
weeks that you were attending outpatient pulmonary rehabilitation programme COMPARED to how often 
you use the video (or do exercises as it recommends) since you have stopped attending the outpatient 
pulmonary rehabilitation programme and as time progresses? 
How did the use of the video for home exercise programme impact on your activities of daily living? Was 
it difficult or was it easy to use the video (or do exercises as it recommends). Also, how appropriate are 
the exercises for home use considering the equipment needed? 
What can you say about the choice of exercises for safe performance when you do them at home without 
somebody to supervise you? Also, how breathless do you get when using the video (or do exercises as it 
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recommends) COMPARED to how breathless the video recommends that you should get in order to 
derive health benefits from the exercises? 
For how long were you able to continue to exercise each time you use the video (or do exercises as it 
recommends) and how do you manage to balance your ‘rest time’ with exertion time? 
THANK YOU FOR YOUR TIME IN PARTICIPATING IN THIS FOCUS GROUP SESSION. 
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APPENDIX 8C: TRANSCRIPT OF THE FOCUS GROUP SESSIONS OF THE STUDY 
TITLED EVALUATION OF PATIENTS’ EXPERIENCE OF USING ‘MOVE-ON-UP’ 
VIDEO FOR HOME BASED EXERCISE PROGRAMME CONCURRENTLY WITH 
OUTPATIENT PR PROGRAMME 
SESSION 1- Tuesday 30th August 2011 
In attendance- Moderator, Independent researcher, Patient I; female, Patient II; male, Pateint III; male, 
Patient IV; male 
Moderator- I welcome you to this focus group. We have here COPD patients who used ‘Move-On-Up’ 
exercise video for home based exercise programme concurrently with outpatient PR. Basically, we would 
be having series of discussions to understand your experience of the use of this video, also sometimes 
referred to as video because we have it in both video and DVD formats. If I may start this way; what are 
your opinions of the knowledge of COPD and exercise as obtained from the video for your use at home?  
In other words, using the video, what are your experiences of it, would you say it has provided you with 
adequate knowledge or do you have your reservations when you think about the amount of knowledge 
you obtained from the video? 
PT II – Em, I think I gained I gained a lot from it. 
PT I- I went through the video before going through the group exercises and it really prepared me for it. 
PT IV- I particularly find it helpful for warm ups. I actually watched it from time to time and I say to 
myself; watching it in a group would be fantastic. We could learn together and have the opportunity to 
discuss. That will be even be more beneficial than just giving it to us to go and watch and use on your 
own. 
Moderator- So watching it in group would be even more beneficial? 
PT IV- Maybe. 
Moderator- Now in terms of the knowledge of the condition itself, how it affects your breathing, how it 
affects your ability to exercise, what to do to manage the breathlessness, how these are all discussed in 
the video. 
PT III-I think I gained good knowledge of the condition from the video but also from the group classes. 
PTII-  No doubt about that.I gained a lot from the video 
Moderator- What can you say about the language used to explain the exercises and other instructions in 
the video considering your level of understanding of your condition (COPD)? 
PTII – For someone like me, I think the explanations are oversimplified. Though, that could be useful for 
some people because we all of us have different abilities to understand things like this. 
Moderator- Okay. What about there being things anyone cannot understand, like clinical terms or 
explanations that sound too abstract? In a way this kind of video is for use of all and so the language 
should reflect that. In other words, everybody who may be a COPD patient, who may have varying levels 
of education or may be in varying field that are non clinical, or non-hospital worker. Bearing this in mind, 
what is your perception of the language in the video?   
PTIV- No, I think the explanations are okay. 
PT I- I can understand everything in it. 
Moderator- When the video was first given to you, what were your expectations? Also, if you are to 
reflect on your expectations and compare your expectations to what you feel after using the video, how 
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much of the expectation can you say was met? Now I want you to reflect on expectation when you were 
receiving the DVDs and compare those expectations to what you derived from using the video.  
PTIV- Watching it on my own has not met my expectations. Fine, I gained to some extent. But, but If I 
were to be watching it in group with others, I believe that will impact more on me. 
PTI- I will say it met my expectations.  
Moderator- Just reflect back, okay someone must have handed the video to you. At the point of receiving 
it, you would have thought, okay maybe this could help me in this area and that area of managing the 
COPD. Did you derive up to your expectations, did you derive more than your expectations or did you 
derive less and in what areas are we talking about. 
PTIV- While I would normally work myself harder and flat out at the group sessions, I rather,  took things 
for granted with the video. Here (referring to the outpatient session), I believe I have to get the best before 
my time on each station is up but with the DVD, I believe I can do my exercises anytime. Fine it has done 
some goods but it is not like coming here. 
PTI- Yes, it is not the same as the group sessions but, it helped me on those days when there is no group 
session and now that you people are yet to give me another opportunity of coming back (to outpatient 
group sessions) it has continued to help. 
PTIII-It provides addition to the things we have done in the classes. Also, like some one said 
earlier, it helped to prepare me for the group session. I think it’s good as first contact before you meet 
people in the group.  
PTII- It also gives you that extra information you need to make up your mind whether to come or not. 
Moderator- Okay. As an individual, can you describe the proportion of the exercises included in the video 
that was helpful to your own particular needs, considering the levels of breathlessness you experience? In 
reflecting on this, I will say, we all have different levels of breathless.  I might be able to do so little and 
quickly get very breathless, thereby stopping. You might be able to do much more before getting 
breathless and as such do higher proportion of the exercises. Another person may be able to do all. Now, 
what proportion do each of you think is helpful to his or her particular needs.  
PTII- I can do most of the exercises 
PTI- I find all of the exercises useful but in doing each, I stop when I can not go further. 
PTIV- That’s right. I give each exercise a go because all of them are important for various reasons. I often 
get quite breathless but I plug on my oxygen and that makes me get better. 
PTIII- Most of the exercises are useful for me. 
Moderator-When you had the information in the video on the benefits of exercise in the management of 
COPD, did the information have any effect on how often you needed to attend outpatient pulmonary 
rehabilitation either by increasing or reducing your attendance? 
PTIV- The information in the video is useful and lets us know the importance of exercises. Indirectly, that 
makes me appreciate the classes. But for me, the greater motivation for attending the class is because I 
look forward to meeting others who we exercise together. The video simply motivates my home 
exercises. The group exercises where you meet others with COPD are inspirational. It should be kept on, 
even if it means paying a small subscription. 
PTIII-The video is motivating. It is a good home thing to have around you. Having said this, the groups are 
more motivating 
PTII- I think the video may have influenced my coming to classes. Yes, also, the people you work with are 
important. You know when you come to the group, you see someone doing so much, then you too want to 
prove that you can do some, don’t  you? The sense of competition isgood!  
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Moderator- What can you say about the explanations and demonstration of the procedures of 
performing the exercises in the video? Did it have any impact on how well or how often you needed to do 
the exercises at home either by increasing or reducing the number of times you exercise at home? Or is it 
like,… not relevant to that. 
PTIV-You know when we are told to do our home bits exercises, you may not do much until the next 
group day. You need extra push to do your home exercises. This is where the video …really helps. I think 
watching the video in a group would be great because then.  
PT I- Maybe that could increase the motivation some more. 
PTIV- Yes! Though we already have people, the staff supporting us in the classes and pushing us to do 
this, do that. 
Moderator- What can you say about, now, how often you do the exercises in the video compared to how 
often the video recommend that you should do them?  Also, what was your experiencing in terms of 
increasing the amount of exercise you do over time (exercise progression)? 
PTI- I try to do the exercises as advised.  On those days that there is no group here(referring to the PR 
outpatient) I try to do the exercises about twice. 
PTII – We were told in the class to do exercises at home. So,I do the exercises everyday. My dog is another 
motivation. 
Moderator-What can you say about how often you use the video (or do exercises as it recommends) 
during the 8 weeks that you were attending outpatient pulmonary rehabilitation programme compared 
to how often you use the video (or do exercises as it recommends) since you have stopped attending the 
outpatient pulmonary rehabilitation programme and as time progresses? 
PTIV- I used to do better with my video when I was attending the classes. I still use it, but attending the 
class from time to time used to make me stick more to it (video) 
PTI- I used the video more frequently when I was attending the group. Since the classes stopped, I used it 
less often. Now, the gym is my strength. I feel watching the video has enriched me because I now 
appreciate the need to continue doing something for myself. 
PTII- I now use it (video) less. I could have loved to maintain the level of exercises through the gym but 
couldn’t afford the result. So, my exercise level has dropped. 
PTIV- My situation fluctuates from time to time. I get on well using it at times, and at times, I find it a bit 
difficult. 
Moderator- How did the use of the video for home exercise programme impact on your activities of daily 
living? Was it difficult or was it easy to use the video (or do exercises as it recommends).  
PTII- I do it in the morning before my day starts, otherwise I may not have the opportunity after that.  
PTIV- I do it, mostly in the morning because this is the time that I need it to keep me on. With my oxygen 
on, I can cope.  
Moderator- So both of you do it in the morning but for different reasons? 
PTIII- I also do it in the morning. For me it is because that is the time my inhaler is most active.  
 Moderator- Okay. 
PTI- I do it at various times of the day. Since I have it in the house, I fit it in around my activities. I don’t 
have problem with that.  
Moderator- How appropriate do you find the video to be for exercises for home use considering the 
equipment needed? 
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PTI- Most of the exercises are self help. Walking, arm exercises. 
PTIV- Yes.  
PTII-You can do it with most things around you.  
Moderator- What can you say about the choice of exercises for safe performance when you do them at 
home without somebody to supervise you?  
PTII- Safe I think 
PTIII- The explanations are good enough. I start and stop at my own will. 
PTIV- I always have my oxygen within reach. Do not overdo it- that’s the sense in it.  
PTIII- Yes 
PTI- Also, for me, I sometimes start with some sort of meditation to feel relaxed before getting on with it. 
Moderator-Also, how breathless do you get when using the video (or do exercises as it recommends) 
compared to how breathless the video recommends that you should get in order to derive health benefits 
from the exercises? 
PTIII- I do get breathless on some of the exercises. On some, I do not get breathless enough. Having a 
chart marked as in the class motivates me to do more. 
PTIV- I think it also has to do with your mood. Sometimes in fact, I push myself way beyond, even on my 
own. 
PT1- If you do it long enough, you will get breathless. I do get reasonably breathless. That is not to say 
one should do too much. You can only do what you can do.  
Moderator- For how long were you able to continue to exercise each time you use the video (or do 
exercises as it recommends) and how do you manage to balance your ‘rest time’ with exertion time? 
PTIII- I do average of thirty minutes each time.  
PTII- I usually have at least an hour to myself, sometimes more…of and on from one exercise to another. 
The video recommends walking and I take the dog on a long walk every morning. 
PTI- When I go on the machine in the gym, I go on for about an hour.  
PT III- I do average of thirty minutes each time. Thirty minutes is for the whole session. Rest, jump up and 
down. That’s me done! (laugh). 
PTI- But there is a break inbetween my hour. I rest inbetween the exercises. 
Moderator- How much time on exercise and how much rest time before going to another exercise? 
PTI- I don’t do the stop watch sort of thing. I listen to my body. 
PTIII- Continue until you’ve had enough. I then rest again till I feel I can resume. No rush. 
All- Laugh 
PTIV- Same for me too.  It’s your home isn’t it?   
PTII-  You  do the exercise until you are quite breathless then stop. The rest period is not monitored. You 
simply go to the next exercise when you feel you can. I don’t time myself. 
Moderator- Well, is there any other thing anyone would want to mention as your experience of using the 
video? 
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PTI- No 
Moderator- Anything interesting that we have not covered, anything you will want to give us as a 
feedback other than the ones we have touched. 
No response. 
Moderator- Well, I think with this, we have come to the end of the focus group session. Indeed, you have 
given us a whole lot of useful information and  I thank you very much for your time. 
PTIII- You’re welcome. 
END OF SESSION- 58 minutes 
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SESSION 2- Tuesday 6th September 2011 
In attendance- Moderator, Independent researcher, Patient I; male, Patient II; female 
Moderator- Good afternoon everyone and welcome to this focus group. Basically, we are here to discuss 
patients experience of using ‘Move-On-Up’ exercise video for home based exercise programme 
concurrently with outpatient pulmonary rehabilitation programme. First, let me ask what your opinions 
on the knowledge of COPD and exercise as obtained from the video for your use at home?  
PTI-My knowledge of using electronic devices is limited  
Moderator- Are you talking of the knowledge to operate a DVD 
PTI- Yes. 
Moderator- Okay 
PTI- I am not too good with these things, iphones e.t.c. Though I have to get someone to help me to 
operate the video and I am now better at it for example, I can now go to specific sections of the video. 
Moderator- Now, what about the knowledge of COPD and the benefits of exercise programme that you, 
do you consider it adequate or would you say it is inadequate? 
PTI- As for that, I do find it very informative. It has given me good information on what exercises I can do 
to improve myself, what to do when I am breathless, walking, and all that. 
 PTII-. It is helpful. Though, I now watch it once in a while, unlike before when I used to watch it more 
regularly. From the bits that I have seen, I find it quite interesting. I will say the information is adequate. 
Moderator- What can you say about the language used to explain the exercises and other instructions in 
the video considering your level of understanding of your condition (COPD)? 
PTI- The language is fine. 
Moderator- You think the words and terms used are appropriate for the population for which the video is 
made or you think some of the language is inappropriate?  
PTII-Anyone can understand the languages used. I don’t think there are any strange terms. 
Moderator- What about your expectations of this video, what were your expectations when the video 
was first given to you, what were your expectations? 
PTII- Well, I was told it is for me to be able to help myself with my COPD  I have not had one before, but 
like any other treatment, I tried to do it as I was told and I think it has really helped. 
Moderator-If you are to reflect on your expectations and compare your expectations to what you feel 
after using the video, how much of the expectation can you say was met? 
PTII-Yes 
PTI- I think so. 
Moderator -As an individual, can you describe the proportion of the exercises included in the video that 
was helpful to your own particular needs, considering the levels of breathlessness you experience from 
time to time? 
PTI- As someone who used to be very active, I played football when I was younger (laugh!!!), I have 
always been very active. I do all the exercises without problem. 
Moderator- Yes, like you said, you have been someone very active, but if we look at the wider picture, 
you may be someone more active than me, yet or me more active than another COPD patient. If we 
consider the varying levels of breathlessness in different COPD patients, even as the same patient, 
411 
 
consider different levels of breathlessness you experience on different days. Of these exercises, what 
proportion would you say is helpful?  
PTII- All the exercises are appropriate for me. I think I am able to manage most of the exercises. I find the 
gardening quite interesting and helpful for me as an activity. I find the walking more challenging. I still do 
it and at least I now know what to do when I get breathless. Sometimes, I stop and do my breathing 
exercises and continue till I finish. 
Moderator- When you had the information in the video on the benefits of exercise in the management of 
COPD, did the information have any effect on how often you needed to attend outpatient pulmonary 
rehabilitation either by increasing or reducing your attendance? 
PTI- Somewhat, it does enhance the tendency to do your exercises including taking your group days very 
serious.  
PTII- It does help to make me do what I am supposed to do. I would say yes, it encouraged me to attend. 
Moderator- What can you say about the explanations and demonstration of the procedures of 
performing the exercises in the video? Did it have any impact on how well or how often you needed to do 
the exercises at home either by increasing or reducing the number of times you exercise at home? 
PTI- The demonstrations stimulates you, don’t they?  
PTII- Yes! Sometimes when I am bored, I switch the video on and that makes me feel more like doing the 
exercises. 
Moderator- How often you do the exercises in the video compared to how often the video recommend 
that you should do them? 
PTII- Like I said, I don’t turn on the video every time anymore but already in my mind, I have times that I 
do my exercises and I already know what to do. In fact, I do it bit by bit several times a day. When I am on 
the bed, when I am sitting, I would be doing it, even when I am on the bed, I will still be doing some forms 
of leg exercises. 
PTI- I do the exercises about three times a week. I have since find my condition has improved a lot. I used 
to be on antibiotics every time. I hated it. But since I have been doing these exercises, I had less need for 
antibiotics. In fact, in the last 10 months or so, I just used antibiotics about three weeks ago.  
Moderator- what was your experiencing in terms of increasing the amount of exercise you do over time? 
PTI-The more exercises, the better I get. Over time, I have been able to do more. Sometimes, I push myself 
even a bit more. 
Moderator- So from the time you started off with few exercises, you have been able to do more than you 
used to be able to?  
PTI-Yes. 
PTII- I have noticed improvements in my breathing. I now exercise for longer before I start to feel 
breathless, then I stop for a while. The exercises have helped a lot! Also, because I am able to manage my 
breathing better, I am more confident to push myself and do more. 
Moderator- What can you say about how often you use the video or do exercises as it recommends, 
comparing the 8 weeks during which  you were attending outpatient pulmonary rehabilitation 
programme to how often you use the video or do exercises as it recommends since you have stopped 
attending the outpatient pulmonary rehabilitation programme and as time progresses? 
PTII- For me, to be sincere, I don’t use it as much as I used to do. Maybe because I believe I now know the 
things I need to do. 
PTII-I use the video less but I still do my exercises. I still do my walking and other things. I know that is 
the only way to keep myself going. 
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Moderator- Okay, how has using the video for home exercise programme impacted on your activities of 
daily living?  For example, was it difficult or was it easy to use the video as recommended? 
PTII- It is fine. For me, I do it alright and I still carry on with my day. It fits in quite well to my programme. 
I often do it without even realizing I am doing it. I just made it part of myself. My only problem is 
sometimes when I am not able to operate the machine. but anytime I feel lost, my grandson helps me to 
fiddle around with it and get it to work. Other times, really, I still carry on doing the exercises without 
playing the video itself. 
PTI-I have no problem fitting it into my day. I just do a couple of the exercises at my convenience. 
Moderator-How appropriate are the exercises for home use considering the equipment needed?  
PTII- Everything in the video is home based. I like the walking. I like ridding bicycle outside in the open. 
PTI- It is okay. They asked you to use things like tomato can and stuffs like that. They are simple things. 
Nothing expensive. Laugh! 
Moderator- What can you say about the choice of exercises for safe performance when you do them at 
home without somebody to supervise you?  We are looking at it now from the angle of safety. You know 
the use of a video for exercise at home on your own is different from when you are in a group been 
supported by a clinician. What are your experience and opinions? 
PTII- I feel okay doing it on my own. I have no worry about safety. I get into it slowly; start with some 
gentle exercises, I go on, stepping up and stepping down and then to the harder ones. I stop when I have 
to or if I start feeling too breathless. I catch my breath and continue.  The exercises are safe as long as you 
don’t overdo it. 
PTI- The exercises are safe.  
PTII- Yes. Just common sense, to know your limit. 
PTI- It is still okay if you want to have someone there in case anything goes wrong. I do have my partner 
around sometimes. Though, without her, I still go on doing things within my limit. 
Moderator-Now when doing the exercises using the video, how breathless do you get?  And how does 
that compare to how breathless the video recommends that you should get in order to derive health 
benefits from the exercises?  We all know that in order for us to get the health benefits, we need to do the 
exercises and push a bit into breathlessness. Do we do as much as is recommended in the video? Or do we 
do less for some reasons? Or do we even do more? 
PTII- Er…, I try to push , though I stop when I have to. I think I get reasonably breathless though. Look, I 
like to do it, I enjoy doing it but an hour for instance can be difficult for me. So I start and stop as required. 
But I get breathless enough. 
PTI- I push to a limit that I can. Just as I do in the classes. 
Moderator- What guides this limit? 
PTI- I get breathless just as much as I do in the in the classes. 
Moderator- Okay, to the next issue.  Giving this kind of treatment to people to use at home means 
handing some responsibility to them. These including knowing how to do enough but again knowing 
when to take a rest.  Now for  how long were you able to continue to exercise each time you use the video 
and how do you manage to balance your ‘rest time’ with exertion time? 
PTII- That is why I said to you I don’t do too much. I push quite alright but I rest whenever I am tired. I do 
my exercises in bits, rest in between and continue after having enough rest. 
Moderator- Okay. 
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PTII-I don’t insist too much on a time frame. I am hypertensive so I have to watch what I do. I know I can’t 
go too far at a go so when my body starts telling me, I listen. 
PTI- For me, I try to go on for about 30minutes before resting. I always try to push myself hard but when I 
am tired, I stop. 
Moderator-Lastly, apart from the different points that we have discussed, are there other observations 
that you wish to share with us concerning your using the ‘Move-On-Up’ exercise video at home 
concurrently with outpatient pulmonary rehabilitation group sessions? 
PTI- Using the video at home has really helped me, it has helped very much, but I still feel doing the 
exercises along with other people as a group does push me to do more compared to when I am doing it on 
my own, alone at home. I like attending the group sessions! 
PTI- I like attending the groups too. Even now, I attend a group in my area and we organize different 
activities. The push is there when things are done in a group, than when you are er…doing it alone. 
Moderator- Okay. Any other observation from your experience? 
No response 
Moderator- Well, thank you for your time and thank you so much for providing us with this much useful 
informations. We will now bring this focus group to a close. Thank you for coming. 
END OF SESSION- 46 minutes 
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SESSION 3- Friday 16th September 2011 
In attendance- Moderator, Independent researcher, Patient I; female  
Moderator- I welcome you to this focus group. 
PT- Thank you. 
Moderator- We are here to have a discussion and find out what are patients experience of using the 
‘Move-On-Up’ exercise video for home based exercise programme concurrently with outpatient 
pulmonary rehabilitation programme. Let me start by asking: What are your opinions on the knowledge 
of COPD and exercise as obtained from the video for your use at home? Do you consider it as adequate or 
inadequate to equip COPD user with the knowledge needed? 
PT- Yes, it’s very good. The video explained COPD very well, you know. They explain what could be wrong 
with your lungs and how it affects the breathings and so on and so forth. It’s a bit annoying as sometimes 
they keep going over things over and over again, but even then it explained the exercises very well. I am 
able to follow the exercises and do my bits and stop when I feel I want to. 
Moderator- So you feel you can do it at your own pace?  
PT- Yes. It’s quite easy to follow and that makes you want to do it. Basically it is the same exercises as you 
do with the physio but this time around you are in charge and you are able to do it at your own pace.  
Moderator- What can you say about the language used to explain the exercises and other instructions in 
the video considering your level of understanding of your condition (COPD)? I mean, this video is made to 
be used by COPD patients regardless of  whether they are hospital workers or in a different industry  in 
which case they are not familiar with certain terminologies. 
PT- I have no problem with that. The language is clear and well understood. There is nothing you don’t 
really understand and it should be okay for most people. 
Moderator- When the video was first given to you, what were your expectations? Also, if you are to 
reflect on your expectations and compare your expectations to what you feel after using the video, how 
much of the expectation can you say was met? 
PT- Well, at the beginning, I did not really know what to expect. After watching it, I kind of know what it 
was meant to do for me or what I was meant to achieve with it. At the end of the day, I would say it met 
my expectation and helped me to be able to do some other things on my own. 
Moderator- As an individual, can you describe the proportion of the exercises included in the video that 
was helpful to your own particular needs, considering the levels of breathlessness you experience? In 
other words, different individuals with COPD have different levels of ability to do exercises, which can be 
referred to as exercise tolerance. In your own case, considering how much exercises you think your body 
can tolerate, what proportion of the exercises included in the video that was helpful to you? 
PT-I find most of it helpful. They make me get out of breath but I still cope doing them. I find out that my 
condition has improved a lot since doing them.  
Moderator- When you had the information in the video on the benefits of exercise in the management of 
COPD, did the information have any effect on how often you needed to attend outpatient pulmonary 
rehabilitation either by increasing or reducing your attendance? 
PT- Well, I will say yes. In fact, there was a time at the day centre that I attend. They want to do exercises. 
I took it down there. There was this lady who just started doing exercises and a couple of others. They all 
joined in and everybody felt it was fantastic.   
Moderator- What can you say about the explanations and demonstration of the procedures of 
performing the exercises in the video?  
PT- Very good. 
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Moderator- Did it have any impact on how well or how often you needed to do the exercises at home 
either by increasing or reducing the number of times you exercise at home? 
PT- Well. It explains to you over and over again with the view of making you understand the exercises 
more and more. That kind of makes you do them better and more often. Isn’t it?   
Still, it is better to do it in a group because of the motivation of the group. 
Moderator- You know for an individual to get the health benefit, the individual is expected to do some 
amount of the exercises.  What can you say about how often you do the exercises in the video compare to 
how often the video recommend that you should do them?   
PT- I do it often enough. In fact initially when I just received it, I do it every now and then. I was doing it 
more than I have been doing it recently.   
Moderator-Also, what was your experience in terms of increasing the amount of exercise you do over 
time (exercise progression)? 
PT-Just as I said, I used to do more when I first started using it. I was using it initially three times a week 
but later, it went down gradually to about once weekly. 
Moderator- What can you say about how often you use the video (or do exercises as it recommends) 
during the 8 weeks that you were attending outpatient pulmonary rehabilitation programme compared 
to how often you use the video (or do exercises as it recommends) since you have stopped attending the 
outpatient pulmonary rehabilitation programme and as time progresses? 
PT- I was using it more often during the time I was attending the group sessions. Somehow, people 
around me was a kind of motivation to do my exercises, even using the video. 
Moderator- How did the use of the video for home exercise programme impact on your activities of daily 
living? Was it difficult or was it easy to use the video (or do exercises as it recommends).  
PT- I do not have problem fitting it into my day. I usually do it in the afternoon because I am out in the 
morning most days of the week. 
Moderator- What can you say about the appropriateness of the video for home use considering the 
equipment needed to do the exercises in it? 
PT- It is okay. No major equipment needed. Walking or using things around the house as weights. Those 
are straight forward exercises. 
Moderator- You know when people come to the group session where you have clinicians, the presence of 
the clinician, physiotherapists and others makes you feel safe. However, when given the DVD to use at 
home for exercises, it means the patient to some extent is now taking that responsibility of ensuring 
safety. What can you say about the choice of exercises for safe performance when you do them at home 
without somebody to supervise you?  
PT- Er…the exercises are safe. As long as you are not over excited about what you are doing.  I don’t have 
any worry about that. 
Moderator- Now we are getting to the last few questions. How breathless do you get when using the 
video (or do exercises as it recommends) compared to how breathless the video recommends that you 
should get in order to derive health benefits from the exercises? 
PT- I get quite breathless. Though, I rest when I feel I can’t go any further.  
Moderator- For how long were you able to continue to exercise each time you use the video (or do 
exercises as it recommends) and how do you manage to balance your ‘rest time’ with exertion time? 
PT-I don’t really time myself. I listen to my body and stop once I feel I am very breathless. I rest for a 
while and start again until I again feel breathless. I find it comfortable to manage myself that way. 
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Moderator-Apart from all that we have discussed, is there any other experience or observation you 
would want to share with us about using the ‘Move-On-Up’ video  for home based exercise programme? 
PT- Not any more really. It has been a pleasant experience. It has been quite helpful.  
Moderator- Thank you very much. I think with that we have come to the end of this very informative  
session. Thank you very much for your time and efforts. 
PT-That’s okay.  
END OF THIRD SESSION- 17 minutes.  
 
